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A B S T R A C T
Background
Tobacco smoking in pregnancy remains one of the few preventable factors associated with complications in pregnancy, stillbirth, low
birthweight and preterm birth and has serious long-term implications for women and babies. Smoking in pregnancy is decreasing in
high-income countries, but is strongly associated with poverty and increasing in low- to middle-income countries.
Objectives
To assess the effects of smoking cessation interventions during pregnancy on smoking behaviour and perinatal health outcomes.
Search methods
In this fifth update, we searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (1 March 2013), checked reference
lists of retrieved studies and contacted trial authors to locate additional unpublished data.
Selection criteria
Randomised controlled trials, cluster-randomised trials, randomised cross-over trials, and quasi-randomised controlled trials (with
allocation by maternal birth date or hospital record number) of psychosocial smoking cessation interventions during pregnancy.
Data collection and analysis
Two review authors independently assessed trials for inclusion and trial quality, and extracted data. Direct comparisons were conducted
in RevMan, and subgroup analyses and sensitivity analysis were conducted in SPSS.
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Main results
Eighty-six trials were included in this updated review, with 77 trials (involving over 29,000 women) providing data on smoking
abstinence in late pregnancy.
In separate comparisons, counselling interventions demonstrated a significant effect compared with usual care (27 studies; average risk
ratio (RR) 1.44, 95% confidence interval (CI) 1.19 to 1.75), and a borderline effect compared with less intensive interventions (16
studies; average RR 1.35, 95% CI 1.00 to 1.82). However, a significant effect was only seen in subsets where counselling was provided
in conjunction with other strategies. It was unclear whether any type of counselling strategy is more effective than others (one study;
RR 1.15, 95% CI 0.86 to 1.53). In studies comparing counselling and usual care (the largest comparison), it was unclear whether
interventions prevented smoking relapse among women who had stopped smoking spontaneously in early pregnancy (eight studies;
average RR 1.06, 95% CI 0.93 to 1.21). However, a clear effect was seen in smoking abstinence at zero to five months postpartum (10
studies; average RR 1.76, 95% CI 1.05 to 2.95), a borderline effect at six to 11 months (six studies; average RR 1.33, 95% CI 1.00 to
1.77), and a significant effect at 12 to 17 months (two studies, average RR 2.20, 95% CI 1.23 to 3.96), but not in the longer term. In
other comparisons, the effect was not significantly different from the null effect for most secondary outcomes, but sample sizes were
small.
Incentive-based interventions had the largest effect size compared with a less intensive intervention (one study; RR 3.64, 95% CI 1.84
to 7.23) and an alternative intervention (one study; RR 4.05, 95% CI 1.48 to 11.11).
Feedback interventions demonstrated a significant effect only when compared with usual care and provided in conjunction with other
strategies, such as counselling (two studies; average RR 4.39, 95% CI 1.89 to 10.21), but the effect was unclear when compared with
a less intensive intervention (two studies; average RR 1.19, 95% CI 0.45 to 3.12).
The effect of health education was unclear when compared with usual care (three studies; average RR 1.51, 95% CI 0.64 to 3.59) or
less intensive interventions (two studies; average RR 1.50, 95% CI 0.97 to 2.31).
Social support interventions appeared effective when provided by peers (five studies; average RR 1.49, 95% CI 1.01 to 2.19), but the
effect was unclear in a single trial of support provided by partners.
The effects were mixed where the smoking interventions were provided as part of broader interventions to improve maternal health,
rather than targeted smoking cessation interventions.
Subgroup analyses on primary outcome for all studies showed the intensity of interventions and comparisons has increased over time,
with higher intensity interventions more likely to have higher intensity comparisons. While there was no significant difference, trials
where the comparison group received usual care had the largest pooled effect size (37 studies; average RR 1.34, 95% CI 1.25 to 1.44),
with lower effect sizes when the comparison group received less intensive interventions (30 studies; average RR 1.20, 95% CI 1.08 to
1.31), or alternative interventions (two studies; average RR 1.26, 95% CI 0.98 to 1.53). More recent studies included in this update
had a lower effect size (20 studies; average RR 1.26, 95% CI 1.00 to 1.59), I2= 3%, compared to those in the previous version of
the review (50 studies; average RR 1.50, 95% CI 1.30 to 1.73). There were similar effect sizes in trials with biochemically validated
smoking abstinence (49 studies; average RR 1.43, 95% CI 1.22 to 1.67) and those with self-reported abstinence (20 studies; average
RR 1.48, 95% CI 1.17 to 1.87). There was no significant difference between trials implemented by researchers (efficacy studies), and
those implemented by routine pregnancy staff (effectiveness studies), however the effect was unclear in three dissemination trials of
counselling interventions where the focus on the intervention was at an organisational level (average RR 0.96, 95% CI 0.37 to 2.50).
The pooled effects were similar in interventions provided for women with predominantly low socio-economic status (44 studies; average
RR 1.41, 95% CI 1.19 to 1.66), compared to other women (26 studies; average RR 1.47, 95% CI 1.21 to 1.79); though the effect
was unclear in interventions among women from ethnic minority groups (five studies; average RR 1.08, 95% CI 0.83 to 1.40) and
aboriginal women (two studies; average RR 0.40, 95% CI 0.06 to 2.67). Importantly, pooled results demonstrated that women who
received psychosocial interventions had an 18% reduction in preterm births (14 studies; average RR 0.82, 95% CI 0.70 to 0.96), and
infants born with low birthweight (14 studies; average RR 0.82, 95% CI 0.71 to 0.94). There did not appear to be any adverse effects
from the psychosocial interventions, and three studies measured an improvement in women’s psychological wellbeing.
Authors’ conclusions
Psychosocial interventions to support women to stop smoking in pregnancy can increase the proportion of women who stop smoking
in late pregnancy, and reduce low birthweight and preterm births.
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P L A I N L A N G U A G E S U M M A R Y
Psychosocial interventions for supporting women to stop smoking in pregnancy
Smoking during pregnancy increases the risk of the mother having complications during pregnancy and the baby being born with low
birthweight and preterm (before 37 weeks). Tobacco smoking during pregnancy is relatively common, although the trend is towards it
becoming less frequent in high-income countries and more frequent in low- to middle-income countries.
The review showed that psychosocial interventions to support women to stop smoking increased the proportion of women who stopped
smoking in late pregnancy and reduced the number of low birthweight and preterm births. There did not appear to be any adverse
effects from the psychosocial interventions, and three studies measured an improvement in women’s psychological wellbeing.
The review includes 86 randomised controlled trials, with data from seventy-seven trials (involving over 29,000 women). Nearly all
studies were in high-income countries. The intervention that supported the most women to stop smoking in pregnancy appeared to be
providing incentives. However, these results are based on only four trials with a small number of women (all in the US), and they only
seemed to help women stop smoking when provided intensively (three trials). Counselling also appeared to be effective in supporting
women to quit, but only when combined with other strategies (27 trials). The effectiveness of counselling was less clear when women
in the control group received a less intensive smoking intervention (16 trials). Feedback also appeared to help women quit, but only
when compared with usual care and combined with other strategies (two studies). It was unclear whether health education alone helped
women quit, but the numbers of women involved in these trials were comparatively small. The evidence for social support was mixed;
for instance, targeted peer support appeared to help women quit (five trials) but in one trial partner support did not. Women also
reported that peer and partner support could be both helpful and unhelpful.
Increasing the frequency and duration of the intervention did not appear to increase the effectiveness. Interventions appeared to be
as effective for women who were poor, as those who were not; but there is insufficient evidence that the interventions were effective
for ethnic (five trials) and aboriginal women (two trials). Trials where the interventions became part of routine pregnancy care did not
appear to help more women to quit, which suggests there are challenges to translating this evidence into practice.
B A C K G R O U N D
Description of the condition
Risks associated with smoking in pregnancy
Tobacco smoking in pregnancy remains one of the few preventable
factors associated with complications in pregnancy, such as pla-
cental abruption, miscarriage, low birthweight (Kramer 1987),
preterm birth (US DHHS 2004; Hammoud 2005; Salihu 2007;
Rogers 2009; Vardavas 2010; Baba 2012), stillbirth and neonatal
death (Kallen 2001). Tobacco smoking also has serious long-term
health implications for women and infants; 5.4 million people per
year currently die from tobacco use, and this is expected to rise to
eight million per year in the next 30 years (WHO 2008a).
Nicotine and other harmful compounds in cigarettes are develop-
mental toxicants (Rogers 2009), which impact on the brain at crit-
ical developmental periods (Dwyer 2008) restricting the supply
of oxygen and other essential nutrients, fetal growth (Crawford
2008), development of organs (Morales-Suarez-Varela 2006), in-
cluding the lungs (Maritz 2008) and neurological development
(Herrmann 2008; Blood-Siegfried 2010). Growing evidence sug-
gests these ’developmental origins of disease’ have life-long impli-
cations (Gluckman 2008).
Youngwomen start smoking formany reasons including: belief it is
a rite of passage into adult life, a gesture against authority, trying to
appearmodern and affluent, or to fit in with social networks (Todd
2001). Tobacco addiction is then caused by nicotine in tobacco
which produces a cascade of actions, including release of “pleasure
enhancing” dopamine, which strengthens associations of positive
feelings with smoking behaviour and appears to be involved in all
addictive behaviours (Schmidt 2004). Some suggest the negative
feelings of “nicotine hunger” and unpleasant symptoms associated
with nicotine withdrawal (Balfour 2004; Hughes 2007) may be
stronger for pregnant women due to the physiological adaptations
in pregnancy which accelerate nicotine metabolism (Ebert 2009;
Ussher 2012a), however a recent study reported less severe with-
drawal symptoms among pregnant women in the first 24 hours of
abstinence, compared to non-pregnant women (Ussher 2012b).
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Epidemiology of smoking in pregnancy
In high-income countries, such as Australia, Canada, Denmark,
NewZealand, Sweden, the United Kingdom (UK) and theUnited
States (US), the prevalence of smoking in pregnancy has declined
frombetween 20% to 35% in the 1980s to between 10% and 20%
in the early 2000s (Cnattingius 2004; US DHHS 2004; Giovino
2007; Dixon 2009b; Tong 2009; Al-Sahab 2010; Tappin 2010),
with significant declines in the last decade bringing the prevalence
of smoking in pregnancy well below 10% by 2010 (Lanting 2012).
However, the decline has not been consistent across all sectors
of society, with lower rates of decline among women with lower
socio-economic status (US DHHS 2004; Pickett 2009; Graham
2010; Johnston 2011b; Lanting 2012). Tobacco smoking in high-
income countries is a marker of social disadvantage and has been
cited as one of the principal causes of health inequality between
rich and poor (Wanless 2004), and understanding these dispari-
ties are central to understanding the tobacco epidemic (Graham
2010). In Scotland, 30% of women living in the most deprived
areas continued to smoke during pregnancy in 2008, compared
to 7% in the least deprived areas (Tappin 2010). Women who
continue to smoke in pregnancy are more likely to: have a low
income, higher parity, no partner, low levels of social support,
limited education; access publicly funded maternity care; and feel
criticised by society (Graham 1977; Frost 1994; Graham 1996;
Tappin 1996; Wakschlag 2003; US DHHS 2004; Ebert 2007;
Schneider 2008; Pickett 2009). The World Health Organization
(WHO) report into the Social Determinants of Health recognises a
paradigmwhereby disadvantagedpeople aremore likely to use sub-
stances in response to their circumstances (WHO 2008b). There
is also a significantly higher prevalence of smoking in pregnancy
in several ethnic and aboriginal minority groups (Wiemann 1994;
Kaplan 1997; Chan 2001; US DHHS 2004; Wood 2008; Dixon
2009b; Johnston 2011b). In Australia, smoking during preg-
nancy is three times more prevalent among Aboriginal and Torres
Strait Islander women (53%) than among non-Aboriginal women
(16%) (Johnston 2011b), and similar disparities are reported be-
tween Maori and non-Maori women in New Zealand (Dixon
2009b). These disparities are largely in accord with social and
material deprivation. However, in some migrant groups, cultural
differences may cut across this social gradient (Troe 2008), which
suggests that there are aspects of smoking socialisation not entirely
explained by material deprivation. In the United States, the high-
est rates of pre-pregnancy smoking were reported among Alaskan
Native women (55.6%), American Indian women (46.9%), and
White women (46.4%), with significantly lower rates (less than
20%) reported among African American, Hispanic and Asian-Pa-
cific women (Tong 2011; Watt 2012). Women who are migrants
or refugees to Australia, Canada, New Zealand, Northern Europe,
theUK, or theUSorwhooriginate fromSouthEast Asia also retain
a lower prevalence of smoking, despite major social disadvantage
(Potter 1996; Small 2000; Bush 2003; Dixon 2009b). However,
second-generation migrant women are more likely to smoke dur-
ing pregnancy than first-generation women (Troe 2008), reflect-
ing movement between stages of ’the tobacco epidemic’ (Lopez
1994).
In low- and middle-income countries there is marked variation
in prevalence of smoking in pregnancy, which reflects the dy-
namic nature of the tobacco epidemic in these regions (Richmond
2003; Polanska 2004; Bloch 2008). Smoking rates among preg-
nant women have been comparatively low (9%) compared to men
(50%), due to historical cultural constraints on women’s smoking
inmany low- tomiddle-income countries (Bloch 2008). However,
the prevalence of tobacco smoking among women is increasing
and is expected to rise to 20% by 2025, shifting the global tobacco
smoking epidemic from high-income countries to low- and mid-
dle-income countries (Samet 2001; Richmond 2003). The highest
rates of smoking during pregnancy were reported in Latin Amer-
ica (18.3% in Uruguay 2004 to 2005) (Bloch 2008) and Eastern
Europe (15% in Romania 2005 to 2006) (Meghea 2010). Low
rates were reported in Pakistan (3%) (Bloch 2008), South East
Asia (1.3%) (Barraclough 1999; Ostrea 2008), and China (2%
in 1999), though increasing rates among female school children
are causing concern (Kong 2008). In India and Africa, rates of
cigarette smoking were low (1.7% and 6.1% pregnant women
reporting smoking cigarettes, respectively), (Steyn 2006; Bloch
2008; Palipudi 2009), while use of smokeless tobacco products was
high among Indian (4.9% to 33.5%) (Palipudi 2009; Bloch 2008)
and African women (6% to 7.5%) (Steyn 2006; Bloch 2008). The
WHO has identified this rise of tobacco use in young females in
low-income, high population countries as one of the most omi-
nous developments of the tobacco epidemic (WHO 2008a), jeop-
ardizing efforts to improvematernal and child health (Cnattingius
2004; Bloch 2008). This increase is beingdrivenby aggressivemar-
keting from tobacco companies, who are predicting high profits
from sales in low- and middle-income countries (Kaufman 2001),
along with increased tobacco production in these regions (FAO
2003), which further entrenches the countries’ tobacco depen-
dence. Marketing strategies are specifically targeted at women and
weak regulation of tobacco company marketing has been linked to
a rapid increase in smoking among women, particularly those who
are vulnerable (Kaufman 2001; Gilmore 2004; Graham 2009). A
survey of women’s knowledge in two African countries suggests
women’s knowledge of the risks of tobacco products was extremely
limited (Chomba 2010), making women more vulnerable to to-
bacco marketing.
Issues around smoking in pregnancy are complicated by the in-
tersection of gender (Healton 2009), where a woman’s role is seen
primarily as a ’reproducer’, and emphasis is placed on the rights of
the unborn fetus (pxii; World Health Organization 2001). There
is a risk these arguments may be used to impose authority over
women’s behaviour, ’blaming’ women for their own plight and
that of their children, and using guilt or othermeans to undermine
self-confidence; further reducing the control women have in their
lives (Greaves 2007a).
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In addition to the socio-economic factors associated with con-
tinued smoking, there are strong psychological associations, es-
pecially with depression and stress (Blalock 2005; Aveyard 2007;
Crittenden 2007; Orr 2012), including race-related stress (Heath
2006; Fernander 2010; Nguyen 2012a). Depressed women are up
to four times more likely to smoke during pregnancy than non-de-
pressed women (Blalock 2005). Despite these strong associations,
there is limited information available about the effects of smoking
and interventions in pregnant women with psychological symp-
toms, as they are often excluded from trials (Blalock 2005). Fur-
thermore, while tobacco control initiatives in high-income coun-
tries have been effective in reducing smoking, the stigmatisations
of smokers has been an unintended consequence (Burgess 2009;
Wigginton 2012), which is being increasingly recognised by the
tobacco control community (Farrimond 2006; Thompson 2007a;
Burgess 2009). Anti-smoking campaigns strive to inform, shock or
shame people into quitting smoking and rarely take into account
low self-esteem, low self-efficacy, poverty, stress and increased car-
ing responsibilities that are common among women who continue
to smoke during pregnancy (Gilbert 2005). A systematic review of
qualitative experiences of women describes how smoking in preg-
nancy triggered “intense feelings of personal responsibility and in-
adequacy” and that women’s responses to social disapproval varied
(Flemming 2013). For some, it provided an incentive to attempt
to quit, while among others it resulted in increased smoking, either
in response to the stress of social pressure or as an act of rebellion
against it (Flemming 2013). Some argue that health risk narratives
and the associated social stigma produced through anti-smoking
campaigns contribute to oppression among marginalised people,
and a consequence is that these strategies may inspire resistance
and resentment rather than compliance (Bond 2012; Wigginton
2012; Flemming 2013).
Although commercial cigarettes are the most prevalent form of
tobacco use worldwide, the use of other forms of tobacco (e.g.
smokeless tobacco, cigars and pipes, and waterpipes) are becom-
ing more popular in many parts of the world, especially low- and
middle-income countries (England 2010). Of particular concern
are increasing efforts by the tobacco industry to commercialise
and market smokeless tobacco products to young adults (Lambe
2007). In high-income countries, the use of smokeless tobacco
appears to be highly localised among some indigenous groups
in Canada and the US, including Lumbee Indian, Navajo, and
AlaskanNative communities (Strauss 1997; Spangler 2001; Patten
2009; Kim 2009a; Kim 2010). In India, one-third (33.5%) of all
pregnant women reported using smokeless tobacco (Bloch 2008).
In the Democratic Republic of Congo, 6% to 41.8% of pregnant
women surveyed reported using other forms of tobacco, primar-
ily snuff (Bloch 2008; Chomba 2010). In South Africa 7.5% of
pregnant women surveyed reported using snuff (Steyn 2006). In
Iran there has been concern over the 8% prevalence of local water-
pipe tobacco smoking among pregnant women (Mirahmadizadeh
2008). These tobacco products may be cheaper and viewed as less
harmful than cigarettes (England 2010). In some cases use may
be a traditional cultural norm or a medicinal aid to reduce nausea
in early pregnancy. However, these products can be high in nico-
tine content and cause nicotine addiction. Use of these products
has been associated with increased oral and pancreatic cancer, and
cardiovascular disease (England 2010). There is a paucity of re-
search into the effect of these products on pregnancy outcomes
and studies into the effects of these products can be challenging
as the chemical content of various toxic compounds is variable
and often poorly regulated. However, limited evidence suggests
smokeless tobacco use is associatedwith decreased birthweight and
preterm birth (Verma 1983; Gupta 2004; Pratinidhi 2010), still-
birth (Gupta 2006; Gupta 2012), maternal anaemia (Subramoney
2008), degenerative placental changes (Ashfaq 2008), and adverse
infant neurobehavioural outcomes (Hurt 2005). Smoking more
than one waterpipe per day (Tamim 2008) or starting to smoke
waterpipes during the first trimester (Mirahmadizadeh 2008) was
also associated with an increased risk of having a low birthweight
baby.
Exposure to environmental tobacco smoke (ETS) also poses risks
to pregnant women and their infants (Yang 2010). Studies sug-
gest the risk may be exacerbated in low-income countries where
exposure to indoor cooking smoke is also common (Kadir 2010).
In China, 75.1% of pregnant non-smoking women were regularly
exposed to environmental tobacco smoke from their husbands’
smoking (Yang 2010). Studies in high-income countries demon-
strate that eliminating smoking in the workplace and other pub-
lic spaces significantly reduces environmental tobacco smoke ex-
posure and improves health outcomes, including preterm births
(Cox 2013). One study in Indonesia reported increased collec-
tive efficacy when environmental tobacco smoke exposure was ad-
dressed through a well-publicised community household smoking
ban (Nichter 2010). However, as these measures do not extend
to homes (Oncken 2009), some argue domestic environmental
tobacco smoke exposure may be increasing as public health poli-
cies restrict smoking of partners in public places, and the social
position of women may limit their ability to enforce smoke-free
policies within their homes (Tong 2009).
A positive theme emerging from this literature is that a higher
proportion of women stop smoking during pregnancy than at
other times in their lives. Up to 49% of women who smoked
before pregnancy ‘spontaneously quit’ before their first antenatal
visit (Quinn 1991;Woodby 1999;Hotham 2008), a quit rate sub-
stantially higher than reported in the general population (Ershoff
1999; McBride 2003; Tong 2008). However, these spontaneous
quitting rates may be lower among women with lower socio-eco-
nomic status (Mullen 1999). There are significant psychosocial
differences between women who ’spontaneously quit’ and women
who continue to smoke in late pregnancy. Women who sponta-
neously quit usually smoke less, are more likely to have stopped
smoking before, have a non-smoking partner, have more support
and encouragement at home for quitting, are less seriously ad-
5Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
dicted, and have stronger beliefs about the dangers of smoking
(Baric 1976; Ryan 1980; Cinciripini 2000; Passey 2012). Pregnant
women are also more likely to use coping strategies to avoid relapse
than non-pregnant women (Ortendahl 2007c; Ortendahl 2008a;
Ortendahl 2009a), however less than a third of these women re-
main abstinent after one year postpartum (CDCP 2002; Fang
2004), supporting qualitative evidence thatmanywomen see preg-
nancy as a temporary period of abstinence for the sake of the baby
(Stotts 1996; Lawrence 2005a; Flemming 2013). Despite high
relapse rates, some studies suggest that the long-term effects of
spontaneous quitting in pregnancy are significant (Rattan 2013),
and others argue this success is important to recognise to avoid
’pathologising’ smoking cessation and eroding confidence in hu-
man agency to overcome problems (Chapman 2010).
Given the complexity of the health and social dimensions of smok-
ing in pregnancy there are conflicting perspectives regarding the
most appropriate approaches. A dominant theme is that smoking
in pregnancy is a lifestyle choice, however, there is concern this
can lead to ’victim blaming’ (Bond 2005), that individualised, be-
haviourist approaches are unlikely to adequately address health in-
equalities alone (Baum 2009), and that drug dependence and ad-
diction is best dealt with in the domain of social policy and public
health (Ebert 2009). Nevertheless, some suggest there is a role for
individual support which is positive, not punitive (Bond 2012),
and others express a concern that framing smoking in pregnancy
solely as a social problem may make health professionals reluctant
to intervene and offer support (McLellan 2000).
Description of the intervention
This review evaluates the effectiveness of individual psychoso-
cial interventions that aim to motivate and support women to
stop smoking in pregnancy, or prevent smoking relapse among
women who have spontaneously quit. Psychosocial interventions
are defined as non-pharmacological strategies that use cognitive-
behavioural, motivational and supportive therapies to helpwomen
to quit, including counselling, health education, feedback, finan-
cial incentives, and social support from peers and/or partners (see
Types of interventions), as well as dissemination trials.
Other smoking cessation intervention reviews
At the time of this update there were 73 other Cochrane reviews
assessing the effectiveness of tobacco smoking cessation interven-
tions for all populations (see Appendix 1). These include reviews
on the following.
• Population wide measures such as: legislative smoking
bans, mass media campaigns, organisational interventions
(workplace and school-based interventions), healthcare financing
systems for increasing use of tobacco dependence treatment,
advertising and promotion to reduce tobacco use, preventing
tobacco smoking in public places, and impact of advertising on
adolescent smoking.
• Community interventions including family-based
programmes, group behaviour interventions, family and carer
interventions for reducing environmental tobacco smoke,
school-based programmes, and school policies.
• Individual psychosocial interventions, including aversive
smoking, acupuncture, hypnotherapy, self-help, exercise,
individual behavioural counselling, motivational interviewing,
stage-based interventions, competitions and incentives,
telephone counselling, mobile phone-based interventions,
Internet-based interventions, nursing and physician advice,
enhancing partner support, feedback, community pharmacy
interventions, training health professionals in smoking cessation,
use of electronic records, prevention of weight gain after smoking
cessation, improving recruitment into cessation programs, harm
reduction, reduction versus abrupt cessation, biomedical risk
assessments, electronic cigarettes, incentives to prevent smoking
in young people, relapse prevention, and interventions to reduce
non-cigarette tobacco use, including waterpipe smoking
cessation.
• Individual pharmacological interventions, including
antidepressants, anxiolytics, nicotine replacement therapy
(NRT), clonidine, mecamylamine, nicobrevin, nicotine agonists,
opioid agonists, cannabinoid type 1 receptor agonists, silver
acetate, lobeline, and nicotine vaccines, increasing adherence to
medications for tobacco dependence, behavioural interventions
as adjuncts to pharmacotherapies, combined pharmacotherapy
and behavioural interventions;and an ‘overview of
pharmacological reviews’.
• Interventions in specific population groups, including
people with: schizophrenia and serious mental illness,
depression, substance abuse, cardiovascular and pulmonary
disease; pre-operative and hospitalised patients; Indigenous
populations and Indigenous youth; and people in dental settings.
• Other reviews, assessing effectiveness of interventions to
recruit patients into smoking cessation programs, and reduce
harm from continued tobacco use.
How the intervention might work
Pregnancy has been described as a ‘window of opportunity’ for
smoking cessation (McBride 2003). Pregnancy increases awoman’s
perception of risk and personal outcomes, therefore strong affec-
tive or emotional responses are more likely to be prompted (Slade
2006; Ortendahl 2008b). It also redefines a woman’s self-concept
or social role (Ortendahl 2007b), especially when failure to com-
ply with a social role results in social stigmatisation (Ortendahl
2007a; Ortendahl 2008c). Psychosocial interventions involve a
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range of social and psychological components which aim to in-
crease motivation or affective or emotional responses to support
pregnant women to stop smoking and support women to develop
coping strategies to avoid relapse (Ortendahl 2007c; Pilling 2010).
For example, counselling, feedback and financial incentives are all
designed to enhance motivation to quit and move women closer
towards the ’action’ stage of change. Thirty-seven individual ’be-
haviour change techniques’ or observable components used in in-
terventions in the previous version of this review have been iden-
tified (Lorencatto 2012).
Psychosocial interventions to support women to stop smoking in
pregnancy increasingly incorporate theoretical frameworks to in-
form, develop and evaluate strategies designed to influence be-
haviour (Green 2005b; Glanz 2008; Michie 2008; Bartholomew
2011).Usingbehaviour change theories in the context of addiction
has been identified as a useful way to identify modifiable deter-
minants and/or behaviour change techniques (Webb 2010).There
are many theories of behaviour, which provide a summary of con-
structs, procedures andmethods for understanding behaviour, and
present hypothesised relationships or causal pathways that influ-
ence behaviour (Michie 2012). While some argue there is little
apparent consensus about which theories are best to use in design-
ing interventions (Noar 2005), most theories of behaviour change
postulate a role for six broad classes of variables (Glanz 2008):
1. attitudes and beliefs about the behaviours or the outcomes
of change (used in health education and counselling strategies);
2. beliefs about self-efficacy or perceived ability to enact and/
or maintain the target behaviour change (used in counselling
strategies such as motivational interviewing or cognitive
behaviour therapy);
3. the role of contextual factors, particularly social factors,
either directly and/or mediated through people’s beliefs (used in
social support strategies);
4. previous experience with the behaviour either directly or
indirectly through the processes of modelling (modelling can be
seen as an element of social influence) (used in social support
strategies);
5. priority for action, a person can only pursue a limited
number of goals of any one time; and
6. the notion of a stage-based or systematic step-like
progression towards behaviour change, which is incorporated
into the assessment stage of many smoking cessation
interventions (Prochaska 1992).
Why it is important to do this review
There are many psychosocial interventions that have been evalu-
ated to support women to stop smoking during pregnancy. This
review synthesises the evidence from these trials to generate evi-
dence, which is of direct relevance for practitioners, policy-mak-
ers, and researchers. Synthesis enables comparison of whether in-
terventions have been shown to be effective in individual studies
and whether this effect has been replicated in other settings. Im-
portantly, individual studies are unlikely to have sufficient power
to evaluate the effect of interventions on perinatal outcomes or to
conduct subgroup analyses to assess if there are differential effects
among vulnerable subpopulations with high rates of smoking dur-
ing pregnancy. Finally, collation of the body of evidence helps to
identify any gaps for future research.
This is the fifth update of this Cochrane review, previously entitled
‘Interventions to promote smoking cessation during pregnancy’. The
first version was published in 1995 on CD Rom and previously
updated in The Cochrane Library in 1999, 2004 and 2009. Pre-
vious versions of this review have demonstrated the potential for
individual interventions during pregnancy to have a modest but
significant effect on reducing smoking, preterm births and infants
born with low birthweight (Lumley 2009). This evidence has been
instrumental in individual psychosocial interventions becoming a
part of routine pregnancy care in many high-income countries in
the past decade (Flenady 2005; Ministry of Health 2007; Fiore
2008;NICE 2010;Wong 2011). These guidelines generally incor-
porate a number of interventions, including identifying women
who smoke during pregnancy, providing advice about risks, and
supporting women to stop smoking.
In this review update, we have ‘split’ the previous version into
two reviews: (1) this review focusing on psychosocial interventions
to support women to stop smoking in pregnancy; and (2) a sec-
ond review specifically focusing on pharmacological interventions
to promote smoking cessation in pregnancy (Coleman 2012b).
This split was necessary as there are different issues of concern
for psychosocial and pharmacological interventions. Psychosocial
interventions are now part of routine care in many high-income
countries and contemporary issues focus on strategies to increase
efficacy, and adaptation of psychosocial interventions to different
contexts and settings, sometimes requiring different study designs
(e.g. cluster trials of implementation). As many interventions in-
volve multiple strategies or use of components which are tailored
to individual women, it is very difficult to assess the indepen-
dent effect of individual components of psychosocial interven-
tions. As the efficacy and safety of pharmacological treatment (e.g.
Nicotine Replacemernt Therapy, Bupropion) during pregnancy
(Slotkin 2008) remains uncertain, more rigid study designs (i.e.
randomised double-blind placebo-controlled trials) are required
to assess the risks and efficacy.
To complement what is known from research literature about
smoking in pregnancy, direct contributions to this review were
sought from women who smoked before or during pregnancy in
1999. Women were identified through community networks, and
their views emphasised the need to focus attention on potential
adverse effects of smoking cessation programmes; in particular,
the consequent guilt, anxiety and additional stress experienced by
those who continue to smoke, especially through ’high-risk’ preg-
nancies, and the detrimental effect on their relationships with their
family and maternity care providers (Oliver 2001).
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In this update, we indirectly considered women’s views reported in
a systematic review of qualitative studies (Flemming 2013), which
reinforce the previous contributions, identifying fourmain themes
which have implications for interventions to support women to
stop smoking in pregnancy.
1. Smoking is an embedded part of the lives of many women
living in disadvantaged circumstances.
2. Women see smoking in pregnancy in terms of the risks it
presents to their unborn baby, which can trigger guilt.
3. Quitting was not seen in unambiguously positive terms and
was seen to have downsides, disrupting relationships and
removing a habit perceived as helping women cope.
4. Partners play an important role in influencing women’s
smoking behaviour in pregnancy, either as barriers or facilitators
to quitting.
We also indirectly considered the views of pregnancy care providers
reported in consultation for a Clinical Practice Guideline on
Smoking Cessation in pregnancy (Williams 2010) in the UK; and
the views of guideline developers requesting evidence for an inter-
national guideline on ’Management of Tobacco Use in Pregnancy’
(CDCP 2013). Some of the major issues and gaps included:
• whether psychological interventions are effective;
• whether interventions are effective for pregnant teens and
other hard-to-reach and vulnerable groups, including ethnic and
minority populations;
• whether interventions are effective for women who are
mentally unwell or experiencing substance misuse;
• whether interventions are effective in low- and middle-
income countries.
In addition to consideration of women’s views and feedback from
guideline developers, we also considered thesis critiques of the
previous version of this review (Gilligan 2008; Vilches 2009),
health programme planning models (Green 2005b; Bartholomew
2011), various publications on factors affecting intervention effi-
cacy (Greenhalgh 2004; Hoddinott 2010), descriptions of inter-
vention components (Lorencatto 2012), and the ’critical factors’
identified by authors of included studies reported in the results or
discussion. As smoking in pregnancy has important impacts on
health inequalities, we have introduced a focus on equity in this
review, as recommended in the ’PRISM-Equity’ guidelines for re-
porting interventions with a potential impact on equity (Welch
2012). We have synthesised this information into a logic model
to identify key variables that may impact on intervention effec-
tiveness (see Figure 1), to guide analysis and subgroup analyses
planning ’a priori’ (Petticrew 2012).
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Figure 1. Logic model for systematic review analysis of potential factors impacting on efficacy of
interventions for supporting women to stop smoking in pregnancy.
O B J E C T I V E S
This review evaluated the effect of psychosocial interventions de-
signed to support women to stop smoking in pregnancy and aimed
to address the following questions.
Primary objectives
• To identify whether psychosocial interventions can support
women to stop smoking in pregnancy
• To compare the effectiveness of the main psychosocial
intervention strategies in supporting women to stop smoking in
pregnancy (i.e. counselling, health education, feedback, social
support, incentives)
Secondary objectives
• To identify if the intensity of the intervention corresponds
to an effect size
• To identify any specific intervention components associated
with an effect (e.g. telephone counselling, self-help manuals)
• To identify if psychosocial interventions in pregnancy have
an impact on health outcomes for the mother (i.e. caesarean
section, breastfeeding) and infant (i.e. mean birthweight, low
birthweight, preterm births, very preterm births, perinatal
mortality)
• To identify if there are any positive or negative
psychological effects reported among women receiving
psychosocial interventions in pregnancy
• To identify participants (women and pregnancy care
providers) views of the psychosocial interventions in this review
• To identify if psychosocial interventions have an effect on
family functioning or other relationships for the mother,
including non-accidental injury
• To identify if psychosocial interventions during pregnancy
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can reduce the proportion of women who start smoking
postpartum
• To identify whether any methods for training and
implementing psychosocial interventions have an effect on the
knowledge, attitudes and behaviour of pregnancy care providers
• To identify whether psychosocial interventions provided for
women who have spontaneously quit smoking in early
pregnancy, can reduce the proportion of women who start
smoking by late pregnancy (relapse)
• To identify whether psychosocial interventions are effective
for women in vulnerable subpopulation groups (including
women categorised as having low socio-economic status, young
women (less than 20 years), ethnic minority and aboriginal
women, and women in low- and middle-income countries
• To identify whether psychosocial interventions, which are
shown to be effective when implemented under trial conditions
by a dedicated research team (efficacy studies), are still effective
when implemented in a routine pregnancy care setting by
existing staff (effectiveness studies)
• To identify if psychosocial interventions to support women
to stop smoking in pregnancy are cost-effective
• To identify if there are any adverse effects reported as a
result of women receiving psychosocial interventions to support
them to stop smoking in pregnancy
• To identify whether recently included studies are as effective
as studies included in previous versions of this review
• To identify if any of the risk of bias assessments have a
significant impact on the effect size of the intervention
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials, cluster-randomised controlled
trials, and randomised cross-over trials of psychosocial interven-
tions where a primary aim of the study was smoking cessation
in pregnancy. Quasi-randomised studies were only considered for
inclusion if there was a very low risk of interference with the se-
quence generation (e.g. allocation by odd or even maternal birth
date or hospital record number).
Types of participants
1. Women who are currently smoking or have recently quit
smoking and are pregnant, in any care setting.
2. Women who are currently smoking or have recently quit
smoking and are seeking a pre-pregnancy consultation.
3. Health professionals in trials of implementation strategies
of psychosocial interventions to support pregnant women to stop
smoking.
Where possible, we have separated outcomes forwomenwho spon-
taneously quit smoking when they become pregnant, and women
who continue to smoke duringpregnancy, as significant differences
have been reported previously (Baric 1976;Ryan1980;Cinciripini
2000; Passey 2012).
Types of interventions
1. Counselling interventions are those which provide
motivation to quit, support to increase problem solving and
coping skills (Ortendahl 2007c; Ortendahl 2008a; Ortendahl
2009b), and may incorporate ’transtheoretical’ models of change
(Prochaska 1992; Prochaska 2007). This includes interventions
such as motivational interviewing, cognitive behaviour therapy,
psychotherapy, relaxation, problem solving facilitation, and other
strategies. Counselling interventions may be provided face-to-
face, by telephone, via interactive computer programs, or using
audiovisual equipment. The duration of counselling may range
from brief interventions (less than five minutes) to more
intensive interventions, which can last for up to an hour and be
repeated over multiple sessions. Counselling may be provided by
a range of personnel, including pregnancy care providers, trained
counsellors, or others, on-site or by referral to specialist stop
smoking services. Interventions that involved provision of videos
with personal stories were included as counselling in this review.
2. Health education interventions are defined as those where
women are provided with information about the risks of
smoking and advice to quit, but are not given further support or
advice about how to make this change. Interventions where the
woman was provided with automated support such as self-help
manuals or automated text messaging, but there was no personal
interaction at all, were coded as health education in this review.
3. Feedback interventions are those where the mother is
provided with feedback with information about the fetal health
status or measurement of by-products of tobacco smoking to the
mother. This includes interventions such as ultrasound
monitoring and carbon monoxide or urine cotinine
measurements, with results fed back to the mother (does not
include where measurements are used for confirming smoking
abstinence in the study).
4. Incentive-based interventions include those interventions
where women receive a financial incentive, contingent on their
smoking cessation; these incentives may be gift vouchers.
Interventions that provided a ’chance’ of incentive (e.g. lottery
tickets) were not included as ’incentives’ in this update, but were
included in counselling and subgroup analysis of trials
incorporating use of lottery tickets will be reported. Gifts and
other incentives to promote participation in the study (but were
not contingent on smoking cessation), were not coded as
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incentive-based interventions in this review.
5. Social support (peer and/or partner) includes those
interventions where the intervention explicitly included
provision of support from a peer (including self-nominated
peers, ’lay’ peers trained by project staff, or support from
healthcare professionals), or partners, as a strategy to promote
smoking cessation.
6. Other strategies, which could not be included in the
categories listed above, including exercise, and dissemination
interventions (where both intervention and control group
received the same intervention, but the dissemination strategy
differed).
In this review we have categorised interventions according to the
’main’ strategy used, however many interventions incorporate sev-
eral components. Therefore, interventions are coded according to
whether the strategy was a:
• single intervention - with only one main strategy used;
• multiple intervention - which included several strategies
being offered to all women;
• tailored intervention - where additional optional strategies
were available for women.
Trials that combined strategies for smoking cessation with other
interventions to promote maternal health in pregnancy were con-
sidered for the review for smoking cessation and reduction out-
comes but not for infant outcome measures such as birthweight,
preterm birth, breastfeeding and perinatal mortality, which might
be attributable to other components of an intervention package.
We have included interventions that offered pharmacological ther-
apies as part of a tailored intervention where there were higher
levels of psychosocial support provided to participants in the inter-
vention arm, compared with the control arm. Trials were excluded
where the sole aim was to reduce: smokeless tobacco use; environ-
mental tobacco smoke exposure; where the primary population
was not pregnant women (e.g. partners, non-pregnant women);
or the intervention was not primarily aimed at cessation during
pregnancy (e.g. postpartum interventions). Studies were included
where smokeless tobacco use, environmental tobacco smoke ex-
posure or partner smoking were targeted in conjunction with in-
terventions addressing the primary aim of supporting pregnant
women to stop smoking in pregnancy. We have included dissemi-
nation studies, where the primary intervention includes strategies
to disseminate smoking cessation interventions in pregnancy care
settings (e.g. training, audit and feedback).
Types of comparisons
Any type of comparison group was included and was coded ac-
cording to the following.
1. ’Usual care’ or no additional intervention reported.
2. Less intensive interventions where the control group
received some of the intervention or an approximation of ’usual
care’ consistently provided by the research team.
3. Alternative interventions, where the control group
received different intervention components than the
intervention group, of the same intensity.
Types of settings
Any setting, including residential and community settings, family
planning clinics, pre-pregnancy planning clinics or general prac-
titioner clinics, prenatal care clinics and hospitals.
The ’PROGRESS-Plus’ criteria (Oliver 2008b; Ueffing 2009)
were used to categorise interventions which were provided for vul-
nerable populations, including: social capital; place of residence;
occupation; education; socio-economic status; ethnicity; age; or
other factors which might impact on vulnerability. These cate-
gories are described in more detail in the methods.
Types of outcome measures
Primary outcomes
1. Smoking abstinence in late pregnancy (point prevalence
abstinence):
i) self-reported or biochemically validated;
ii) biochemically validated only.
Secondary outcomes
1. Continued abstinence in late pregnancy after spontaneous
quitting (relapse prevention) in early pregnancy (self-reported or
biochemically validated).
2. Smoking abstinence in the postpartum period (self-reported
or biochemically validated):
i) zero to five months;
ii) six to 11 months;
iii) 12 to 17 months;
iv) 18 months or longer.
3. Smoking reduction from the first antenatal visit to late
pregnancy:
i) numbers of women reducing smoking (any definition,
> 50% self-reported, or biochemically validated);
ii) biochemical measures (mean cotinine and thiocynate);
iii) mean cigarettes per day (self-reported).
4. Perinatal outcomes:
i) mean birthweight;
ii) low birthweight (proportion less than 2500 g);
iii) very low birthweight (less than 1500 g);
iv) preterm births (proportion less than 37 weeks);
v) stillbirths;
vi) neonatal deaths;
vii) all perinatal deaths.
5. Mode of birth (caesarean section).
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6. Breastfeeding initiation and breastfeeding at three and six
months after birth.
7. Psychological effects: measures of anxiety, depression and
maternal health status in late pregnancy and after birth.
8. Impact on family functioning and other relationships in
late pregnancy and postpartum.
9. Participants’ views of the interventions, both women’s and
pregnancy care providers’ views.
10. Measures of knowledge, attitudes and behaviour of health
professionals (obstetricians, midwives and family physicians)
with respect to facilitating smoking cessation in pregnancy.
11. Cost-effectiveness.
12. Adverse effects of smoking cessation programmes.
Search methods for identification of studies
This is the fifth update of this review and the details of previous
searches are described in other published versions of this review
(Lumley 1995a; Lumley 1995b; Lumley 1995c; Lumley 1995d;
Lumley 1999; Lumley 2004; Lumley 2009).
Electronic searches
We searched the Cochrane Pregnancy and Childbirth Group’s Tri-
als Register by contacting the Trials SearchCo-ordinator (1March
2013).
The Cochrane Pregnancy and Childbirth Group’s Trials Register
is maintained by the Trials Search Co-ordinator and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE;
3. weekly searches of Embase;
4. handsearches of 30 journals and the proceedings of major
conferences;
5. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Details of the search strategies for CENTRAL, MEDLINE and
Embase, the list of handsearched journals and conference pro-
ceedings, and the list of journals reviewed via the current aware-
ness service can be found in the ‘Specialized Register’ section
within the editorial information about the Cochrane Pregnancy
and Childbirth Group.
Trials identified through the searching activities described above
are each assigned to a review topic (or topics). The Trials Search
Co-ordinator searches the register for each review using the topic
list rather than keywords.
Searching other resources
We also checked cited studies while reviewing the trial reports and
key reviews. Where necessary, we contacted trial authors to locate
additional unpublished data.
We did not apply any language restrictions.
[In addition, authors conducted a supplementary search for non-ran-
domised studies, for the background and discussion, in MEDLINE,
Embase, PsycLIT, and CINAHL (June 2008 to 1 March 2013) using
the search strategy detailed in Appendix 2.]
Data collection and analysis
Selection of studies
Two review authors independently reviewed the full text of search
results from the Cochrane Pregnancy and Childbirth Group and
potential trials identified through other sources (CC/SP) to de-
termine if they met the inclusion criteria for this review. Where
there was disagreement, advice from co-authors was sought (SO/
JC/AO/JT) and consensus reached by discussion.
Data extraction and management
Two review authors independently extracted data from the pub-
lished reports without blinding as to journal, author, or research
group. For each trial the following aspects were reported and coded
into EPPI-Reviewer software (Thomas 2010). Independent data
extraction was checked and areas of conflicting judgement were
resolved by consensus, and where necessary discussion with co-au-
thors. A summary of data collected is outlined in Appendix 3 and
a summary reported for individual studies in the Characteristics
of included studies table.
Assessment of risk of bias in included studies
We assessed the methodological quality of the included studies as
recommended in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2008). The ’quality assessment’ from pre-
vious reviews has been replaced with the ’Risk of bias’ assessment.
(1) Sequence generation (checking for possible selection
bias)
We have described for each included study the methods used to
generate the allocation sequence, and have assessed the methods
as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non random process, e.g. alternate
clinic date; odd or even date of birth; hospital or clinic record
number);
• or unclear risk of bias.
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Studies where sequence generation was assessed as inadequate and
there is a reasonable opportunity to interfere with random alloca-
tion (e.g. alternate clinic date) have been excluded in this update
of the review. Studies randomised by odd or even date of birth
or medical record number have continued to be included in this
review as there is limited reasonable opportunity to manipulate
the allocation.
(2) Equal baseline characteristics (checking for possible
selection bias)
To further assess the risk of selection bias, we assessed whether
the baseline characteristics were equal in each included study, and
have assessed them as:
• low risk of bias (baseline characteristics were assessed and
equal in both study arms);
• high risk of bias (where there were significant differences in
baseline characteristics, suggesting possible bias in the selection
of participants);
• or unclear risk of bias.
(3) Allocation concealment (checking for possible selection
bias)
We have described for each included study the method used to
conceal the allocation sequence in sufficient detail to determine
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment. We
have assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (e.g. open random allocation; unsealed or
non-opaque envelopes; medical record number; date of birth);
• or unclear risk of bias.
(4) Blinding (checking for possible performance bias) of
study participants and intervention providers
We have described for each included study the methods used, if
any, to blind study participants and intervention providers from
knowledge of which intervention a participant received. However,
it is rarely feasible in psychosocial interventions to blind women or
the intervention providers to group allocation. We have assessed
the methods as:
• low risk of bias;
• high risk of bias;
• or unclear risk of bias.
(5) Blinding (checking for possible performance bias) of
outcome assessor
We have described for each included study the methods used, if
any, to blind outcome assessors from knowledge of which inter-
vention a participant received as recommended (West 2005). We
have assessed the methods as:
• low risk of bias;
• high risk of bias;
• or unclear risk of bias.
(6) Dealing with incomplete outcome data (checking for
possible attrition bias through withdrawals, dropouts,
protocol deviations, and intention-to-treat analysis)
We have described for each included study and for each outcome
or class of outcomes the completeness of data including attrition
and exclusions from the analysis. We have noted whether attritions
and exclusions were reported, the numbers included in the analysis
at each stage (compared with the total randomised participants),
reasons for attrition or exclusion where reported, and whether
missing data were balanced across groups. We considered it was
reasonable to exclude women from the final analysis who had
experiencedmiscarriage or fetal demise, developed serious medical
conditions, moved out of the area, or changed to another provider
of care. However, as there are also clear associations between these
outcomes and smoking, we have categorised the risk of attrition
bias as ’unclear’.Where possible, we included all other randomised
women in themeta-analysis.Where datawere not provided in such
a way to enable inclusion of all other randomised participants, we
have categorised these studies as high risk of attrition bias. We
have assessed the methods as:
• low risk of bias (outcomes for all randomised participants
included in analysis);
• high risk of bias (outcomes for all participants not reported,
particularly if unequal attrition in both study arms);
• or unclear risk of bias, which includes exclusions for
medical conditions or moving.
(7) Reporting all outcomes (checking for possible selective
reporting bias)
We have described for each included study how the possibility of
selective outcome reporting bias was examined by us and what we
found. We assessed the methods as:
• low risk of bias (where it is clear that all of the studies’ pre-
specified primary outcomes and all expected outcomes of interest
to the review have been reported);
• high risk of bias (where not all the studies’ pre-specified
outcomes have been reported); one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• or unclear risk of bias.
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(8) Reliability of outcome measures used (checking for
possible detection bias)
The unreliability of self-report as a measure of smoking status in
healthcare settings, especially in maternity care (Pettiti 1981), was
noted even in the first pregnancy trial (Donovan 1977). While
this finding has not always been consistent (Fox 1989; Pickett
2009; Windsor 1985), the majority of other trials show substan-
tial misclassification by self-report, with up to a quarter or a third
of women who describe themselves as non-smokers having levels
of salivary or urine cotinine (a metabolite of nicotine) incompat-
ible with self-description (Mullen 1991; Petersen 1992; Kendrick
1995; Lillington 1995; Walsh 1997; Moore 2002; Tappin 2005;
Parker 2007). A degree of misclassification is not surprising given
the social stigma associated with smoking in pregnancy, and there
appears to be less misclassification in non-pregnant populations
(Patrick 1994). Some studies suggest that measurement of absti-
nence is reasonably accurate, but that there is greater inconsis-
tency with reporting the amount of cigarettes smoked (Klebanoff
1998; Venditti 2012). Given this potential for bias, biochemical
validation of smoking abstinence is now the standard for smok-
ing cessation studies (West 2005; Shipton 2009). Use of cotinine
concentration (saliva, urine or plasma) is the most sensitive and
specific (saliva less than 15 ng/mL and urine less than 50 ng/mL).
However, cotinine does not distinguish between smoking and use
of nicotine replacement products, so expired air carbon monoxide
is the preferred method for detecting recent smoking (less than 9
ppm) in many studies. Trials measuring cotinine need to ask par-
ticipants about NRT use (available over the counter), ignore high
levels in NRT users, and verify smoking abstinence with carbon
monoxide levels (West 2005). However, several studies including
use of NRTdid use cotinine cut-offs to distinguish between smok-
ers and non-smokers (Hegaard 2007). There may also be differ-
ential misclassification between intervention and control groups,
though no investigations have published this effect. We have de-
scribed for each included study whether the smoking outcome was
biochemically validated (including measures used) or assessed by
self-report only, and have included data on misclassification by
self-report where they have been reported:
• low risk of bias (biochemical validation);
• high risk of bias (no biochemical validation);
• or unclear risk of bias (including partial biochemical
validation of a sample of the study population).
(9) Implementation of intervention
There are three main types of potential implementation problems
trials (Walsh 2000):
• not all participants in the intervention groups receiving the
intervention;
• intervention group participants not receiving all
components of the intervention;
• control groups receiving the intervention.
Failure to implement the intervention as planned limits the expo-
sure of women to the intervention, and may negatively impact on
the effectiveness of the intervention. Where possible, we included
a description of any process evaluation reported. We have assessed
the implementation of the intervention as:
• low risk of bias (where process evaluation suggests the
majority of participants received the intervention as planned);
• high risk of bias (where process evaluation suggests a
significant proportion of women did not receive the intervention
as planned);
• or unclear risk of bias (where process evaluation is not
reported).
(10) Risk of control group contamination
Exposure of the control group to aspects of the intervention is
a common challenge for intervention trials, particularly studies
where healthcare providers are required to offer an intervention to
some women, and not to others. Some trials use cluster-randomi-
sation in order to reduce the risk of contamination, particularly
when healthcare providers are involved in the intervention. The
most likely impact is to increase the effect in the control arm, re-
ducing the potential effect size between the intervention and con-
trol arms of the study. We have assessed the methods as:
• low risk of bias, where the intervention providers are
separate from the control group or strategies are employed to
minimise the risk (such as cluster-randomisation);
• high risk of bias, where the same provider is required to
administer the intervention to both study arms, or there is
specific reporting of suspected contamination in the trial report;
• or unclear risk of bias.
(11) Other bias
Wehave considered any other potential sources of bias in the study,
including whether recruitment was equal in both arms of cluster-
randomised trials, and assessed these as:
• low risk of bias;
• high risk of bias;
• or unclear risk of bias.
Measures of treatment effect
Dichotomous data
All data were entered into RevMan 5.2.5 and SPSS 20 for analysis.
For dichotomous data, we have presented risk ratios (RR) with
95% confidence intervals. Analysis was conducted on the logged
risk ratio, and then converted back to risk ratios for presentation
purposes. In this update, smoking cessation outcomes have been
converted from an ’odds ratio’ for continued smoking, to a ’RR’
for quitting, in line with other Cochrane Tobacco Group reviews.
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Therefore, an average RR > 1 in smoking cessation outcomes are
positive in this review. Where less outcome events are desirable
(e.g. preterm births, low birthweight infants, mean cigarettes per
day), an average RR < 1 is a positive outcome. Analysis tables are
labelled accordingly.
For two of the binary outcomes, abstinence in late pregnancy and
perinatal deaths, zero cell counts for events in both the treatment
and control groups were evident for one study each. The affected
studies were Olds 1986 (abstinence in late pregnancy) and Valbo
1996 (perinatal deaths). This is problematic because the formula
for calculating relative risk effect sizes requires non-zero cells (i.e.,
the numerator cannot be zero). Whilst RevMan 5.2.5 automati-
cally corrects for zero events in one group, amanual ’fix’ is required
when both groups have zero events. The solution as recommended
by theCochrane statistician peer reviewer was to enter the values as
zero in the analysis, which means the effect sizes are not estimable
and those studies are effectively excluded from those analyses. The
affected analyses are Analysis 9.1 for Olds 1986 and Analysis 1.16
and Analysis 11.15 for Valbo 1996. For all three of these affected
analyses, the initial set of relevant studies was two; the result is that
no pooled effect could be calculated because instead of two effect
sizes we only have one effect size for each of these analyses. These
instances are clearly marked in the results section.
Continuous data
For continuous data, we used the mean difference (MD) if out-
comes were measured in the same way between trials (e.g. birth-
weight).Weused the standardisedmeandifference (SMD) to com-
bine trials that measured the same outcome, using different meth-
ods (e.g. biochemically-validated smoking reduction).
Where standard errors (SE) were reported instead of standard de-
viations (SD), we used the RevMan calculator to calculate the ef-
fect size estimate. In one study, the SDwas calculated from the SE.
Where no SDs or SEs were reported, we estimated the mean SD
from available studies, as recommended in the Cochrane Hand-
book 16.1.3.1 (Higgins 2008). The mean birthweight SD was cal-
culated from 13 studies with available SDs (mean SD 578), and
imputed for six studies. The mean cigarettes per day SD was cal-
culated from 14 studies with available SDs (mean SD 6.5), and
imputed for five studies.
Unit of analysis issues
There are good reasons for considering random allocation of mid-
wives, clinics, health educators, hospitals, general practitioners,
or antenatal classes to intervention or comparison group, rather
than random allocation of pregnant women. It may be difficult for
pregnancy care providers to treat women differentially according
to the intervention or usual care protocol, and not to introduce co-
interventions in one or other groups (contamination). As women
within a cluster are more likely to be similar to one another, and
less like the women in another cluster, outcomes from cluster-ran-
domised trials were adjusted for the intra-cluster correlation for
the data to be included in this review. Adjusting for the clustering
of studies means that cluster trials could be analysed in the same
models as individual randomised trials.
Adjustment for cluster randomisation was conducted using a re-
ported intra-cluster correlation (ICC) if available, and if not, a
range of ICCs (from 0.003 to 0.20) was assumed and a sensitivity
analysis conducted as recommended by (Merlo 2005). The results
of the sensitivity analyses showedno substantial difference between
the different ICCs (RRs were the same to at least three decimal
places across ICC calculations). As such, for studies in which an
ICC was not reported, an ICC value of 0.10 was used for the
primary analysis and the cluster trials were included by adjusting
the SEs (reported ICCs were used where available). The methods
used for individual studies are reported in the Characteristics of
included studies and Table 2. The adjustment involved reducing
the size of each trial to its ‘effective sample size’ by dividing the
sample size by the ’design effect’, where the design effect is equal
to 1 + (m - 1) × ICC, and m is the average cluster size (see Section
16.3.4 of the Cochrane Handbook, Higgins 2008).
Dealing with missing data
Due to the nature of the intervention, there is a high likelihood
that women withdrawing from the study or not providing a bio-
chemical sample for analysis, without a ’plausible explanation’ (e.g.
miscarriage/fetal demise, moving out of the area or changed to an-
other provider of care) are likely to be continuing smokers. Where
sufficient information has been reported or has been supplied by
the trial authors, we have re-includedmissing data from each treat-
ment group in the analyses to complywith recommendedoutcome
criteria assessment for smoking cessation trials (West 2005). Only
data which were excluded for medical reasons (e.g. miscarriage or
preterm birth) or moving from study site were not re-included in
this review. We have indicated where an intention-to-treat (ITT)
(or available case) analysis was carried out for the smoking cessa-
tion outcome in the published report, or adjusted for this review.
These assessments and any adjustments are reported in the ’Risk
of bias’ tables (see incomplete outcome data). Where data could
not be re-included, we conducted sensitivity analysis to determine
the effect of inclusion of trials assessed as ’high risk’ of attrition
bias.
Assessment of heterogeneity
We examined levels of heterogeneity in all pooled analyses
(Cochran 1954). We used the I² statistic to quantify heterogene-
ity (i.e., inconsistency) among the trials in each analysis (Higgins
2008) and Chi2 tests to assess the presence of significant variation
amongst effect sizes (i.e., whether the observed effects are signif-
icantly different from chance) (Lipsey 2001; Higgins 2008). For
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the Chi2 tests, in addition to the P value, we report the Q-statistic
calculated by the test and the degrees of freedom of the test.
We expected to find a substantial degree of heterogeneity given the
breadth of types of interventions, which are broadly categorised as
’psychosocial’ and the differences in comparisons. Therefore, we
attempted to minimise heterogeneity in this update by reporting
separate comparisons for each main intervention strategy (coun-
selling, health education, feedback, incentives, and social support;
and whether the intervention was provided as a specific smoking
intervention or as part of a broader intervention to improve ma-
ternal health) and comparison type (usual care, less intensive in-
tervention, or alternative intervention). Further, we grouped stud-
ies within each comparison according to whether the intervention
was provided as a single, multiple or tailored intervention.
To indicate considerable statistical heterogeneity, we set a threshold
of inconsistency of I2 > 75% and a Chi2 significance level of P <
0.05. Where considerable heterogeneity was evident, we did not
present pooled results. We further explored heterogeneity by pre-
specified secondary analysis identified during development of a
logic model (see Figure 1 and section on Subgroup analysis and
investigation of heterogeneity for a description).
Assessment of reporting biases
Concerns about publication bias have been raised after observa-
tions that research evaluations showing beneficial and/or statis-
tically significant findings are more likely to be published than
those that have undesirable outcomes or non-significant findings
(Higgins 2008). If this phenomenon does occur, then reviews of a
biased evidence base will draw biased conclusions. Unfortunately,
it is difficult to assess publication bias because there is no way of
knowing the extent of what has not been published.
As a result of these concerns, researchers have developed ways of
estimating the extent to which there may be some publication bias
in the evidence base. Funnel plots (scatter plots in which the effect
size from individual studies are plotted against a measure of study
precision) are a common method for assessing the possibility of
publication bias. Ideally, the spread of effect sizes should be such
that there ismore scattering of effect sizes at the bottomof the plot,
where there is less precision, with a narrowing of the scattering
towards the top, where there is greater precision.
Following guidance (Sterne 2001; Higgins 2008), we produced
a funnel plot of the RR for the primary outcome on the x-axis,
and the SE of the log RR on the y-axis, for each of the main
comparisons (Analyses 1 through 10). Only the funnel plots for
’counselling versus usual care’ (Analysis 1.1, Figure 2) and ’coun-
selling versus less intensive intervention’ (Analysis 2.1, Figure 3)
are shown, because the remaining comparisons had too few effect
sizes to reliably detect asymmetry in the funnel plot. In the fig-
ures, the vertical line indicates the random-effects pooled effect
size estimate. In the absence of publication bias, we would expect
a roughly symmetrical distribution of effect sizes in the inverted
funnel shape. Two review authors examined the plot for publica-
tion bias; under the assumption that publication bias is detectable
in these funnel plots, we conclude that it is unlikely that publica-
tion bias has biased the findings of this review.
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Figure 2. Funnel plot of comparison: 1 Smoking cessation interventions: counselling vs usual care, outcome:
1.1 Abstinence in late pregnancy.
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Figure 3. Funnel plot of comparison: 2 Smoking cessation interventions: counselling vs less intensive
intervention, outcome: 2.1 Abstinence in late pregnancy.
Data synthesis
We used the statistical methods described in the Cochrane Hand-
book (Higgins 2008). We adopted a random-effects approach us-
ing method of moments estimators. The comparison analyses and
forest plots were generated in RevMan 5.2.5, andmeta-regressions
and other subgroup analyses (using an analog to the ANOVA)
were conducted in SPSS 20.0 using macros developed by Wilson
2005. When examining statistical significance, P values greater
than 0.05 were considered non-significant. Where only one study
was included in the comparison, the outcomes are not displayed
in a separate comparison table and are reported in text only in
the results, and data used is displayed in Comparison 11 of ’all
outcomes bymain intervention strategy’ (see Analysis 11.1 for pri-
mary outcome and subsequent analyses for secondary outcomes).
Effect sizes that were included in the subgroup analyses for the pri-
mary outcome (reported in Section 1.2 of the results) were checked
for outliers. First, skewness and SE of the skewness were calcu-
lated for the primary outcome in SPSS. Skewness was considered
to be statistically significant at the 0.05 level when the skewness
value divided by its SE was greater than 1.96. Second, given that
skewness was detected, we checked for univariate outliers, which
were defined as effect sizes greater than two SDs above or below
the unweighted mean.
A sensitivity analysis was conducted to test whether Winsorising
the outliers (i.e. changing the value of the effect size estimate to the
mean ± 2 SDs), which is recommended in Lipsey 2001, affected
the pooled effect size estimates. The analyses on the Winsorised
datasets were conducted in SPSS, while the unchanged datasets
were analysed in RevMan.
There was no substantial difference between pooled effect size
estimate for the primary outcome when outliers unchanged (risk
ratio (RR) 1.45, 95% confidence interval (CI) 1.27 to 1.64) and
pooled effect size estimatewith outliersWinsorised (RR1.44, 95%
CI 1.27 to 1.63).
Multivariate outliers of the primary outcome (i.e. abstinence in late
pregnancy) were also explored using the predictor variables main
intervention strategy (counselling, feedback, incentives, and social
support, with health education and the one study with ’other’
intervention type as the reference category). As recommended by
Tabachnick 2001, the Mahalanobis distance of each study was
compared to theChi2 critical value of 18.47 (based onP < .001 and
df =4). The Mahalanobis distance of none of the studies exceeded
this value. Therefore, no multivariate outliers were identified for
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the primary outcome in terms of intervention strategy.
For the comparison analyses (conducted in RevMan and reported
in Section 1.1 of the Results), we used the raw (i.e. notWinsorised)
effect sizes in the analyses. This is because the subsets of studies
are typically too small to reliably detect outliers.
The number needed to treat for benefit (NNTB) (Altman 1998)
was calculated to give an approximation of how many women
would need to receive the intervention for one of them to avoid
an adverse outcome. We used the Visual Rx programme (Cates
2008) and based the computation on the random-effects pooled
odds ratio effect size calculated in RevMan 5.2.5. We used the
odds ratio rather than the risk ratio as this is invariant to whether
the outcome is presented as a beneficial or adverse outcome (Cates
2002).
Subgroup analysis and investigation of heterogeneity
Investigation of heterogeneity is critical in such a large review that
includes many different types of interventions and comparisons. It
is possible that there are significant differences between subgroups
of studies based on characteristics of the interventions, partici-
pants, comparisons, study bias etc, as outlined in Figure 1. In the
section on Assessment of heterogeneity above, we described how
we identified the presence or absence of heterogeneity; in the cur-
rent section, we describe how we attempted to identify the main
sources of variability in the effect size estimates, that is, to attempt
to explain inconsistency across studies. We therefore explored how
the observed effectiveness differs under different conditions.
Subgroup analyses
Where subgroup analyses were possible for the primary outcome,
they were conducted on the whole dataset in SPSS 20 using an
adapted ANOVA test. Ideally, the results of the subgroup analy-
ses should produce a non-significant within-group heterogeneity
statistic (i.e. the P value for QW should be > 0.05) to indicate that
the effect sizes within a group are statistically similar to each other.
If the subgroups are significantly different from each other, then
the between-group heterogeneity statistic will be significant (i.e. the
P value for QB will be < 0.05). If the between-group heterogeneity
statistic QB is not statistically significant, then the proposed sub-
group variable does not significantly explain differences between
the effect sizes.
Two investigations of heterogeneity requiredmeta-regression anal-
yses. These were (1) a model that included two indicators of the
difference in intensity of the intervention and control conditions
and (2) a model that included both self-help manuals and tele-
phone support as predictors. Meta-regressions were conducted in
SPSS 20 using an adapted regression analysis. The overall fit of the
regression model is indicated by two statistics: QM and QR QM is
the variability associated with the regression model, while QR is
the random error variability (that which is not accounted for by
the model). A significant QM suggests that significant variation in
the effect size distribution has been explained by the model, and
is therefore desired. A significant QR , on the other hand, suggests
that variability beyond that explained by the model remains, and
is thus not ideal (Lipsey 2001).
Subgroup analyses for the primary outcome
We considered both clinical and statistical heterogeneity in the
dataset. For the primary outcome, we did not calculate an over-
all pooled effect size for all intervention types versus all compar-
ison types because clinical heterogeneity makes the overall effect
size difficult to interpret. Instead, we focused our analysis of the
primary outcome on subgroup analyses, which statistically test
the significance of differences between groups, and trends in the
pooled effects for different subgroups. The following variables
were included in subgroup analyses conducted in SPSS 20 for the
primary outcome of smoking abstinence in late pregnancy.
1. Main intervention strategy (counselling, health education,
incentives, feedback, social support, or other).
2. Comparison type (usual care, less intensive interventions,
or alternative interventions).
3. Biochemically validated versus self-report outcomes.
4. Intensity of the intervention (duration and frequency).
5. Features of the intervention (self-help manuals and
telephone support).
6. Socio-economic status of the participants.
7. Newly included studies in this review update.
It is important to note that the subgroup analyses described below
do not take into account interactions in the data. For example,
the models do not include both intervention type and comparison
type in the samemodel, so we did not test how these factors might
interact. Whilst this is a limitation of the analyses presented, we
feel that there is still value in determining overall trends across
the dataset. Firstly, this allows better comparison with previous
versions of the review, for which the review had not separated the
studies by comparison. Secondly, it allows us to consider whether
what the corpus of studies looks like and whether there are trends
across all of the studies. Throughout, we have distinguished be-
tween statistical heterogeneity and conceptual (or clinical) hetero-
geneity, and we hope that these subgroup analyses help to explore
these different types of variation more thoroughly. We also note
that in future updates of the review, we hope to be able to incor-
porate the increasingly popular methods of network meta-analysis
to better address all of these issues.
Heterogeneity in the secondary outcomes
For most secondary outcomes, we did not calculate an overall
pooled effect but instead focused on comparisons within clinically
homogeneous subsets. However, for infant outcomes, we calcu-
lated overall pooled effect sizes for all intervention types versus all
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comparison types, for two reasons. Firstly, there was less extreme
clinical heterogeneity in terms of intervention strategy in the in-
fant outcomes. Secondly, as a primary objective of this review is to
determine whether psychosocial interventions to support women
to abstain from smoking in pregnancy have an impact on infant
and maternal health outcomes, and large numbers are needed to
detect relatively rare events, the pooled infant outcomes are infor-
mative. The overall pooled effect size estimates demonstrate the
relationship between being randomised to a smoking cessation in-
tervention and birth outcomes only, rather than the effectiveness
of any particular intervention strategy.
Due to the small number of studies reporting the secondary out-
comes, we were limited in the range of subgroup analyses (i.e. tests
for statistical heterogeneity) that we could conduct. As such, com-
parisons for the secondary outcomes were limited to description
of pooled effect sizes for the subgroups, rather than statistical tests
of between-group differences.
Descriptions of trends across studies
To gain a greater understanding of key issues that we were not
able to synthesise statistically, we present narrative summaries of
the intervention effectiveness for dissemination trials; intervention
effectiveness by ethnicity of the participants; and other participant
characteristic analyses reported by study authors.
Sensitivity analysis
Concerns have been raised about whether clinical trial efficacy will
translate to clinical effectiveness when implemented in healthcare
practice (Walsh 2000). To determine whether effectiveness studies
(defined as those assessing the implementation of an intervention
that uses existing service providers) demonstrate a beneficial out-
come in the absence of efficacy trials (those provided by dedicated
research staff ), we conducted a sensitivity analysis with efficacy
trials excluded. The pooled effect size estimate, 95% confidence
interval, and I2 value of the effectiveness-only studies was then
compared with the overall pooled effect size estimate and its pre-
cision and I2 value.
A number of potentially significant factors were identified during
data extraction and coding of the trials (e.g. where ’counselling’
was provided by a video-tape rather than in person; where ’coun-
selling’ included optional provision of nicotine replacement ther-
apy or incentives etc.). The studies with these characteristics were
highlighted and sensitivity analyses conducted for these studies,
and the effect that removing them had on the remaining studies
in the comparison.
Assessment of risk of bias across studies
Assessment of the risk of bias across studies was conducted through
subgroup analyses in SPSS 20 using an adapted ANOVA test. We
used subgroup analyses rather than an elimination approach to
sensitivity analysis for two reasons. Firstly, the subgroup analysis
allows us to test whether high or low risk of bias studies have sta-
tistically different pooled effect sizes. Secondly, we included the
’unclear risk of bias’ studies as a subgroup in the analyses, which
allows us to check for missing data problems. For some of the risk
of bias types, many of the studies did not report sufficient infor-
mation to be able to assess the potential risk of bias. Through the
subgroup analysis, we could test whether there was a systematic
difference between poorly reported studies and those with assess-
able risk of bias.
We conducted risk of bias analyses for the following bias types on
the primary outcome.
• Random sequence generation selection bias.
• Allocation concealment selection bias.
• Incomplete outcome data attrition bias.
• Selective reporting bias.
• Detection bias (biochemical validation of abstinence).
• Blinding of participants and personnel.
• Blinding of outcome assessment.
• Incomplete implementation.
• Equal baseline characteristics in study arms.
• Contamination of control group.
• Other bias.
Due to the small numbers of effect size estimates for the 16 sec-
ondary outcomes for which we calculated effect size estimates,
very few subgroup analyses by risk of bias type were possible. Only
four of the outcomes had sufficient data to be analysed in terms of
only one or two of the 12 possible risk of bias types. Given this, we
did not conduct risk of bias analyses for the secondary outcomes.
However, where possible we reported the average RR for studies
assessed as having a high and low risk bias.
R E S U L T S
Description of studies
Results of the search
The original version of this review included a total of 19 studies
identified up until 1993 included as separate reports in the Preg-
nancy and Childbirth CD Rom: behavioural strategies for reduc-
ing smoking (n = 9) (Lumley 1995a); counselling for reducing
smoking in pregnancy (n = 1) (Lumley 1995b); advice as a strategy
for reducing smoking (n = 6) (Lumley 1995c); and feedback as a
strategy for reducing smoking (n = 3) (Lumley 1995d).
Following publication of a protocol in 1998, a search was con-
ducted by the Pregnancy and Childbirth Group for the second
update of the review published in The Cochrane Library in 1999.
This update included a total of 44 trials: 37 trials including 16,916
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women providing data on smoking cessation and over 800 women
in five trials of relapse prevention (Lumley 1999).
The third update in 2004 was based on a search until July 2003
conducted by the Pregnancy and Childbirth Group, the Tobacco
Addiction Group Trials Register and a search of MEDLINE, Em-
base, PsycLIT and AustHealth. A total of 65 trials were included
involving over 20,000 women: 48 trials provided data on smoking
cessation, six additional cluster trials involving over 7500 women
were not included in the meta-analysis (Lumley 2004).
In the fourth update, published in 2009; a search from January
2003 to June 2008 identified 898 reports which were screened,
the full text of 35 reports were reviewed and a total of 73 studies,
involving over 20,000 women, were included (72 provided out-
come data): 56 randomised and quasi-randomised trials and nine
cluster-randomised trials provided primary outcome data for this
update (Lumley 2009).
In this fifth update of the review, we screened 2030 abstracts (in
addition to the search of the Pregnancy and Childbirth Group’s
Trials Register) and reviewed the full text of 64 reports. We iden-
tified 16 new studies meeting the inclusion criteria. As a result of
a change in the inclusion criteria we excluded 13 studies from the
previous version of the review, including nine quasi-randomised
trials, as well as four randomised controlled trials of pharmaco-
logical interventions which are now included in a separate review
(Coleman 2012b). These are listed in Characteristics of excluded
studies. We also included four studies that had been previously ex-
cluded (three cluster trials and one abstract report of a trial), as well
as nine studies that did not report any outcomes which could be
used in meta-analyses, and which are reported in a separate table.
We combined two reports of relapse prevention (Ershoff 1995;
Secker-Walker 1995) as ‘Associated References’ to the primary pa-
pers reporting smoking cessation (Ershoff 1989; Secker-Walker
1994), and another paper which did not report any usable out-
comes (Solomon 1996) as an ’Associated reference’ to the primary
report (Secker-Walker 1998). A total of 77 randomised controlled
trials, involving over 29,000 women with relevant outcome data,
were included in the meta-analysis for this report (primary out-
come data for 21,948 women participating in 70 trials and sec-
ondary outcome data only for a further 7404 women participating
in seven trials). A further nine without outcomes are included but
results summarised in Table 1, making a total of 86 studies in-
cluded in this update. See Figure 4 for summary of search results.
Figure 4. Search flow chart.
21Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Included studies
Participants
Over 29,000 pregnant women participating in 77 trials with out-
comes included in the meta-analysis were assessed as current or re-
cent ‘smokers’ at recruitment. The criteria used to assess a woman
as a ‘smoker’ varied substantially between trials, and are detailed
for each study in the Characteristics of included studies table.
There were 1740 women who reported they had ’spontaneously
quit’ smoking when they became pregnant, and had outcomes re-
ported separately from women who continued to smoke. In one
study only one third of the study population smoked commer-
cial cigarettes, while two thirds chewed traditional or commercial
smokeless tobacco (Patten 2009).
Participants were generally healthy pregnant adult women over
16 years of age, with 19 trials explicitly excluding women with
medical or psychological complications. The majority of trials
(n = 47) included women categorised as having low socio-eco-
nomic status; 43 of these measured the primary outcome. Most
trials included women over 16 years of age, with only two tri-
als explicitly targeting young women under 20 years (Albrecht
1998; Albrecht 2006) and one study including women over 15
years of age (Donatelle 2000). Four trials were specifically targeted
towards women with ‘psychosocial risk factors’ (Graham 1992;
Belizan 1995; Albrecht 1998; El-Mohandes 2011) and two tri-
als were conducted among women requiring methadone treat-
ment for opioid addiction (Haug 2004; Tuten 2012). Most tri-
als recruited women at the first antenatal clinic visit and during
the second trimester of pregnancy, excluding women in the last
trimester due to limited time remaining to receive the intervention.
However, four trials were explicitly targeted towards women who
continued to smoke in late pregnancy (’heavy smokers’) (Valbo
1994; Valbo 1996; Stotts 2002; Stotts 2009). Seven studies in-
cludedmainly women belonging to an ethnicminority population
(Graham 1992; Lillington 1995; Gielen 1997; Manfredi 1999;
Malchodi 2003; El-Mohandes 2011; Ondersma 2012). Two tri-
als were conducted in aboriginal communities (Creative Spirits
2013) among Aboriginal women in Australia (Eades 2012) and
Alaskan Native women the US (Patten 2009), and one trial in-
cluded more than 40% Maori women in New Zealand (McLeod
2004). Twenty-eight studies explicitly excluded women who were
not able to speak English (n = 26), Danish (Hegaard 2003) or
Swedish (Hjalmarson 1991). In eight studies access to a telephone
or video recorder was required for participation in the study. In
two studies, women using nicotine replacement therapy were ex-
cluded (Malchodi 2003; Tuten 2012).
Interventions
Of the studies which had outcomes included in the meta-analysis
(n = 77/86), the main intervention strategies were categorised as
counselling (n = 48), health education (n = 7), feedback (n = 7),
incentives (n = 4), and social support (n = 10). In one study the in-
tervention was classified as ’intensive dissemination’ as both arms
received the same counselling intervention, with only the dissem-
ination differing (Campbell 2006), and is therefore reported as a
separate comparison. In seven studies, the primary aim of the study
was to improve maternal health, which included a smoking ces-
sation component of counselling (El-Mohandes 2011); feedback
(Reading 1982; LeFevre 1995) and social support (Olds 1986;
Belizan 1995; Bullock 1995; Bullock 2009). These studies are re-
ported as separate comparisons and only smoking outcomes are
included, as there is potential for other aspects of these interven-
tions to impact on birth outcomes.
One trial was designed exclusively for women who had sponta-
neously quit smoking (Lowe 1997), and 11 trials included a relapse
prevention component for women who had spontaneously quit.
Interventions which were provided only during the postpartum
period were excluded from this review, though many interventions
during pregnancy continued support into the postpartum period
and measured postpartum outcomes.
Smoking cessation interventions implemented during pregnancy
differ substantially in their intensity, their duration, and the peo-
ple involved in their implementation. In 31/77 studies the inter-
vention was coded as a single intervention, therefore the ’main
intervention strategy’ most accurately reflects the type of interven-
tion. However in 33 studies the intervention was coded as ’multi-
ple’, where other components of the intervention were offered to
all women. In 12 studies the intervention was coded as ’tailored’
whereby different intervention components were offered and tai-
lored to women’s needs. For example, two trials offered optional
nicotine replacement therapy as part of a counselling intervention
(Hegaard 2003; Eades 2012), and one trial offered nicotine re-
placement therapy to both intervention and control participants
(Patten 2009).Most counselling studies involved face-to-face con-
tact, using a variety of strategies either alone or in combination
(such as motivational interviewing, cognitive behavioural therapy,
stages of change). Three trials with the main intervention strategy
coded as counselling included a lottery chance for women who re-
ported quitting (Sexton 1984; Walsh 1997; Parker 2007); five in-
cluded support for peers (Donatelle 2000; Solomon 2000; Hajek
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2001; Vilches 2009; Eades 2012) and three included support for
partners to quit (Thornton 1997; Vilches 2009; Eades 2012). The
duration and frequency of the intervention also varied consider-
ably, as illustrated in Figure 5 and Figure 6.
Figure 5. Duration of contact for each condition by publication year.
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Figure 6. Frequency of contact for each condition by publication year.
Thirteen of the counselling interventions involved telephone
counselling and in five of these studies all counselling was pro-
vided via telephone (Ershoff 1989; Bullock 1995; Solomon 2000;
Stotts 2002; Rigotti 2006), and one had only brief additional face-
to-face contact (Bullock 2009). Twenty-six studies included self-
help manuals as part of the intervention, and in five studies there
was a brief introduction to the manuals (less than five minutes)
and the intervention was therefore coded as counselling (Ershoff
1989; Messimer 1989; Price 1991; Valbo 1994; Moore 2002),
with sensitivity analysis conducted to assess the independent ef-
fect of these five studies. In six studies the intervention was pro-
vision of a video alone (Secker-Walker 1997; Cinciripini 2000),
with a brief intervention (Price 1991) or as part of a counselling
intervention (Walsh 1997; Manfredi 1999; Windsor 2011), and
these were also coded as counselling as the videos included sto-
ries from women. Five studies included use of computers in the
intervention, three of which were part of another main strategy
(Lawrence 2003; Vilches 2009; Ondersma 2012); one which in-
cluded interaction with a pregnancy care provider and was there-
fore coded as counselling (Tsoh 2010) and another in which the
computer-generated messages were the only intervention and was
therefore coded as health education (Strecher 2000). In one study
the provision of the self-help manual was the only intervention
(Hjalmarson 1991), and was therefore coded as health education
only as there was no explicit personal component to the interac-
tion. One study provided a mailed audiotape and self-help man-
ual only (Petersen 1992) and one study provided only automated
text-messaging (Naughton 2012); these were coded as health ed-
ucation, as there was no clear personal component. Three other
studies that reported the intervention consisted of advice to quit
only, either in person (Donovan 1977; Lilley 1986) or by post
(Burling 1991) were coded as health education.
Five dissemination trials were identified, carried out in Australia
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(Lowe 2002; Campbell 2006) and the US (Manfredi 1999; Pbert
2004; Windsor 2011), two of which reported only dissemination
outcomes (Manfredi 1999; Lowe 2002) and not the primary out-
comes of abstinence in late pregnancy, therefore outcomes not able
to be included in the meta-analysis are reported in Table 1. In 26
studies the intervention was provided by staff involved in routine
pregnancy care (coded as effectiveness studies), and in 43 studies
the intervention was provided by dedicated research project staff
(coded as efficacy studies), or via automated technology (n = 8),
(coded as unclear).
Comparisons
Women in the control arms in 44 of the 77 trials received in-
formation about the risks of smoking in pregnancy and were ad-
vised to quit as part of ’usual care’. In 16 of these 44 trials the
comparison/control group was described as receiving ’usual care’
without specifying further what constituted usual practice (at a
particular time and in a particular setting) with respect to advice
and assistance. In 31 trials the comparison group received some
kind of ’less intensive’ intervention, which included studies where
a dedicated research team consistently provided what they con-
sidered to be ’usual care’ for women in the comparison group. In
two studies the comparison group received an ’alternative inter-
vention’, which was categorised as having the same intensity as
the intervention group. One was a counselling intervention using
cognitive behavioural therapy compared with traditional health
education (Cinciripini 2010) and another compared provision of
incentives, contingent or not contingent on smoking status (Heil
2008). As expected, the intensity of interventions and controls has
increased over time, as indicated by the change in duration (Figure
5) and frequency of contact during the interventions (Figure 6).
Setting
Included trialswere conducted between1976 and2012 and almost
all trials were conducted in high-income countries. This includes
the USA (57), Canada (1), the UK (13), Norway (3), Sweden (1),
Holland (1), Spain (1), Australia (5), and New Zealand (2). Only
two trials have been conducted in middle-income countries: one
trial was conducted in four Latin American countries (Argentina,
Brazil, Cuba and Mexico) (Belizan 1995), and the other in Poland
(Polanska 2004). Neither trial had biochemically validated smok-
ing outcomes. Most trials of interventions to support pregnant
women were conducted in public hospitals or community ante-
natal clinics.
Outcomes reported
Primary outcomes
Sixty randomised controlled trials and 10 cluster-randomised tri-
als reported the primary outcome measure of smoking abstinence
in late pregnancy, up to and including the period of hospitalisation
for birth (21,948 women), and in 49 trials (including seven clus-
ter-randomised trials), the abstinence was biochemically validated.
Nineteen studies reported whether there was a differential effect
among women from different ethnic groups, socio-economic sta-
tus, or other factors such as depression or partner smoking. Nine
studies did not report any outcomes which could be included in
meta-analysis and a summary table of outcomes for these studies
is reported in Table 1.
Secondary outcomes included in meta-analysis
Fourteen trials reported continued abstinence in late pregnancy
among women who had quit spontaneously before the interven-
tion, one of which was a trial exclusively for women who had
spontaneously quit, so did not also report the primary outcome
(Lowe 1997).
Thirty-two trials reported continued abstinence in the postpartum
period at zero to five months (n = 26), six to 11 months (n =
13), 12 to 17 months (n = 5) and 18 months and over (n =
2). Two of these trials did not have outcomes in late pregnancy
as the assessment was undertaken at home after birth (Strecher
2000; Polanska 2004). Continued abstinence for baseline smokers
and spontaneous quitters are combined in this outcome measure
for some studies, with abstinence among baseline smokers only
reported where available. The details of the outcomes for each
study are reported in the Characteristics of included studies table.
Thirty-four trials reported various measures of smoking reduction
in late pregnancy, including self-reported ’any reduction’ (n = 7),
self-reported reduction greater than 50% (n = 5), and biochem-
ically validated reduction (n = 6). Two trials recorded both self-
reported and biochemically validated reduction (Windsor 1985;
Tappin 2005); in these cases we have included only the validated
data in the analysis. Other reduction measures of reduced smok-
ing included mean biochemical cotinine (n = 6) thiocyanate (n
= 1), or mean cigarettes per day (n = 20). Three studies that re-
ported smoking reduction did not include the primary outcomes
of smoking abstinence (Donovan 1977; LeFevre 1995; Vilches
2009).
Nineteen trials reported mean birthweight, one of which had not
reported any smoking cessation outcomes (Haddow 1991). Four-
teen trials reported rates of low birthweight babies (less than 2500
g) and three reported rates of very low birthweight babies (less
than 1500 g). Fourteen studies reported rates of preterm births less
than 37 weeks’ gestation (n = 14). Other trials reporting perinatal
outcomes included: perinatal deaths (n = 4), stillbirths (n = 7),
neonatal deaths (n = 4), and neonatal intensive care unit (NICU)
admissions (4).
Other perinatal outcome measures reported included fetal growth
(Cope 2003; Heil 2008), mean Apgar scores (Tuten 2012), and
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head circumference (Cope 2003).
Secondary outcomes included in narrative synthesis
Three trials measuredmode of birth (Thornton 1997; Cope 2003;
Tappin 2005).
Three trials measured breastfeeding initiation and/or duration (
Panjari 1999; McLeod 2004 and an associated reference to Heil
2008) (Higgins 2010a).
Nineteen studies reported baseline psychological measures of in-
terventions, three studies reported associations between smoking
outcomes and psychological measures, and nine studies reported
psychological outcomes.
No studies reported measures of family functioning. However
three studies reported perceptions of partner (McBride 2004)) and
peer support (Bullock 2009;Hennrikus 2010), and one study pro-
vided analysis of social networks (Stotts 2009).
Twenty-six trials addressed issues identified as important towomen
in a consultation for this review; with two associated references
(Berg 2008; Washio 2011) to included studies (Rigotti 2006; Heil
2008), reporting effects of smoking cessation on maternal weight
gain.
Seven studies explicitly included the views of women or commu-
nity in development of the intervention; and 32 trials reported
women’s views about the content or delivery of the intervention.
Three studies reported measures of knowledge, attitudes or prac-
tice among pregnancy care providers (Haug 1994; Secker-Walker
1994; Lawrence 2003).
Five studies reported cost-effectiveness measures (Windsor 1985;
Ershoff 1989; Dornelas 2006; Parker 2007; Heil 2008).
Two studies reported rates of women who reported an increase in
smoking (adverse events) (Haug 1994; Tappin 2005).
Excluded studies
Seventy-five studies did not meet the eligibility criteria and were
excluded from the review, for the following reasons:
• design not adequately randomised (e.g. cohort studies, pre-
post design, quasi-experimental designs);
• primary population was not pregnant women or
intervention was not primarily aimed at cessation during
pregnancy (e.g. postpartum interventions, intervention for
partners, non-pregnant women);
• trial evaluated efficacy of pharmacological treatment with
equal psychosocial support in both arms;
• cluster-randomised trials with insufficient information (e.g.
number of clusters) provided to enable adjustment for clustering.
See Characteristics of excluded studies for details.
Risk of bias in included studies
Allocation
Sequence generation was described and adequate in 35 trials. In
48 trials the sequence generation was not described or simply de-
scribed as ‘randomised’ so it was unclear whether this was ade-
quate or not. Three trials were included which had non-random
sequence generation, such as allocation bymedical record numbers
and birthdate, as it was considered the risk of interference with this
sequence is low. There are also many studies where the method
of sequence generation was not reported. Quasi-randomised tri-
als where there was a potential for interference, such as clinic at-
tendance day or other quasi-randomised methods were excluded
from this update of the review and the reasons are listed in the
Characteristics of excluded studies table.
Themethodof randomisationwas not described in sufficient detail
to permit assessment of whether the allocation was concealed at
the time of trial entry in 63 studies. In only 12 studies was the
allocation adequately concealed and in 11 studies there was clearly
no concealment of group allocation.
Equal baseline characteristics
As the sequence generation was not reported in the majority of
trials, we assessed whether the baseline characteristics were equal
and these were assessed as adequate in 37 studies, unclear (mi-
nor differences or not reported) in 33 studies, and inadequate or
significant differences in 16 studies. Of the 48 trials with unclear
sequence generation, 18 had equal baseline characteristics, seven
had unequal baseline characteristics and in 23 there were some
minor differences or the baseline characteristics were not reported.
Blinding
Very few trials had any blinding of participants or providers, as this
is not practicable in delivering most psychosocial interventions.
In 60 studies the participants and providers were clearly aware of
group allocation, it was unclear in 15 studies, and in one study
they were able to blind participants and/or providers to group
allocation.
Blinding of the outcome assessment was rarely reported and was
assessed as adequate in 11 studies, unclear in 74 studies, and in-
adequate in one study.
Incomplete outcome data
Withdrawals from the trials were common. When women were
recruited at their first antenatal visit some participants had a mis-
carriage or a termination of pregnancy before the timewhen smok-
ing behaviour was reassessed. These women were often excluded
from outcome measurement, which means that important out-
comes linked in observational studies to smoking exposure were
not ascertained. Assessing smoking at 20 to 28 weeks instead of
at 36 to 38 weeks would reduce the need to exclude women with
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particularly adverse outcomes, since their smoking status in mid-
pregnancy would have been ascertained before preterm birth or
a perinatal death had occurred. Others moved out of the area or
changed to another provider of care. The latter was a common
cause of attrition in those trials carried out among populations
characterised by severe poverty and the receipt of special needs
benefits such as Medicaid, or WIC (food program for women,
infants and children) clinics.
In studies where there was longer-term follow-up, attrition was
sometimes high; approximately half of the included studies had
high levels of missing data (greater than 20%) for some outcomes.
All randomised women were included in analysis for the primary
outcome (abstinence in late pregnancy) in 25 trials. In 41 trials,
some women were excluded from the analysis due to miscarriage
or pregnancy loss, or moving, and these were assessed as unclear
risk of attrition bias as there are some associations with smoking.
In 20 trials, primary outcome data were missing and were unable
to be included in this review, and they were assessed as inadequate
due to risk of attrition bias. Levels of attrition for each study
and information about any intention-to-treat analysis have been
reported in the ’Risk of bias’ tables .
Selective reporting
It was not clear in many trials the extent of outcome data that
were collected and therefore, unclear whether the outcomes were
selectively reported in 42 studies. All primary outcomes were ad-
equately reported in 30 studies, and 14 studies were assessed as
inadequately reporting primary outcomes.
Other potential sources of bias
Detection bias from misclassification by self-report
Fifty-two trials reported biochemical validation of the primary
outcome measure, smoking abstinence. In seven trials there was
unclear or partial validation of smoking status. Twenty-seven trials
measured smoking status by self-report and are included in this
review as ‘high risk’ of bias. Later trials more often relied on a def-
inition of smoking abstinence requiring biochemical validation.
Implementation of intervention
Some studies reported process evaluation demonstrating chal-
lenges implementing the intervention and delivering it to all
women (Walsh 2000). In 26 studies, process evaluation suggested
that the majority of women received the intervention as planned,
however 31 studies reported that many women had not received
the intervention as planned and in 29 studies it was unclear or not
reported.
Smoking cessation interventions implemented during pregnancy
differ substantially in their intensity, their duration, and the people
involved in their implementation.The timingof the final antenatal
assessment of smoking status varied considerably between trials
between the second and third trimester. Thismay have affected the
amount of time the participants were exposed to the intervention
(if it involved ongoing support), as well as the number of those
lost to follow-up and measurement of perinatal outcomes.
Exposure of the control group to the intervention
Another problem with trials in this area can be ’contamination’ or
exposure of the control group to intervention components, partic-
ularly if the study is being implemented in a routine care setting.
Fifty-eight trials were implemented by dedicated research staff or
technology and were assessed as having a low risk of exposing the
control group to the intervention. In 12 studies it was unclear, and
in 16 studies the authors reported problems with exposure of the
control group, or the intervention was provided by routine care
providers and the study design was assessed as having a ’high risk’
of control group exposure.
Other bias
No other risk of bias was suspected in 68 studies. However, in nine
studies there were some other risks, such as unequal recruitment
to study arms in cluster-randomised trials or financial conflicts of
interest, and in nine studies it was unclear if there may be other
risks of bias.
Change in ’usual care’
In many cases the comparison/control group was described as re-
ceiving ’usual care’ without specifying further what constituted
usual practice (at a particular time and in a particular setting) with
respect to advice and assistance. It can be seen from Figure 5 and
Figure 6 that current ’usual care’ may be a more substantial inter-
vention than the defined intervention in some of the earliest trials
(for example, Baric 1976).
A summary of Risk of bias’ assessments in the included trials is set
out in Figure 7 and Figure 8.
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Figure 7. ’Risk of bias’ summary: review authors’ judgments about each risk of bias item for each included
study.
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Figure 8. ’Risk of bias’ graph: review authors’ judgments about each risk of bias item presented as
percentages across all included studies.
Effects of interventions
A total of 88 meta-analyses are reported in this review. Meta-
analyses were conducted and are presented in data tables for a total
of 11 comparisons involving 59 outcomes. Data for comparisons
with only one study reporting an outcome are reported in text, but
not displayed. In addition, eight non-prespecified meta-analyses
conducted in Revman 5.2.5 were reported in text, to assess the
effect of factors identified during data extraction and coding (e.g.
where ’counselling’ involved provision of a videotape only). The
results of 21 meta-analyses conducted in SPSS 20 to assess risk
of bias and sensitivity analyses are also reported in text and not
reported in tables.
1. Primary outcome: Smoking abstinence in late
pregnancy
1.1 Comparisons: Main intervention strategy compared with
usual care, less intensive intervention, or an alternative
intervention, and subgrouped by single, multiple or tailored
components.
Table 3 presents a cross-tabulation of themain intervention strate-
gies and comparison type, for studies that report the primary out-
come. The large number of cells that have very few (i.e., n ≤ 2) or
zero studies means that it is not appropriate to run an interaction
analysis with these two variables. Therefore, the synthesis in this
section was not achieved through meta-analytic subgroup analy-
ses; rather, the synthesis is a description of trends in the weighted
pooled effect size estimate for subsets of studies based on the in-
tervention strategy, the comparison type, and the number of com-
ponents in the intervention (single component, multiple compo-
nents, and tailored components). As such, we cannot draw any
conclusions about statistical differences between subsets of studies
in this section.
1.1.1 Counselling versus usual care
In trials where the main intervention strategy was counselling and
the control group received ’usual care’, the difference between in-
tervention and control groups was significantly different from zero
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(27 studies; average risk ratio (average RR) 1.44, 95% confidence
interval (CI) 1.19 to 1.75), I2 = 55%, see Analysis 1.1.
In subsets of studies, the effect size estimate was significantly differ-
ent from zero where counselling was combined with other strate-
gies (11 studies; average RR 1.59, 95% CI 1.15 to 2.21), I2 = 45%
or tailored to the needs of individual women (six studies; average
RR 1.49, 95% CI 1.01 to 2.20), I2 = 75%, but the effect was un-
clear when counselling was provided as a single intervention (10
studies; average RR 1.12, 95% CI 0.89 to 1.42), I2 = 11%.
There was no significant difference in biochemically validated ab-
stinence in late pregnancy in a single study where smoking ces-
sation counselling was provided as part of a broader intervention
to improve maternal health (El-Mohandes 2011) and the control
group received usual care (RR 1.00, 95% CI 0.72 to 1.40). The
analysis for this comparison is not displayed in a table as only one
study met the criteria.
1.1.2 Counselling versus less intensive interventions
In trials where the main intervention strategy was counselling and
the control group received a less intensive intervention, the effect
size had borderline significance (16 studies; average RR 1.35, 95%
CI 1.00 to 1.82), I2 = 74%, see Analysis 2.1. In subsets of studies,
the effect size was significantly different from zero for the single
trial (Walsh 1997) where counselling was tailored to individual
needs (RR2.39, 95%CI 1.03 to 5.56), and included lottery tickets
for women who were abstinent from smoking, but there was no
clear difference where counselling was provided alone (n = 5), or
in combination with other strategies (n = 10).
1.1.3 Counselling versus alternative intervention
There was no significant effect in the single study (Cinciripini
2010) that compared one counselling strategy (CBT) to an alter-
native counselling intervention (traditional health education or
motivational interviewing) (RR 1.15, 95% CI 0.86 to 1.53). The
analysis for this comparison is not displayed in a table as only one
study met the criteria.
Other counselling subset analyses (not displayed)
In two studies where counselling was provided as part of a tailored
intervention that included optional nicotine replacement therapy
and was compared with usual care (Eades 2012; Hegaard 2003),
the effect was not significantly different from zero (average RR
1.63, 95% CI 0.25 to 10.50), I2 = 59%.
In two studies where ’counselling’ involved only provision of a
video tape (Secker-Walker 1997;Cinciripini 2000) comparedwith
a less intensive intervention, the effect was unclear as it was not
significantly different from zero and there was considerable het-
erogeneity (average RR 2.31, 95% CI 0.08 to 65.02), I2 = 78%,
and the effect on the subgroup of ’single’ counselling interventions
compared with usual care continued to be borderline non-signifi-
cant when these two studies were removed from the pooled results
(average RR 1.52, 95% CI 0.99 to 2.34). The effect was not sig-
nificantly different from zero in a single study (Price 1991), which
provided brief advice (less than five minutes) in conjunction with
provision of a video, compared with usual care (RR 3.94, 95% CI
0.45 to 34.41).
Five studies coded as counselling provided brief advice (less than
five minutes) and a self-help manual (Ershoff 1989; Messimer
1989; Price 1991; Valbo 1994;Moore 2002). Four of these studies
reported abstinence in late pregnancy and the combined effect was
not significantly different from zero (average RR 1.28, 95% CI
0.79 to 2.07), I2 = 54%.
Four studies coded as counselling included peer and/or partner
support as part of a tailored intervention (Solomon 2000; Hajek
2001; Vilches 2009; Eades 2012) compared with usual care, and
the combined effect of two studies that reported abstinence in
late pregnancy (Hajek 2001; Eades 2012) was not significantly
different from zero (average RR 1.09, 95% CI 0.82 to 1.44), I2 =
0%.
Three studies coded as counselling (tailored) included support for
partners to quit smoking (Thornton 1997; Vilches 2009; Eades
2012) compared with usual care, and two studies that reported
abstinence in late pregnancy (Thornton 1997; Eades 2012) did
not show a combined effect that was significantly different from
zero (average RR 1.23, 95% CI 0.66 to 2.31), I2 = 0%.
Three studies coded as multiple or tailored counselling that in-
cluded a lottery chance for women who reported abstinence
(Sexton 1984; Walsh 1997; Parker 2007) had a combined effect
that was significantly different from zero (average RR 1.98, 95%
CI 1.61 to 2.42), I2 = 6%. Two studies that measured self-re-
ported abstinence compared with usual care (Sexton 1984) and
a less intensive intervention (Parker 2007) showed a significant
effect (average RR 1.69, 95% CI 1.21 to 2.36), and the effect of
the single study that reported biochemically validated abstinence
(Walsh 1997) was also significantly different from zero (RR 2.39,
95% CI 1.03 to 5.56).
1.1.5 Health education versus usual care
For studies in which the main intervention strategy was health
education and the control group received usual care, the pooled
effect size estimate was not significantly different from zero (three
studies; average RR 1.51, 95% CI 0.64 to 3.59), I 2= 28%, see
Analysis 3.1. The effect size estimate was not significant in subsets
of trials where health education was provided alone (n = 2) or in
combination with other strategies (n = 1); or when the analysis was
restricted to studies with biochemical validation of abstinence, see
Analysis 3.2.
1.1.6 Health education versus less intensive interventions
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The effect was not significantly different from zero in trials where
health education was compared with a less intensive intervention
(two studies; average RR 1.50, 95%CI 0.97 to 2.31), I2 = 0%, and
there was little difference whether health education was provided
alone (n = 1), or in combination with other strategies (n = 1), see
Analysis 4.1.
Other health education subset analyses (not displayed)
Two studies coded as health education involved provision of self-
help manuals with no additional advice (Hjalmarson 1991) or an
audiotape (Petersen 1992) and the combined effect was not sig-
nificantly different from zero (average RR 1.28, 95% CI 0.79 to
2.07), I2 = 7%. When these studies were removed from the health
education subgroup, the combined effect of the remaining three
studies (Lilley 1986; Burling 1991; Naughton 2012) was statisti-
cally significantly different from zero (average RR 1.93, 95% CI
1.01 to 3.69), I2 = 0%.
A single study coded as health education that provided advice
via a computer (Strecher 2000), compared with a less intensive
intervention reported an effect that was not significantly different
from zero in abstinence at six weeks postpartum (RR 1.00, 95% CI
0.91 to 1.09).
The effect of a single study coded as health education that pro-
vided advice and motivational statements via text compared with a
less intensive intervention (Naughton 2012), was not significantly
different from zero (RR 1.59, 95% CI 0.68 to 3.73).
1.1.7 Feedback versus usual care
For the two trials where the main intervention was feedback, pro-
vided in combination with other strategies, and the control group
received usual care (Valbo 1994; Cope 2003), the combined ef-
fect size estimate was significantly different from zero (average RR
4.39, 95% CI 1.89 to 10.21), I = 0%, see Analysis 5.1.
The effect of self-reported smoking abstinence in late pregnancy
was not significantly different from zero in a single study that pro-
vided ultrasound feedback alone (with no smoking cessation ad-
vice) as part of a broader intervention to improve maternal health
and usual care for the control group (Reading 1982) (RR 2.11,
95% CI 0.98 to 4.52). The analysis for this comparison is not
displayed in a table as only one study met the criteria.
1.1.8 Feedback versus less intensive interventions
Two studies assessed the effectiveness of feedback compared with
less intensive interventions. The effect size estimates of both studies
- one in which feedback was provided alone (Bauman 1983) and
one in which feedback was provided in combination with other
strategies, for women still smoking in late pregnancy (Stotts 2009),
were not significantly different from zero; (average RR 1.19, 95%
CI 0.45 to 3.12), I = 49%, see Analysis 6.1.
1.1.9 Incentives versus usual care
There was no significant difference in rates of biochemically val-
idated abstinence in the pooled results of two studies where the
main intervention strategy was financial incentives and the con-
trol group received usual care (average RR 3.59, 95% CI 0.10 to
130.49). However, there was significant heterogeneity ( I2 = 82%)
and interaction between the subgroups (Chi2 4.03, P = 0.04), so
caution is needed considering the combined effect of these tri-
als. The analysis included a trial of incentives (single interven-
tion) (Tuten 2012) (RR 20.72, 95% CI 1.28 to 336.01) and a
trial of ’low intensity’ incentives (multiple intervention) provided
with assistance of a computer program and counselling via a com-
puterised program (Ondersma 2012) (RR 0.90, 95% CI 0.25 to
3.23), see Analysis 7.1.
1.1.10 Incentives versus less intensive or alternative
interventions
The effect was significantly different from zero in the single trial
where incentives were provided in combination with peer sup-
port and the control group received a less intensive intervention
(Donatelle 2000) (RR 3.64, 95% CI 1.84 to 7.23). The analysis
for this comparison is not displayed in a table as only one study
met the criteria.
The effect was also significantly different from zero in the single
study where the intervention group received incentives contingent
on smoking status (single intervention), and the control group
received an equally intensive alternative intervention of incentives
which were not contingent on smoking status (Heil 2008) (RR
4.05, 95% CI 1.48 to 11.11). The analysis for this comparison is
not displayed in a table as only one study met the criteria.
Another trial of incentives included a second comparison arm of
non-contingent incentives (Tuten 2012), which demonstrated a
significant effect (RR 18.21, 95% CI 1.33 to 294.43), although
this effect size estimate was not included in themeta-analysis (only
the comparison with the usual care condition was included in the
meta-analyses in this review).
1.1.11 Social support versus less intensive interventions
The combined effect size estimate of six trials where the main in-
tervention strategy included peer or partner (social) support and
the control group received a less intensive intervention was not
significantly different from zero (average RR 1.29, 95% CI 0.94
to 1.78), I = 18%, see Analysis 8.1. However, the effect was sig-
nificantly different from zero in five trials which included peer
support (average RR 1.49, 95% CI 1.01 to 2.19), I2 = 3%, see
Analysis 8.2. In the single trial where the intervention involved
partner support (McBride 2004), there was no significant effect
in self-reported abstinence (RR 1.02, 95% CI 0.70 to 1.50).The
analysis for this comparison is not displayed in a table as only one
study met the criteria.
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1.1.12 Social support as a component of a broader maternal
health intervention versus usual care
The effect size was significantly different from zero in one study
where tailored peer support was provided as part of a broader
intervention to improvematernal health and compared with usual
care (RR 1.83, 95% CI 1.22 to 2.73), see Analysis 9.1. A further
study in which tailored peer support was provided as part of a
broader intervention to improve maternal health and compared
with usual care with biochemically validation smoking cessation
(Olds 1986) had zero events in both study arms and the effect size
estimate was therefore ’not estimable’ in Revman 5.2.5. As such,
we could not calculate a pooled effect for this comparison.
1.1.13 Social support as a component of a broader maternal
health intervention versus less intensive intervention
There was no significant effect in two studies where telephone peer
support was provided as part of a broader intervention to improve
maternal health, and the control group received a less intensive
intervention (average RR 0.80, 95%CI 0.46 to 1.39); see Analysis
10.1 and Analysis 10.2.
1.2 Subgroup analyses
The following subgroup analyses were conducted on the whole
dataset using all studies for the primary outcome (smoking ab-
stinence in late pregnancy) (see Analysis 11.1 for list of studies).
These analyses were conducted in SPSS using Winsorised data.
1.2.1 Subgroup analysis 1: Main intervention strategy
Three of the main intervention strategy subgroups had pooled ef-
fect size estimates that were significantly different from a null ef-
fect, indicating that abstinence in late pregnancy was significantly
greater in the treatment than in the control group for these strate-
gies: incentives (four studies; average RR 2.95, 95% CI 1.55 to
5.63, I2 = 15%), feedback (five studies; average RR 2.08, 95% CI
1.23 to 3.50, I2 = 26%), and counselling (45 studies; RR 1.36,
95% CI 1.17 to 1.57, I2 = 0%). However, there was no signifi-
cant difference between treatment and control groups in subgroup
analyses of trials where the main intervention strategy was social
support (10 studies; average RR 1.29, 95% CI 0.92 to 1.80, I2 =
0%), or health education (five studies; RR 1.50, 95% CI 0.90 to
2.51, I2 = 0%). There was not a significant between-group differ-
ence (QB (4) = 7.70, P = 0.10) and there was within-group homo-
geneity (as indicated by low I2 in each subgroup and non-signif-
icant Q-statistics for each subgroup; overall QW (64) = 57.86, P
= 0.69). One study, Campbell 2006, was treated as missing from
this analysis as the intervention type category was unclear.
1.2.2 Subgroup analysis 2: Comparison type
We conducted a subgroup analysis to test for differences in the
pooled effect size estimate of studies grouped by their comparison
type. As there were only two studies with alternative intervention
comparators that also reported the primary outcome, we used a
pooled estimate of the between-study variance (τ 2) following the
method described in Borenstein 2009. The results suggests that
there is no statistically significant difference between effect size
estimates grouped by comparison type (QB (2) = 1.53, P = 0.47).
Studies with comparisons consisting of usual care comparisons
had the highest pooled effect size estimate (37 studies; average RR
1.34, 95% CI 1.25 to 1.44), I2 = 53%, followed by less intensive
interventions (30 studies, average RR 1.20, 95%CI 1.08 to 1.31),
I2 = 64%, and the effect size estimate for studies with an alternative
intervention comparisons was not statistically different from zero
(two studies, average RR 1.26, 95% CI 0.98 to 1.53), I2 = 82%.
Forest plot not shown. It should be noted that studies where the
comparison group received only ’usual care’ were also more likely
to provide a low intensity intervention, as shown in Figure 5 and
Figure 6, and discussed below.
1.2.3 Subgroup analysis 3: Biochemically validated versus
self-report outcomes
Given concerns about the potential biases (e.g. social desirabil-
ity bias) of self-report measures of smoking behaviours, we con-
ducted a subgroup analysis comparing biochemically validated
smoking abstinence and self-reported abstinence. The results sug-
gest that there is no statistically significant difference between the
two groups of effect sizes (QB (1) = 0.06, P = 0.80; QW (67) =
61.33, P = 0.67), and there was a similar pooled effect size es-
timate for biochemically validated outcomes (49 studies; average
RR 1.43, 95% CI 1.22 to 1.67, I2 = 0%), compared to self-re-
ported outcomes (20 studies; average RR 1.48, 95% CI 1.17 to
1.87, I2 = 11%). Although this does not help us to explain the
significant heterogeneity in the dataset, it gives us greater confi-
dence in combining self-report with biochemically validated out-
comes in further analyses. One study, Thornton 1997, was treated
as missing from this analysis as the use of biochemical validation
was unclear.
1.2.4 Subgroup analysis 4: Intensity of the intervention
There was no significant difference between effect sizes estimates
subgrouped according to the frequency of contact in the interven-
tion (QB (5) = 8.88, P = 0.11); see Table 4 for the pooled effect
size estimates by group. Moreover, there was no significant differ-
ence between effect sizes estimates subgrouped according to the
duration of contact in the intervention (QB (5) = 5.43, P = 0.37);
see Table 5 for the pooled effect size estimates by group.
To explore whether the difference in intensity between conditions
was a significant predictor of the outcome, a meta-regression was
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conducted. The model included two predictor variables: the dif-
ference between the intervention and control group frequency of
contact categorisations, and the difference between the interven-
tion and control group duration of contact categorisations. The
analyses indicated that neither the magnitude of the difference in
duration nor frequency of contact significantly predicted the pri-
mary outcome (QM (2) = 0.17, P = 0.92; QR (65) = 63.14, P =
0.54;R2 = 0.00).
1.2.5 Subgroup analysis 5: Features of the intervention (self-
help manuals and telephone support)
A meta-regression with two dichotomous predictor variables - the
use of self-help manuals and the availability of telephone support
- was conducted. Of the studies that reported the primary out-
come, 24 studies offered self-help materials to participants and
13 provided telephone support (three of these offered both). The
analyses indicated that neither self-help materials (B = -0.14, SE =
0.13) nor telephone support (B = -0.14, SE = 0.15) significantly
predicted the primary outcome (QM (2) = 1.83, P = 0.40; QR (67)
= 63.54, P = 0.60;R2 = 0.03).
1.2.6 Subgroup analysis 6: Socio-economic status (SES) of
the participants
For the primary outcome of abstinence in late pregnancy, there
was no significant difference between the two groups of studies
with women categorised as ’low’ or ’not low’ SES (QB (1) = 0.11, P
= 0.74). The pooled effect size estimate for interventions provided
for women categorised as ’low’ SES interventions was similar (44
studies; average RR 1.41, 95% CI 1.19 to 1.66, I2 = 1%), to
those provided for women categorised as ’not low’ SES (26 studies;
average RR 1.47, 95% CI 1.21 to 1.79, I2 = 0%).
1.2.7 Subgroup analysis 7: Newly included studies in this
review update
Of the 70 studies reporting smoking abstinence in late pregnancy
outcomes, 50 came from studies in the previous review (Lumley
2009), while 20 were from new studies identified in the updated
search. We conducted this subgroup analysis to address concerns
that newer trials may have a reduced effect due to the increased
information about the risks of smoking in pregnancy in the general
population. Although effect sizes from the newly-included studies
tended to be lower (20 studies; average RR 1.26, 95% CI 1.00 to
1.59, I2= 3%), than those from the previous version of the review
(50 studies; average RR 1.50, 95% CI 1.30 to 1.73, I2= 0%),
this difference was not statistically significant (QB (1) = 1.51, P =
0.22).
1.3 Description of trends in intervention effectiveness:
dissemination trials (not displayed)
There were five dissemination trials, defined as trials where the
intervention was provided at an organisational level and strate-
gies were employed to influence the practice of pregnancy care
providers (Manfredi 1999; Lowe 2002; Pbert 2004; Campbell
2006; Windsor 2011). The combined effect of three trials that re-
ported abstinence in late pregnancy (Pbert 2004; Campbell 2006;
Windsor 2011) was not significantly different from zero (average
RR 0.96, 95% CI 0.37 to 2.50), I2 = 72%.
1.4 Description of trends in intervention effectiveness:
ethnic and aboriginal participants (not displayed)
The synthesis in this section was not achieved through meta-an-
alytic subgroup analyses; rather, the synthesis is a description of
trends in the weighted pooled effect size estimate for subsets of
studies based on ethnicity of the participants. As such, we cannot
draw any conclusions about statistical differences between subsets
of studies in this section.
The combined effect of five studies (four counselling trials, one
incentives trial) among women predominantly from a minority
ethnic group (African-American and/or Hispanic) that reported
abstinence in late pregnancy was not significantly different from
zero (average RR 1.08, 95% CI 0.83 to 1.40), I2 = 0%. Of those
five trials, three were conducted with African-American women
(Gielen 1997; El-Mohandes 2011; Ondersma 2012) (average RR
1.01, 95% CI 0.75 to 1.37), I2 = 0%. The effect size estimate
in a single trial among African-American and Hispanic women
(Lillington 1995) was not significantly different from zero (RR
1.97, 95% CI 0.70 to 5.50). A single trial of social support de-
veloped specifically for Hispanic women in this review (Malchodi
2003) did not demonstrate a significant effect size estimate (RR
1.12, 95% CI 0.61 to 2.06).
The combined effect for the two tailored counselling interven-
tions provided for aboriginal women in Australia (Eades 2012)
and Canada (Patten 2009) did not show a significant difference
between treatment and control groups in rates of abstinence in
late pregnancy (average RR 0.40, 95% CI 0.06 to 2.67), I2 = 0%.
1.5 Description of participant characteristic analyses
reported by study authors
The following is a narrative synthesis of the findings of subgroup
analyses reported by primary study authors.
Low socio-economic status (SES)
Of seven studies which reported sensitivity analysis by a measure
of SES, four reported lower abstinence rates or a negative associ-
ation with quitting among women with lower SES (Baric 1976;
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McLeod 2004; Pbert 2004; Rigotti 2006), two reported no signif-
icant difference (Ershoff 1989; Tappin 2005), and one study re-
ported 4/5 successful quitters had not graduated from high school
(Secker-Walker 1997).
Ethnicity or race
Of nine studies which reported outcomes or sensitivity analysis by
ethnic status, one study reported the intervention was less effective
among Hispanic and African-American women (Kendrick 1995),
one study reported the intervention was less effective among His-
panic compared to African American women (Lillington 1995),
three studies reported no difference in outcomes by race or eth-
nicity (Burling 1991; Strecher 2000; Dornelas 2006), and four
studies reported higher quit rates among African-American and/
or Hispanic women compared to other women (Petersen 1992;
Windsor 1993; Pbert 2004; Parker 2007).
Depression
Two studies that reported outcomes by rates of depression reported
a negative association between smoking abstinence and depression
(Cinciripini 2000; Rigotti 2006).
Low social support
Three studies that reported measures of social support reported a
negative association with low social support (e.g. single mothers)
and quitting (Loeb 1983; Thornton 1997; Rigotti 2006).
Partner smoking
Of four studies reporting associations with partner smoking and
abstinence in late pregnancy, two reported no significant difference
(Rigotti 2006; Stotts 2009) and two reported a negative association
(i.e. lower rates of quitting amongwomenwhose partners’ smoked)
(McLeod 2004; Polanska 2004).
1.6 Sensitivity analysis
1.6.1 Efficacy versus effectiveness trials
Given concerns about whether clinical trial efficacy will translate
to clinical effectiveness when implemented in healthcare practice
(Walsh 2000), we conducted a sensitivity analysis to determine
whether effectiveness studies (defined as those assessing the imple-
mentation of an intervention that uses existing service providers)
demonstrate a beneficial outcome. That is, efficacy trials (those
provided by dedicated research staff, n = 43) were excluded from
the analysis. The frequencies of key variables for the 26 effective-
ness studies (three of which did not report the primary outcome
and so were not included in the aforementioned analysis) are pre-
sented in Table 6. For the 23 effectiveness trials with primary out-
come data, the pooled effect size estimate significantly favoured
the intervention group (average RR 1.42, 95% CI 1.11 to 1.82).
This group of studies, however, was substantially heterogeneous
(I2 = 67%; Q (22) = 66.37, P < .001). The pooled effect size esti-
mate for effectiveness studies is very similar to the overall pooled
effect size estimate (average RR 1.44, 95% CI 1.27 to 1.63) of
the full sample (n = 70), although the effectiveness studies have
a wider confidence interval and slightly greater heterogeneity. We
can therefore conclude that our overall pooled effect size estimate
(n = 70 studies) is not likely to be an over-estimate, although the
addition of the efficacy trials introduced greater precision to the
estimate.
1.6.2 Assessment of risk of bias across studies
Random sequence generation selection bias
Not calculable due to insufficient numbers of studies with high
risk of bias. Twenty-seven studies were classified as low risk of bias,
three were high risk of bias, and the remainder were unclear.
Allocation concealment selection bias
Ten studies were classified as low risk of bias, 11 were high risk
of bias, and the remainder were unclear. There was no significant
between-group heterogeneity (QB (2) = 5.22, P = 0.07), although
high risk studies had a larger pooled effect size estimate (averageRR
2.11, 95% CI 1.48 to 3.00, I2= 0%) compared to low-risk studies
(average RR 1.33, 95% CI 0.99 to 1.79, I2= 0%), or unclear bias
studies (average RR 1.36, 95% CI 1.17 to 1.58, I2= 1%).
Incomplete outcome data attrition bias
Twenty-two studies were classified as low risk of bias, 13 were
high risk of bias, and the remainder were unclear. There was no
significant between-group heterogeneity (QB (2) = 0.13, P = 0.94).
The mean effect size was largest for studies rated as high on this
type of bias (average RR 1.47, 95% CI 1.09 to 1.99, I2= 0%),
followed by unclear risk of bias (average RR 1.45, 95% CI 1.22
to 1.73, I2= 0%), and low risk of bias (average RR 1.39, 95% CI
1.10 to 1.75, I2= 13%).
Selective reporting bias
Twenty-nine studies were classified as low risk of bias, eight were
high risk of bias, and the remainder were unclear. There was no
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significant between-group heterogeneity (QB (2) = 3.56, P = 0.17).
The mean effect size was largest for studies rated as low on this
type of bias (average RR 1.67, 95% CI 1.34 to 2.06, I2= 0%),
followed by high risk of bias (average RR 1.50, 95% CI 1.09 to
2.08, I2= 0%), and unclear risk of bias (average RR 1.28, 95% CI
1.08 to 1.52, I2= 0%).
Detection bias (biochemical validation of smoking abstinence)
Forty-nine studies were classified as low risk of bias, 20 were high
risk of bias, and onewas unclear. There was no significant between-
group heterogeneity (QB (1) = 0.06, P = 0.80). The mean effect
size was similar, but largest, for studies rated as high on this type of
bias (average RR 1.48, 95% CI 1.17 to 1.87, I2= 11%), followed
by low risk of bias (average RR 1.43, 95% CI 1.22 to 1.67, I2=
0%); the one unclear study was treated as missing in this analysis.
Blinding of participants and personnel performance bias
Not calculable due to insufficient numbers of studies with low risk
of bias.
Blinding of outcome assessment detection bias
Not calculable due to insufficient numbers of studies with high or
low risk of bias.
Other bias (such as unequal recruitment to study arms in
cluster trials; potential conflict of interest)
Fifty-four studies were classified as low risk of bias, eight were
high risk of bias, and the remainder were unclear. There was no
significant between-group heterogeneity (QB (2) = 1.28, P = 0.53).
The mean effect size was largest for studies rated as low on this
type of bias (average RR 1.47, 95% CI 1.28 to 1.69, I2= 0%),
followed by high risk of bias (average RR 1.38, 95% CI 0.96 to
1.99, I2= 0%), and unclear risk of bias (average RR 1.18, 95% CI
0.82 to 1.70, I2= 0%).
Incomplete implementation
Twenty-two studies were classified as low risk of bias, 27 were high
risk of bias, and the remainder were unclear. There was a significant
between-group difference for this type of bias (QB (2) = 7.07, P
= 0.03), though this is due to the difference in studies coded as
’unclear’ (average RR 1.87, 95% CI 1.47 to 2.38, I2= 0%). Low
risk of bias studies, assessed as having good implementation, had
a similar effect size (average RR 1.33, 95% CI 1.10 to 1.62, I2=
17%) to high risk of bias studies (average RR 1.27, 95% CI 1.06
to 1.51, I2= 0%).
Equal baseline characteristics in study arms
Thirty studies were classified as low risk of bias, 15 were high risk
of bias, and the remainder were unclear. There was no significant
between-group heterogeneity for this type of bias (QB (2) = 4.79,
P = 0.09). The mean effect size was largest for studies with unclear
risk of this type of bias (average RR 1.67, 95% CI 1.33 to 2.10, I
2= 20%), followed by low risk of bias (average RR 1.45, 95% CI
1.21 to 1.74, I2= 0%), and high risk of bias (average RR 1.13,
95% CI 0.86 to 1.47, I2= 0%).
Contamination of control group
Forty-nine studies were classified as low risk of bias, 13 were high
risk of bias, and the remainder were unclear. There was no signifi-
cant between-group heterogeneity (QB (2) = 2.12, P = 0.35). The
mean effect size was largest for studies with unclear risk of this
type of bias (average RR 1.50, 95% CI 1.07 to 2.11, I2= 0%), fol-
lowed by low risk of bias (average RR 1.48, 95% CI 1.28 to 1.71,
I2= 0%), and high risk of bias (average RR 1.19, 95% CI 0.90 to
1.56, I2= 29%), which were not significantly different from the
null effect.
2. Secondary outcomes
2.1 Relapse prevention
In examining trends in separate comparisons of studies, the ef-
fect was not statistically different from zero in eight trials where
the intervention was counselling and the control group received
usual care (average RR 1.06, 95% CI 0.93 to 1.21; see Analysis
1.3) or four trials comparing counselling with a less intensive in-
tervention (average RR 1.05, 95% CI 0.98 to 1.13; see Analysis
2.3). Single studies comparing health education with usual care
(Petersen 1992) and social support with a less intensive interven-
tion (McBride 2004) also did not show a significant difference
between intervention and control groups (RR 0.97, 95% CI 0.71
to 1.31 and RR 1.02, 95% CI 0.89 to 1.16, respectively), figures
not displayed as comparisons as only single studies.
2.2 Continued abstinence in the postnatal period
2.2.1 Zero to five months
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In examining trends in separate comparisons of studies, a signifi-
cant difference in abstinence at zero to five months was seen be-
tween intervention and control groups only in trials where coun-
selling was compared with usual care (10 studies; average RR 1.76,
95%CI 1.05 to 2.95, see Analysis 1.4). However there was consid-
erable heterogeneity between trials (I2 = 83%) and subgroups (Chi
2 25.05 P < 0.0001), so these results should be considered with
caution. Within this comparison, there was a significant effect in
single interventions (average RR 1.52, 95% CI 1.13 to 2.05) and
multiple interventions (average RR 2.32, 95% CI 1.44 to 3.72),
but not in the single tailored intervention (average RR 0.88, 95%
CI 0.80 to 0.97). There was also a significant difference in ab-
stinence in a single trial where incentives were compared with an
alternative intervention (Heil 2008) (RR 9.73, 95% CI 1.29 to
73.13, analysis not displayed in a table as only one study met the
criteria).
However, the difference between intervention and control groups
was not statistically significant in trials where: counselling was
compared with a less intensive intervention (six studies; average
RR 1.17, 95% CI 0.82 to 1.66; see Analysis 2.4); or where social
support was comparedwith a less intensive intervention (two stud-
ies; average RR1.36, 95%CI 0.46 to 4.07; see Analysis 8.3); There
was also no clear effect where health education was compared with
a less intensive intervention (two studies; average RR 1.29, 95%
CI 0.52 to 3.22, see Analysis 4.2), but there is considerable hetero-
geneity in this comparison (I2 = 93%, Chi2 = 25.03, P < 0.0001),
so these pooled results should be considered with caution. No sig-
nificant difference between intervention and control groups was
noted in single studies (analyses not displayed in a table as only
one study met the criteria) comparing two alternative counselling
interventions (Cinciripini 2010) (RR 1.05, 95%CI 0.63 to 1.76);
health education versus usual care (Petersen 1992) (RR 1.02, 95%
CI 0.75 to 1.38); or counselling as part of a broader intervention
to improve maternal health (El-Mohandes 2011) (RR 1.46, 95%
CI 0.97 to 2.19); or where social support was provided as part of a
broader strategy to improve maternal health (Bullock 2009) (RR
0.96, 95% CI 0.51 to 1.81).
2.2.2 Six to 11 months
In examining trends in separate comparisons of studies, the effect
bordered on a significant difference from zero between interven-
tion and control groups in a separate comparison of counselling
and usual care (six studies; average RR 1.33, 95% CI 1.00 to 1.77;
Analysis 1.5), but not when counselling was compared with a less
intensive intervention (three studies; average RR 1.08, 95% CI
0.83 to 1.40, see Analysis 2.5 . Additionally, there was not a signifi-
cant difference between intervention and control groups when so-
cial support was compared with a less intensive intervention (two
studies; average RR 1.09, 95% CI 0.83 to 1.42; see Analysis 8.4),
or in single studies comparing two alternative counselling inter-
ventions (Cinciripini 2010) (RR 0.76, 95% CI 0.33 to 1.73) or
contingent and non-contingent incentives (Heil 2008) (RR 3.24,
95% CI 3.24, 95% CI 0.35 to 29.82) (results not displayed as
there was only one study in these comparisons).
2.2.3 12 to 17 months
In examining trends in separate comparisons of studies, there was
a significant difference between the treatment and control in the
two trials comparing counselling versus usual care (average RR
2.20, 95% CI 1.23 to 3.96, see Analysis 1.6), but not in two trials
where counselling was compared with a less intensive intervention
(RR 1.25, 95% CI 0.71 to 2.20, see Analysis 2.6); or a single trial
(McBride 2004) where a multiple social support intervention was
compared with a less intensive intervention (RR 1.22, 95% CI
0.92 to 1.64, analysis not displayed in a table as only one study
met the criteria).
2.2.4 18+ months
Two trials of counselling combined with other strategies, and
compared with usual care, measured self-reported continued ab-
stinence beyond 17 months postpartum (Secker-Walker 1994;
Lawrence 2003). However, no significant difference was reported
between intervention and control groups (average RR 1.25, 95%
CI 0.57 to 2.73, see Analysis 11.7).
2.3 Smoking reduction
No significant biochemically validated reductions were reported
in any comparisons, including a comparison of counselling with
usual care (three studies; RR 1.11, 95% CI 0.54 to 2.26, see
Analysis 1.8) or counselling with less intensive interventions (two
studies; RR 1.35, 95% CI 0.98 to 1.87, see Analysis 2.8). No sig-
nificant difference in biochemically validated reduction was seen
in single study by Tuten 2012 (analyses not displayed in a table as
only one study met the criteria) comparing incentives with usual
care (RR 7.62, 95%CI 1.92 to 30.25), which also demonstrated a
significant difference between intervention and control groups in
mean cotinine (standardised mean difference (SMD) -0.87, 95%
CI -1.36 to -0.39). El-Mohandes 2011, comparing counselling as
part of a broader maternal health strategy similarly did not report
a significant difference between intervention and control groups
in mean cotinine (SMD 0.11, 95% CI -0.17 to 0.39). The differ-
ence was also statistically different from zero for one study (Sexton
1984) measuring mean thiocynate (SMD -0.29, 95% CI -0.44 to
-0.15), but not for mean cotinine (SMD -0.05, 95% CI -0.14 to
0.05), see Analysis 1.10.
There was also no statistically significant difference in self-reported
reduction in smoking (mean cigarettes per day) seen in compar-
isons of: counselling and less intensive interventions (two stud-
ies; SMD -0.11, 95% CI -0.30 to 0.09, see Analysis 2.9); or
health education compared with usual care (two studies, pooled
effect not calculated due to considerable heterogeneity I2 = 76.8%,
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see Analysis 3.3). No difference in self-reported smoking (mean
cigarettes per day) was also seen in several single studies (results not
displayed as only one study met criteria), including: Hjalmarson
1991, which compared health education with a less intensive in-
tervention (SMD0.02, 95%CI -0.15 to 0.18); Tuten 2012 which
compared incentives with usual care (SMD -0.23, 95% CI -0.69
to 0.23); LeFevre 1995 which compared feedback as part of a
broader maternal health intervention with usual care (SMD 0.23,
95% CI 0.16 to 0.30); or Bullock 1995 which compared social
support as part of a broader maternal health intervention with a
less intensive intervention (SMD 0.15, 95% CI -0.34 to 0.64).
The difference was not significantly different from zero in self-
reported reduction (over 50%) in a single study (Hartmann 1996)
which compared counselling and usual care (RR 1.59, 95% CI
0.98 to 2.57); or (Solomon 2000) which compared social support
with a less intensive intervention (RR 0.96, 95%CI 0.64 to 1.44).
Similarly, no difference in self-reported ’any’ reduction in smoking
was seen in a single study (Reading 1982) where feedback as part
of a broader maternal intervention was compared with usual care
(RR 0.95, 95% CI 0.42 to 2.18).
However, significant differences in self-reported reductions in
smoking were seen in separate comparisons of: counselling and
usual care for ’any self-reported reduction’ (two studies; average
RR 1.61, 95% CI 1.06 to 2.43, Analysis 1.9) and mean cigarettes
per day (nine studies; SMD-0.25, 95%CI -0.46 to -0.03, Analysis
1.11); counselling and less intensive interventions (two studies;
average RR 1.35, 95% CI 1.07 to 1.71, Analysis 2.7); feedback
and usual care (two studies; average RR 1.69, 95% CI 1.24 to
2.31, see Analysis 5.2); and social support as part of a broader ma-
ternal health intervention with usual care in mean cigarettes per
day (SMD -0.28, 95% CI -0.45 to -0.11, see Analysis 9.2). One
single study comparing feedback and usual care (Valbo 1994) also
reported a significant reduction in mean cigarettes per day (RR
-0.63, 95% CI -1.03 to -0.24; results not displayed as only one
study in comparison).
2.4 Infant outcomes
As a primary objective of this review is to determine if psychosocial
interventions to support women to stop smoking in pregnancy
have an impact on infant and maternal health outcomes, and large
numbers are needed to detect relatively rare events, the pooled in-
fant outcomes are included in this section of the review. These out-
comes demonstrate the relationship between being randomised to
a smoking cessation intervention and birth outcomes only, rather
than the effectiveness of any particular intervention strategy.
2.4.1 Low birthweight
The pooled results of 14 trials which reported lowbirthweight (less
than 2500 g) demonstrated a significant reduction (average RR
0.82, 95%CI 0.71 to 0.94; see Analysis 11.11). This pooled effect
represents the following intervention strategies: eight counselling,
two health education, one feedback, two incentives, and one so-
cial support. The number needed to treat for benefit (NNTB)
in terms of low birthweight is 61, with a 95% CI of 38 to 204.
Presented in a different way, nine out of every 100 participants in
the control group experienced low birthweight births, compared
to seven (95% CI six to eight) out of 100 for the intervention
group. In contrast, there was no significant difference in three trials
(two counselling and one feedback intervention) which reported
infants born very low birthweight (less than 1500 g) (average RR
1.11, 95% CI 0.62 to 2.01, see Analysis 11.12).
In separate comparisons of studies, the effect was no longer signif-
icantly different from zero in smaller comparisons of counselling
and usual care (six studies; average RR 0.87, 95% CI 0.70 to 1.08,
see Analysis 1.12) or less intensive interventions (two studies; av-
erage RR 0.58, 95% CI 0.32 to 1.04, see Analysis 2.10), as large
sample sizes are required to detect a significant difference in this
outcome. There was no significant effect on the proportion of in-
fants born low birthweight (less than 2500 g) in any of the single
studies (results not displayed in tables) comparing: health educa-
tion and usual care (Donovan 1977) (RR 1.10, 95% CI 0.66 to
1.84) or a less intensive intervention (Hjalmarson 1991) (RR0.60,
95% CI 0.28 to 1.29); feedback and usual care (Haddow 1991)
(RR 0.82, 95% CI 0.63 to 1.06); incentives and usual care (Tuten
2012) (RR 0.47, 95% CI 0.20 to 1.11) or an alternative interven-
tion (Heil 2008) (RR 0.43, 95% CI 0.12 to 1.49); or social sup-
port and a less intensive intervention (Malchodi 2003) (RR 1.00,
95% CI 0.33 to 2.99). The effect remained non-significant in the
three trials reporting very low birthweight infants (less than 1500
g) when separated into comparison of counselling and usual care
(Analysis 1.13) and in a single study (Haddow 1991) comparing
feedback and usual care (RR 0.90, 95% CI 0.35 to 2,32).
2.4.2 Preterm births
Pooled data from 14 studies reporting preterm births (less than
37 weeks’ gestation) showed a statistically significant reduction
in preterm births among women receiving psychosocial interven-
tions (average RR 0.82, 95% CI 0.70 to 0.96; see Analysis 11.13),
compared to women in the control groups. This pooled effect
represents eight counselling, two health education, two feedback,
and two incentives intervention strategies. The number needed
to treat for benefit in terms of preterm births is 71, with a 95%
CI of 42 to 341. Presented in a different way, eight out of every
100 participants in the control group experienced preterm births,
compared to seven (95% CI six to eight) out of 100 for the inter-
vention group.
In separate comparisons of studies, the effect was no longer signifi-
cantly different from zero in comparisons of counselling and usual
care (five studies; average RR 0.90, 95% CI 0.64 to 1.27, Analysis
1.14), counselling and less intensive interventions (three studies;
average RR 0.82, 95% CI 0.47 to 1.42, Analysis 2.11), or feed-
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back and usual care (two studies; average RR 0.60, 95% CI 0.28
to 1.29, Analysis 5.3), as large sample sizes are required to detect
these relatively rare outcomes. Nor was a significant effect seen in
comparisons which had only a single study (results not displayed
in tables), including: health education and usual care (Donovan
1977) (RR 1.05, 95% CI 0.53 to 2.00) or a less intensive inter-
vention (Hjalmarson 1991) (RR 0.76, 95% CI 0.32 to 1.80); or
incentives compared with usual care (Tuten 2012) (RR 0.58, 95%
CI 0.20 to 1.66) or an alternative intervention of non-contingent
incentives (Heil 2008) (RR 0.38, 95% CI 0.11 to 1.30).
2.4.3 Mean birthweight
Pooled data from 19 studies reporting mean birthweight showed
there was a statistically significant increase in mean birthweight of
40.78 g among women receiving the intervention (95% CI 18.45
to 63.10g, see Analysis 11.14), compared to women in the control
group. The difference in mean birthweight was statistically signif-
icantly different from zero in subgroups of trials using counselling
(n = 12) and incentives (n = 2) as the main intervention strategy,
but was not significant in subgroups of trials using health educa-
tion (n = 2), feedback (n = 2), or social support (n = 1) as a main
intervention strategy.
In examining trends in separate comparisons of studies, the effect
was borderline significant in comparisons of counselling and usual
care (nine studies; MD 36.72, 95% CI 0.70 to 72.74, z = 2.00, P
= 0.05, see Analysis 1.15), but not for comparisons of counselling
and less intensive interventions (three studies; MD 56.02, 95%CI
-31.46 to 143.50, see Analysis 2.12), or feedback and usual care
(two studies; MD 79.43, 95% CI -53.05 to 211.91, see Analysis
5.4). There was no significant difference in mean birthweight in
single studies (results not displayed in separate comparisons, only
in comparison 1) comparing: health education and usual care
(Donovan 1977) (MD -12.00, 95% CI -102.29 to 78.29) or less
intensive interventions (Hjalmarson 1991) (MD 71, 95% CI -
26.58 to 168.58); incentives and usual care (Tuten 2012) (MD
162, 95% CI -132.93 to 456.93) or non-contingent (alternative)
incentives (Heil 2008) (MD 253, 95% CI-3.67 to 509.67); or
social support provided as part of a broader maternal health inter-
vention and a less intensive intervention (Malchodi 2003) (MD
28, 95% CI -152.48 to 208.48).
2.4.4 Perinatal deaths
Pooled data did not showa significant difference between interven-
tion and control groups in perinatal deaths (four studies; average
RR 1.13, 95% CI 0.72 to 1.77, see Analysis 11.15; although note
thatValbo 1996 had anon-estimable effect), stillbirths (seven stud-
ies; average RR 1.22, 95% CI 0.76 to 1.95, see Analysis 11.16),
neonatal deaths (four studies; average RR 1.15, 95% CI 0.44 to
3.06, see Analysis 11.17) or neonatal intensive care unit (NICU)
admissions (four studies; average RR 0.78, 95% CI 0.59 to 1.04,
see Analysis 11.18). These pooled effect size estimates, however,
were based on small numbers of studies and had low power to
detect clinically important differences. A number of trials also ex-
cluded women who had a perinatal death or a preterm birth from
the study population.
In separate comparisons of studies, there was no significant effect
seen in comparisons of counselling and usual care for: stillbirths
(four studies; average RR 1.08, 95% CI 0.51 to 2.30, Analysis
1.17), neonatal deaths (three studies; average RR 2.06, 95% CI
0.61 to 6.92, Analysis 1.18), or NICU admissions (two studies;
average RR 0.82, 95% CI 0.52 to 1.29, Analysis 1.19). There was
unclear evidence in relation to counselling and usual care for peri-
natal deaths because the effect size for one of the two studies (Valbo
1996) was not estimable due to zero events in both groups, there-
fore pooled effect size not calculable (see Analysis 1.16). There
was no significant effect observed for feedback and usual care in
stillbirths (two studies; average RR 1.28, 95% CI 0.69 to 2.39,
Analysis 5.5). There was no difference in single studies (results not
displayed in comparison tables, only in comparison 1) compar-
ing: counselling and a less intensive intervention (Ershoff 1989) in
stillbirths (RR 1.84, 95% CI 0.17 to 20.04); health education and
usual care (Donovan 1977) in perinatal deaths (RR 4.40, 95% CI
0.49 to 39.08); feedback and usual care (Haddow 1991) in peri-
natal deaths (RR 1.05, 95% CI 0.59 to 1.87) or neonatal deaths
(RR 0.40, 95% CI 0.08 to 2.07); incentives and usual care (Tuten
2012) in NICU admissions (RR 0.75, 95% CI 0.45 to 1.25); or
incentives and an alternative (non-contingent incentive) interven-
tion (Heil 2008) in NICU admissions (RR 0.76, 95% CI 0.24 to
2.49).
NB. The following sections for outcomes 2.4.5 to 2.12 are nar-
rative descriptions based on the findings reported in the stud-
ies, rather than on results of statistical synthesis
2.4.5 Other infant outcomes
Two trials (Cope 2003; Heil 2008) reported significant increases
in fetal growth measures including fetal femur length and fetal
abdominal circumference, and infant length, but no significant
difference in head circumference between control and interven-
tion groups. Two trials reported no significant difference in Ap-
gar scores at one and five minutes post-birth (Cope 2003; Tuten
2012).
2.5 Mode of birth
None of the three trials measuring mode of birth by intervention
group (Thornton 1997; Cope 2003; Tappin 2005) reported a
significant difference in the rate of operative births by intervention
group.
2.6 Breastfeeding
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There were mixed results for the effect of interventions on breast-
feeding. Two trials that measured breastfeeding initiation (Panjari
1999; McLeod 2004) showed no significant difference in initia-
tion or duration of breastfeeding in control or intervention arms.
One trial of contingency management measured a significant ef-
fect on breastfeeding duration (Heil 2008) at both eight weeks
and 12 weeks postpartum.
2.7 Psychological effects
Nineteen studies reported baseline psychological measures of in-
terventions, reinforcing the findings from observational studies
that there are significant psychological symptoms among many
pregnant women who smoke. Up to 75% of pregnant women
who smoked had current or previous psychological symptoms
(Belizan 1995; Ershoff 1999; Cinciripini 2010; Ondersma 2012)
and approximately 20% to 25% of women reportedmajor depres-
sion based on CES-D scale assessments (Blalock 2005; Dornelas
2006; Bullock 2009; Cinciripini 2010; El-Mohandes 2011). Four
studies identified baseline depression or stress as a ‘mediator’ or
‘predictor’ of continued smoking at follow-up (Crittenden 2007;
Linares 2009; Stotts 2009; El-Mohandes 2011), suggesting de-
pressive symptoms may be an ‘independent contributor to the
problem of continued smoking during pregnancy’ (Linares 2009).
Nine trials reported post-intervention psychological outcome
measures and none reported any negative psychological effects.
Six trials showed that smoking cessation interventions in preg-
nancy do not increase stress and psychological symptoms for
women (Manfredi 1999; Panjari 1999; Aveyard 2004; Rigotti
2006; Solomon 2006; El-Mohandes 2011). Furthermore, three
studies demonstrated that smoking cessation interventions have
the potential to improve women’s psychological wellbeing and self-
esteem (Stotts 2004; Bullock 2009; Cinciripini 2010) and self-
efficacy (Stotts 2004).
2.8 Impact on family functioning and other relationships
No studies reported measures of family functioning. Studies re-
porting analysis of social networks (Stotts 2009), suggest a sig-
nificant interaction between smoking networks (household and
other) or partner smoking (Bullock 2009) and continued smok-
ing of participants in late pregnancy. Two studies reporting per-
ceptions of partner (McBride 2004) and peer support (Hennrikus
2010) had mixed findings. Pregnant women reported less nega-
tive partner support through pregnancy, but this increased in the
postpartum period (McBride 2004). Women in another study re-
ported an increase in both positive and negative support from a
peer including: comments about the woman’s lack of willpower,
trying to make them feel guilty, expressing anger about smoking
and trying to scare women about smoking (Hennrikus 2010).
2.9 Participants views
Twenty-six trials included women’s views of the interventions, 12
studies reported providers’ views of the interventions and two stud-
ies reported measures of knowledge, attitudes or practice among
pregnancy care providers.
Women’s views
Twenty-nine studies reported that they addressed in the interven-
tion issues identified as concerns by women when consulted for
this review (Oliver 2001); including ‘coping with stress and emo-
tions’, misconceptions about smoking risks, and feelings of guilt.
Two studies described using interactive discussions to address is-
sues of concern to individual women (Sexton 1984; Hennrikus
2010).
Three studies reported outcomes related to maternal weight gain.
One study (Sexton 1984) reported a slightly higher mean weight
gain in the intervention group (12.9 kg) compared to the control
group (11.9 kg). Two other studies did not report weight gain
by intervention exposure but reported that women with a ‘high
concern’ about weight gain were less likely to quit smoking during
pregnancy or remain abstinent postpartum (Berg 2008), and an-
other reported an increased weight gain of 2.8 kg in women who
were abstinent compared to women who continued to smoke (P =
0.04), with an estimated 0.34 kg increase in weight gain for every
10% increase in smoking abstinence (Washio 2011).
Two studies explicitly mentioned consideration of women’s views
in developing the intervention (Albrecht 1998; Cinciripini 2010),
and six studies described the involvement ofwomen or community
members in the development of the intervention (Windsor 1985;
Belizan 1995; Gielen 1997; Albrecht 2006; Patten 2009; Eades
2012).
Thirty-two studies reported women’s views about the content and
delivery of the interventions. When asked, most women gave
favourable feedback on the intervention and intervention ma-
terials (Baric 1976; Ershoff 1989; Belizan 1995; Bullock 1995;
Lillington 1995; Secker-Walker 1997; Walsh 1997; Cinciripini
2000; Strecher 2000; Tappin 2000; Hajek 2001; Cope 2003;
Tappin 2005; El-Mohandes 2011; Ondersma 2012), particularly
audiovisual materials (Windsor 1993; Patten 2009; Ondersma
2012) and telephone support (Bullock 1995; Solomon 2000;
Rigotti 2006; Bullock 2009). Women offered personal contact
and a manual considered the personal contact the most important
element and women appreciated printed materials much less if
they were also offered a video, although the video combined with
printed materials was no more effective than the printed materials
alone (Secker-Walker 1997; Cinciripini 2000). Similarly, women
offeredmotivational interviewing for relapse preventionweremore
likely to be satisfied than those offered a booklet, although the
motivational interviewing was no more effective (Ershoff 1999.
Women participating in a study in Ireland (Thornton 1997) re-
ported the importance of providing the intervention in privacy,
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and suggested that telephone follow-up between visits and a video
would have been helpful components in that intervention. Two
studies reported that even if they did not like it, women expected
to be asked about smoking from their care provider (Walsh 1997;
McLeod 2004). Two trials using computer-assisted technology
were rated positively (Strecher 2000; Ondersma 2012), but in an
earlier trial women expressed concern about entering personal in-
formation into a computer (Ershoff 1999).
Despite positive feedback about the content of the intervention,
several trials reported difficulty recruiting and retaining women’s
participation in the intervention (Loeb 1983; Secker-Walker 1994;
Cinciripini 2000; Stotts 2004; Patten 2009), andmany studies had
low participation rates. In a multimodal intervention including
counselling and nicotine replacement therapy (NRT), only 87/
327 women in the intervention group participated in counselling
and only 75 women used NRT (Hegaard 2003).
Offering additional group sessions for smoking cessation was gen-
erally a poorly accepted intervention even in otherwise success-
ful trials (Loeb 1983; Windsor 1985), though one study reported
groups were well accepted (Sexton 1984). Hypnosis was also a
poorly accepted intervention in two studies (Sexton 1984; Valbo
1996). Five studies reported women’s negative views of interven-
tion components, including: use of carbon monoxide monitor-
ing and prompt cards (Thornton 1997); some peer support be-
haviours (Hennrikus 2010), limited perceived efficacy of booklets
(Moore 2002), and phone messages (Ershoff 1999).
Providers’ views
Ten studies reported providers’ views of the intervention. While
providers’ views about the interventions were generally positive, a
recurrent theme was their concern about the time taken by the in-
tervention (Kendrick 1995; Hajek 2001; Moore 2002; Campbell
2006) and the impact on their relationship with women (Hajek
2001; Wood 2008). Sixty-five per cent of midwives asked to use
a carbon monoxide monitor and provide ’stage of change’-based
advice considered that this could not be achieved in the time avail-
able. This led to less than full implementation and variable moti-
vation to promote smoking cessation counselling among staff in
some studies (Kendrick 1995; Moore 2002), but not all (Windsor
2011). One of the reasons given for tailoring messages to ‘stages of
change’ was to address providers’ concerns that interventions may
alienate women not ready to quit (Hajek 2001). A survey of gen-
eral practitioners suggested the smoking status of the provider in-
fluenced participation in intervention delivery (Haug 1994). De-
spite these challenges, engagement and involvement of providers
was identified as a critical element of implementation (Lowe 1997;
McLeod 2004; Campbell 2006) and providers reported that they
would like more involvement (Tappin 2000).
2.10 Measures of knowledge attitudes and behaviour of
health professionals with respect to facilitating smoking
cessation in pregnancy
Two trials reported positive effects of the interventions on mid-
wives’ understanding, confidence in delivering the intervention,
optimism that the intervention may influence women’s smoking
behaviour (Lawrence 2003) and obstetric knowledge and practice
(Secker-Walker 1992).
2.11 Cost-effectiveness
Four studies reported that the interventions were cost-effective
using a variety of measures. Pregnancy-specific, self-help materi-
als were more cost-effective than standard smoking cessation in-
formation or self-help materials (Windsor 1985). Specific esti-
mates include: a benefit-cost ratio of 2.8:1 (Ershoff 1990); 1 (non-
smoker): $84 (Parker 2007); and an average cost of $56 per person
for each smoking cessation intervention, and $299 to produce a
non-smoker at the end of pregnancy (Dornelas 2006).
2.12 Adverse effects
Three studies thatmeasuredwhetherwomen increased their smok-
ing following exposure to the intervention showed mixed re-
sults. One trial reported a slightly lower level of cotinine in
the intervention group, compared to the control group (Tappin
2005), another reported no difference in self-reported smoking
(Hjalmarson 1991), and another reported an increase in smoking
among women who did not quit (Haug 1994).
D I S C U S S I O N
Summary of main results
Studies in this review demonstrate that psychosocial interventions
can support women to stop smoking in pregnancy. Importantly,
the interventions do not appear to have any negative physical or
psychological effects, are positively received by most women, and
may improve psychological wellbeing. Incentives had the largest
effect size, but only when provided intensively. Counselling was
effectivewhen provided in conjunction with other strategies or tai-
lored to individual women, but it is unclear whether any types of
counselling are more effective than others. Peer support appeared
to be effective, but only when provided as a targeted intervention
and not as part of a broader intervention to improve maternal
health. It is unclear whether partner-assisted support helps women
to quit. Feedback appeared to be effective when combined with
other strategies, such as counselling, and comparedwith usual care,
but not less intensive interventions. Health education was not ef-
fective in separate comparisons, but the pooled effect was signif-
icantly different from zero in subgroup analyses. Among women
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who received psychosocial interventions there was a significant re-
duction (18%) in preterm births (less than 37 weeks’ gestation),
the proportion of babies born low birthweight (18%) (less than
2500 g), and a significant increase in mean birthweight of 41 g.
Using data from this review, the NNTB to prevent one infant be-
ing born low birthweight is 61 (95% CI 38 to 204); and 71 in-
terventions (95% CI 42 to 341) to prevent one infant being born
preterm. These findings provide strong and clear evidence about
the risks of smoking during pregnancy, supporting recommenda-
tions that it may be an integral part of strategies to reduce preterm
births (Green 2005a). Given the benefits of stopping smoking in
pregnancy for the woman and her infant, this would seem to be
an important intervention, particularly when applied at a popula-
tion level. However, it remains unclear from dissemination trials
whether interventions are effective when implemented into rou-
tine pregnancy care.
Among the subgroups of ’main intervention strategies’ categorised
in this review, the four studies that included use of incentives had
the strongest effect. Three trials that compared provision of inten-
sive incentives with usual care (Tuten 2012), incentives and social
support compared with a less intensive intervention (Donatelle
2000), and contingent incentives compared with non-contingent
incentives (Heil 2008), were significantly different from zero. A
three-armed trial, which included a non-contingent arm (Tuten
2012), also showed a significant effect. These non-contingent
comparisons provide a ’time-matched’ alternative comparison of
similar intensity, which helps to identify if it is the ’additional as-
sistance’ or incentives which are effective (Mantzari 2012). The
effect was also significantly different from zero in the pooled re-
sults of three counselling interventions that included lottery tick-
ets (Sexton 1984; Walsh 1997; Parker 2007). These findings are
consistent with other reviews of financial incentives in pregnancy
(Higgins 2012) and the mechanisms for the effectiveness of incen-
tives for reducing substance abuse more generally has been well
documented (Higgins 2008b). However, the results of the incen-
tives trials should be considered with caution as they are based on
few trials with a very small number of women (less than 500), all of
whom were in the US. Additionally, there was no effect from one
trial of ’low intensity’ incentives (’CM Lite’) combined with an
interactive computer-generated counselling program (Ondersma
2012), which relied on women initiating contact with the research
team for urine cotinine testing, and provided a maximum of only
five verification and ’incentive’ interactions, with less than half
the women in this arm submitting even one urine test. Interest-
ingly, women in this four-armed trial who received the interactive
computer-generated counselling program alone were more likely
to quit than women who received the combined incentive and
computer-counselling intervention (see Ondersma 2012).
Pooled results of interventions in which counselling was the main
intervention strategy showed a significant effect in abstinence in
late pregnancy. However, in separate comparisons, the effect of
counselling was only significantly different from zero when com-
bined with other strategies or tailored to individual needs. There
was no significant difference seen when one type of counselling
(cognitive behavioural therapy (CBT)) was compared with tradi-
tional health education (Cinciripini 2010), or when counselling
was provided as part of a broader intervention to improve mater-
nal health (El-Mohandes 2011). Group interventions were gen-
erally not well accepted in this population of pregnant women,
despite being reported as a potentially well accepted intervention
in the general population (Bauld 2010). Feedback was effective
when combined with other strategies such as counselling, and only
when compared with usual care. Findings from this review sup-
port recommendations that pregnant womenmay need more sup-
port than just brief advice or health education (Coleman 2004),
as it was unclear whether health education alone helped women
to quit. However, there was a significant pooled effect among the
three trials of health education when two studies were removed
providing only self-help materials or an audiotape with no addi-
tional personal advice, which is similar to findings in another re-
view (Murthy 2010), and which concluded that apart from brief
physician advice, there was limited clarity on the duration of in-
terventions required by other professionals.
Social networks have been suggested as a major cause of relapse
(Nguyen 2012b), and a systematic review of qualitative studies
identified partners as one of the most important influences on
women’s smoking and relapse (Flemming 2013). In this review,
peer support appeared to be effective when provided as a targeted
intervention, and when social support was provided as part of a
broader intervention to improve maternal health, but not when
[telephone] support was compared with a less intensive interven-
tion. It is unclear from the single trial of partner-assisted support
(McBride 2004) that this strategy can help women to stop smok-
ing. Furthermore, counselling interventions that included support
for partners to quit also did not show a significant effect, and there
were mixed results in the four studies reporting associations be-
tween quitting and partner smoking. Mixed results have similarly
been reported in a systematic review of five randomised controlled
trials (Duckworth 2012), and another review of seven studies re-
ported a non-significant effect (Hemsing 2012), concluding that,
“Despite the importance of partner smoking, there are very few ef-
fective smoking cessation interventions for pregnant/postpartum
women that include or target male partners”. This raises questions
about arguments that amajor reason for themodest effect of smok-
ing interventions is the focus on individual behavioural change
rather than acknowledging social factors and focusing on exter-
nal motivation (Okoli 2010). Additionally, feedback fromwomen
demonstrates the support from both partners and peers can some-
times be negative, which raises concerns about the potential risks
for vulnerable women in physically or emotionally violent rela-
tionships. Evidence from this review suggests that while partner
and peer support may be important factors influencing smoking
behaviour, eliciting peer and partner support that is positive and
can actually support women to stop smoking in pregnancy is a
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challenge.
The lack of a clear difference in effect seen by increasing inter-
vention intensity challenges the validity of the assumption that
ever-increasing the intensity of support will increase quit rates,
as has been reported by other commentators (Lando 2001), and
supports views that there may be an upper limit of what women
accept (Chapman 2012). Newly included studies in this review
had lower effect sizes than older studies in the previous version,
despite a general trend towards higher intensity interventions in
more recent trials. It may be that women who continue to smoke
are not getting ’more hard core’ but that there are many options
already available and additional strategies may not be offering a
lot of extra benefit, as risks of smoking during pregnancy, due
to health education campaigns, are well known in high-income
countries (Campion 1994; Eriksson 1996; Eriksson 1998). One
study found relapse within the first two weeks was predictive of
continued abstinence, and suggested this indicates that intensive
support during the earlier period of nicotine withdrawal may be
an important component of interventions (Higgins 2006b).
Studies in this review suggest the effect during pregnancy contin-
ues into the postpartumperiod, up until approximately 18months
postpartum, though the smaller effect size shows many women
who did quit during pregnancy relapse postpartum. Some suggest
that many pregnant smokers simply suspend their smoking for
the duration of pregnancy as opposed to quitting altogether or
they commit to ’temporary abstinence’ for pregnancy (Stotts 1996;
Lawrence 2005a; Flemming 2013), but these relapse rates are sim-
ilar for non-pregnant women (Bombard 2012). Rather than being
disappointed by these limited effects, some authors suggest health-
care workers should focus on the positive aspects of these findings
and reinforce the positive decisionsmanywomen aremakingwhen
pregnant (Hotham 2008). High post-pregnancy relapse rates have
led to some commentators calling for an extension of the period
of support for women to stop smoking (Coleman-Cowger 2012).
Hjalmarson 1991 reported a high proportion of women abstain-
ing from smoking during their hospital stay for the birth, and sug-
gests this may be an opportunity for intervention to reduce the
risk of postpartum relapse. These findings suggest there may be
a need for different approaches to promote continued abstinence
postpartum, including focusing on the benefits for the mother,
without excessive emphasis solely on the benefits for the baby.
While results are mixed, studies in this review suggest there is
a reduction in self-reported smoking but not biochemically val-
idated smoking. Continued nicotine and cigarette exposure may
have effects on other outcomes not measured in this review. The
level of reduction required to improve health outcomes remains
unclear (Secker-Walker 2002a). One study analysing data from
Kendrick 1995 suggested that reduction in smoking to fewer than
eight cigarettes a day is necessary to avoid reduction in infant
birthweight (England 2001), and estimated approximately a mean
birthweight which was 200 g higher among women who quit
smoking after enrolment, compared to women who continued to
smoke during pregnancy. Therefore, extrapolating these data to
this review, if all women in the intervention groups stopped smok-
ing and none of those in the control group did, the expected mean
birthweight difference would be about 200 g, rather than 41 g.
With an absolute difference of six in every 100 women stopping
smoking, the expected mean difference from the extent of smok-
ing cessation alone would have been about 12 g. This suggests
that smoking reduction is also happening to a greater extent in the
intervention than comparison groups, in line with self-reported
changes.
There was no evidence from studies in this review that smoking
cessation increases the rate of caesarean section (Thornton 1997;
Cope 2003; Tappin 2005), contrary to concerns raised by women
about the effects of increased fetal size (Sexton 1984). One obser-
vational study modelled increases in birthweight (from 2450 g to
2550 g) in Guatemala and found an increased risk in caesarean
section due to obstruction of eight in every 1000 cases, but this
was outweighed by a reduction in caesarean section due to fetal
distress of 34 per 1000 cases (Merchant 2001).
Women who smoke are less likely to initiate breastfeeding (Amir
2001a; Amir 2002a; Donath 2004; Einarson 2009; Disantis
2010b), and breastfeed for shorter duration (Sayers 1995; Horta
1997). Therefore, supporting women to initiate and maintain
breastfeeding should be considered an important part of any in-
tervention in this population group, and reported as an outcome
in intervention studies. Studies in this review had mixed reports
of the effect of smoking cessation interventions on breastfeeding
(Panjari 1999; McLeod 2004; Higgins 2010b).
Studies in this review (Cinciripini 2000; Rigotti 2006) support
a recent qualitative study that concluded “Pregnant women with
mental disorders appearmoremotivated...yet find itmore difficult,
to stop smoking” (Howard 2013), and other studies that report
higher rates of quitting among women with higher self-esteem and
self-efficacy (Massey 2013). For these reasons, healthcare workers
have reported difficulty addressing smoking with pregnant women
(Wood 2008). Qualitative studies have identified concerns about
adverse effects of quitting, or increased guilt over continued smok-
ing, on women’s psychological wellbeing and capacity to cope with
adverse circumstances, with follow-on effects to the women’s fam-
ilies (Oliver 2001; Wood 2008; Flemming 2013). In earlier ver-
sions of this review, it has been difficult to assess the effect of in-
terventions on depression, as, despite the strong associations with
poor mental health and smoking in pregnancy, women with men-
tal illness were frequently excluded from trials. However, mental
wellbeing has been addressed in more recent trials and, contrary to
the above concerns, there is no evidence from studies in this review
that there are any negative psychological consequences from de-
livery of individual smoking cessation interventions in pregnancy.
Rather, feedback fromwomen from studies in this review was pos-
itive with women feeling that “somebody cared” (Bullock 1995).
Three studies have shown that provision of psychosocial support
can in fact improve women’s psychological wellbeing, which has
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the potential to have enormous benefits for the mother, the in-
fant, and the whole family (Bullock 1995; Stotts 2004; Cinciripini
2010).
In earlier versions of this review, there appeared to be little evi-
dence of the involvement of pregnant womenwho smoked or care-
givers being involved in the design and evaluation of interventions
(Oliver 2001). However, there has been increasing discussion of
women’s preferences for cessation support in recent years (Ussher
2004). Studies included in this review suggest women prefer in-
dividual personal contact, particularly by telephone, though stud-
ies inclusive of telephone support in this review did not appear
to be significantly more effective. Rates of satisfaction with inter-
ventions delivered by computers or mobile phones were generally
positive, but again there was no evidence in this review that the
use of these technologies increased the rate of abstinence in late
pregnancy. Nevertheless, acceptability of an intervention is an im-
portant aspect of population-based interventions.
Some evidence suggests that women in high-income countries are
more likely to smoke to control their weight, and that female
body image is extensively targeted by tobacco marketing cam-
paigns (Pomerleau 2000; CDCP 2002; Levine 2006), although
concerns about gaining weight through stopping smoking during
pregnancy were not raised by any of the women consulted for this
review (Oliver 2001). The systematic review of qualitative studies
of women smoking in pregnancy (Flemming 2013) found two
studies mentioning weight gain as a factor in considering smoking
cessation. Hotham 2002 found that fear of weight gain was a bar-
rier to smoking cessation for somewomen andLawson 1994 found
some women used smoking to cope with weight gain.Three stud-
ies in this update of the review (Sexton 1984; Berg 2008; Washio
2011) address weight gain. Only one study reported a small in-
crease in weight gain among women in the intervention group
(Sexton 1984). This concern should be considered in interven-
tions, with interventions available to support women to avoid un-
wanted weight gain (Farley 2012). It should be noted that weight
gain in pregnancy may not necessarily be a negative outcome for
many women, particularly women in low- and middle-income
countries. The association between smoking and glucose intol-
erance, a potential mechanism for these effects, remains unclear
(Wendland 2008). A Cochrane systematic review of interventions
for preventing weight gain after smoking cessation mentioned nei-
ther pregnancy nor breastfeeding (Parsons 2009) and therefore
cannot be relied upon for evidence relevant to a population where
weight may fluctuate for normal physiological reasons and where
babies may be sensitive to drug treatments in utero or when breast-
feeding.
Public health impact of the interventions
Importantly, psychosocial interventions to support women to stop
smoking during pregnancy reduce the population-attributable risk
of preterm birth (by 18%) and low birthweight (by 18%), with
approximately 71 interventions required to prevent one preterm
birth and 61 interventions to prevent one infant being born with
low birthweight. As such, smoking cessation is recommended as
a key recommendation for reducing the risk of recurrent preterm
birth (Chang 2012; Cypher 2012). The number of interventions
needed to treat for benefit is extraordinarily low, given the serious
clinical consequences of these adverse outcomes. Based on the ef-
fectiveness published in the 2004 version of this Cochrane review,
if 75% of pregnant women in the US disclosed their smoking sta-
tus and all received the intervention, then it has been estimated
that 31,573 (6%) ’new quitters’ would be gained and the preva-
lence of smoking in pregnancy would potentially decrease from
16.4% to 15.6% (Kim 2009b). While these effect size estimates
may appear modest, the response to interventions is similar to that
of psychosocial interventions to reduce type 2 diabetes mellitus,
hypertension and asthma, all of which are conditions that involve
a combination of medical illness, personal choice and environ-
mental factors (McLellan 2000). Importantly, the high prevalence
of these conditions in the community means that interventions
with a modest effect size estimate can have a substantial impact
on population health if widely implemented.
Economic costs
Studies in this review report variable cost-effectiveness measures
and costs of interventions. Based on a NNTB of one quitter for
each 19 interventions, our cost estimates ($US1,064) based on
$US56 per interventions is significantly higher than the $US299
reported in Dornelas 2006. However, even with higher estimates,
other studies that evaluated the cost-effectiveness of these in-
terventions clearly show that there is a ‘rapid return on invest-
ment’ (Lightwood 1999). Early studies estimated the smoking-
attributable maternal costs during pregnancy alone ranged from
$US150 million to $US995 million in the early 1990s (Adams
1998), with 2004 estimates of $US122 million or $US279 per
smoker (Adams 2011). Estimated birth and first year costs for both
mothers and infants attributed to smoking were $1142 to $1358
per smoking woman over a decade ago (Aligne 1997;Miller 2001;
Adams 2002). Infant costs are approximately 10 times maternal
costs, accounting for 90%of costs in the first year. Lowbirthweight
produces the highest economic burden as it is the most common
adverse outcome (Hueston 1994; Miller 2001). A 1% drop in
smoking prevalence was estimated to prevent approximately 1300
low birthweight live births and save $US21million in direct medi-
cal costs (Lightwood 1999). Inclusion of smoking attributable and
environmental tobacco smoke exposure costs in birth and child-
hood conditions, pushes estimates into the billions (Aligne 1997),
and long-term costs due to chronic disease up to $US57 billion
in 1997, in the US alone (Bartlett 1994). An economic evalua-
tion of data provided in the 2009 version of this review estimated
the societal benefits from these interventions could be in excess of
500 million pounds sterling per annum in the United Kingdom
43Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Taylor 2009). In contrast with that finding, the quality of diet
in pregnancy (in high-income countries) has not been shown to
affect the mean birthweight of infants over 32 weeks’ gestation
(Rogers 1998). While there is variation in reported costs depen-
dent on conditions included and changing healthcare costs (Ayadi
2006), it is clear that healthcare costs due to smoking in pregnancy
are substantial.
Impact on health inequalities
In high-income countries, the reduction in rates of smoking has
not been as substantial in women experiencing psychosocial dis-
advantage, as for the general population. Hence smoking has been
identified as a major preventable cause of the health inequalities
experienced by women who suffer psychosocial disadvantage, in-
cluding psychological illness, low educational attainment, young
early motherhood, lack of social support, and limited employ-
ment (Graham 2006). Some of the reasons may be that disad-
vantaged women are unable to change the environmental factors
that increase the risk of smoking; population-based interventions
may have the effect of being judgemental and alienate women;
and women are unable to change generational patterns (Graham
2009). Several authors have suggested that women who continue
to smoke in late pregnancy would be unlikely to benefit from the
usual antenatal interventions, which rely on women’s capacity for
self-initiation, self-control and social resources, which they sug-
gest helps to explain why it remains such an intractable problem
(Wakschlag 2003; Pickett 2009) and that individual interventions
alone are unlikely to impact on inequalities (Baum 2009). How-
ever, subgroup analysis of studies included in this review refutes
these arguments and suggests that individual interventions pro-
vided during pregnancy have similar effectiveness among women
with low socio-economic status (SES), as women who are not clas-
sified as having low SES, despite several studies reporting a lower
effect among participants with lower SES (Baric 1976; McLeod
2004; Pbert 2004; Rigotti 2006). This supports qualitative stud-
ies that suggest individual support, which is positive rather than
punitive, has an important role (Bond 2012). Therefore, individ-
ual psychosocial support should form a part of the tobacco con-
trol ‘package’ to reduce smoking during pregnancy, in conjunc-
tion with population-based measures, which have also been shown
to have a significant impact on birth outcomes (Adams 2012;
Cox 2013) and reducing smoking in disadvantaged populations
(Thomas 2008).
The pooled results were not significantly different from zero in
eight studies, which were developed predominantly or specifically
for ethnic and aboriginal minority women, including African-
American women (Gielen 1997; Manfredi 1999; El-Mohandes
2011; Ondersma 2012), African American and Hispanic women
(Lillington 1995), Hispanic women (Malchodi 2003), Alaskan
Native Women (Patten 2009) and Australian Aboriginal and Tor-
res Strait Islander women (Eades 2012). This is despite primary
authors in several studies reporting subgroup analysis of higher
quitting rates amongAfrican-American andHispanic women than
other women (Petersen 1992; Windsor 1993; Pbert 2004; Parker
2007). These studies tended to involve women more in the de-
velopment of the intervention and all used several recommended
strategies to tailor the intervention (American Legacy Foundation
2012) for initiatives that aim to address the disparities in to-
bacco use; including hiring culturally competent staff, conduct-
ing formative research to identify community needs, piloting and
field-testing programs, ‘cultural tailoring’ of smoking cessation
resources, and collaborating with key stakeholders and commu-
nity organisations. Three studies adapted ‘SCRIPT’ materials in
the US (see Windsor 2011), which include: ’asking’ about smok-
ing status; ’advising’ women to quit; ’assisting’ women to quit by
providing advice on skills and materials such as video’s and self-
help materials; and arranging for follow-up by referral at future
appointments. Two studies developed audiovisual resources for
African American (Ondersma 2012) and Alaskan Indian (Patten
2009) women, and these resources received positive feedback. De-
spite interventions being reported as feasible and acceptable to
communities, there were challenges with implementation and few
demonstrated an effect size estimate that was significantly different
from zero. Further suggestions included trying to recruit from dif-
ferent settings and including elders to improve recruitment, and
recognising the importance of broader social interventions for po-
tentially reaching a larger proportion of pregnant women (Patten
2009). Other reviews of interventions in non-pregnant aboriginal
peoples have demonstrated interventions can be effective (Carson
2012), and suggest mobile phone technology may be a feasible
intervention strategy (Johnston 2013). Only one study included
women using smokeless tobacco products, and identified conflict-
ing beliefs about the effect of these products during pregnancy and
the primary change recommended by participants in the study
was to provide “more objective” information on the risks of Iqmik
(smokeless tobacco) use for the infant (Patten 2009).
Most interventions have been developed in high-income countries
and there is very limited information about the effectiveness of
psychosocial interventions for individual women in low- to mid-
dle-income countries (Murthy 2010). The restrictions on tobacco
marketing inhigh-income countriesmay result in an increase in to-
baccomarketing companies in low- andmiddle-income countries.
Smoking has the potential to undermine health improvements in
low- andmiddle-income countries and a range of interventions are
needed to manage the emerging epidemic (Lopez 1994; Abdullah
2004). However, given the modest effect size estimate of individ-
ual interventions, population-based tobacco control strategies are
an urgent priority, as there is now a brief ’window of opportunity’
to prevent the increase of smoking among women in many low-
income countries (Chomba 2010).
Translation of evidence into practice
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The first trials of anti-smoking interventions during pregnancy
were published more than 30 years ago (Baric 1976; Donovan
1977). The first trial to demonstrate the reversibility of the birth-
weight reduction associated with smoking by an intensive inter-
vention during pregnancy was published in 1984 (Sexton 1984).
Since then, attempts at widespread implementation of psychoso-
cial interventions to support women to stop smoking in preg-
nancy have demonstrated many of the challenges of translat-
ing ‘evidence into practice’, particularly non-pharmacological evi-
dence (Windsor 1998; Windsor 2000b; Lowe 2002;Moore 2002;
NICS 2003; McLeod 2004; Herbert 2005; McDermott 2006;
Abatemarco 2007; Manfredi 2011).
Studies in this review can be conveniently categorised within
a framework for translation of research into practice (Nutbeam
2006), which suggests progression through several stages from;
problem definition (descriptive studies) and formative research for
intervention design; intervention efficacy research; to implemen-
tation in routine/normal settings (effectiveness research); dissemi-
nation across several settings; and institutionalisation (as interven-
tions are provided as part of routine care). Many studies in this re-
view clearly defined the problemand conducted formative research
for intervention development (Katz 2008; Gilligan 2009), par-
ticularly interventions developed for vulnerable women, includ-
ing young women (Albrecht 1998; Albrecht 2006). The modest
but significant efficacy of psychosocial interventions provided by
researchers has been well demonstrated by studies in this review,
including counselling interventions.
The transfer of an intervention from one setting to another may
reduce its effectiveness if elements are changed or aspects of the
materials are culturally inappropriate. An example in these tri-
als was the performance of the Windsor self-help manual. This
was developed and shown to be effective in Birmingham, Al-
abama (Windsor 1985; Windsor 1993). However, when it was
implemented into routine care (Windsor 2011), used in Balti-
more with peer counsellors who receivedminimal training instead
of trained health educators (Gielen 1997), adapted for Alaskan
Native women (Patten 2009) and transferred to other countries
(Lowe 1998a; Lowe 1998b), the effectiveness was much lower. An
analysis of health promotion trials has concluded that where the
providers are also the researchers (more likely in single centre stud-
ies than multicentre studies), they appear to be better providers
for influencing behavioural outcomes and about the same as other
providers for other outcome domains (Oliver 2008a). The larger,
multicentre trials may therefore be a more accurate representation
of implementing policy than smaller, single centre trials. In this
review, interventions provided by usual care providers were as ef-
fective as interventions provided by researchers, including coun-
selling interventions.However, there was substantial heterogeneity
in sensitivity analyses of trials provided by usual care providers in
this review, which supports the views that there are many variables
to consider when implementing interventions in routine settings
(Hoddinott 2010).
Despite evidence of efficacy and effectiveness, dissemination trials
of counselling interventions into pregnancy care settings suggest
challenges to translating this efficacy research into routine prac-
tice and policy. Data from the five dissemination trials that tar-
geted the intervention at the organisational level, demonstrated
significant effects in terms of increased implementation of inter-
ventions in routine practice, although challenges were reported
and this did not translate into a significant reduction in rates of
smoking among women in the intervention arms of these studies.
One study that provided clinics with resources and referral options
reported an increase in women’s recall of receiving interventions
(Manfredi 1999). A significantly higher program implementation
rate was reported when using an intervention based on Rogers’
’Diffusion of Innovation’ theory (43% compared with only 9%
implementation in the control group after one year), but there
were no data on the impact on smoking outcomes (Lowe 2002).
An increased uptake of the intervention by staff was demonstrated
using ‘active’ dissemination compared to a simple mail-out of in-
formation (Cooke 2001), but not at levels sufficient to have a
significant impact on smoking outcomes in women (Campbell
2006), which was similar to other dissemination trials reporting
smoking outcomes (Pbert 2004; Windsor 2011). Another non-
randomised study compared the use of the RE-AIMdissemination
model to increase the reach, efficacy, adoption, implementation,
maintenance of interventions (Lando 2001) and concluded that
multi-faceted approaches using strategies from each intervention
were most likely to improve implementation.
There are a number of possible explanations for the limited effect
in dissemination trials. Firstly, many of the studies that recruited
individual women did not provide information on the number
of women who were eligible for inclusion or were approached to
take part in trials. The ’participation rate’ would have provided
useful information about the general ‘acceptability’ of the inter-
vention, as well as the degree of ‘selection bias’ in the study popu-
lation (Sedgwick 2013). Among those studies that did report the
proportion approached and recruited from the total ‘eligible’ pop-
ulation, low participation rates were often reported. Therefore,
some of the evidence in this review is from selective samples of
the population of women who smoke during pregnancy. Women
participating in studies (Mullen 1997) were more likely to be in
contemplative and preparation stages of change, be ‘recent quit-
ters’ and have a lower gestational age, compared to women not
participating studies (Ruggiero 2003). The majority of women
categorised as ‘Black’, ‘White’ and ‘Native American’ did enrol in
the study, while women categorised as ‘Hispanic’ were less likely
(51.6%) to enrol and the majority of Asian women did not enrol
(Ruggiero 2003). Dissemination trials and ‘cluster trials’ that ran-
domise clinics or providers are therefore likely to provide a more
accurate estimate of the likely effect in a non-selective population
of pregnant women.
Secondly, the implementation of interventions under conditions
less stringent than an individually-randomised controlled trialmay
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be reduced, which may limit exposure of the intervention group
to the intervention, or components of the interventions (Walsh
2000). Several trials implemented in routine care settings by mid-
wives (Moore 2002; DeVries 2006), doctors (Valbo 1994; Walsh
1997), and routine clinic staff (Kendrick 1995) reported diffi-
culties with implementation. Some of the issues included: vari-
able perceptions of smoking cessation as part of the providers’
role (DeVries 2006), stating they were too busy and did not have
enough time to complete the intervention (Dunkley 1997;Haines
1998; Hajek 2001; Valanis 2001b; Leviton 2003), difficulty re-
cruiting providers to the study (Lawrence 2003), providers report-
ing pessimismabout the efficacy of the intervention (Moore 2002),
and lack of acceptability of resources (Lowe 1998a; McBride
1999). Several studies reported positive ’facilitators or enabling
factors’ associated with implementation. Proposed criteria for in-
terventions to be implemented into routine maternity care in-
clude: having programmaterials readily available; feasible provider
time commitments; clear training requirements; minimal organ-
isational and administrative barriers (Strand 2003); and program
components that are acceptable to providers and women (Haynes
1998;Cabana 1999;Grol 1999;Walsh 2000;Cooke 2001a).Writ-
ten resources, a written protocol to identify staff responsibilities,
and reimbursement have also been suggested as other strategies
to improve implementation (Hartmann 2007). A significant in-
crease in both intervention delivery and smoking outcomes was
seen in a cluster trial that supported staff with training based on
national guidelines, a clinic management system, and establish-
ment of program boards (Pbert 2004). Suggestions to overcome
the barriers in a busy clinic setting included increasing the use
of referral services and technology to reduce demand on clini-
cians’ time (Moore 2002). Subsequently, use of referral services
such as ‘quitline’ (Williams 2010) and technology-driven inter-
ventions have gained popularity in the past five years (Tsoh 2010;
Naughton 2012; Ondersma 2012). In theUnited Kingdom (UK),
most services reported use of ‘quitline’ referral services (Williams
2010). One excluded (non-randomised) study in South Australia
(Bowden 2010), describes positive experiences and perceptions of
staff in implementing a ’Smoke-free Pregnancy’ Project involving
brief ’5A’s’ intervention and referrals to ‘quitline’. While use of
materials such as self-helpmaterials and technological aids did not
appear to significantly increase rates of smoking abstinence in this
review, they may help to increase the feasibility and reduce the
costs of delivering interventions.
A third possible explanation for the limited effect seen in imple-
mentation is that trials that involve broader implementation across
the system and provision by usual care providers (effectiveness
studies), may result in greater exposure of the comparison group to
the intervention. While the difference was not significantly differ-
ent, the pooled effect size was lower among trials that were assessed
as having a high risk of contamination in this review. One study
illustrated this effect by including a ‘historical control’ group, in
which only 4% stopped smoking, compared to 10% who stopped
in the randomised ‘concurrent control’ and 12% in the interven-
tion group who stopped (Windsor 2011).
Institutionalisation, where interventions are part of routine care,
is the final stage of the evidence-practice translation process. Aus-
tralia, Canada, the UK and the United States (US) have developed
guidelines recommending all pregnant women receive interven-
tions to promote smoking cessation in pregnancy (Aveyard 2007;
Fiore 2008). However, studies of clinicians practice in Canada,
the US and Argentina suggest that while the majority (50% to
100%) ‘ask’ about smoking status, rates of assistance with effective
strategies to support women to stop smoking are very low (11.5%
to below 50%) (Floyd 2001; Hartmann 2007; Tong 2008; Mejia
2010; Okoli 2010). Strategies to address the deficiencies identi-
fied in these surveys are reported (Chapin 2004) and several stud-
ies in this review have trialled strategies to adapt these guidelines
and improve implementation into routine settings (Tsoh 2010;
Ondersma 2012). A recent survey suggests attitudes may be shift-
ing in the UK about the provision of advice and support, but not
the efficacy of the interventions (Beenstock 2012). A recent survey
of women giving birth in Australia suggests there has been a signif-
icant increase in the provision of smoking advice and support in
routine pregnancy care from 2000 to 2008, though half of smok-
ers still did not receive the full complement of advice and support
according to state guidelines, and there was marked variability ac-
cording to where and from whom women received antenatal care
(Perlen 2013).
Strategies to increase disclosure of smoking status
Barriers to implementation have been identified at each step of
service provision in relation to support for smoking cessation in
pregnancy. This includes detection of women who smoke so they
can then be offered a supportive intervention (Tappin 2010). As
previously noted, self-reported disclosure of smoking status can be
variable. Disclosure is influenced by several factors, including the
stigma and guilt associated with smoking in pregnancy, the rela-
tionship between the care provider and the way the woman is asked
about smoking. In general, it appears that less direct questioning
increases disclosure, for example, changing the question format
from ‘yes’ or ‘no’ to a series of multiple choice questions and asking
women to best describe their smoking status (Mullen 1991). There
is some evidence from the literature around broader substance use
in pregnancy, that asking about substance use of family members
(e.g. secondhand smoke exposure) first (Chasnoff 2005; Chasnoff
2007), and leaving sensitive probing personal questions until later
in the interview, when a rapport has been established. The ratio-
nale is that this provides an opportunity for the woman to gauge
the response of the healthcare provider and feel more confident
disclosing her smoking status. In the UK, ‘opt out’ carbon monox-
ide screening has been proposed to increase disclosure (Tappin
2010; Bauld 2012). Biochemical validation of smoking status is
an understandable pre-requisite prior to receipt of contingent in-
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centives, to provide feedback on cotinine levels as a motivational
aid; or in the context of a smoking trial. However, the benefits
and rationale for not accepting women’s disclosure outside these
contexts is unclear and was not well received by women in this
review (Thornton 1997). Furthermore, there are questions about
the accuracy of carbon monoxide monitoring among women with
high secondhand smoke exposure (McLaren 2010), and whether
there are any adverse effects from routine screening, such as in-
creased domestic violence or effects on mental health.
Adverse effects of interventions
While psychosocial interventions do not pose the same risks to
fetal health as pharmacological agents in pregnancy, there are con-
cerns about the potential unintended consequences of these inter-
ventions that aim to encourage pregnant women to stop smoking
(Burgess 2009). The potential adverse effects identified in this re-
view include: increased smoking; unhelpful peer or partner sup-
port; stigmatisation; and nicotine withdrawal.
Despite the number of studies reporting smoking reduction, only
three studies reported rates of women who increased smoking by
intervention group, and these showed mixed results (Hjalmarson
1991; Haug 1994; Tappin 2005). It would be helpful for stud-
ies to measure any increased smoking, particularly in light of re-
cent qualitative evidence that suggests anti-smoking advice may
increase resistance to smoking messages for some women (Bond
2012; Flemming 2013).
There has been an increasing focus on the partners and peers of
pregnant women, with the additional aim of facilitating cessation
by the women themselves (Stanton 2004; Gage 2007). In some
cases this reflects cultural and demographic patterns of smoking,
where smoking rates are still highest amongst men (Loke 2005;
Kazemi 2012); in others, interest in environmental barriers that
hinder smoking cessation has led to an understanding of the influ-
ence of awoman’s social networks on smoking behaviour (McBride
2004). Studies in this review suggest that there are both positive
and negative aspects to partner and peer assistance with supporting
women to stop smoking in pregnancy (McBride 2004; Hennrikus
2010). This legitimises concerns about the potential adverse effects
on relationships and women’s position (Greaves 2007a). There-
fore, these risks should be taken into consideration when develop-
ing interventions involving partners or peers, particularly in sub-
populations or regions where protection for women’s rights are less
than optimal. Pro-active measures to identify women at risk and
ensure their safety should be implemented as part of interventions
involving peer or partner support (Greaves 2007b).
No studies measured the impact of interventions on stigmatisa-
tion of women. However, studies of psychological impact do not
suggest there are any negative effects, and individual psychological
support may be beneficial (Stotts 2004; Bullock 2009; Cinciripini
2010). Nevertheless, public health professionals must remain ever
vigilant when implementing population-based measures, as poli-
cies can disrupt highly complex systems and unintended conse-
quences of tobacco policy may differentially impact on vulnerable
population groups (Healton 2009). Stigmatisation research sug-
gests that such policies may have unanticipated outcomes for vul-
nerable mothers, including decreased mental health; increased use
of alcohol or cigarettes; avoidance or delay in seekingmedical care;
and poorer treatment by health professionals (Moore 2009). This
stigmatisation may be compounded for some population groups,
such as racial minority groups (Bond 2012; Flemming 2013).
Few studies reported the effect of nicotine withdrawal, which is a
gap given that these withdrawal effects may be more acute during
pregnancy (Ussher 2012a; Ussher 2012b).
Overall completeness and applicability of
evidence
Most of the included studies were carried out in high-income
countries and it is not clear whether the results are applicable in
other contexts. Given the rapidly evolving nature of the smoking
epidemic in low- to middle-income countries, this is a major gap
in the current body of evidence.
Many of the studies that recruited individual women did not pro-
vide information on the number of women who were eligible for
inclusion or were approached to take part in trials (i.e. the par-
ticipation rate), which would have provided useful information
about the general ‘acceptability’ of the intervention, as well as the
degree of ‘selection bias’ in the study population (Sedgwick 2013).
Among those studies that did report the proportion approached
and recruited from the total ‘eligible’ population, low participa-
tion rates were often reported. Therefore, some of the evidence in
this review is from selective samples of the population of women
who smoke during pregnancy and may affect the applicability of
the evidence into routine settings.
The review includes a relatively large number of studies focusing
on educational and counselling interventions but relatively few
focusing onother approaches, such as the use of incentives andpeer
support. Furthermore, there are limited data for some outcomes
(e.g. some perinatal outcomes, family functioning).
Quality of the evidence
The studies included in the review were of mixed quality and there
is a substantial level of heterogeneity amongst the trial results (I2
often greater than 50%); hence, we would emphasise the need to
consider theRisk of bias’ tables and urge cautionwhen interpreting
the combined effect of the interventions.
Potential biases in the review process
The timing of the final antenatal assessment of smoking status
varied considerably among trials between the second and third
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trimester. This may affect the amount of time the participants
were exposed to the intervention (if it involved ongoing support),
as well as the number of those lost to follow-up and measurement
of perinatal outcomes.
Agreements and disagreements with other
studies or reviews
Agreements and disagreements with the previous
review
There have been significant changes in the inclusion criteria for
this update, with the ‘splitting’ of the previous review into phar-
macological interventions (Coleman 2012b), and the exclusion of
quasi-randomised trials. In this update we have changed the out-
come from continued smoking (odds ratio), to quitting (risk ratio)
so it is consistent with other Cochrane reviews from the Tobacco
Addiction Group, and we have included ‘number needed to treat
for benefit’ analyses, as this is likely to be of greater relevance to
service providers. In this update we have also revised all data ex-
traction to ensure that missing data and ’Risk of bias’ assessments
from all trials have been dealt with consistently across the five up-
dates, so there are someminor amendments to some trial data from
previous versions. However, the major findings from this review
are similar to the previous review, with minor differences in effect
size estimates, namely:
• psychosocial interventions which include counselling,
incentives and feedback support women to stop smoking in
pregnancy are effective in supporting women to quit, reducing
low birthweight infants and preterm births;
• interventions including use of incentives continue to have
the largest effect size estimate, but the sample size is very small so
these results should be interpreted with caution.
Themaindifferences from the previous review are that a significant
effect was demonstrated in:·
• continued abstinence in the postpartum period.
A significant effect was not demonstrated in:
• a new subcategory of trials providing ‘health education’
only;
• a new subcategory of trials using social support, although a
significant effect was seen in the combined results of trials using
targeted peer support, but not in the single trial using partner-
assisted support.
Agreements and disagreements with other Cochrane
reviews
See Appendix 1 for a full list of other reviews of smoking inter-
ventions.
Pharmacological interventions in pregnancy
A review of pharmacological interventions to support women to
stop smoking
in pregnancy (Coleman 2012b) did not report a significant effect
(RR 1.33, 95% CI 0.93 to 1.91) http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD010078/abstract.
Effects of types of interventions for the general population
Relapse prevention
The findings in this review of a significant effect on re-
lapse prevention in the early postpartum period contrast to
findings in another Cochrane review of relapse prevention (
Hajek 2009). However, relapse prevention interventions for
women who had spontaneously quit in this review did not
demonstrate a significant effect, which is similar to the find-
ings of Hajek 2009. http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD003999.pub3/abstract.
Enhanced partner support
The findings in this review were similar to findings in a review of
enhanced partner support in the general population (Park 2012),
which did not demonstrate a significant effect (RR 0.99, 95%
CI0.84 to 1.15). See http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD002928.pub3/abstract.
Stages of change
A systematic review of stage-based interventions concluded they
are no more effective in general than interventions that do
not tailor the intervention according to the stage of change
(Riemsma 2003). http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD004492.pub4/abstract This is similar to the find-
ings in the previous version of this review.
Individual behavioural support
Our review findings for counselling interventions were sim-
ilar to those reported by Lancaster 2005a in a review of
individual interventions (RR 1.39, 95% CI 1.24 to 1.57),
with little difference between intensive support and brief
interventions. See http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD001292.pub2/abstract.
Self-help materials
Our review findings were different from a review of provision of
self-help materials in the general population (Lancaster 2005b)
that demonstrated a modest but significant effect (RR 1.21, 95%
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CI 1.05 to 1.39), particularly when thematerials were tailored (RR
1.31, 95% CI 1.20 to 1.42). See http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD001118.pub2/abstract.
Competitions and incentives
The findings of our review contrast with findings of a review of in-
centives among the general population (Cahill 2011a) that showed
no significant difference. See http://onlinelibrary.wiley.com/doi/
10.1002/14651858.CD004307.pub4/abstract. Given the sub-
group analysis in our study is based on a very small number of
studies and participants, our results should be viewed with cau-
tion.
Effects of interventions among other population groups
Psychosocial interventions among patients with coronary
heart disease
The findings of this review are similar to findings of psychosocial
interventions among patients with coronary heart disease (Barth
2008), another population with strong motivational factors to
stop smoking (odds ratio (OR) 1.66, 95% CI 1.25 to 2.22), with
high heterogeneity, and a reduced effect among validated smoking
outcomes (OR 1.44, 95% CI 0.99 to 2.11).
Pre-operative interventions
The effect of brief smoking cessation interventions among
the patients preparing for surgery was similar to our re-
view (RR 1.41, 95% CI 1.22 to 1.63), although the ef-
fect of intensive interventions was significantly higher than
in our review. See http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD002294.pub3/abstract.
Hospitalised patients
Our results were similar to those among hospitalised patients (RR
1.37, 95% CI 1.27 to 1.48). See http://onlinelibrary.wiley.com/
doi/10.1002/14651858.CD001837.pub3/abstract.
Interventions in Indigenous populations
The findings of our review were in contrast to a review of four
studies of non-pregnant Indigenous communities (Carson 2012)
in New Zealand (2), United States (1) and Australia (1) that re-
ported a modest but significant effect using psychosocial inter-
ventions, two of which were supplemented with pharmacological
therapy.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Psychosocial interventions can support women to stop smoking in
pregnancy, and reduce preterm births and infants born low birth-
weight. Therefore, psychosocial support to stop smoking should
be considered for women who are pregnant, or seeking to be-
come pregnant. Contrary to concerns that women may be upset
by offering support to stop smoking, studies in this review sug-
gest women expect and appreciate the support, and interventions
are more likely to improve women’s psychological wellbeing than
worsen it. Qualitative evidence suggests this support should be
positive, not punitive (Bond 2012), and is sensitive to potential
feelings of guilt and worry, and concerns about the impact of quit-
ting on women’s lives and their relationship with significant others
(Flemming 2013). Burgess 2009 suggests it may help for health-
care providers to become aware of any of their own biases against
mothers who smoke.
Evidence from this review suggests provision of health education
and risk advice is not sufficient, and any psychosocial support
should include multiple or tailored intervention components that
provide help with strategies to quit, positive encouragement and
other strategies, such as incentives, feedback or peer support. Part-
ner support does not appear to be effective from the single study
in this review, and care is needed when including peer or part-
ner-support components, as some peer and/or partner-support be-
haviours may be unhelpful, and may potentially expose vulnera-
ble women to increased risk. Inclusion of support for breastfeed-
ing and prevention of weight gain should also be considered as
part of smoking interventions for pregnant women, as obesity has
overtaken smoking as a major cause of preterm births in high-in-
come countries (Flenady 2011). Given the high co-morbidity with
psychological symptoms and the potential to improve psycholog-
ical wellbeing, interventions that include psychological support
for women with symptoms should be considered. Studies in this
review suggest many women resume smoking after pregnancy, so
consideration should be given to messages that reinforce the ben-
efits for the mother, rather than solely focusing on benefits for the
infant.
There is limited evidence from this review that increasing the in-
tensity of the intervention corresponds to an increased effect size.
Therefore, consideration should be given to the quality of the in-
tervention, and providing support that is convenient for women
and does not unnecessarily overburden them. Consultation with
women and local piloting of programs shown elsewhere to be ef-
fective may be a good place to begin to develop strategies suit-
able for each population. Additionally consultative processes that
involve healthcare providers and organisational leaders should be
another important consideration for implementation.
Given the clear difficulties which most women still smoking at
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the first antenatal visit have in stopping smoking, population-
wide strategies for smoking control in the whole community are
needed to reduce the initiation of smoking by young women: ac-
tion to prevent sales of tobacco products to young people, prohi-
bition of smoking in all public places, increases in tobacco taxa-
tion, workplace smoking cessation programs and bans on tobacco
sponsorship (WHO 2008a). However, these interventions should
incorporate strategies to reduce risks identified in this review, in-
cluding stigmatisation, and negative effects on relationships; avoid
singling out mothers and focus more broadly on ’parents’; avoid
depicting mothers who smoke as ’harming’ their infants, but as
women who are important in their own right; and assisting vul-
nerable women to develop alternative ’coping’ strategies to deal
with living in difficult circumstances (Burgess 2009). Given the
strong association between social inequality and continued smok-
ing by pregnant women shown in this review, there is a rationale
to support WHO recommendations to reduce social inequalities
in the wider community (WHO 2008b).
Implications for research
There is little doubt about ‘whether’ psychosocial interventions
are effective in reducing smoking, preterm births or infants born
with low birthweight. What is not clear is ‘which’ interventions
are effective, ‘how’ these interventions work, ‘who for’ and ‘how’
should these interventions should be implemented, disseminated
and institutionalised. As smoking rates have decreased in the gen-
eral population in high-income countries, it is becoming increas-
ingly recognised that smoking has become more closely correlated
with entrenched social disadvantage and psychological co-morbid-
ity (Shoff 2013). Studies are needed that refine interventions to
address the specific needs of these subpopulations, without com-
poundingproblems of social alienation and low self-efficacy.Given
the shifting demographics and burden of diseases from tobacco
smoking from high- to low- and middle-income countries, more
research is needed to develop strategies which are appropriate for
these settings. In reflecting on whether the objectives of this re-
view have been addressed, the authors feel that further research is
needed into:
• the feasibility and effectiveness of interventions in low- and
middle-income countries, particularly given the aggressive
tobacco marketing in these regions;
• how to implement and disseminate interventions into
routine care, and measures of whether they are effective when
implemented at a population level;
• the feasibility and effectiveness of the use of incentives to
support pregnant women to quit smoking, including evaluation
of any adverse effects or negative unforeseen circumstances for
pregnant women or the broader community;
• demonstrating effective interventions, including
descriptions of how these were developed, to support ethnic and
aboriginal women, and young women to stop smoking;
• interventions to support women with mental illness to stop
smoking, and whether interventions that improve mental health
can also help women to quit smoking;
• developing strategies to ensure that smoking interventions
do not have a negative impact on breastfeeding, which would
counteract some of the health benefits of quitting smoking for
both the mother and her infant;
• whether the timing of the psychosocial support is
important, for instance, is more frequent support required in the
early stages of quitting and less frequent support required later?
A WHO expert working group (Hunt 2012) recently recom-
mended research in three areas to help reduce smoking during
pregnancy:
• social and cultural factors influencing pregnant women’s use
of tobacco and exposure to secondhand smoke;
• interventions to promote tobacco cessation and reduce
secondhand smoke exposure during pregnancy in high-, low-
and middle-income countries;
• describing non-cigarette tobacco use by women and
characterising the resulting risks for adverse pregnancy outcomes.
In 2009 the National Institute of Clinical Excellence developed
guidance onQuitting smoking in pregnancy and following childbirth.
Background documents for this guidance (Bauld 2010a; Williams
2010) identified a number of gaps in existing evidence, including:
• whether the way the intervention is delivered influences the
effect;
• whether the site or setting influence the effect;
• evidence of effective interventions for vulnerable
population groups, including teenage mothers, disabled mothers,
women with mental illness, and other women.
Future trials need to include the following elements:
• number of potentially eligible women and number agreeing
to participate, as this can help to assess the degree of selection
bias in the trial and the potential acceptability and
generalisability if implemented at a population level;
• strategies to minimise contamination, as this appears to
have an impact on the effect size;
• a description of the intervention in sufficient detail for its
replication even if the detail requires a separate paper;
• process data as evidence of implementation;
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• women’s views of the intervention, particularly if partner or
peer support are incorporated;
• biochemical validation of non-smoking status;
• nicotine withdrawal and adverse effects such as increased
smoking, or disengagement with services;
• the collection of perinatal outcome data on birthweight,
preterm birth and perinatal deaths, particularly for nicotine
replacement therapy trials;
• collection of outcome data on breastfeeding, weight gain,
operative delivery, maternal psychological wellbeing, and the
perceived impact of the intervention on family functioning or
other significant relationships;
• subgroup analysis by vulnerabilities (to enable an equity
analysis);
• the impact factor or intra-cluster correlation needs to be
reported, in order to assess the effect of clustering and include
cluster-randomised trials in meta-analysis.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Albrecht 1998
Methods 3-armed randomised-controlled trial (pilot study) evaluated 2 different interventions
provided to ’pregnant teens’ to reduce smoking in pregnancy and relapse postpartum.
The hypothesis was that an intervention including peer support would be more effective
than the intervention alone.
Study conducted in Pittsburgh, USA. Data collection dates not reported
Participants Inclusion criteria: 12 to 20 years of age; 4 to 28 weeks’ gestation; reported smoking at
least 1 cigarette a day; single marital status; no previous live birth; able to read and write
English.
Exclusion criteria: Pregnancy complications preventing attendance at group sessions or
participation in a home study program.
Recruitment: Participants were recruited through local prenatal clinics and public
schools. 84 women recruited (not known how many were eligible or approached) and
randomised (C = 29, I1 = 29, I2 =26).
Baseline characteristics: Mean cigarettes/day at first visit: C = 6.44; I1 (TFS) = 5.87;
I2 (TFSB) = 6.81.
63% African-American heritage, 37% European-American heritage
Progress+ coding: Coded as single (low social capital) and young age (less than 20)
Interventions Control: 30 minutes individual educational session with project nurse including infor-
mation about the risks of smoking to themother and the fetus and brochures on smoking
and pregnancy.
Intervention 1 (TFS): Cognitive behavioural group model designed specifically for
adolescents based on problem-behaviour theory: eight modules to heighten awareness
and attention to smoking messages; build and enhance smoking cessation skills; teach
skills for maintenance of smoking control; includes experiential learning and round
robin discussion. TFS was modified to include additional information on smoking and
the fetus, body image changes and overall health. The intervention also included social
activities, immediate rewards and adult modelling.
Intervention 2 - TFS plus peer support (TFSB): Utilised all the components of TFS
plus 1-to-1 support through a non-smoking peer (buddy) chosen by the young woman.
Buddies were asked to attend all 8 sessions and to be available at other times for rein-
forcement of techniques learned and encouragement for continued cessation
Main intervention strategy: Social support (multiple intervention) compared to less
intensive intervention. TFSB compared with TFS and control in this review as outcomes
only reported as combined figures
Intensity rating: Frequency (C = 2, I = 6); Duration (C = 2, I = 6).
Intervention provided by project staff:efficacy study.
Outcomes Biochemically validated point prevalence abstinence at 4-6 weeks post baseline (late
pregnancy*)
Reduction in exhaled CO and self-reported mean cigarettes per day are reported as
’reduction’ but actual post-intervention measures weren’t reported so are not included
in this review. Baseline modified Fagerstrom Tolerance questionnaire for adolescents to
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Albrecht 1998 (Continued)
assess nicotine dependence
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as ’randomly assigned’.
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 46/84 had complete outcome data
(high attrition rate = 45%),UC=12 (41%)
, TFS = 13 (46%), TFSB = 13 (50%). No
explanation for attrition. ITT analysis not
mentioned. All those lost to follow-up were
included as continuing smokers in this re-
view
Selective reporting (reporting bias) High risk Only smoking outcomes reported and out-
comes not reported separately for each of
the control arms
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk CO level (>= 8 ppm) in exhaled air used to
identify smokers.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Provider and participants unable to be
blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed there was a ’sig-
nificant drop out rate’ (45%)
Equal baseline characteristics in study arms Unclear risk Baseline smoking characteristics similar,
but other baseline characteristics not re-
ported
Contamination of control group Low risk Intervention provided by research project
staff.
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Albrecht 2006
Methods 3-armed randomised controlled trial evaluated the short- and long-term effects of 2
smoking cessation strategies tailored to support pregnant adolescents to attain abstinence
in pregnancy and maintain abstinence postpartum
The study was conducted in 5 hospital-based and 2 community-based prenatal clinics
in Pittsburgh, Pennsylvania, USA. Years of data collection not reported
Participants Inclusion criteria: ’Pregnant teens’ aged 14 to 19 years; 12 to 28 weeks’ gestation; able to
read, write, and understand English; smoking at least 1 cigarette per day; single marital
status; having no previous live births; and capable of being reached by telephone
Exclusion criteria: pregnancy complications (i.e., bleeding or preterm labor) or required
confinement to home by their physician
Recruitment: During prenatal assessment, adolescents self-reporting smoking were in-
vited to participate in study. Those expressing interest signed a consent form to allow
the research team to contact them. Expressions of interest also advertised through flyers
and brochures
470 screened; 142/224 (63%) eligible women randomised (C = 50; I1: (TFS) = 47; I2:
(TFS + B) = 45.Baseline characteristics: Number of cigarettes per day before pregnancy:
Control 15.75 (10.38); I1: (TFS) 14.08 (7.22); I2: (TFSB) 14.62 (9.72)
Fagerstrom dependence score: Control 3.38 (2.05); I1: (TFS) 3.44 (1.79); I2: (TFSB)
3.68 (1.89)
Progress + coding: Low SES, Low educational attainment, low social capital (single)
and young age (< 20 years)
Interventions Control: Usual care that all teens would typically receive from a healthcare provider
throughout their pregnancy. Smoking during pregnancy was addressed in the clinic
by giving the teens educational materials on this subject during the initial prenatal
visit. In this study, this material was explained and distributed to the participants by a
research team member during the initial assessment. The meetings lasted 45-60 minutes
and occurred at 1 of the antenatal clinics or centrally located community site. During
the meeting, addresses and telephone numbers of the control group participants were
updated after completion of the assessment. Prior to leaving the meeting, participants
were informed of the date and time of their next assessment. Participants also received
an attendance incentive (e.g. lipstick, nail polish). If the participant had delivered, the
attendance incentive was a baby item
Intervention 1 (TFS): The TFS intervention consisted of an 8 week group program
designed to promote and maintain smoking abstinence based on the Cognitive Behav-
ioral Theory, with modification that incorporated developmental components of Jessor’s
Problem Behavior Theory, including a peer buddy and a peer co-leader for peer mod-
elling and sanctioning on smoking. Information pertinent to pregnancy and smoking
was provided at the beginning of the 8-week program.
Intervention 2 (TFS-B): The TFS-B group received the same 8-week programming,
but participants were required to bring a non-smoking female of a similar age as their
buddy to the sessions. The role of the buddy was to reinforce smoking cessation strategies
and to provide social support to the participant throughout the study
Main intervention strategy: Social support (multiple intervention) compared to a less
intensive intervention. The control group and TFS-B are compared in this review
Intensity rating: Frequency (C = 2, I = 6); Duration (C = 3, I = 6).
Provided by dedicated project staff: efficacy study.
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Albrecht 2006 (Continued)
Outcomes Biochemically validated point prevalence abstinence 8 weeks (late pregnancy*) and 1
year (6-11 months post partum*) after the intervention
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Consenting adolescents were assigned ran-
domly to 1 of 3 group assignments (TFS,
TFS-B, or control) by a computer algo-
rithm with a permutated block design,
stratified by entry site
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk High attrition: C = 60% (i.e. 40% did
not complete 1 yr follow-up), TFS = 55%,
TFS-B = 53%. Participants included in
primary aim analysis pertaining to ran-
domised treatment assignment, regardless
of adherence to study treatment (ITT anal-
ysis)
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking status (point prevalence absti-
nence) using salivary cotinine (> 10 ng).
Women reporting less than 1 cigarette per
day with salivary cotinine 10-15 ng had
salivary nicotine assessment to rule out en-
vironmental exposure, and were classified
as smokers if that test was > 5 ng
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers unlikely to be
blinded to this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessor not reported.
Incomplete implementation High risk Process evaluation showed poor implemen-
tation with almost 50% participants not
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Albrecht 2006 (Continued)
completing study
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk Intervention provided by research team.
Baric 1976
Methods A randomised controlled pilot study to evaluate whether medical advice had a effect on
smoking cessation in pregnancy
Study conducted in Bolton, England. Years of data collection not reported
Participants Inclusion criteria: Pregnant smokers at their first antenatal visit, less than 20 weeks’
gestation
Exclusion criteria: Not reported.
Recruitment: Women recruited from public antenatal clinic at Bolton and District
General Hospital. 510 women screened, 142 eligible, 8 moved house and could not be
followed up, and 24 women had spontaneously quit. 110 women randomised: control
= 47, intervention = 63
Baseline characteristics: 89% heavy smokers and 75% had been smoking for 5 years
or more
72% ’working-class’ (majority low SES) and 75% had no educational qualifications
Progress+ coding: Low SES and low educational attainment.
Interventions Control: Usual care, which was advice at the discretion of the doctor.
Intervention: 1 to 1 counselling (’a short interview’) from a senior medical student
which involved discussion of the disadvantages of smoking during pregnancy: risk to the
fetus; long-term risks of physical and intellectual impairment and possible reasons for
this; possible effects on the mother’s own health; costs of smoking; special dangers of
smoking in late pregnancy; various ways to help someone to stop smoking. Given strong
encouragement to quit and to make a commitment to do so. If this was not agreed then
reduction to less than 5 cigarettes a day. Half the intervention group were given a diary
to record each cigarette smoked and a gift of a free smoking diary
Main intervention strategy: Counselling (single intervention) compared with usual
care.
Intensity: Frequency (C = 0, I = 1); Duration: (C = 0, I = 1).
Usual care intensity: Frequency = 1, duration = 1.
Intervention conducted by existing staff (medical student): effectiveness study
Outcomes Self-reported abstinence 11 weeks after baseline visit (late pregnancy*)
Smoking reduction reported for whole cohort, not by intervention group, therefore not
included in this review
Discusses participants’ views of intervention.
Notes
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided. Described as
“randomly divided”.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk There are some missing data in the tables.
It is not clear if there was any overall loss
to follow-up or whether missing data relate
to specific outcomes only. All randomised
women included in this review and those
lost to follow-up were included as contin-
uing smokers in this review
Selective reporting (reporting bias) Unclear risk No other outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Smoking outcomes were self-reported by
participants during a visit at home. There
was no biochemical validation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention at first antenatal
visit.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Medical student provided intervention
(not usual care provider)
Bauman 1983
Methods Randomised controlled trial of use of exhaled CO feedback for promoting smoking
cessation in pregnancy
Study conducted in Guildford County, North Carolina, USA over 6 months in 1981
Participants Inclusion criteria: Women currently or recently smoking, attending public clinics
Exclusion criteria: Not reported.
All women attending antenatal care orientation sessions were randomly allocated to
experimental or control groups
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Recruitment: 226women entered prenatal programand170 (75%) included in analyses.
The authors compared those who did not participate and did not find any significant
differences. 47% (79/170) were current smokers (C = 43, I = 36)
Baseline characteristics: 43% had completed high school education, 56% were black,
80%classified as having no pregnancy risks other than smoking. 38% in the first trimester
and 46% in the second trimester of pregnancy
Progress+ coding: Low SES as all attending public prenatal clinic.
Interventions Control:Women were read a 135 script that described the relationship among cigarette
smoking, CO, and the harmful consequences of smoking
Intervention: Experimental group received same information as control group, and they
provided breath specimen in which CO was measured, with feedback of the result
Main intervention strategy: Feedback (single intervention) compared to a less intensive
intervention
Intensity: Frequency (C = 1, I = 1); Duration (C = 1, I = 1).
Implemented by regular health educators: effectiveness study
Outcomes Biochemically validated abstinence 6 weeks after intervention (late pregnancy*)
Exhaled CO (ppm), but no SD reported; unclear if ’quantity of cigarettes’ is mean
cigarettes per day; recency of smoking; depth of inhalation
Notes Not clear whether this was a group intervention - in which case there was no adjustment
for clustering
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear exactly how many women were
randomised to each group, however we as-
sume that those reported as ’current smok-
ers’ in table 1 are the baseline numbers,
which were all included in this review
Selective reporting (reporting bias) Unclear risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of reported smok-
ing behaviour for those followed up (CO
>= 9 ppm in exhaled air)
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Intervention was carried out by clinical
staff, no participant blinding reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All women apparently received the inter-
vention.
Equal baseline characteristics in study arms Low risk No difference between experimental and
control arms on 12 variables measured
Contamination of control group Low risk Implemented by regular health educators
at the maternity clinics
Belizan 1995
Methods Randomised controlled trial of psychosocial support in pregnancy which aimed to im-
prove maternal health, including reducing smoking during pregnancy
Conducted in 4 countries in Latin America (Argentina, Brazil, Cuba, and Mexico) from
January 1989 to March 1991
Participants Inclusion criteria: High-risk women whose antenatal care began at 15-22 weeks’ gesta-
tion, singleton pregnancy, 1 or more of the following: prior LBW infant; preterm birth;
perinatal/infant death; < 18 years; body weight <= 50 kg; height <= 150 cm; low fam-
ily income (local definitions applied); < 3 years school; crowded household (4 or more
persons/bedroom); smoking; not living with husband or partner.
Exclusion criteria: Heart or renal failure; diastolic BP > 100 mmHg; history of cervical
cerclage; Rh negative; mental disease or any chronic disease that might interfere with
pregnancy
Recruitment: 2,235 women met eligibility criteria and gave consent (I = 1115-though
1110 in table, C = 1120)
Baseline characteristics: Smokers (I = 23.9%, C = 21.8%), with variation between
countries - Argentina (I = 21.9%, C = 20.6%), Brazil (I = 40.7%, C = 33.1%), Cuba
(I = 27.4%, C = 28.9%), Mexico (I = 9%, C = 6.8%). Mean cigarettes per day at
randomisation: C = 7.9, I = 7.5
Progress+ coding: Low SES based on place of residence (low family income 20% in
Cuba, 52% in Mexico, 53% in Brazil and 100% in Argentina)
Interventions Control: Routine antenatal care, otherwise unspecified.
Intervention: Flexible use of a standardised manual, based on site-specific ethnographic
studies of needs, fears, expectations, social support networks, including detailed descrip-
tions of situations likely to occur during home visits. 4 to 6 home visits of 1 to 2 hours
with emphasis on psychosocial support, education on health habits including better nu-
trition, reducing smoking alcohol and other drugs, reducing their physical workload,
recognition of alarm signs and symptoms, improved access to hospital facilities, rein-
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forcement of health service utilisation. Additional components were a poster, a booklet,
hotline to project office, guided tour of hospital, encouragement of family support and
participation. Intervention was provided by specially trained female social workers or
obstetric nurses with previous experience of childbirth
Main intervention strategy: Social support (tailored) compared with usual care.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 5).
Usual care frequency and duration = 0 (unclear).
Intervention provided by study team: efficacy study.
Outcomes Self-reported point prevalence abstinence at 36 weeks’ gestation (late pregnancy*); Mean
cigarettes per day.*
Multiple perinatal and maternal health outcome data were collected, but not included
in this review as other aspects of the intervention may have had an impact
Baseline state anxiety score.
Notes Sample size was planned for the primary trial objective.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Centrally prepared, method not stated.
Allocation concealment (selection bias) Low risk Allocation was by opening sealed, opaque
envelopes.
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition 202/2230 (9%): 101 in each arm.
Unclear what attrition among smokers and
no ITT analysis of drop-outs as continuing
smokers, so not able to re-include smokers
who dropped out in this review
Selective reporting (reporting bias) Unclear risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking behaviour.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Home visitors were aware of group allo-
cation. Social support intervention with
home visits
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The evaluation of the interventions was
conducted by a team of independent pro-
fessional interviewers who were not in-
formed of the characteristics of the study
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Incomplete implementation Low risk Most (83%) of the women randomly as-
signed to the intervention group received
the planned number of home visits, and
90% were visited at least once
Equal baseline characteristics in study arms Low risk The distribution of risk factors was similar
in the 2 groups and the 2 groups had similar
demographic, obstetric, and psychological
characteristics at baseline
Contamination of control group Low risk The clinic personnel were unaware of the
identity of thewomen in the control group,
and no attempts were made to inform them
of which women were in the intervention
group. Health educators providing inter-
vention were separate from care providers
Bullock 1995
Methods Randomised controlled trial of telephone support for improving maternal health out-
comes, including smoking cessation during pregnancy
Study conducted in a metropolitan city in the south island of New Zealand fromMarch
to December 1993
Participants Inclusion criteria: Women with telephone access, who were either single or with an
unemployed partner, less than 20 weeks’ gestation
Exclusion criteria: None stated.
Recruitment: Recruited in the outpatient department of a large maternity hospital, or
its associated GP practices, or self-referral via an introductory letter, phone call, and full
discussion of “Healthy Mothers/Healthy Babies”
The eligible population was 221 women of whom 49 were never located, 23 were not
interested, 10 refused after explanation, and 8 moved away, did not speak English or
had a miscarriage. 131 (59%) participated (103 OPD, 22 from GPs, 6 self-referred) (C
= 66, I = 65 randomised). Just over 50% were smokers (C = 35, I = 31).
Baseline characteristics: Mean cigarettes per day at baseline = 6.
88% European, 10% Maori. 53% single.
Progress+ coding: Low SES.
Interventions Control:Package of publicly available educationalmaterial on healthy behaviours during
pregnancy.
Intervention: Package plus weekly telephone call from trained volunteer with the aim
of providing minimal support until 12 weeks after birth; aim “to be a friend and a good
listener”; to ask about symptoms; signs; alcohol; drugs; smoking and meals in every
call; to encourage attendance at antenatal clinic appointments and to ask about “feeling
stressed”.
Intervention provided by 19 female volunteers, trained for the project with a “case load”
of 2 to 6 women each
Main intervention strategy: Social support (single intervention) compared to a less
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intensive intervention
Intensity: Frequency (C = 2, I = 6); Duration (C = 1, I = 4).
Intervention provided by project staff: efficacy study.
Outcomes Self-reported abstinence at 34/40 (late pregnancy*).
Mean cigarettes per day*.
Anxiety and depression scores at baseline and 34/40. There were other intervention
components which might have influenced these outcomes
Notes No process evaluation is reported. No sample size justification
SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random assignment
to control or intervention in balanced
blocks of 50
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk Data being reported were analysed on 122/
131 of randomised women (control = 63/
66, intervention = 59/65). 1 woman re-
quested to be removed from the study, but
there were 8 women who for various rea-
sons had incomplete data. p477 4.5% con-
trol 9.2% intervention. Only a proportion
were smokers (I = 31, C = 35), and the at-
trition among these is not reported so we
were unable to re-include them in the anal-
ysis for this review
Selective reporting (reporting bias) Unclear risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking behaviour.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Caregiver blinded to allocation. Women
not blinded to intervention
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk No process evaluation.
Equal baseline characteristics in study arms Unclear risk Baseline psychosocial variables (stress; so-
cial support; self esteem; depression; anxi-
ety) reported inTable 2.Demographic vari-
ables not reported
Contamination of control group Unclear risk Care providers blinded to allocation and
not involved in intervention delivery
Bullock 2009
Methods Randomised controlled trial (2 x 2 factorial design) evaluating nurse delivered telephone
social support (“Baby BEEP”) to improve a range of maternal health outcomes, including
smoking during pregnancy.
Study conducted in 21 rural Women, Infant and Children Nutritional Supplement
(WIC) clinics in a Midwestern state, USA, from January 2002 to July 2006
Participants Inclusion criteria:Women attending rural WIC clinic who reported smoking at least 1
cigarette per day, spoke English, were 18 years or older, and less than 24 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: When a woman attending a WIC clinic reported current smoking, staff
explained the availability of a smoking cessation study and asked permission to provide
her name and telephone number to the Baby BEEP research team. If the woman agreed,
a nurse from the research team was assigned to contact her to arrange a face-to-face visit
to explain the study and request written consent
1420 referrals from WIC clinics, 932 eligible, 695 (75%) randomised (C = 171; I1
(booklets) = 179; I2 (social support) = 175, I3 (social support+booklets) = 170.
Baseline characteristics: > 90% ’ready to quit this pregnancy’.
Fagerstrom scores: C = 4.8, I1 (Booklets) = 5.0, I2 (SS) = 4.9, I3 (SS+booklets) = 4.7
Mean age: 22 years, 95% white, 63% high school diploma, 70% in relationship
Psychosocial assessments indicated participants experienced high levels of perceived stress
and depression and low levels of support generally and from partners
Progress+ coding: Low SES as women recruited from WIC clinics.
Interventions Control:Quit Smoking for Good pamphlet from the American Heart Association and
instructed that a member of the research team would call each month to arrange a saliva
sample,measure exposure to tobacco smoke and ask some questions for 2more interviews
Intervention (3 arms):
I1 Serialised Pregnancy-Smoking Cessation Booklets (Booklets):Eight booklets com-
prised a programcalled “Stop Smoking!A Special Program for PregnantWomen” adapted
to a 7th grade reading level. The first booklet was given to the woman at the recruitment
visit without counselling, and the 7 remaining booklets were mailed at weekly intervals
I2 Nurse-Delivered General Social Support (SS): scheduled weekly telephone call and
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24-hour access to the nurse for any additional social support needed. The research nurse’s
role on the calls was to use empathetic listening skills and provide social, emotional and/
or informational support in response to each woman’s individual needs, such as stressors
she was facing and ways she could manage her stress responses. The nurses kept logs
of all conversations so that they would be able to follow-up on issues of importance on
subsequent calls and as a measure of treatment integrity.
All participants in these intervention study groups were encouraged to call the nurse any
time they felt stressed or the need to talk, and they were also provided with a refrigerator
magnet and a business card with their nurse’s first name and a toll-free number. The
nurses received 40 h of training for the telephone support intervention. Each research
nurse was given information about a variety of community resources available
I3 SS+Booklets:
This review included comparisons with the control group and I3 (SS+Booklets).
Main intervention strategy: Social support (tailored) compared to a less intensive in-
tervention
Intensity: Frequency (C = 1, I = 6); Duration (C = 1, I = 4).
Intervention provided by project staff: Efficacy study.
Outcomes Biochemically validated point prevalence abstinence at 28-32 weeks’ gestation* (late
pregnancy) and 6 weeks post-delivery (0-5 months postpartum*)
Perceived stress scale, prenatal psychosocial profile, mental health index 5; readiness to
stop smoking; Fagerstrom Test for Nicotine Dependence. Subgroup analysis for patterns
of quitting and associations with partner smoking
Notes Process evaluation to follow-up phone calls. Low attrition rate suggested as indicator of
acceptability
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Assignments were prepared individually for
each nurse, were computer generated using
SAS
Allocation concealment (selection bias) Low risk Opaque, sealed envelope, prepared by the
principle investigator that contained the
study group assignment
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition:Nine had a spontaneous abortion
(C = 2, I1 = 3, I2 = 3, I3 = 1) or non-viable
infant (C = 0, I1 = 4,I2 = 1, I3 = 4) andwere
excluded from the analysis in this review.
Those who dropped out and were lost to
follow-up for other reasons were included
in the final analysis as continuing smokers
(C = 7, I1 = 11, I2 = 11, I3 = 7).
However, 165 women were lost to lab er-
ror in analysing their saliva samples and
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were not included in analysis. Only 530/
695 (76%) randomised participants were
included in this analysis
C = 126 andI3 = 124 included in this re-
view.
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk 165/695 sample lost. Self-reported absti-
nence in remaining women biochemically
validated using salivary cotinine (30 ng/mL
or less classified as non-smokers)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The nurses who collected samples when
they conducted the follow-up interviews
in late pregnancy and 6-weeks postdelivery
were aware of the study group assignment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The laboratory was blind to study group
assignment while running the cotinine
analyses. The assistants who collected the
monthly saliva samplemay ormay not have
been blinded to the study group but the
rule was to treat all the women the same
way
Incomplete implementation High risk Percent of calls completed in each of their
caseloads ranged from 58% to 80% (p400)
Equal baseline characteristics in study arms Low risk Characteristics appear equal.
Contamination of control group Low risk Care-providers not involved in provision of
the intervention
Burling 1991
Methods Randomised controlled trial of CO feedback and brief directive feedback to reduce
smoking in pregnancy
Study conducted in a large US municipal hospital antenatal clinic, over an 18-month
study period (dates not specified)
Participants Inclusion criteria: Pregnant women, currently smoking, at any gestation, attending a
clinic for ’uncomplicated pregnancies’
Exclusion criteria: Very young age (not specified) or “complications” (not specified)
Recruitment: All attending women were screened for smoking by questionnaire + CO
breath measurement (>= 9 ppm) (over 50% were current smokers) and 139 women were
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randomly assigned (C = 69, I = 70)
Baseline characteristics: An average of 12.7 cigarettes per day.
The population consisted primarily poor and stable ’working class’ Caucasian women.
(52.4%), Black (44.6%) and Asian (3%)
Progress+ coding: Low SES.
Interventions Control:Usual care, where a clinic nurse provided health education, including smoking.
Intervention: A personal letter from the Chief (physician) of the prenatal clinic within
3 days of the visit, mentioning the CO test, discussing the risks of smoking to herself
and the fetus and urging her to stop plus the American Cancer Society pamphlet (“Why
start life under a cloud?”) about the negative effects of smoking and simple guidelines
for self-directed smoking cessation
Main intervention strategy: Health education (single intervention) compared to usual
care. CO feedback was provided to both groups so not included as a feedback trial
Intensity: Frequency (C = 0, I = 1), Duration (C = 0, I = 1).
Usual care intensity: Frequency = 1, Duration = 1.
Intervention provided by routine clinic staff: Effectiveness study
Outcomes Biochemically validated point prevalence smoking cessation at 34 weeks’ gestation (late
pregnancy*)
Notes Simple intervention so no process evaluation.
Clinic-wide implementation so no consent sought.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No consent sought and no loss to follow-
up apparent.
Selective reporting (reporting bias) Unclear risk None apparent. Primary outcomes re-
ported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of reported be-
haviour by exhaled CO (>= 9 ppm counted
as smoking)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The authors state that clinic staff were un-
aware of group allocation. Women would
not have been blind to educational inter-
vention
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All intervention participants provided with
letter. No information regarding whether
they read it or not
Equal baseline characteristics in study arms Unclear risk There were no significant baseline differ-
ences between 2 groups in terms of age,
ethnicity, term of pregnancy, number of
children, number of reported cigarettes
smoked, or CO
Contamination of control group Low risk Intervention was a letter so unlikely to be
sent to control group in error
Byrd 1993
Methods This randomised controlled study aimed to evaluate the effectiveness of nurse counselling
to reduce smoking in pregnancy.
The study was conducted in 2 community-based obstetric clinics in Milwaukee (USA).
Study dates unclear
Participants Inclusion criteria: Pregnant, ‘a current smoker’, English speaking, visually able to read
12 point typeset, being able to give free consent, and expecting to reside in Milwaukee
following delivery
Exclusion criteria: Not specified.
Recruitment: 50% of patients enrolled in third trimester. 57 women randomised, but
unclear how many to each group
Baseline characteristics: Cigarette consumption mean at entry = 8.6
93% participants smoked fewer than 10 cigs per day.
79% Black, 16% had partner, 70% single, 77% unemployed, 32% < grade 12 education,
61% < $10,000 per year
No coding as outcomes not able to be included in this review
Interventions Control:A smoking cessation booklet at 6th grade reading level or 11 minute videotape.
Intervention: Booklet or video Nurse counselling based on 4 As recommended by
National Cancer Institute. The nurse intervention was a systematic tailored smoking
cessation approach that was based on the 4 A (Ask, Advise, Assist, Arrange) approach by
the National Cancer Institute
Main intervention strategy and intensity not coded as not included in meta-analysis
Outcomes Self-reported smoking status (20% had CO screening) 1 month after enrolment, in the
ninth month of pregnancy, and 1 month postpartum. But not reported by intervention
group so unable to include any outcomes in meta-analysis
Notes
100Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Byrd 1993 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of sequence generation not stated.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of the 57 participants enrolled in the study,
50were available for 1 and 9month follow-
up, and 48 responded to the 1 month post-
partum survey. All non-respondents were
considered to be smokers at follow-up and
considered to have made no quit attempts
in the follow-up interval
Selective reporting (reporting bias) Unclear risk Outcomes not reported by intervention
group, but did not claim results were sig-
nificant
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status for 80% sam-
ple.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personal unlikely to be
blinded in educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Home visits.
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Methods Cluster-randomised controlled trial which aimed to assess 2 methods of disseminating
smoking cessation programmes to public antenatal clinics
Study conducted in Newcastle, New South Wales, Australia. Data collection dates not
reported
Participants Inclusion criteria: Public antenatal clinics with an antenatal clinic and more than 500
births per year (unit of randomisation). Women who attended the clinics and reported
to be current smokers were the unit of analysis
Exclusion criteria: Under 16 years of age, too sick, non-English speaking, illiterate,
attendance was first visit
Recruitment: 23/25 public hospitals agreed to participate 22 clinics randomised (C =
11, I = 11). Assume smoking prevalence identifies eligible smokers (2284 in control
clinics and 2821 in intervention clinics). Included in post-dissemination assessment: C
= 688, I = 781
Baseline characteristics: Smoking details not reported.
Proportion more than high school: 22%; Language other than English at home: C =
35%, I = 33%
Progress+ coding: Low SES as all attending a public pre-natal clinic.
Interventions The cessation programme “Fresh Start for you and your baby”, developed by Windsor,
based onCBT,was used.More details are described inWalsh 1997.Coded as a counselling
(multi-modal) intervention.
Control: Simple dissemination of programme to clinics which included mail out of
written information on programme benefit and resources
Intervention: Intensive dissemination of programme which included written informa-
tion and feedback about programme benefits to managers, provision of programme re-
sources, offers of visits to explain programme and provide training, sample smoking ces-
sation policy, regular contacts to offer support, and computerised feedback on activities
Main intervention strategy: Intensive dissemination vs less intensive dissemination.
Intensity:Not coded as same intervention for women in both arms (counselling-tailored)
. This study is not included in intensity analysis
Study provided by existing service providers: effectiveness study
Outcomes Primary outcomes were the proportion of women whose smoking status was assessed
and were provided smoking cessation advice
Biochemically validated point prevalence smoking cessation at end of pregnancy* (The
proportion of women who had been smokers when they first visited the clinic who had
now quit, p99) was a secondary outcome for this study
Provider views of interventions discussed.
Notes No intracluster correlation or impact factor reported, so sensitivity analysis conducted
using 4 ICCs and figures adjusting using ICC of 0.1 in outcome tables. See Table 2 for
adjustment calculations.
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk Methodof randomallocationnot specified,
but taken within strata based on clinic size
and baseline smoking rates
Allocation concealment (selection bias) Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
High risk One clinic excluded as did not report final
data and some missing data for post-dis-
semination measures. No ITT of women
dropping out of study. Only women com-
pleting study measures included in analy-
sis. Unable to re-include in this review
Selective reporting (reporting bias) Low risk Smoking status and recall of intervention
reported.
Other bias High risk There was a shorter recruitment period (1
week instead of 2 weeks) at post-dissemina-
tion for the 11 largest clinics (out of the 22
clinics involved), so the sample sizes have
been adjusted to account for the shorter re-
cruitment period for those clinics, by in-
creasing the sample size to what they would
have expected to have recruited if the pe-
riod was over 2 weeks instead of 1. We have
adjusted for these estimates in this review
as outlined in Table 2.
Also lower recruitment in control arms
compared to intervention arms
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Exhaled CO >= 9 ppm.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention. Neither women
nor providers would have been blind to the
intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed good imple-
mentation in intervention group. However
time constraints within clinics meant that
training sessions could not be repeated.
Although training permitted information
about the programme to be provided to
clinicians and the training videotape mod-
elled smoking cessation skills, the time pe-
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riod was usually inadequate to provide skill
development as originally planned. p100
Equal baseline characteristics in study arms Low risk Patient population differences on nearly all
14 characteristics were minimal (less than
5%)
Contamination of control group High risk Similar proportions of control women re-
ceived the specific risk information which
indicated that midwives had increased the
pre-study level of usual care advice
Cinciripini 2000
Methods Randomised controlled trial evaluating provision of videotaped vignettes for promoting
smoking cessation and relapse prevention during pregnancy
Study conducted in a community-based university setting, Texas, USA. Data collection
dates not reported
Participants Inclusion criteria: Volunteers who were willing to quit within 2 weeks.
Exclusion criteria:Women smoking < 3 cigarettes per day; < 18 years; > 30 weeks’ preg-
nant; do not have a working video recorder (approximately 12% Americans); depressed
Recruitment: Through local media, such as newspaper, radio, subscriber letters, com-
munity business flyers, waiting room posters
146 women screened and 82 women who met inclusion criteria were randomised (C =
40, I = 42)
Baseline characteristics: Mean cigarettes/day at first visit: C = 14.5, I = 17.3.
Progress+ coding: None.
Interventions Control: Received a quit calendar and tip guide.
Intervention: As for control plus were mailed a video with 6 x 25-30 minute vignettes
covering a range of topics and strategies from initial quitting to relapse prevention
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention
Intensity: Frequency (C = 2, I = 2), Duration (C = 1, I = 4).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated point prevalence abstinence obtained within 2-3 days of quit
date, 4-5 weeks after the quit date (late pregnancy)* and 1 month postpartum (0-5
months postpartum*).
Participant evaluation of intervention materials.
Associated references report association of quitting and depressive disorders. CES-D
scores at baseline only
Notes Authors say women in this study tend to be heavier smokers than described in previous
studies
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 61% of participants completed all as-
sessments. All those with missing data were
treated as continuing smokers in this review
Selective reporting (reporting bias) Low risk Pre-specified outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk All reports of abstinence were validated by
measurement of salivary cotinine
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Video mailed to participants. Not clear if
UC givers were aware of group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed only 53% of the
intervention group viewed 1-3 of the 6
videos. 47% did not view them
Equal baseline characteristics in study arms Low risk No significant difference in socioeconomic
variables between groups
Contamination of control group Low risk Video mailed out to participants only.
Cinciripini 2010
Methods Randomised controlled trial to evaluate a depression-focused intervention which aims
to promote smoking cessation during pregnancy
Study conducted in Texas (USA) between January 2005 and January 2008
Participants Inclusion criteria: >= 16 years of age, to be <= 32 weeks pregnant, to have smoked
at least a puff or more during the past 7 days, to have a telephone, and to express a
willingness to quit smoking during the study (i.e., women with a goal of only reducing
cigarette consumption were not eligible)
Exclusion criteria: Currently participating in psychotherapy or other smoking cessa-
tion treatment, had unstable medical conditions that would adversely affect attendance,
or demonstrated psychological instability during the screening (e.g., high suicide risk,
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symptoms of cognitive disorder, or severe intellectual impairment)
Recruitment:Throughnewspaper and television advertisements, and physician referrals.
730 women were screened for basic eligibility by telephone. 266/294 (90%) eligible
women were randomised (C = 133, I = 133)
Baseline characteristics: Smoking rate before finding out pregnant (mean cigarettes per
day): I = 16.8 (8.7), C = 15.8 (9.1);
Current smoking rate (mean cigarettes per day): I = 9.8 (7.1), C = 9.7 (6.7)
Fagerstrom Test for Nicotine Dependence score I = 3.2 (2.1), C = 3.5 (2.0)
63% receiving medicaid or county health care, 54% African-American, 10% Hispanic,
33.5%Caucasian; 31.9% had less than high school education. 34.2% had family income
< $10,000
75.5% had lifetime major depressive disorder (23.5% current major disorder)
Progress+ coding: None.
Interventions Ten individual counselling sessions were scheduled for 60 min. Each session consisted of
15 min of standard behavioural and motivational smoking cessation counselling (com-
mon to both groups). Counselling typically involved active efforts to prepare for quitting
and maintaining abstinence using self-monitoring of their smoking prior to the quit
date, identification of high-risk situations for smoking, and development of coping skills
and support before and after the quit date. Therapists used motivational enhancement
strategies based on techniques of motivational interviewing if resistant to quitting.The
core features included exploration of participant ambivalence, use of open-ended ques-
tions, reflective listening, expressed empathy, rolling with resistance, and use of strategies
to develop perceived discrepancy between smoking behaviour and important personal
goals and values
Control: The primary goal of the HW treatment was to educate women on ways to
decrease stress, to respond to stressful events, and to take care of themselves physically
during their pregnancies. The purpose was to provide a time- and attention-matched
control for CBASP that was pregnancy relevant but instructional in nature-typical of
health-education interventions. Participants chose from a list of discussion topics, in-
cluding stress, pregnancy symptoms, sleep, exercise, yoga, relaxation training, time man-
agement, parenting tips, dealing with anger, negative thoughts and feelings, and post-
partum depression.
Intervention: CBASP was originally developed for the treatment of chronic depression.
The primary CBASP treatment strategy is a social problem-solving exercise called Sit-
uational Analysis (SA), which is a technique used to create awareness of the contin-
gent relationship between participants’ behaviour and outcomes in stressful interpersonal
situations. Another CBASP treatment strategy involved increasing participants’ aware-
ness of the contingent relationship between their behaviour and interpersonal outcomes
within the therapeutic relationship and to apply this learning to relationships within the
participants’ daily living arenas. The CBASP model assumes that repeated practice of
SA within and outside of treatment and increased understanding of participants’ inter-
personal impact on the therapist lead to acquisition of new perceptual and behavioural
skills that improve interpersonal problem resolution. In turn, this is assumed to decrease
interpersonal stress and depressive symptoms
Main intervention strategy: Counselling (single intervention) compared to alternative
intervention
Intensity: Frequency (C = 6, I = 6); Duration (C = 6, I = 6).
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Outcomes Biochemically validated 7-day point prevalence abstinence at end of 10 weeks treatment
(late pregnancy*); Smoking cessation 3 & 6 months after treatment, smoking cessation
3 (0-5*) & 6 (6-11*) months postpartum. Continuous and prolonged abstinence also
reported
Depression (CES-D scores) and probability of cessation 6 months post-treatment
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Adaptive randomisationwas used to stratify
the groups on age, race, history of depres-
sion, baseline smoking rate, baseline de-
pressive symptom severity (CES-D >= 16)
, and longest duration of last depressive
episode
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 3 months: C = 9/133, I = 22/
133; 6 months C = 42/133, I = 54/133. All
analyses were carried out on the intent-to-
treat sample, which included 128 partici-
pants in the Intervention group and 129
control - excluding only those who expe-
rienced a miscarriage during the study (5
participants in Intervention and 4 partici-
pants in control)
Selective reporting (reporting bias) Low risk All primary outcomes reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking status (7-day point prevalence
only) using expiredCO (<4ppm) through-
out treatment and salivary cotinine (< 15
ng/mL) at follow-up contacts
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers unlikely to be
blinded to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Incomplete implementation Low risk Process evaluation showed high levels of
compliance with counselling standards in
both groups. Participants attended an av-
erage of 8/10 sessions of approximately 58
mins
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group Low risk There is a potential risk with the same
counsellors providing counselling for the
intervention and control groups. However
global competence ratings forCBASP,HW,
and the smoking cessation counselling in-
terventions were measured on a scale rang-
ing from 1 (does not attempt intervention)
to 4 (good use of intervention). No differ-
ences in competence between the groups
were noted, averaging 3.8 (SD across con-
ditions. Statistical agreement of compe-
tence ratings between primary and sec-
ondary raters was high, with a Cohen’s
kappa (Landis & Koch, 1977) of .93 (95%
CI 0.86 to 1.0)
Cook 1995
Methods Randomised controlled trial of counselling to support women to stop smoking during
pregnancy in the USA. Location and dates of data collection not reported (abstract only
available)
Participants Inclusion criteria: Self-reported smokers presenting for prenatal care before 24 weeks’
gestation
Exclusion criteria: Not specified.
150 women randomised. Data for only 43 women (C = 20, I = 23) who had delivered by
the time of report are available. 2 women in control group had baseline cotinine levels
consistent with abstinence so are not included (C = 18, I = 23)
Baseline characteristics: Not reported.
Progress+ coding: None.
Interventions Control:Discussion of smoking risks by a nutritionist and again by a resident physician
at initial prenatal visit
Intervention:Control + regularmeetings with a smoking cessation counsellor and physi-
cian reinforcement at each visit. The women also received biochemical feedback from
urine cotinine
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C=1, I=5); Duration (C=1, I=3). Estimates for intervention as
little detail provided
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Outcomes Biochemically validated point prevalence abstinence at term or birth (late pregnancy*);
>50% reduction in mean cotinine*; and mean birthweight*
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk One woman in the intervention group
dropped out of the study and was not in-
cluded in the original analysis but has been
re-included as a continuing smoker in this
review, but not included in the mean birth-
weight analysis
Selective reporting (reporting bias) High risk Preliminary results only available. Final re-
sults not reported and unable to be accessed
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urine cotinine
but cut-off levels not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible for participants and personnel
to be blinded to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Baseline characteristics not reported (ab-
stract only).
Contamination of control group High risk Appears that same physician provided ad-
vice to control and intervention women,
and not clear if this was not repeated for
control group
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Methods Randomised controlled trial evaluating effectiveness of feedback from a point-of-care
cotinine test for supporting women to stop smoking during pregnancy
Study conducted in Birmingham, UK. Dates of data collection not reported
Participants Inclusion criteria: ’Current smokers’ (> 10 mg/L in preliminary urine cotinine result)
Exclusion criteria: Not specified.
Recruitment: Seen at initial antenatal visit and given brief explanation of test and aims
of research, and asked to give verbal consent to participate in study. Women then had
urine screened for cotinine and completed a questionnaire
745/856 (87%) eligible women agreed to participate and were randomised (C = 447, I =
298 in flow chart and 409 in results text). 280 women were smokers (C = 164, I = 116)
Baseline characteristics: Average consumption of 11.8 cigarettes per day. Other char-
acteristics not reported
Progress+ coding: None
Interventions Control: Routine counselling from a doctor or midwife. Urine measured at initial visit
but no feedback given to woman
Intervention: Six-minute urine test completed in their presence. Results given as a num-
ber and graphic illustration. A specific quit date within the next 14 days was mutually
agreed and the woman was given a printed leaflet containing practical advice on how to
reduce their smoking measurement at each visit. A positive friendly attitude of providers
- information, feedback, encouragement protocol was repeated whenever the patient
returned to the clinic up to and including the 36 week visit, with measurement, ques-
tioning about changes in smoking, specific events on the quit date and reinforcement of
advice
Main intervention strategy: Feedback (multiple intervention) compared to usual care.
Intensity: Frequency (C = 0, I = 5); Duration (C = 0, I = 3). Usual care intensity: F = 1,
D = 1
Intervention provided by study staff: Efficacy study.
Outcomes Biochemically validated point prevalence smoking cessation at 36 weeks’ gestation (late
pregnancy*)
Proportion with ’some reduction*’ (20%-80% urine cotinine).
Mean birthweight* and length. Preterm births* reported in attrition and re-included in
both numerator and denominator for this outcome
Gestation, type of delivery, and Apgar scores collected but results not reported
Participants view of interventions reported.
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quasi-randomised: New referrals to 3 large
inner-city hospital antenatal clinics were
randomised on the basis of their allocated
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hospital unit number, even numbers being
placed in the case or intervention group,
or those who were provided with feedback
from the smoking test at point of care. p675
Allocation concealment (selection bias) High risk Group allocation could be anticipated.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only 83/116 women in the control group
and 109/164 women in the intervention
group completed the study. Those who
dropped out for medical reasons: miscar-
riage (C = 2, I = 3) or premature delivery (C
= 6, I = 13), or transferred care (C = 3, I = 5)
were excluded (C = 11, I = 21) from smok-
ing outcome analysis. Those who failed to
attend appointments, or refused further in-
volvement were re-included as continuing
smokers in this review (C = 18, I = 34),
leaving a total sample of C = 101, I = 143
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias High risk Clear financial conflict of interest declared
by author (directorship of company pro-
ducing feedback tests).
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking status biochemically validated
with urine cotinine (> 10 mg/L indicates
active smoker)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither providers nor women were blind
to intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Contamination unlikely with provision of
specific biochemical test
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Methods Randomised controlled trial of “Significant Other Supporter” (SOS) program, of social
support anddirect financial rewards to reduce smokingduringpregnancy andpostpartum
Study conducted in Oregon WIC program sites, USA, between June 1996 and June
1997
Participants Inclusion criteria: Women smoking (even a puff in the last 7 days); less than 28 weeks’
gestation; over 15 years of age; literate in English
Exclusion criteria: Not specified.
Recruitment: 220/309 (71%) eligible women were randomised (C = 108, I = 112)
Baseline characteristics: Mean salivary cotinine at baseline: I = 45.4; C = 45.7.
Caucasian (I = 90%, C = 88%), household income < $20000 (I = 87%, C = 89%), Single
(I = 47%, C = 42%), Mean age (I = 23.5, C = 24.0)
Progress+ coding: Low SES.
Interventions Control: Verbal and written information on the importance of smoking cessation, a
pregnancy specific smoking cessation self-help kit, and monthly telephone calls for self-
reports on their smoking status.
Intervention: As for the control group plus were asked to designate a social supporter
(preferably a female non-smoker), and were advised both she and her supporter would
receive an incentive: participants were given $50 voucher for each month biochemically
confirmed as quit. Supporter received $50 voucher in first month and at 2 months
postpartum, and $25 voucher for other months
Main intervention strategy: Incentives (multiple intervention) compared with a less
intensive intervention
Intensity: Frequency (C = 2, I = 6), Duration (C = 1, I = 3)-estimated duration as limited
information available
The intervention was delivered by trained program staff or research staff: efficacy study
Outcomes Biochemically validated point prevalence smoking cessation at 34 weeks’ gestation (late
pregnancy*) and 2 (0-5*) months postpartum
Notes Data in outcome tables is inconsistent.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk High attrition rates I = 32%; C = 51.5%
(reasons not specified), but all drop-outs in-
cluded as continuing smokers in this anal-
ysis
Selective reporting (reporting bias) Low risk Main outcomes reported.
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Reported quitting validated by salivary co-
tinine analysis (> 30 ng/mL considered to
be smokers). Salivary thiocyanate also used
(> 100 ug/mL considered to be smokers)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither providers nor women were blinded
for this educational intervention with in-
centives
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk No process evaluation reported.
Equal baseline characteristics in study arms Unclear risk Preliminary analysis indicates no signifi-
cant differences exist between randomised
groups on baseline demographic character-
istics
Contamination of control group Low risk Control group not reported clearly - how-
ever intervention given by trained research
staff rather than usual care providers so un-
likely that there was contamination
Donovan 1977
Methods Randomised controlled trial of medical advice to stop smoking in pregnancy
Study conducted in 3 public maternity units in the UK. Dates of data collection not
stated
Participants Inclusion criteria: Pregnant women < 35 years; currently smoking >= 5 cigarettes/day
and had been smoking >= 1/day at the onset of pregnancy; < 30 weeks’ gestation at first
visit; no prior perinatal death; not seeking termination
Exclusion criteria: Not further specified.
Recruitment: Consecutive series of patients who contacted 3 maternity units regard-
ing confinement were posted reply-paid questionnaires (including smoking questions),
which were used to select eligible participants
588 women provided consent and were randomised.
Baseline characteristics: Mean cigs/day at beginning of pregnancy (C = 17.6, I = 17.9)
; mean cigs/day at study entry (C = 15.2, I = 15.2),
Mean age (C = 24.2, I = 23.8). Even distribution of social class categories
Progress+ coding: None.
Interventions Control: ANC usually provided by the hospital, including any anti-smoking advice
which may have been given routinely
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Intervention: Individualised medical advice by clinic doctor,
(i) tell the woman the facts about smoking in pregnancy;
(ii) encourage questions about these facts;
(iii) once the woman has agreed to try, discuss how she may best give up;
(iv) follow-up the advice at all later contacts. Medical records labelled asking other staff
to reinforce advice
Details of the intervention are in Donovan 1975.
Main intervention strategy: Health education (single intervention) compared to usual
care
Intensity: Frequency (C = 0, I = 5); Duration: (C = 0, I = 2)-estimate. Usual care
intensity: F = 1, I = 1
Intervention provided by existing service providers: effectiveness study
Outcomes Self-reportedmean cigarettes/day at 4 stages of pregnancy (late pregnancy*); mean birth-
weight*; low birthweight*; preterm birth* (< 36 weeks); perinatal deaths*. No data on
smoking cessation
Notes Discussion of common problems identified when advising women to stop and on the
contextual factors which encourage the continuation of smoking.
Major inconsistency in smoking reports pre and post-birth is a problem in this trial
Actual standard errors were able to be incorporated into software for this update (previ-
ously SD 500 used), so effect size estimates have altered slightly
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Twins (C = 2, I = 6) and miscarriages (C
= 17, I = 11) not included in analysis. 552
women analysed (C = 289, I = 263). No
further attrition reported
Selective reporting (reporting bias) Unclear risk Smoking cessation rates not reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking behaviour.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Notes labelled. Caregivers asked to rein-
force information. Educational interven-
tion
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation of the reinforcement of
advice showed little difference between the
groups in recall of advice being given
Equal baseline characteristics in study arms Unclear risk From table 2 characteristics appear to be
equal - but there is no statement or statistic
confirming this
Contamination of control group High risk Same providers offering intervention and
control advice. Process evaluation of the re-
inforcement of advice showed little differ-
ence between the groups in recall of advice
being given
Dornelas 2006
Methods Randomised controlled trial of counselling and telephone support to support women to
stop smoking during pregnancy and post-partum
Study conducted inHartford, Connecticut (USA), between January 2001 andDecember
2002
Participants Inclusion criteria: Pregnant women, over 18 years old, less than 30 weeks’ gestation,
current smokers (recent quitters included in associated relapse prevention paper (Morasco
2006).
Exclusion criteria: Recent history of abuse or dependence on alcohol or other non-
nicotine substance, major psychiatric illness, no access to a telephone
Recruitment: Study conducted in the prenatal clinic of a non-profit tertiary care com-
munity hospital. Written consent obtained. Unclear how many eligible women partici-
pated. 140 women enrolled in study. 33 spontaneously quit (C = 19, I = 14), 107 were
randomised but 2 were excluded due to missing data, leaving 105 included in analysis
(I = 53, C = 52)
Baseline characteristics: 70.5% smoked less than 10 cigarettes per day at baseline.Mean
20.8 (12.37) pre-pregnancy
66% Hispanic, 17% Caucasian, 11% African American. 61% unemployed, 54% less
than high school education, 60% single, 49% household income < $15000/yr, 52% 1
or more depression items and 19% all 4 items
Progress+ coding: Low SES and minority ethnic group.
Interventions Control: Usual care according to standard smoking cessation guidelines, with providers
offered 2 x1h training sessions. Research study co-ordinator provided all participants
with a booklet, inserted a chart prompt to remind providers to provide personalised quit
messages at each visit, and audited charts to ensure the advice was documented
Intervention: 1 90-minute psychotherapy session provided by masters-prepared mental
health therapist trained in smoking cessation. The main goals were to assess readiness to
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quit, identify potential psychological or social problems that might pose as barriers to
quitting, and set a quit date. This was followed by bi-monthly telephone calls from the
therapist during pregnancy, and monthly calls after delivery
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention
Intensity: Frequency (C = 5, I = 6), Duration (C = 2, I = 6).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated 7-day point prevalence abstinence in late pregnancy* and 6 (6-
11) months postpartum*
Aggregated results by week of gestation to enter study. An associated study (Morasco
2006) reports abstinence rates for recent quitters (relapse prevention*)
Cost-effectiveness of ’cost per quitter’.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No description of methods of randomisa-
tion.
Allocation concealment (selection bias) Unclear risk No description.
Incomplete outcome data (attrition bias)
All outcomes
High risk 2/107 randomised women were excluded
from analysis due to missing data and were
unable to be re-included in this report as
the group allocation is not reported.The re-
maining dropouts (18% at 6 months post-
partum) are included as continuing smok-
ers in this analysis
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation with exhaled CO
readings (cut off < 8 ppm but all partici-
pants less than 4 ppm)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention so blinding not
feasible.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Incomplete implementation High risk Process evaluation showed 17/53 did not
receive the phone calls as planned
Equal baseline characteristics in study arms Unclear risk No significant differences in any of the
baseline characteristic between the 2 groups
Contamination of control group Low risk Counselling and follow-up sessions pro-
vided by psychotherapist not involved in
usual care
Dunkley 1997
Methods Randomised controlled trial ofmidwifery counselling to support women to stop smoking
in pregnancy
Study conducted in a large UK maternity service. Data collection dates not specified
Participants Inclusion criteria: Pregnant and booked for maternity care; <18 weeks’ gestation; cur-
rently smoking 1 or more cigarettes/day
Practising midwives regularly attending antenatal clinic.13 midwives selected for the
intervention group and 13 for the control group
Exclusion criteria: Not specified.
Recruitment: All women identified as smokers in a busy teaching hospital with 3700
deliveries a year received a letter asking if they would like to participate. 100 women
participated (described as ’all 100 women contacted’) and were randomised (C = 50, I =
50)
Baseline characteristics: ’Contemplators’ (C = 70%, I = 60%), ’pre-contemplators’ (C
= 15%, I = 22%), ’ready for action’ (C = 15%, I = 18%)
No other baseline characteristics reported.
Progress+ coding: None.
Interventions Control: Usual care.
Intervention: Midwives were trained to assess the stages of change and provide a be-
havioural intervention, using the Health Education Authority material “Helping preg-
nant smokers quit: training for health professionals”, 1994
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency (C = 0, I = 5), duration (C = 0, I = 2)-based on estimated brief
contact (< 5min) at a standard number of antenatal visits (8), as very little information
about intervention provided. Usual care intensity: F = 0, I = 0
Intervention provided by existing staff: effectiveness study
Outcomes Self-reported smoking cessation at 37 weeks (late pregnancy)*; and at 4 weeks (0-5
months*) postpartum
Reduction in cigarettes/day; “stage of change” at 11 to 18 weeks vs 37 weeks. No bio-
chemical validation of smoking status. Care providers’ views discussed
Notes No process evaluation reported.
Abstract data used. States ’after one year’ which is assumed to be of year of the study, at
37 weeks’ gestation, as reported in figure one. As there were no quitters in the control
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group, the relapse rates of 4% within 1 month postpartum are assumed to be from the
treatment group only
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk Described as ’randomly allocated’.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 94 of 100 randomised women followed up
(reasons for attritionnot reported).No ITT
analysis reported. However, all drop-outs
re-included as continuing smokers in this
review
Selective reporting (reporting bias) Unclear risk All outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking status.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel unlikely to be
blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Midwives randomised so low risk of con-
tamination.
Eades 2012
Methods Randomised controlled trial which aims to promote smoking cessation and relapse pre-
vention during pregnancy and postpartum
The study was conducted in 3 urban community-controlled health services in far north
Queensland and Western Australia June 2005 and December 2009
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Participants Inclusion criteria: Pregnant Aboriginal or Torres Strait Islander women attending their
first antenatal appointment at 1 of the Aboriginal community-controlled health services
at or before 20 weeks’ gestation;
were aged 16 years or older, were self-reported current smokers or recent quitters (quitting
when they knew they were pregnant); and were residents of the local area
Exclusion criteria: Women whose pregnancy was complicated by a mental illness or
they were receiving treatment for chemical dependencies other than tobacco or alcohol
use
Recruitment: 1119/1180 women attending the antenatal clinic were assessed for eligi-
bility. 263/379 (69%) eligible women agreed to participate (C = 115, I = 148)
Baseline characteristics: Median cigarettes per day: C = 10 (4-15), I = 10 (5-15);
Spontaneous quitting since pregnancy: C = 8, I = 24
100% Aboriginal and Torres Strait Islander women. Partner (C = 88%, I = 92%)
Progress+ coding: Low SES and minority ethnic group.
Interventions Control: Usual care consisting of general advice from a GP about quitting smoking,
based on existing brief intervention guidelines
Intervention: Intervention developed after review of the literature and consultation with
service providers and community members. At first antenatal visit women received a
scripted invitation from the doctor to quit smoking and advised to quit ’cold turkey’ and
return to the clinic in 3-5 days and at 7-10 days. The woman received an appointment
reminder card, fridge magnet, and a letter for other household members requesting
their support. Women were asked to bring a partner or support person with them
on their second visit. Women still smoking after 7-10 days were offered NRT if no
contra-indications. Follow-up visits were conducted by female Aboriginal or Torres Strait
Islander health workers and midwives who received training from a behavioural scientist
and a GP, a study manual and a 1 page guide with scripted advice
Main intervention strategy: Counselling (tailored) compared to usual care.
Intensity: Frequency (C = 0, I = 4), Duration (C = 0, I = 3). Usual care intensity: F = 1,
D = 1
Existing staff delivered intervention: effectiveness study.
Outcomes Biochemically validated point prevalence smoking abstinence* and relapse prevention*
at 36 weeks’ gestation (late pregnancy)
Post-partum cessation (6 months) not reported due to very high rates of attrition
Notes Cluster-randomisation by weeks but number of weeks not reported. No analysis for
adjustment for clustering reported. Treated as individually randomised controlled trial
in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An Excel computer program was used to
randomly allocate weeks to intervention or
control for all clinics
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Eades 2012 (Continued)
Allocation concealment (selection bias) High risk Author notes lack of allocation conceal-
ment a methodological limitation of the
study, which may account for unequal al-
location in study arms
Incomplete outcome data (attrition bias)
All outcomes
Low risk High rates of attrition (C = 37/115, I =
50/148) at end of pregnancy (reasons not
reported). Very high attrition at 6 months
post-partum. ITT analysis. Women lost to
follow-up or with missing smoking status
were classified as current smokers
Selective reporting (reporting bias) Unclear risk 6 months postpartum outcomes not re-
ported due to high attrition
Other bias High risk Unequal numbers in each group with
greater allocation to intervention groups
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported smoking cessation biochem-
ically validated using urinary cotinine (<
250 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Clinic staff made aware of treatment allo-
cation at beginning of each week and un-
likely participants were blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor blinding not reported.
Incomplete implementation High risk 64% doctors adhered to protocol and a
lower proportion of nurses and health
workers
Equal baseline characteristics in study arms High risk A slightly higher proportion of interven-
tion group were in clinic 1, a slightly lower
proportion had a partner, and had recently
quit
Contamination of control group High risk Same antenatal care providers delivered in-
tervention and control arms. High likeli-
hood of contamination noted in discussion
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El-Mohandes 2011
Methods This randomised controlled trial examines whether an integrated behavioural interven-
tion improves pregnancy outcomes, including smoking cessation
The study was conducted in 6 community-based clinical sites serving minority women
(African-Americans and Hispanics) in Columbia, USA, from July 2001 to July 2004
Participants Inclusion criteria: Women attending prenatal care in 6 community-based sites who self-
identified as belonging to a minority group, being >= 18 years,
< 29 weeks pregnant, a DC resident and English speaking. Had to have 1 risk factor
(smoking, ETSE, depression, and IPV). Only women reporting smoking at baseline are
included in this review
Exclusion criteria: Suicidal women.
Recruitment: 2913 women approached while waiting for prenatal appointments. 1044/
1398 (75%) eligible women provided signed consent to participate in the study (C =
523, I = 521)
302 women reported smoking ’1+ puff in the preceding 6 months and 198 reported
’active’ smoking at baseline. These 198 ’active’ smokers at baseline are included in this
analysis (C = 92, I = 106)
Baseline characteristics:
100% African American, 43.7% reliant on social housing, ~80% Medicaid recipients
Progress+ coding: Minority ethnic group and low SES.
Interventions Control: Not reported-usual care.
Intervention: The 10-session intervention was delivered during prenatal (eight sessions)
and postpartum (2 booster sessions) care visits. 4 prenatal sessions were considered min-
imal adherence. The session duration was approximately 35 min. The smoking inter-
vention was consistent with the Smoking Cessation or Reduction in Pregnancy Trial
(SCRIPT) and the Counseling and Behavioral Interventions Work Group of the United
States Preventive Services Task Force recommendations, a 5-step behavioral counselling
approach. The intervention was tailored to the woman’s stage of change. Women were
encouraged to avoid triggers and to use alternative coping and behavioural change strate-
gies. The intervention included content to address both active smoking and ETSE,
whether or not they met criteria for ETSE. Women with other risk factors (IPV, depres-
sion and drug or alcohol use) also received additional targeted interventions to address
those issues
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 4).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated smoking cessation prior to delivery* (late pregnancy) and at 8-
10 weeks (0-5 months*) postpartum. Mean urine cotinine*
Outcomes also reported by intervention group for environmental tobacco smoke expo-
sure, depression, intimate partner violence and illicit drug use
Detailed pregnancy outcomes reported but not included in this analysis as they were not
reported by smoking status at baseline, and these outcomes may be affected by several
of the multi-modal interventions aimed at reducing risk factors other than smoking
Notes Detailed participant satisfaction and intervention acceptability was reported in an asso-
ciated reference (Katz 2008).
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El-Mohandes 2011 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Site- and risk-specific block randomisation
to IG or UCGwas conducted. A computer
generated randomisation scheme consid-
ered all possible risk combinations within
each of the recruitment sites
Allocation concealment (selection bias) Low risk Investigators and field workers were
blinded to the block size. Recruitment staff
at each site called in the details of the risk
profile for a new recruit, and the assign-
ment was generated centrally by the data
co-ordinating centre
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: 104/500 (21%) prior to deliv-
ery and 116/500 (23%) in the postpartum
assessment. Participant data were analysed
according to their care group assignment,
regardless of whether they received any in-
tervention sessions, using an ITT model
Selective reporting (reporting bias) Unclear risk Data onwomen spontaneously quitting be-
fore pregnancy were not reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking cessation biochemically validated
using salivary cotinine (< 10 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers not able to
be blinded by dedicated intervention
providers minimised risk of contamination
of study arms
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk 4 research teams were allocated to ensure
blinding of outcome assessors
Incomplete implementation High risk Process evaluation showed16%womendid
not attend any sessions, 43% randomised
womendid not complete first follow-up in-
terview and 31% did not complete 2nd fol-
low-up interview
Equal baseline characteristics in study arms Low risk No significant differences noted.
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El-Mohandes 2011 (Continued)
Contamination of control group Low risk Persons delivering intervention were sepa-
rate from care provider team
Ershoff 1989
Methods Randomised controlled trial of self-help booklets to support women to stop smoking in
pregnancy
Study conducted in 5 health centres of the same HMO in Los Angeles (USA), from
1985 to 87
Participants Inclusion criteria: English-speaking women attending 1 of 5 health centres for prenatal
care, < 18 weeks’ gestation; still smoking >= 7 cigarettes a week
Exclusion criteria: Not specified further.
Recruitment: 323 who self-reported still smoking >= 7 cigs/week were randomised (C
= 158, I = 165). 242 included in final analysis (C = 116, I = 126). 228 women who had
spontaneously quit also included (C = 108, I = 110)
Baseline characteristics (smokers): Prepregnancy smoking: 27.3% 1-10 cigs/day, 14%
11-19 cigs/day, 58.7% 20+ cigs/day. At intake: 71.9% 1-10 cigs/day, 14.9% 11-19 cigs/
day, 13.2% 20+ cigs/day. Spontaneous quitters: mean pre-pregnancy cigarettes/day = 10.
3
Smokers: 64% white, 73% had high school or some college education, 59.9% married
Progress+ coding: None.
Interventions Control: 2-page pamphlet on hazards of smoking and on the need to quit; 2 minutes
discussion with a health educator (within a 45 minutes individual conference); advised
of free 5 session smoking cessation program available through the HMO. Coverage in
antenatal classes remained unchanged.
Intervention: As for the control group + first of series of 8 self-help booklets aimed to
increase motivation for quitting; teach behavioural strategies for cessation and relapse
prevention; 3minutes introduction to these by health educator; asked tomake a commit-
ment to read the first 1 and list reasons for not smoking; others mailed weekly. Booklets
were pregnancy-specific, multi-ethnic, and at a 9th Grade reading level
Main intervention strategy: Counselling (single intervention) compared to less inten-
sive intervention
Intensity: Frequency (C = 6, I=6), Duration (C = 4, I = 4). Estimate based on uptake
of optional HMO sessions x 5 approximately 20-40 mins
Intervention provided by existing health staff: effectiveness study
Outcomes Biochemically validated abstinence at 34 weeks’ gestation (late pregnancy*)
Ershoff 1995 reports relapse prevention* among women who had spontaneously quit
Ershoff 1990 reports birth outcomes (mean birthweight*; low birthweight*; preterm
birth* (< 37 weeks); stillbirths*) and cost outcomes (economic evaluation)
Associated reference (Mullen 1991) describes question structure’s to improve accurate
disclosure of smoking status
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
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Ershoff 1989 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) High risk The authors state that women had been
randomised in advance of their visit. It was
not clear how women were recruited to the
study or gave consent for participation.The
health educator turned over a ’pre-assigned
card’ to randomise women
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Smokers: Attrition I = 39/165, C = 44/158
not included in analysis. Losses due to ter-
mination (C = 11, I = 7); miscarriage (C
= 13, I = 12); disenrolment or transfer to
another HMO (C = 18, I = 20)
Spontaneous quitters: Attrition 22% -
Abortion (n = 5), miscarriage (n = 17), dis-
enrolment from HMO or transfer (n = 25)
Not re-included in analysis for this review
as excluded for medical reasons or moving
Selective reporting (reporting bias) Unclear risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urinary cotinine
levels. For participants reporting no smok-
ing and low exposure to passive smoke
urine cotinine had to be less than or equal
to 10 ng/mL. For participants reporting a
relapse and high exposure to passive smoke
some values could be as high as 29 ng/mL
though at least 1 sample had to be 10 ng/
mL or less
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The authors state that the health educator
delivering the intervention was not aware
of group allocation, but materials were pro-
vided to the experimental group at the
clinic visit. Prenatal care providers were
blinded to group assignment and no effort
was made tomodify their usual counselling
practices
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Ershoff 1989 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation reports good implemen-
tation.
Equal baseline characteristics in study arms Unclear risk With the exception of partners smoking
status.
Contamination of control group Unclear risk Prenatal care providers no involved in in-
tervention so risk of contamination likely
to be low
Ershoff 1999
Methods 3-armed randomised controlled trial of interactive computer program and telephone
counselling to support women to stop smoking in pregnancy
Study conducted in a large group model managed care organisation in Los Angeles,
California (USA) with recruitment from November 1996 to June 1997
Participants Inclusion criteria: Smokers were identified at first visit as women who self-report “smok-
ing now”, “smoke but have cut down since pregnancy”, or “smoke from time to time”
Exclusion criteria: < 18 years of age, > 26 weeks’ gestation, do not speak English, or
smoked less than 7 cigarettes pre-pregnancy
Recruitment: Researchers attempted to phone 931 women. 150 could not be contacted,
90 refused to be interviewed, 158 were not eligible and 34 were excluded as they expe-
rienced miscarriage (n = 34). 390/458 women (82%) agreed to participate (C = 131,I1
= 133, I2 = 126).
Baseline characteristics: Pre-pregnancy mean cigs per day: C = 17.1 (9.7), I1 = 17.6
(9.8), I2 = 16.3 (7.6). Mean cigs per day at intake: C = 6.6(7.3), I1 = 6.7(6.5), I2 = 6.3
(6.5).
60% white, approximately 50% college educated, with a mean age of 29.4. Mean
cigarette/day at first visit = 6.6
Progress+ coding: None.
Interventions 3 interventions, based on stages of change model.
Control: Received a 32-page self-help booklet “living smoke-free”.
Intervention 1 (interactive computer program-IVR): received the same self-help book-
let and had access to a computerised interactive telephone support system, which pro-
vided customised messages from a voice model. Participants responded to questions us-
ing a touch-tone keypad.
Intervention 2 (motivational interviewing): received the same self-help booklet and
4-6 x 10-15 minute telephone counselling sessions by nurse educators trained in moti-
vational interviewing. A personalised postcard sent to reinforce verbal communication
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention (self-help booklet). Arms 1 and 3 only are compared in this review
Intensity: Frequency (C = 2, I = 6), Duration (C = 1, I = 3).
125Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ershoff 1999 (Continued)
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated smoking cessation at 34weeks’ gestation (late pregnancy*).Mean
cigarettes per day*
Baseline mental health index and Cohen’s perceived stress scale.
Number of quit attempts and movement in stages of change.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “random assignment”
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 58/390 (14.87) due to abortion
(n = 31), disenrolment from health plan (n
= 22) and preterm birth less than 32 weeks
(n = 5). Lost to follow-up not included as
continuing smokers in analysis as attrition
due to medical reasons and moving not re-
included in this review, and attrition from
each study group not reported separately
Selective reporting (reporting bias) Unclear risk Results were difficult to interpret.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urinary cotinine
levels (< 80 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Authors state that care providers were blind
to group allocation. Educational interven-
tion so blinding women not feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete implementation Low risk Good process evaluation of each of the
methods. 79.2% received at least 1 call.
Mean 4 calls lasting 12 mins each
Equal baseline characteristics in study arms Low risk No significant differences reported.
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Ershoff 1999 (Continued)
Contamination of control group High risk 11% control group received individual
smoking cessation counselling as they were
classified as high risk patients
Gielen 1997
Methods Randomised controlled trial of counselling and a self-help guide to support women to
stop smoking during pregnancy
Study conducted in Baltimore (USA). Study dates not reported
Participants Inclusion criteria: Pregnant women currently smoking (even 1 puff in the past 7 days)
, either African-American or white
Exclusion criteria: > 28 weeks’ gestation; changing to another prenatal clinic or could
not complete baseline interview
Recruitment: 2,319 women assessed, 32% currently smoking by above definition. 72
were excluded for gestation, ethnicity or changing providers, leaving 662 eligible of
whom 510 agreed to participate (77%). 25 quit prior to first visit, 18 did not wish to
quit, leaving 467 (C = 235, I = 232) randomised
Baseline characteristics: Mean cigarettes/day at intake I = 9.7, C = 7.5 (P = 0.01).
85% were on medical assistance. African American: I = 81% C = 89%
Progress+ coding: Low SES and ethnic minority population.
Interventions Control: Usual clinic and inpatient smoking cessation: A brief discussion with a nurse/
health counsellor about the risks of smoking; a recommendation to quit and pamphlets
from the area’s voluntary agencies.
Intervention: Peer health counsellors recruited from local communities, received 2 ses-
sions training from PIs who explained content, rationale and how it was to be provided,
then observed in practice by PIs with feedback to her.
(i) A Pregnant Woman’s Guide to Quit Smoking (RA Windsor), 6th Grade level.
(ii) 15 minutes 1:1 counselling session with peer health counsellor on how to use the
Guide, showing how it is organised to be used daily, and discussing women’s thoughts
and concerns about quitting, targeting cessation or relapse prevention, as appropriate.
(iii) Educational materials for cessation support persons included with the Guide.
(iv) Reinforcement at each clinic visit from doctors and nurses, written prescription to
stop smoking provided directly from doctor to woman; 2 letters of encouragement (from
the doctor and the counsellor) mailed to the woman 1-2 weeks after her first visit
Main intervention strategy: Counselling (multiple intervention) compared to usual
care
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I=2). Usual care intensity F = 1, I
= 1
Intervention provided by study staff: Efficacy study.
Outcomes Biochemically validated 7-day point prevalence abstinence in hospital after delivery (late
pregnancy*), 6 (6-11*)months postpartum abstinence, and >50% reduction in cotinine*
from baseline to late pregnancy interview.
Smoking cessation data collected at 3 months but not reported
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Gielen 1997 (Continued)
Notes Guide developed through needs assessment with pregnant women, constructs from the
PRECEDE/PROCEED diagnosis and social learning theory, tested with focus groups,
additional section on relapse prevention, and on passive smoking postpartum.
Results show high rate of misclassification by self-report (I = 37%, C = 48%)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk Described as “randomly assigned”.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 16.3% attrition due to miscarriage, termi-
nation and change of care provider (C = 37,
I = 34). 145/391 (37%) remaining women
did not provide saliva samples and were
treated as smokers in the analysis but those
lost to follow-up for other reasons were ex-
cluded from the analysis in reports and in
this review
6* months postpartum abstinence was col-
lected and only small sample of 6-month
data reported (C = 48, I = 46), however all
missing data included as continuing smok-
ers in this review
Selective reporting (reporting bias) High risk - month postpartum outcomes not re-
ported andminimal follow-up for 6-month
postpartum data
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-report of ’not even a puff in past 7 days’
biochemically validated by salivary cotinine
< 30 ng/mL
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showing good imple-
mentation.
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Gielen 1997 (Continued)
Equal baseline characteristics in study arms Unclear risk Women in control group reported signif-
icantly fewer cigarettes per day and more
likely to be African-American
Contamination of control group High risk Same care providers delivering intervention
who were providing care to control group
Graham 1992
Methods This randomised controlled trial aimed to measure the effectiveness of home-based
visiting from trained lay-persons to reduce low birthweight.
The study was conducted in the prenatal clinic of a university hospital in Cleveland,
USA, from March 1987 to September 1989
Participants Inclusion criteria: Living within 5-mile radius of clinic, 17-28 weeks’ gestation, ‘low’
family function rating, at least 1 stressful life event during pregnancy, and additional risk
factors such as smoking, low maternal weight-height ratio, aged over 27 years, or history
of a previous premature baby
Exclusion criteria: White patients, difficulty reading English.
Recruitment: Every person registering at clinic was eligible to be screened. The first 105
screened participants were dropped from the study when it was found that they had
difficulty reading the questions. 1326 women screened. 1022 ‘low risk, 190 ‘high risk’
women - of which 145 were randomised (I = 87, C = 58). 8.5% of low risk and 15%
high risk women were smokers
Baseline characteristics: Smoking characteristics not reported.
Predominantly black, poor, inner city population.
No progress plus coding as outcomes not able to be included in this review
Interventions Control: Routine care from obstetrical staff in the clinic.
Intervention: 2 non-professional black women who demonstrated rapport with women
served as home-visitors and were trained in childbirth education, community resources,
and nutrition during pregnancy. 4 x 1 hour home visits occurred at 4-6 week intervals.
The home visitors followed a protocol which included psychosocial support, efforts at
stress reduction, information on health risks (especially smoking and drinking), nutrition
education, and a small gift
Main intervention strategy: Not coded as outcomes not included in this review.
Outcomes Smoking outcomes were not able to be included in this review as it is unclear how many
smokers were included in each study arm. Low birthweight was the primary outcome
for this study, but was not included in this review, as aspects other than the smoking
component of the intervention may have had an effect on birthweight. See Table 1 for
summary of outcomes not able to be included in this meta-analysis
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Graham 1992 (Continued)
Random sequence generation (selection
bias)
Low risk Table of random numbers.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk 24/87 dropped out and unclear if included
in analysis. 7 refused intervention, 11 could
not be contacted, 5 transferred care, 1 mis-
carried prior to visit
Numbers reported as randomised different
in abstract (154) and flow chart (145)
Selective reporting (reporting bias) Unclear risk Unclear if selective reporting as smoking
cessation was not the primary aim of the
intervention
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Not applicable. Smoking outcomes not re-
ported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and home visitors not blinded, as
would be expected in an educational inter-
vention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed only 63/87
women received home visits
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Home visiting intervention so risk contam-
ination of control group is low
Haddow 1991
Methods Randomised controlled trial of providing feedback on cotinine to support women to
stop smoking in pregnancy and reduce low birthweight
Study conducted in physicians offices and clinic sites within Maine (USA) from 1984
to 1987
Participants Inclusion criteria: Pregnant women with a singleton live pregnancy; having maternal
serum AFP screening at 15-20 weeks’ gestation; who smoked >= 10 cigarettes a day
Exclusion criteria: Not further specified.
Recruitment: Physicians approached (no consent from women). 25,628 women com-
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Haddow 1991 (Continued)
pleted maternal serum screening form, 97% answered question on smoking and 17%
smoked >= 10 cigs/day. 2848 women were randomised (C = 1425, I = 1423)
Baseline characteristics:Mean cigs/day at baseline: C = 16.3, I = 16.1
Maternal education (mean years): C = 11.8, I = 11.9.
Progress+ coding: None.
Interventions Control: Standard medical care not otherwise specified.
Intervention: Report on cotinine generated for her physicianwith interpretation relating
smoking level to birthweight. Physician explained this to the woman and also gave her a
copy of the report and a pregnancy-specific booklet about how to quit, using the cotinine
information also + repeat measure 1 month later, 2 copies to physician, comparison of
1st and 2nd cotinine, report commenting on the change and its interpretation
Main intervention strategy: Feedback (multiple intervention) compared to usual care
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). Usual care intensity: F = 0,
I = 0
Intervention provided by existing staff: Effectiveness study
Outcomes No smoking cessation data. Smoking data limited to comparability at first assessment
and mean serum cotinine levels, which could not be included as they are disaggregated
by low and high study site participation
Mean birthweight*; low* and very low* birthweight; preterm birth* (< 37 weeks); still-
births (> 20 weeks)*; neonatal deaths*; postneonatal deaths
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk 2700/2848 (94.8%) included in analysis.
3% lost to follow-up and 2% multiple
gestations or fetal deaths. Only 695/1343
(48%) women in the intervention groups
provided repeat serum cotinine for com-
parison.No ITT analysis. No smoking out-
comes reported and unable to re-include
data for mean cotinine and birth outcomes
Selective reporting (reporting bias) High risk Results difficult to interpret. Smoking ces-
sation not recorded
Other bias Low risk No other bias detected.
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Haddow 1991 (Continued)
Biochemical validation of smoking absti-
nence (detection bias)
High risk Serum cotinine measurement at baseline
for both the experimental and comparison
groups but it was not clear that any follow-
up measurements were made for the com-
parison group
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Caregivers aware of group allocation. Ex-
perimental group given feedback on serum
cotinine levels
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed less than good
implementation with differential impact
on perinatal outcome by completeness with
second blood samples taken for cotinine
measurement
Equal baseline characteristics in study arms Unclear risk Intervention groups similar at trial entry.
Contamination of control group Low risk Intervention not provided by care provider.
Hajek 2001
Methods Cluster-randomised controlled trial of a brief midwife-delivered intervention to support
women to stop smoking in pregnancy
Study conducted in nine hospital and community trusts in the UK. Years of data collec-
tion not reported
Participants 290 midwives randomised to provide intervention or control care
Inclusion criteria:Pregnant women currently smoking or stopped within the last 3
months
Exclusion criteria: Not further specified.
Recruitment: Women were recruited at first visit (approximately 12 weeks’ gestation)
. Estimated 8700 eligible women. Only 178/290 (61%) midwives (C = 86, I = 92)
recruited any women. Financial incentives were paid to boost recruitment. 1287 women
provided informed consent
Baseline characteristics: Current smokers (C = 440, I = 441); Spontaneous quitters (C
= 135, I = 114). 189 current smokers were assessed as ’not motivated to stop’ therefore
received no intervention. Mean cigs/day: Smokers (C = 9.7, I = 10.1), Ex-smokers (C =
10.9, I = 12.6)
> 70%married, 26%-27% smokers and 10%-15% ex-smokers had no educational qual-
ifications
Progress+ coding: None.
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Hajek 2001 (Continued)
Interventions Control: Midwives received 1 hour of training to discuss the study and were asked to
provide usual care and any usual pamphlets
Intervention:Midwives received 2 hours training which included using the COmonitor
and providing ’stage of change’ based advice, CO assessments. Intervention group also
received written advice and motivational materials for current and recent smokers, in-
cluding designating a ’quit date’, a ’quiz’ and the offer of ’buddying’ to another pregnant
smoker for support
Main intervention strategy: Counselling (tailored) compared to usual care.
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 2). Usual care intensity: F = 1,
D = 1
Intervention provided by routine midwives: Effectiveness study
Outcomes Biochemically validated point prevalence abstinence at birth (late pregnancy*), relapse
prevention*, and self-reported continuous abstinence at 6 (6-11) months postpartum
among baseline smokers* and spontaneous quitters.
Birthweight for smokers and ex-smokers reported, but not by intervention group so not
included in this review
Participants and midwives views of interventions reviewed.
Notes Clustering effect not reported, so sensitivity analysis conducted using 4 ICCs and out-
come figures adjusted using conservative intracluster correlation of 0.1. See Table 2 for
adjustment calculations for cluster trials.
Discussion of barriers includes 65% of midwives reporting the intervention could not
be undertaken in the time they had available. Sample size justification
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Cluster-randomisation of midwives ade-
quate. Consecutive names on a list of mid-
wives
Allocation concealment (selection bias) Unclear risk Midwives randomised.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 167/1287 (12.9%) (C = 83, I = 84) ex-
cluded from analysis due to moving away,
being untraceable or deemed unsuitable
for follow-up (e.g. miscarriage). 1120 in
sample. 51/1287 non-responders were in-
cluded as continuing smokers
Selective reporting (reporting bias) Unclear risk Unclear if all outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by expiredCO<10
ppm.
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Midwives aware of allocation group. Edu-
cational intervention. Blinding women not
feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment not re-
ported. Not blinded if performed by mid-
wives
Incomplete implementation High risk Process evaluation showed poor implemen-
tation in some areas.
Equal baseline characteristics in study arms High risk Control group slightly more interested in
quitting smoking and less nicotine depen-
dent
Contamination of control group Low risk Cluster trial design tominimise risk of con-
tamination.
Hartmann 1996
Methods Randomised controlled trial of self-help materials and health education to support
women to stop smoking in pregnancy
Study conducted in a teaching hospital (academic) clinic in North Carolina, USA from
August 1991 to January 1993
Participants Inclusion criteria: Pregnant women who smoke.
Exclusion criteria: > 36 weeks’ gestation, psychiatric diagnosis.
Recruitment: 842/846 (99%) women attending the clinic completed survey and 793/
846 provided a CO breath sample.; 2 were excluded as > 36 weeks’ gestation; 1 for
psychiatric diagnosis; leaving 266 (32%) eligible smokers (smoked at least once in the
prior week). 12 refused, 4 were missed, 2 were not pregnant and 1 was a private patient.
247 women randomised
Baseline characteristics: Mean cigs/day (C = 14.4, I = 13.5), Want to quit (C = 81%,
I = 84%). Smokers in household (C = 75%, I = 78%)
White (C = 74%, I = 78%), Single (C = 44%, I = 47%), < 12yrs education (C = 43%, I
= 48%)
Progress+ coding: Low SES.
Interventions All 1-4 year residents given didactic and role play training for smoking cessation coun-
selling, including self-assessment of current techniques and skills, which they were asked
to continue with for the control group.
Control: Standard care; residents reminded not to alter amount or time of this; help
was provided if woman sought it and prenatal classes included discussion of substance
abuse, including cigarettes.
Intervention: (i) residents provided counselling at each visit, and a brief script aimed
at setting a quit date or negotiated an alternative assignment such as a smoking diary at
every contact;
(ii) given Windsor’s self-directed 7-day smoking cessation guide;
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(iii) quit date patients given written prescription to quit, letter of support from doctor,
contacted by volunteer smoking cessation counsellor to review the quit plan and encour-
age follow-through charts flagged, prompts with flow sheet, most recent CO and self-
report included for care provider;
(iv) successful quitters sent an encouraging postcard each week
Main intervention strategy: Counselling (multiple intervention) compared to usual
care
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 2). Usual care intensity: F = 1,
D = 1
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated abstinence at last prenatal visit (late pregnancy*). > 50% reduc-
tion in self-reported smoking*; Mean cigarettes per day*
Cost-effectiveness data reported.
Notes SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers.
Allocation concealment (selection bias) High risk State that neither the enrolling nurse nor
the patient were aware of allocation, but
experimental group notes were flagged
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition 40/247 (16%)(4miscarriages first
trimester, 3miscarriages second trimester, 3
terminations, 15 moved to alternative care,
and 12 lost to follow-up) 207 included in
analysis (C = 100, I = 107). Those lost
to follow-up not able to be re-included in
analysis in this review as numbers not re-
ported by study arm
Selective reporting (reporting bias) Unclear risk Not apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Exhaled CO measured at each visit for the
experimental group and at 3 visits for the
comparison group. < 5 ppm counted as
non-smokers
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Hartmann 1996 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Case notes flagged. States patient not aware
of randomisation status
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk No process evaluation reported.
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group High risk Concerns about residents having to treat
similar/consecutive patients differently,
and self-help manuals accidentally given to
some controls. Discussion section reports
evidence of contamination with self-help
materials being given to controls
Haug 1994
Methods Cluster-randomised controlled trial of brief GP counselling to support women to stop
smoking in pregnancy and prevent relapse postpartum
Study conducted in Western Norway from November 1986 to November 1987
Participants Inclusion criteria: No indications of serious social or medical problems, living with a
partner, and smoking at least 5 cigarettes per day before pregnancy and still smoking at
least 1 cigarette per day at the first checkup
Exclusion criteria: Not further specified.
Recruitment: All 398 GPs in western Norway were invited by mail to participate in
the study. 187 participating GPs were asked to recruit 4 pregnant and 4 non-pregnant
women for the study, at the first checkup in the first trimester. 1/3 pregnant and non-
pregnant women ended up in control groups. The GPs who recruited pregnant women
for the intervention groups recruited non-pregnant women for the control groups. 2379
pregnant women screened, 674 fulfilled inclusion criteria, 144 refused to participate
(21%). 530 pregnant women were randomised (unclear how many each group)
Baseline characteristics:Mean age starting smoking 27.6, mean cigs per day = 9.5.
Mean age 25.9. 18-34 years of age, all living with a partner
Progress+ coding: None.
Interventions Control: Ordinary control programme during pregnancy and for first year after delivery
(usual care)
Intervention: (i) < 15 mins GP consultation at initial visit about hazards of smoking,
how to stop and how to avoid relapse; (ii) information about problems related to ’the
smoking fetus’; (iii) delivered with aid of a 5-page ’flip-over’; (iv) 8-page booklet. Women
invited to consult their GPs after 1, 6, 12 and 18 months to discuss their smoking habits
Main intervention strategy: Counselling (multiple intervention) compared with usual
care
136Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Haug 1994 (Continued)
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 1). Usual care intensity: F = 0,
D = 0
Intervention provided by existing staff (GPs): Effectiveness study
Outcomes Self-reported abstinence 6 months after study entry (late pregnancy*), biochemically
validated at 12 months after study entry (0-5 months postpartum*), self-reported absti-
nence 15 (6-11 months postpartum*) and 18 months after study entry (12-17 months
postpartum*)
Sef-reported reduction and increase in smoking.
An associated reference (Haug 1992) reports results of a survey of GPs delivering the
intervention
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk GPs described as randomly allocated.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 180/530 dropped out due to spontaneous
abortions (24), serious complications (8),
moved to another district (31) or for other
unknown reasons (117). Only 350/530 (C
= 98, I = 252) included in analysis and we
were unable to re-include those lost to fol-
low-up for other reasons in this review as
theywere not reported by group allocation.
Further dropouts not explained (C = 97
and I = 244 in outcome tables-re-included
in this review as continuing smokers)
Selective reporting (reporting bias) High risk Not clear if biochemically validated out-
comes reported.
Other bias High risk Unequal recruitment to study arms (higher
recruitment in intervention arms)
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemical validation of smoking only at
study entry and after 12 months (urinary
thiocynate). Unclear if those who had high
thiocynate levels were considered smokers.
No cut-off levels reported
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 59% residents did not document consulta-
tion. 1 component dropped
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group High risk Same providers asked to provide control
and intervention arms for pregnant and
non-pregnant women
Haug 2004
Methods Randomised controlled trial of motivational enhancement therapy to support women
to stop smoking in pregnancy
Dates of research and location not stated. Assume USA from author affiliations
Participants Inclusion criteria: Opioid-dependent women, <= 26 weeks’ gestation, receiving meth-
adone, currently smoking at least 5 cigarettes per day, enrolled in hospital prenatal pro-
gram.
Exclusion criteria: Not further specified.
Recruitment: During first 48 hours of 7-day residential program. 77 women ran-
domised. 14 women excluded from analysis due to miscarriage, abortion, premature
delivery and miscalculated gestational age. 63 included in analysis (I = 30, C = 33)
Baseline characteristics: Mean cigarettes per day 19.9 (SD 11.5).
Approximately 50% had lifetime major depressive disorder, 32% were depressed in
last month, and 39% had anxiety disorder. 84% African American, 79% single, 97%
unemployed. 94% had less than high school education. Not coded for equity analysis as
outcomes not able to be included in this review
Interventions Control: Health practitioner advice by trained research staff and printed materials from
American Lung Association and American Cancer Society
Intervention: As control + Motivational Enhancement therapy using ‘ProjectMATCH’
manual with modifications for nicotine dependence, provided over 4 sessions by masters
level research associates
Main strategy and intensity not coded as outcomes unable to be included inmeta-analysis
Outcomes Mean cigarettes per day,mean exhaledCO,mean cotinine,movement in stages of change
were collected and authors report that there was no significant difference. However, not
actual figures were provided to be able to include these outcomes in meta-analysis in this
review
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Just states participants were ’randomly as-
signed’ to 1 of 2 conditions
Allocation concealment (selection bias) Unclear risk Not stated
Incomplete outcome data (attrition bias)
All outcomes
High risk Participant attrition was 14% (n = 9). Final
figures not reported so unclear how many
included in analysis
Selective reporting (reporting bias) Unclear risk Actual smoking rates not reported, despite
this being a primary outcome for the study.
However, authors did not claim resultswere
significant
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Cotinine and CO validationmeasured, but
not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Intervention providers and women not
blinded as counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation Unclear risk Process evaluation not reported.
Equal baseline characteristics in study arms Unclear risk Intervention group had lower mean edu-
cation levels, were more likely to be Cau-
casian, and had higher rates of pre-preg-
nancy cigarettes per day. Other factors
equal
Contamination of control group Low risk Masters level research associates provided
the intervention.
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Hegaard 2003
Methods Quasi-randomised trial of counselling and optional nicotine replacement therapy, to
support women to stop smoking in pregnancy
Study conducted in a large midwifery centre in the Netherlands, with data collection
from 1996 to 1998
Participants Inclusion criteria: All pregnant women attending first prenatal visit.
Exclusion criteria: Inability to speak Danish, age below 18 years, gestation of more than
22 weeks, verified psychiatric diseases, and alcohol or drug abuse
Recruitment: 696/905 (77%) eligible women attending first antenatal clinic who
smoked agreed to participate in study (informed consent) and were randomised (C =
347, I = 348). 647 included in final analysis (C = 320, I = 327)
Baseline characteristics: Mean cigs/day = 11, Significant difference in partner smoking
(I = 67%, C = 77%, P = 0.03), mean salivary cotinine (C = 141, I = 139)
Mean age 29 yrs, > 12 yrs in school (C = 45%, I = 43%), mostly married
Progress+ coding: None.
Interventions Control: Usual care, which included routine information about the risk of smoking in
pregnancy and general advice on smoking cessation or reduction in a standard 30-minute
consultation
Intervention: (i) Extended initial consultation (from 30 to 40 minutes) which included
a dialogue about smoking and motivation for cessation
(ii) written information about risks of smoking and passive smoking
(iii) invitation to join smoking cessation program, based on CBT. The program involved
9 appointments (individually or in a group) over a period of 14 weeks. 3 attendances
prepared participants for quitting and 6 were used to maintain cessation and to hand
out NRT. CO readings at each visit
(iv) NRT offered to all women (2 mg gum or 15 mg patch x 16 h) for 11 weeks
(v) encouragement at subsequent 5-6 antenatal visits.
Main intervention strategy: Counselling (tailored) compared with usual care.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 6). Usual care intensity: F = 1,
D = 1
Intervention provided by specially trained midwife (study staff ): Efficacy study
Outcomes Biochemically validated smoking cessation at 37weeks’ gestation (late pregnancy*),mean
birthweight*, low birthweight*. Preterm births* reported in attrition and re-included in
both numerator and denominator for this outcome
Regression analysis for passive smoke exposure, years of education reported
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quasi-randomised by odd or even birth
date. Included in review despite inadequate
sequence generation as there is a low likeli-
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hood of interference with birthdate alloca-
tion
Allocation concealment (selection bias) High risk Quasi-randomised by odd or even birth
date.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 10 had miscarriage or stillbirth
(C = 5, I = 5); 21 moved out of area (C
= 12, I = 9); 17 had a premature delivery
(C = 10, I = 7). These were excluded from
analysis
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking cessation validated by salivary co-
tinine <= 30 ng/mL
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers and participants not able to be
blinded to educational intervention and
NRT provision not blinded (no placebo)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation High risk Only 87 women (27%) accepted participa-
tion: 81 in a group and 6 women accepted
an individual smoking cessation program.
71 of 87 participants (82%) participated
in 3 or more of a total of 9 meetings in
the smoking cessation program. 75 (86%)
of 87 women participating in the smoking
cessation program were using nicotine sub-
stitution in the form of a 15 mg nicotine
patch (16 h/day) or 2 mg nicotine chewing
gum or a 15 mg nicotine patch (16 h/day)
plus 2 mg nicotine chewing gum
Equal baseline characteristics in study arms Unclear risk Mostly equal except more women were ex-
posed to passive smoking in the home in
the intervention group (77%) than in the
control group (67%) (P = 0.03)
Contamination of control group Unclear risk The strengths of the study include ab-
sence of treatment diffusion as all partici-
pants in the intervention group were seen
by specially trained midwives as opposed
141Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hegaard 2003 (Continued)
to participants in the control group who
were all consulting midwives without such
training. The study enjoys a second advan-
tage which is that intervention and con-
trol group participants were seen at differ-
ent week days and hence could not easily
share information.
The secretaries summoning the pregnant
women were continuously reminded about
this allocation criterion to avoid treatment
diffusion between the intervention and the
control group. p814
Heil 2008
Methods Randomised controlled trial of financial incentives to support women to stop smoking
in pregnancy and prevent relapse postpartum
Study conducted in Greater Burlington, Vermont (USA) with data collection from 2001
to 2003
Participants Inclusion criteria: Self-reported smoking (even a puff in the last 7 days), gestational age
less than 20 weeks, living within study clinic county and not planning to move until at
least 6 months postpartum, and speaks English
Exclusion criteria: Incarceration or previous participation in the study or living with
anyone who has previously participated in the study
Recruitment: Participants were recruited from 1 of 4 large obstetric practices in the
Women, Infants and Children (WIC) program. 182 women were eligible for the study,
and 82 (45%) agreed to participate. Mean gestation at recruitment (I = 8.9, C = 9.5).
77 included in analysis (C = 40, I = 37)
Baseline characteristics: Pre-pregnancy cigarettes per day (I = 18.7, C = 18.4),
Health insurance (I = 19%, C = 13%).
Progress+ coding: Low SES as WIC program recipients.
Interventions Control (non-contingent voucher): Participants received voucher independent of smok-
ing status. US$ 15.00 per antenatal visit and US$ 20.00 per postpartum visit, to result
in comparable average earnings to the contingent group. Both groups received routine
advice from the clinic
Intervention (contingent voucher): participants chose a quit date, and reported daily to
the clinic for COmonitoring for 5 days, then urine cotinine monitoring twice weekly for
7 weeks, weekly for 4 weeks, and then every 2 weeks for the remainder of the pregnancy.
Vouchers were given dependent on biochemical validation, beginning at US$ 6.25 and
escalated by US$ 1.25 to a maximum of US$ 45.00. Positive test results reset voucher
back to original value, but 2 consecutive negative tests restored value to pre-reset value.
It is unclear who delivered the intervention
Main intervention strategy: Incentives (single intervention) compared to alternative
intervention
Intensity: Frequency (C = 6, I = 6), Duration (C = 6, I = 6).
Intervention provided by study staff: efficacy study.
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Outcomes Biochemically validated smoking cessation at >= 28 weeks’ gestation (late pregnancy*),
12 weeks (0-5 months*) and 24 weeks’ (6-11 months*) postpartum. Reduction in mean
cotinine
Meanbirthweight*, gestational age, fetal growthmeasures (US), andproportionofNICU
admissions*, low birthweight* infants, and preterm births*
Nicotine withdrawal symptoms reported in associated reference (Heil 2004).
Notes Sample size justification. Some discussion of cost implications
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomisation stratified to
clinics”. Details of randomisation not de-
scribed
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 5 women withdrew from the study due to
fetal demise or termination of pregnancy
and were not included in the final analysis
(I = 3, C = 2)
Selective reporting (reporting bias) Low risk Detailed birth outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation using exhaled CO
for 5 days (< 6 ppm) and then urine coti-
nine (< 80 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers not blinded as
receiving incentives for participation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Compliance with periodic assessments was
relatively high (83%-95%)
Equal baseline characteristics in study arms Low risk No significant differences in socio-demo-
graphics or smoking characteristics were
noted
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Contamination of control group Low risk Very unlikely - as clear voucher schemes for
abstinence and non-abstinence
Hennrikus 2010
Methods Randomised controlled trial of mobilising peer social networks to support pregnant
women to stop smoking
The study was conducted in urban Women, Infants and Children (WIC) clinics in
Minnesota and an urban university outpatient obstetric clinic in Ohio, USA from 2005
to 2007
Participants Inclusion criteria: Pregnant women in the first or second trimester, a current smoker,
and at least 18 years old
Exclusion criteria: Not further specified.
Recruitment: Each eligible and consenting participant identified a woman in her social
network to act as a supporter. 872 women screened in waiting areas. 82/156 (53%)
eligible women and their supporters agreed to participate (C = 28, I = 54)
Baseline characteristics:Median number of cigarettes smoked per day = 5 (range = 1-25)
and 52% smoked their first cigarette within 30 min of waking. 52% of supporters were
current smokers and 22% were former smokers. There were no significant differences
between study arms
67% from racial minority groups, 65% had high school education or less. Median age =
24
Progress+ coding: Low SES as all WIC program recipients.
Interventions Control: 1 in-person counselling session for control and intervention participants de-
signed to increase motivation to quit and provide information about community smok-
ing cessation resources
Intervention: Peer-supporters in the intervention group had 1 in-person visit and
monthly telephone sessions. The primary goal was to develop strategies to help the par-
ticipant quit smoking by identifying specific activities to support efforts to quit. Women
and their supporters were given a pregnancy scrapbook that included pages related to
smoking cessation tasks
Main intervention strategy: Social support (single intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 2, I = 4), Duration (C = 2, I = 5- estimated)
Intervention provided by specific staff: Efficacy study.
Outcomes Biochemically validated smoking status just prior to expected delivery date (late preg-
nancy*) and 3 (0-5*) months postpartum
Women’s perceptions of peer support behaviours reported (both positive and negative)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Blocked random allocation sequence
Allocation concealment (selection bias) High risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: C = 25%, I = 11% by end of
pregnancy. C = 19%, I = 32% by 3months
postpartum. Report ITT analysis for end of
pregnancy validated quits. 7 women who
had miscarriages were excluded from the
analysis. All randomised participants in-
cluded in the analysis in this review (drop-
outs included as continuing smokers)
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported smoking status biochemically
validated using urinary cotinine (< 100 ng/
mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and
providers to this social support interven-
tion
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded as ’evaluation
staff were blinded to group assignment’
Incomplete implementation High risk Process evaluation showed over 90% sup-
porters received at least 1 counselling ses-
sion, but contacts with supporters occurred
less frequently than the planned monthly
intervals because of difficulty reaching sup-
porters
Equal baseline characteristics in study arms Unclear risk Significantly more intervention partici-
pants had other children (78% vs. 57%, P
= 0.052) and significantly fewer were white
(22% vs. 54%, P = 0.016), but other char-
acteristics equal
Contamination of control group Low risk Contaminationunlikelywith this interven-
tion which required researchers to contact
intervention group at home
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Hiett 2000
Methods Randomised controlled study of health education and feedback to support women to
stop smoking
Location and study dates unclear. Assume USA due to author affiliations
Participants Inclusion criteria: Women enrolling for prenatal care.
Exclusion criteria: Not further specified.
Recruitment: 49 women randomised (I = 26, C = 23).
Baseline characteristics: Not reported (abstract only).
Interventions Control: Usual prenatal care.
Intervention: Education and at least 8 encounters with a program counsellor. Peak flow
values and CO levels were obtained at each prenatal visit and shared with intervention
group participants only
Main intervention strategy and intensity not coded as outcomes not reported
Outcomes Smoking cessation (biochemically validated) was collected but actual figures not reported
so unable to include results in this meta-analysis. Peak flow values reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States ‘women were randomised into two
groups’.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Data not reported.
Selective reporting (reporting bias) High risk Actual figures not reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of smoking status
using urine cotinine and CO (cut-off levels
not reported)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel unlikely to be
blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
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Equal baseline characteristics in study arms Low risk Groups similar with maternal age, fager-
strom scores, initial peak flow values and
initial urine cotinine levels
Contamination of control group Unclear risk Not stated who delivered intervention.
Hjalmarson 1991
Methods Quasi-randomised trial of a self-help manual to support women to stop smoking in
pregnancy
Study conducted in public health maternity clinics in Gothenburg, Sweden, with data
collection from 1987 to 1988
Participants Inclusion criteria: Pregnant women registered as daily smokers (at least 1 cigarette per
day), gestational age less than 12 weeks, and speak Swedish
Exclusion criteria: Not further specified.
Recruitment: 13/14 public health clinics participated. Women born days 1-10 of each
monthwere allocated to the control group andwomen born on days 11-31were allocated
to the intervention group. Unequal group sizes were allocated as it was expected more
intervention women would refuse to participate. 723 eligible continuing smokers were
randomised (C = 231, I = 492). 417/492 (85%) of the intervention group agreed to
participate, and the control group were not asked for consent
Baseline characteristics: Mean cigs/day 16.8. Mean age 28.4 years.
Progress+ coding: None.
Interventions Control: Given an information sheet by their doctor with basic facts about smoking and
pregnancy, as included in the last pages of the self-help manual
Intervention: Given a self-help manual on stopping smoking, based on Windsor 1985.
The manual was revised and pilot tested. The manual contained 2 phases, a preparatory
(one week) and cessation phase. The smoker was given new assignments every day to the
quit day and the tasks were based on the principle of behaviour therapy. The cessation
period was followed for the first 5 days with new information daily
Main intervention strategy: Health education (single intervention) compared to less
intensive intervention
Intensity: Frequency (C = 1, I=1), Duration (C = 1, I = 1).
Intervention provided by existing staff (obstetrician provided self-help manual): Effec-
tiveness study
Outcomes Biochemically validated smoking cessation at 30-34 weeks’ gestation (late pregnancy*)
, 8 weeks postpartum (0-5 months), mean birthweight*, preterm births* (< 36 wks)
, low birthweight babies*, mean cigarettes per day at 30-34 weeks’ gestation among
baseline smokers*.Mean cigarettes per day at baseline, week 12-14, week 30-34 among all
randomised women, 8 weeks after delivery among baseline smokers and all randomised
women
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook.
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Allocation by birth date is not random se-
quence. However, this study was included
as interference is unlikely with birth dates
Allocation concealment (selection bias) High risk Allocation would not be concealed as allo-
cated by birth dates (days 1-10 = control,
days 11-31 = intervention)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Loss to follow-up from miscarriage and
moving out of district (C = 10%or 23, I =
11% or 46), not included in analysis. How-
ever, all other dropouts included as contin-
uing smokers
Selective reporting (reporting bias) Low risk All primary outcomes appear to be re-
ported.
Other bias High risk Unclear why there are 444 in intervention
group and 209 in control group, when re-
port states 10% of 231 were excluded and
11% of 492 were excluded
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of smoking status
using serum thiocynate (100 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel unlikely to be
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Manual given to all women who agreed to
participate (85% of total assigned to inter-
vention - i.e. 15% refused to participate)
Equal baseline characteristics in study arms Unclear risk Only age and mean no of cigarettes re-
ported.
Contamination of control group Low risk Unlikely control group would accidentally
be given the self-help manual
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Methods Randomised controlled trial of stage of change orientated motivational interviewing to
support women to stop smoking in pregnancy
The study was conducted in infertility and prenatal clinics in 3 hospitals in Ontario
(Canada), with data collection from January 1996 to July 1999
Participants Inclusion criteria: Newly referred infertile and pregnant patients who reported smoking
more than 3 cigarettes in past 6 months
Exclusion criteria: Women attending genetic counselling or with habitual abortion or
who had previously been evaluated in consultation
Recruitment: All women attending infertility and prenatal clinics who reported smoking
were invited. Unclear how many were eligible. 110 pregnant women randomised (I =
56, C = 54)
Baseline characteristics: Mean cigs/day = 12.19 (SD 6.81); (I = 13.43 +-7.07, C = 12
+- 6.69
Interventions Control: Standard information that was already provided in the clinics about the impact
of smoking on pregnancy
Intervention: Scripted stage-based information and encouragement to quit at each pre-
natal visit by physicians, Stage-specific information booklet, optional referral for more
in-depth counselling in a smoking cessation clinic
Main intervention strategy: Counselling (tailored intervention) compared with usual
care
Intensity not coded as outcomes unable to be included in meta-analysis
Outcomes Stage of change, biochemically validated cessation at 12 months post follow-up but
data for intervention and control groups were combined so outcomes were unable to be
included in this review. See Table 1 for description of outcomes.
Relative value of intervention components reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised using computer-generated,
blocked schedule, administered through
numbered, opaque, sealed envelopes
Allocation concealment (selection bias) Low risk Opaque sealed envelopes.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No attrition reported and not stated how,
if any, dropouts were assessed
Selective reporting (reporting bias) High risk Smoking cessation outcomes not reported.
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Biochemical validation with exhaled CO,
but levels used to determine smoking status
were not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers and women not able to be
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated whether outcome assessors
blinded.
Incomplete implementation Unclear risk Process evaluation not reported.
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group High risk Same care providers offering intervention
and control interventions, therefore high
risk of contamination
Kendrick 1995
Methods Cluster-randomised controlled trial to support women to stop smoking and prevent
relapse during pregnancy and postpartum
Study conducted inpublic prenatal andWICclinics inMaryland,Colorado andMissouri
(USA), with data collection from 1987 to 1991
Participants Inclusion criteria: Smoking defined as “even a puff within the last 7 days before the
women knew she was pregnant”, whowere aggregated into ’enrolment smokers’ (smoked
within 7 days before study enrolment) and ’recent quitters (smoked before they thought
they were pregnant)
Exclusion criteria: Not further specified.
Recruitment: 1741/5262, 1936/6087 and 1895/4943 pregnant women screened in
Colorado, Missouri and Maryland respectively, with nearly 50% of women in each state
smoking. Participation rates ranged from 66% in Maryland to 79% in Missouri
Baseline characteristics: Mean cigarettes/day at enrolment combined for smokers = 12
cigarettes/day
High proportions were young, < 12 years education, white, unmarried and poor. Mean
gestation at enrolment = 15.2 - 16.6 weeks
Progress+ coding: Low SES.
Interventions Control: Usual care not otherwise specified by usual clinic staff.
Intervention: Based on stages of change, but differed by State, locally adapted with some
detailed development.
Colorado: 1-5 minutes counselling; assessing smoking status; quitting tips; supportive
statements by nurse-clinicians; healthcare providers’ Guide; 8 brochures for pregnant
smokers; additional 1 for women postpartum.
Maryland: brief clinic-based counselling program + self-help material focusing on the
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stages of quitting.
Missouri: “becoming a life-long smoker” six minutes with clinic patient brochures, flip
charts; 1-2 minutes at WIC clinics training staff, chart documentation and forms.
All included effects of smoking on the fetus; benefits of quitting; quitting techniques;
developing social support; preventing relapse and limiting exposure to environmental
tobacco smoke. All materials were at 6th Grade reading level
Main intervention strategy: Counselling (multiple intervention) compared to usual
care
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1). Usual care intensity: F = 0,
D = 0
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated point prevalence abstinence at 8 months gestation (late preg-
nancy*). Smoking outcomes for ’recent quitters’ (relapse prevention) were not reported.
Birthweight and proportion of low birthweight babies are not reported by intervention
group so were unable to be included in meta-analysis
Notes Intracluster correlation of 0.003 reported and used for adjusting outcome figures in
analysis. Substantial misclassification of self-report as non-smoking: 28% at enrolment;
35% at 8th month; 49% of self-reported quitters at intervention clinics; 32% of self-
reported quitters at control clinics. Process evaluation suggested less difference between
I and C clinics than might have been expected.
Project staff felt that the use of existing staff to deliver the new interventions and to
collect data affected the study negatively especially given the time needed to process
questionnaires and urine samples. This led to less than full implementation and variable
motivation to promote smoking cessation counselling among staff
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Clinics stratified by size of clinic and also
by prior low birthweight programme (Col-
orado) or % minority clients (Maryland),
and randomly assigned to deliver either in-
tervention or continue with standard care.
No details of randomisation provided
Allocation concealment (selection bias) Unclear risk Cluster-randomised trial.
Incomplete outcome data (attrition bias)
All outcomes
High risk In the 3 states combined, the reasons for
loss to follow-up at the eighth month
were early termination of pregnancy (7.
6%); enrolment after 32 weeks (6.1%);
lost, moved, or unable to locate (27.7%)
; referred to another care provider (2.8%);
and refused data collection (1.0%). The to-
tal number of enrolment smokers were not
reported by intervention groups, and attri-
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tion rates were not reported by interven-
tion groups, sowewere unable to re-include
data for respondents lost to follow-up. Re-
port states loss to follow-up was balanced
in experimental and control groups. Vary-
ing enrolment and attrition rates in differ-
ent centres. No ITT analysis
Selective reporting (reporting bias) Unclear risk High rates of non-disclosure for smoking
outcomes.
Other bias Unclear risk Uneven recruitment to study arms inMary-
land, which affected the overall allocation
(C = 1767, I = 1467)
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urinary cotinine
(> 85 ng/mL indicates active smoker)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear whether participants and providers
were aware of clinic allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation reported that imple-
mentation was less than ideal
Equal baseline characteristics in study arms Low risk Intervention and control sites were similar
at enrolment, indicating that stratification
and randomisation had been effective (data
not shown)
Contamination of control group Unclear risk Many patients at control clinics also re-
ported having received (non-SCIP) mate-
rials and counselling which indicated that
usual care included exposure to smoking
cessation messages
Lawrence 2003
Methods 3-armed cluster-randomised trial of self-help manuals and computer-generated advice
to support women to stop smoking in pregnancy
Study conducted in community midwife clinics in theWest Midlands region of the UK,
with data collection from July 1998 to March 2001
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Participants Inclusion criteria: Head midwife in every trust in region invited to participate and 16/
19 agreed to participate. 204 potential midwifery practices identified, and 103 excluded
by head midwife as those trusts were already involved in other regions or the practice
crossed trust boundaries. Women were eligible if aged 16 years or over and a ’current
smoker’ at booking
Exclusion criteria: Women not fluent in English.
Recruitment: 72/101 practices were randomly sampled (C = 24, I1 = 24, I2 = 23).
Further practices were later added to each arm due to slow recruitment, particularly in
the control arm (C = 17, I1 = 12, I2 = 0), leaving active practices (C = 32, I1 = 30, I2
= 22). Participating midwives were asked to recruit all eligible women seen in routine
antenatal appointments. Initial target of 1440 participants was reduced to 900 due to
slow recruitment . Eligible smokers approached: C = 328/965 (34%),I1 (manuals) =
327/694 (47%), I2 (computer) = 397/529 (75%). Participation rate: C = 289/328 (88%)
, I1 = 305/327 (93%),I2 = 324/397 (82%).
Baseline characteristics:Mean cigarettes per day at baseline were similar between groups
(reported in 6 smoking categories). Majority (over 60%) smoked 5-20 cigarettes per day
and over 50% had a partner who smoked. Median fagerstrom score 3 in all arms
63.6% of participants on < $300/week.
Progress+ coding: Low SES.
Interventions Control: Standard care. Midwives received a half-day training on research protocol, and
asked all midwives to give women the Health Education Authority booklet “Thinking
about stopping”
Intervention 1 (self-help booklets): Midwives received 2 and a half days training on
theory of transtheoretical model. Participants received a set of 6 stage-based self-help
manuals “Pro-Change programme for a healthy pregnancy”. The midwife assessed each
participant’s stage of change and pointed the woman to the appropriate manual. No
more than 15 minutes was spent on the intervention
Intervention 2 (self-help booklets+computerised advice): Midwives received the same
training as for I1, and participants received the same self-help manual and intervention
as I1. Additionally, the participants used a computer programme, which consisted of
questions and auto feedback of what stage they were in and what this meant, and a
range of other concepts. It took about 20 minutes for the woman to complete. Printed
information of the feedback was sent to the participant within a week of the intervention
Main intervention strategy: Counselling (multiple intervention) compared with usual
care. Intervention 2 were combined and compared with the control arm in this review
Intensity: Frequency (C = 0, I = 3); Duration (C = 0, I = 3). Usual care intensity: F = 1,
D = 1
Intervention provided by existing staff (Midwives providing self-help manuals): effec-
tiveness study
Outcomes Biochemically validated point prevalence abstinence at 28-30 weeks’ gestation (late preg-
nancy)* (T3) and 10 days post-birth* (T4) (0-5 months postpartum).
Effect of midwife training (attitudes, expectations, confidence, concerns and routine
practice) was assessed by pre-post training questionnaires
Subsequent papers (Lawrence 2005b) measure and describe self-reported smoking ces-
sation at 18 months postpartum, movement in stage of change, partner quitting, social
support mobilisation, and the stress of receiving the intervention
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Notes Intracluster correlation of 0.003 reported and used for adjusting outcome data included
in this meta-analysis (see Table 2). Sample size calculation given, but unable to recruit
sufficient numbers
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computerised minimisation programme
was used to stratify 72 eligible practices into
3 equal groups from 101 available practices
Allocation concealment (selection bias) High risk Further practices were added to the sample
because of slow recruitment - these were
not randomly allocated
Incomplete outcome data (attrition bias)
All outcomes
Low risk Different rates of recruitment and follow-
up in different arms of the trial. 272 (C=
1 04, I1 = 86, I2 = 82) women (22.5%)
withdrew from the study or were lost to
follow-up. Data on smoking status were
only available for 67% of women. Where
there was no urine sample available women
were treated as continuing smokers. All
randomised participants were included in
the denominator in this analysis, with only
those reported as confirmed non-smokers
at T4 included as quitters
Selective reporting (reporting bias) Unclear risk Not apparent.
Other bias High risk Slow recruitment to standard care arm, so
additional practices needed to be added
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine analysis (< 1.5 ug/L).
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither providers nor women blinded to
this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete implementation Low risk 77% T4 questionnaires complete in I2.
154Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lawrence 2003 (Continued)
Equal baseline characteristics in study arms Low risk There was little difference at recruitment
between the midwives or recruited women
in the 3 trial arms
Contamination of control group Low risk Cluster design to reduce risk of contami-
nation.
LeFevre 1995
Methods A randomised controlled trial (RADIUS) of routine ultrasound screening to improve
perinatal outcomes, including smoking in pregnancy
The study was conducted in Missouri, USA, with data collection from November 1987
to May 1991
Participants Inclusion criteria: Last menstrual period known within 1 week, gestational age < 18
weeks, no plans to change providers. All women enrolled in the RADIUS study who
reported any smoking in the year before enrolment in the study were evaluated in the
subgroup analysis
Exclusion criteria:Medical or obstetric complications, planning an ultrasound for other
reasons, twin pregnancy, not intending to continue pregnancy
Recruitment: 53,367 pregnant women were screened for entry into RADIUS study; 32,
317 ineligible or excluded; leaving 21,050. 3163 refused (85% participation), 2357 had
miscarriage or change of provider; leaving 15,530 randomised (C = 7718, I = 7812), 23.
8% (3,571) of whom were smokers in year before enrolment , and 1901 who were still
smoking at enrolment. 3,571 smokers included in this analysis (C = 1803, I = 1768)
Baseline characteristics:
95% aged 20-35, 95% white, Education: high school or less (C = 30%, I = 29%), some
college (C = 29%, I = 30%), college graduation (C = 42%, I = 41%)
Progress+ coding: None.
Interventions Control: Ultrasounds only if ordered by their physician for medical reasons
Intervention: Ultrasound at 18-20 and 31-33 weeks, no details about feedback to the
mother or others. No specific smoking intervention provided
Main intervention strategy: Feedback (single intervention) as part of a broader inter-
vention to improve maternal health compared to usual care
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). Usual care intensity: F = 0,
D = 0
Intervention provided by study staff: efficacy study.
Outcomes Mean number of cigarettes per day*.
Self-reported smoking cessation recorded on birth certificate, but unable to determine
how many smokers in each group so smoking outcomes not included in this review
Mean birthweight, preterm births (< 36 weeks), very preterm birth (< 33 weeks), and
adverse perinatal outcomes, but were not included in this review as other aspects of the
intervention may have impacted on perinatal outcomes
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Notes SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified computer randomisation.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Small loss to follow-up (approximately 2%)
. Miscarriage: C = 63, I = 64, records lost
or moved: C = 121, I = 131, leaving C =
7534, I = 7617; Available case analysis but
smoking cessation was not a primary out-
come
Selective reporting (reporting bias) Low risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Smoking status not revealed to sonog-
rapher. Intervention not explicitly about
smoking cessation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk The mean number of sonograms obtained
was 2.2 per woman in the ultrasound-
screening group
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk The mean number of sonograms obtained
was 0.6 per woman in the control group
and 55 percent had no sonograms. Only
2% of control group had 2 ultrasounds
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Methods A randomised controlled trial of counselling intervention to support women to stop
smoking in pregnancy
The study was conducted in an antenatal clinic in Newcastle Hospital (UK), fromMarch
to May 1982
Participants Inclusion criteria: All pregnant women currently smoking >= 1 cigarette a day at the
time of the first antenatal clinic under care of 4 consultant obstetricians
Exclusion criteria: Women 28 weeks’ gestation or more.
Recruitment: 156 smokers identified in clinics and 5 were excluded as over 28 weeks’
gestation. 151 randomised (C = 74, I = 77)
Baseline characteristics: Mean cigarettes per day before pregnancy: C = 18.3, I = 18.
1. Mean cigs per day at booking: C = 14.4, I = 15.1. Mean age: C = 25 years, I = 22.7
years. Partner unemployment: C = 53%, I = 57%
Progress + coding: Low SES as study in ’deprived area’ and high partner unemployment
Interventions Control: Usual antenatal care with possible exposure to a concurrent television series (6
x 10-minute programme on stopping smoking in pregnancy).
Intervention: (i) 10minutes anti-smoking advice fromSHO (Resident) based onHealth
Education Council Booklet “So you want to stop smoking for you and your baby”,
an additional leaflet from the same source, and copies of the booklet for other family
members;
(ii) woman’s GP sent a letter describing the purpose of the study and a booklet, asked to
reinforce the information at usual contacts;
(iii) 2 weeks later a letter of reinforcement was sent to the woman;
(iv) four weeks later there was a pre-planned home visit to provide anti-smoking advice
with a letter of the same advice sent if the woman was not at home;
(v) possible exposure to the concurrent TV series.
Main intervention strategy: Health education (multiple intervention) compared to
usual care
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 2) Estimate. Usual care
intensity: F = 1. D = 1
Intervention provided by existing staff (resident): Effectiveness study
Outcomes Self-reported smoking cessation 9-16 weeks after booking visit (late pregnancy*). Mean
cigarettes per day* (the SD used in the analysis in this review was calculated from a P
value of 0.05 given in the paper)
Notes Short interval between intervention and assessment.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as balanced “simple random al-
location” in blocks.
Allocation concealment (selection bias) Unclear risk Information not provided.
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Small loss to follow-up, some missing data
but balanced across groups. Attrition6/151
(4%, C = 3, I = 3): not pregnant (C = 1),
1 guilt over previous stillbirth (I = 1), and
miscarriages or medical complications (C =
2, I = 2). 145 included in analysis (C = 73,
I = 72)
Selective reporting (reporting bias) Low risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of self-reported
smoking cessation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither women nor providers blinded to
this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk A home visit at 4 weeks was made to the
remaining 76 test patients. 31 (41%) were
found at home; 29 were given further anti-
smoking advice; 45 (59%) were out and a
letter of encouragement was left
Equal baseline characteristics in study arms Unclear risk Mean age of test mothers 22.7, controls 25.
Report notes other variableswere equal, but
figures are not reported
Contamination of control group Low risk Main component home visit.
Lillington 1995
Methods Cluster-randomised controlled trial of ’Time for a Change’ behavioural intervention
to support low income African American and Hispanic women to stop smoking and
prevent relapse in pregnancy and prevent relapse postpartum
Study conducted in 4 Women, Infant, and Children (WIC) clinics in south and central
Los Angeles (USA) from October 1990 to December 1992
Participants Inclusion criteria: 4 clinic sites identified from similar neighbourhoods and pair-
matched based on ethnic mix. Pregnant women at least 18 years of age who had smoked
in the previous year
Exclusion criteria: Not further specified.
Recruitment: Clinics randomly assigned. All pregnantwomenwere asked about smoking
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and participants in intervention sites were asked for informed consent. 8019 women
screened (419 current smokers and 692 ex-smokers). 768/1102 (69%) current (410) or
ex-smokers (692) entered the study. 18% refused (198), 12% (132) ineligible due to
young age, early delivery or referral to a different clinic
Baseline characteristics: Smoking: Current 40.5% (I = 51%, C = 36.5%); ex-smoker
59.5% (I = 49%, C = 63.5%)
Mean age 26.8 (I = 27.3, C = 26.6). African American 53%, Hispanic 42.6%
Progress+ coding: Low SES in this review as WIC clinic recipients, and ethnic minority
population
Interventions Control: Usual care, including printed information about the risks of smoking during
pregnancy and a group quit-smoking message as part of the initial WIC visit
Intervention: (i) Assessment of smoking motivation and intention to quit. (ii) Bilingual
health educators (Spanish and English) with bachelors degrees provided 15 minutes in-
dividual counselling that included risk information and quit messages or reinforcement.
(iii) Self help guide ’Time for a change’ with an explanation of how to use it and be-
havioural counselling.(iv) Explanation of how to win prizes by completing activity sheets
(v) booster postcard 1 month after study entry
Main intervention strategy: Counselling (multiple intervention) compared with usual
care
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 2). Usual care intensity: F =
1, D = 1
Intervention provided by dedicated study staff: efficacy study
Outcomes Self-reported smoking cessation and relapse prevention at 9 months gestation (late preg-
nancy*), and 6 weeks postpartum (0-5 months postpartum*)
Differential quite rates reported by African-American and Hispanic ethnic status
Participants views of intervention.
Notes Adjustment for clustering not reported. Adjustment in this review as per Table 2.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk 4 participating clinics were identified from
similar neighbourhoods and pair-matched
based on ethnic mix. 2 clinics were ’ran-
domly assigned’ as control sites, and 2 clin-
ics were assigned as intervention sites
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 28% attrition (213/768), C = 28%, I =
25% (not stated how many from each arm,
so not able to be re-included in this review).
Drop-outs due to inability to contact, mis-
carriage or discontinuance with the WIC
program. 555 included in analysis (C =
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400, I = 155)
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias High risk Unequal recruitment to each study arm.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported abstinence only. Only able to
obtain biochemical validation with salivary
cotinine (cut-off 20 ng/mL) on 111/254
women who reported they were not smok-
ing. High misclassification. Self-reported
rates used in this review
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers and women not able to be
blinded due to educational nature of inter-
vention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Only 12/155 women returned and com-
pleted 12 worksheets.
Equal baseline characteristics in study arms High risk Intervention group had a significantly
higher proportion of smokers at baseline
(51% vs 36%) and a significantly lower
proportion of participants in the third
trimester for the initial WIC visit (27% vs
36%)
Contamination of control group Low risk Cluster trial at service level with minimal
contact with control organisations
Loeb 1983
Methods Randomised controlled trial of interventions (individual and group), based on the ’MR-
FIT’ trial, to support women to stop smoking during pregnancy
Study conducted in 1 of 2 hospitals in the Kaiser Permanente HMO of Oregon (USA),
with women recruited between July 1979 and September 1980
Participants Inclusion criteria: Pregnantwomenwho answered ’yes’ to a questionnaire aboutwhether
they now smoked
Exclusion criteria: Not further specified.
Recruitment: 3856 pregnant women screened in first antenatal visit: 963 self-reported
current smokers (25%) were randomised (C = 486, I = 477). All women in intervention
group were invited to participate in study but high refusal rates (37%). After some
changes to recruitment strategy refusal rate dropped to 30.6%
Baseline characteristics: Partner smoking: 74.1%.
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Mean age 23.3 years. 66.2% married. 21% smokers in receipt of public assistance but
only 7% of non-smokers
Progress+ coding: None.
Interventions Control: Usual care: normal medical care for the duration of their pregnancy
Intervention: (i) letter of invitation, reminder letter;
(ii) group information meeting on programme for respondents with short information
session by physician;
(iii) individual session with trained smoking counsellor;
(iv) 6 x 1.5 hour group sessions, once a week;
(v) subsequent optional support groups, individual sessions and phone calls
Main intervention strategy: Counselling (tailored intervention) compared with usual
care
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 6). Usual care intensity: F = 0,
D = 0
Intervention provided by dedicated project staff: efficacy study
Outcomes Self-reported smoking cessation in late pregnancy*. Biochemically validated with cord
blood thiocyanate in a subsample (C = 24, I = 29)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details of randomisation.
Allocation concealment (selection bias) Unclear risk Described as “randomly assigned”.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rates high at all stages of this study.
Approximately 45% lost to follow-up. I
= 271/477 (56.8%) completed last ques-
tionnaire, with ’similar numbers in control
group’ (C = 276/486). However. all drop-
outs included as continuing smokers in this
review
Selective reporting (reporting bias) Unclear risk Birth outcomes reported by smoking sta-
tus, not intervention group
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemical validation with urine thiocy-
nate at delivery on a small subsample (C =
24, I = 29)
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers not blinded to
allocation.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Very poor response to group sessions so in-
tervention changed over the course of the
trial to individual counselling, which also
had very low participation overall: 18% ac-
tive; 25.2% dropped out; 38% did not par-
ticipate; 18% could not be contacted
Equal baseline characteristics in study arms Unclear risk Differences between intervention and con-
trol group not reported
Contamination of control group Low risk Usual care providers not delivering inter-
vention.
Lowe 1997
Methods A randomised controlled trial of brief counselling to support women who had recently
quit smoking to prevent relapse during pregnancy and postpartum
The studywas conducted alongside a concurrent trial (Windsor 1993) to support women
to stop smoking during pregnancy, relapse prevention among women who had stopped
smoking since the beginning of pregnancy, in 4 public maternity clinics in Birmingham,
Alabama (USA) from 1987 to1989
Participants Inclusion criteria: Pregnant women reporting as having quit within 3 months of first
prenatal visit
Exclusion criteria: Not further specified.
Recruitment: 106/115 women who were invited agreed to participate (92%) and were
randomised (C = 54, I = 52)
Baseline characteristics: All recent quitters within 3 months of first visit. No other
baseline characteristics reported, though report states there was no significant differences
in age, race, gestation, or smoking history between intervention and control, or those
lost to follow-up
Progress+ coding: None.
Interventions Control: Usual prenatal care, including nurses’ advice to all women not to smoke.
Intervention: i) 10-minute counselling by health educator using smoking relapse pre-
vention materials on effects of smoking; benefits of maintaining cessation; possible prob-
lems; smoking triggers; solutions to smoking cues; strategies for staying quit, contract,
and flip chart (5th grade reading material)
ii) “stay quit buddy” encouragement, non-smoking gifts and pamphlets,
iii) clinic reinforcement by prenatal staff through reminder form in the notes and to
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confirm abstinence, praise, encourage continuing cessation
Main intervention strategy: Counselling (multiple intervention) compared to usual
care
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 2). Usual care intensity: F = 1,
D = 1
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated relapse in late pregnancy*.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 3 had a miscarriage, 4 moved and 2 had
babies for adoption, leaving C = 2/54, I =
7/52 included in analysis. Smoking status
reported on 80% (C = 38, I = 40), but ITT
analysis for main outcome, so those subse-
quently lost to follow-up treated as contin-
uing smokers
Selective reporting (reporting bias) Unclear risk Unclear what data were collected. Only
smoking outcomes reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of non-smoking or
reporting smoking less than or equal to 7
cigarettes since quitting with salivary thio-
cyanate analysis (cut-off levels not stated)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Notes flagged. Providers and women not
blinded to allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showed good imple-
mentation.
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Equal baseline characteristics in study arms Low risk Figures not reported but author states there
was no difference
Contamination of control group High risk Issues of possible ’contamination’ in clinics
with individual randomisation discussed
Lowe 2002
Methods Cluster-randomised trial to evaluate dissemination of a behavioUrally-based program to
support women to stop smoking in pregnancy
Study conducted in Queensland (Australia). Data collection dates not stated
Participants Inclusion criteria: Public hospitals which provided antenatal and delivery care for 10 or
more patients a year, had less than 50% Aboriginal and Torres Strait Islander population,
and did not currently provide any antenatal smoking cessation care
Exclusion criteria: Not further specified.
Recruitment: Hospitals were matched on number of births, location of population
centre (rural/metropolitan), and whether they had a specific antenatal clinic
80 (92% public hospitals) hospitals eligible. 10 omitted as they stopped providing ante-
natal care. 70 hospitals (35 pairs) included
Baseline characteristics: Characteristics of individuals not reported.
No outcomes included in study so not coded.
Interventions Control: Received ‘awareness’ phase of intervention based in Rogers’ Diffusion of Inno-
vation theory. Flyers were distributed to all hospitals
Intervention: Control +‘Persuasion’ phase, which included an educational workshop and
presentation. ‘Implementation phase’ where each hospital conducted the recommended
program
Main intervention strategy: Intensive dissemination vs less intensive intervention. No
outcomes to include in analysis
Intensity: NA
Outcomes Self-reported implementation of program at each hospital. Success was defined as the
routine offer of an evidence-based smoking cessation program to at least 80% of the
pregnant clients who smoke
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Report states hospitals were randomised
into intervention and control groups,
within matched pairs
Allocation concealment (selection bias) Unclear risk Not reported.
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Incomplete outcome data (attrition bias)
All outcomes
High risk Complete follow-up could not be obtained
primarily due to the inability to contact ei-
ther the medical superintendent or the di-
rector of nursing after a minimum of 3 at-
tempts
High attrition (37% hospitals), though
those not respondingwere included in anal-
ysis as ‘not implemented’
Selective reporting (reporting bias) Unclear risk Smoking cessation rates not reported, but
not included as an aimof this dissemination
study
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Smoking status not assessed in this dissem-
ination study.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear whether control hospitals were
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation High risk 37% reported as ’not implemented’.
Equal baseline characteristics in study arms Low risk Matching of the hospitals was successful
as there were no differences in number of
births, rurality, and whether they had a spe-
cialised antenatal service at baseline
Contamination of control group Low risk Cluster design likely to minimise risk of
contamination.
Malchodi 2003
Methods Randomised controlled trial of peer counselling to support women to stop smoking in
pregnancy
Study conducted in a large urban clinic in Hartford Hospital (USA), with recruitment
from January 1998 to February 2000
Participants Inclusion criteria: Pregnant women who smoke at least 1 cigarette per day in week
before learning of pregnancy, less than 20 weeks’ gestation, literate in English or Spanish,
18 years of age or older, and intending to carry to term
Exclusion criteria: Women using smokeless tobacco or nicotine replacement products,
or who reported current substance abuse or dependence
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Recruitment: All pregnant women screened at first prenatal visit and invited if met
criteria. Informed consent obtained. Participation rate not reported, but states high
smoking prevalence in pregnancy (29%) and hospital had over 4000 deliveries per year,
and only 142 women recruited to study (C = 75, I = 67)
Baseline characteristics: Mean cigarettes/day at baseline significantly higher in inter-
vention group: C = 11.2 (SD 8.4); I = 13.3 (SD 13.3). Baseline CO C = 7.25 (SD 8.4),
I = 5.12 (SD 5.01). Short term Fagerstrom score: C = 3.8 (2.87), I = 4.2 (2.44)
Mean age C = 26, I = 26. Approximately 40% 12 years education or above. > 85% single.
63% Black, 12%-13% Hispanic, 23%-24% white. ’Low-income, uninsured women’.
Progress+ coding: Low SES, ethnic minority, single population.
Interventions Control: Usual care, which included the program of “Ask, Advise, Arrange and Assist”,
based on cognitive behaviour, described by Windsor 2000a, and provision of self-help
materials, and smoking cessation counselling as per protocol as each visit
Intervention: As for the control group + peer counselling from lay community health
outreach workers (telephone or home visits). Peer counsellors received 2 x 3 hours of
training
Main intervention strategy: Social support (single intervention) compared to less in-
tensive intervention
Intensity: Frequency (C = 5, I = 6), Duration (C = 2, I = 5).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated smoking abstinence*, and reduction (cigarettes/day) at 36weeks’
gestation (late pregnancy). Mean exhaled CO
Mean birthweight* and proportion of babies* born low birthweight were provided by
the study authors (unpublished data)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated list.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk High attrition rates (C = 27/75 or 36%, I
= 29/67 or 43%). ITT analyses for whole
sample and for those remaining at follow-
up
Selective reporting (reporting bias) Unclear risk Birth outcomes only reported by smoking
status not intervention group
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine levels at baseline and at 36
weeks’ gestation (200ng/mL cut-off ). Ex-
haled CO at each prenatal visit (< 8 ppm)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk States that caregivers were masked but
women may have discussed but edu-
cational/counselling support intervention
that women may have discussed with care-
givers
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Process evaluation suggests reasonable im-
plementation (median 6 contacts for those
who remained in study), but high attrition
limits exposure to intervention
Equal baseline characteristics in study arms High risk The peer counselling group had a greater
proportion of heavier smokers at baseline
Contamination of control group High risk Discussion notes that quit rate in control
group higher than expected and that ’usual
care’ in this trial may be more comprehen-
sive. Which is likely as prompts etc were
provided as part of trial participation to
remind providers to offer support as per
guidelines. Providers were also given train-
ing about the guidelines from trial staff
Manfredi 1999
Methods Cluster-randomised controlled dissemination trial of “It’s Time” program, in 33 prenatal,
family planning and paediatric clinics
Study was conducted in Chicago (USA) between November 1994 and July 1996
Participants Inclusion criteria: 33 prenatal, family-planning and well-child clusters at 12 public
health clinics were included. Services were matched into pairs on type of public health
clinic (health department, neighbourhood health centre, university clinic), location (ur-
ban/rural), and racial mix. 10 months baseline measures were taken. The intervention
was randomly assigned to 6 intervention and 6 control public health clinics
Exclusion criteria: Not further specified.
Recruitment: 1495 smokers identified (21% of women screened). 77% (1112) women
in intervention group and 85% (1045) women in the control group agreed to participate.
63% (516) women in intervention group and 61% (548) women in control group
completed the follow-up assessments (T2)
Baseline characteristics: Mean cigarettes per day: C = 10.96, I = 12.01,
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Black C = 68.3%, I = 81.2%, > high school ed C = 39.2%, I = 38.9%
Not coded as no outcomes included in review.
Interventions Control: Not stated.
Intervention: (i) Provider focused: Charts flagged with ‘smoker’ sticker, charts prepared
with booklets and agreement form, documentation;
(ii) Patient focused: motivational video played in waiting room, posters, brief provider
advice, booklet, agreement form, letters reminding women of advice, 15-minute moti-
vational interview
Main intervention strategy: Counselling (multiple intervention) vs usual care. Intensity
not coded as no outcomes able to be included in this review
Outcomes Dissemination and smoking cessation outcomes reported, but not able to include in this
review as we were unable to separate pregnant women from women attending family
planning and paediatric clinics
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Just states ‘randomly allocated’.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk 37%-39% attrition (due mostly to lack of
working telephones) and not clear how ac-
counted for in analysis. Conducted analy-
sis which suggests those lost to attrition did
not differ significantly in race, cigarettes,
stage of readiness, motivation, or confi-
dence
Selective reporting (reporting bias) Unclear risk Actual outcomes for each service not re-
ported so difficult to assess
Other bias Low risk No other bias detected
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status, not biochem-
ically validated.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and provider not able to be
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Incomplete implementation Unclear risk Not reported, despite being a dissemina-
tion trial.
Equal baseline characteristics in study arms Unclear risk Smokers in intervention clinics slightly
older and more likely to be African-Amer-
ican
Contamination of control group Low risk Low risk of contamination as cluster trial.
Mayer 1990
Methods 3-armed randomised controlled trial comparing 2 smoking cessation interventions to
support women to stop smoking in pregnancy
Study conducted in WIC clinics in Grand Rapids, Michigan (USA), from 1985 to 86
Participants Inclusion criteria: Pregnant women currently smoking (>= 1 cigarette/day).
Exclusion criteria: Not further specified.
Recruitment: 271/641 attending the clinics (42%) identified as smokers. 219/271 (81%)
agreed to participate and were randomised (C = 77, I1 = 70,I2 = 72).
Baseline characteristics: Mean cigarettes/day prior to pregnancy I = 19.9, C = 20.3.
75% white. 76.5% on medicaid.
Progress+ coding: Low SES as WIC recipients.
Interventions Control: Usual care which included printed information about the risks of smoking in
pregnancy.
Intervention 1 (risk information): 10-minute discussion with a health educator using a
flip chart and a brochure but with no behaviour change counselling or self-help manual.
Intervention 2 (multi-component): 20-minute 1:1 counselling including risk informa-
tion (“Because I Love My Baby” Am Lung Assoc, flip chart and brochure to take away)
, and behavioural change manual adapted from Windsor 1985 and the Am Lung Assoc
“Freedom from Smoking” focusing on contracting and self-monitoring (CBT)
Main intervention strategy: Counselling (multiple intervention) compared to usual
care. Intervention 2 compared with control in this review
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I= 2). Usual care intensity: F = 1,
D= 1
Unclear whether intervention provided by existing staff or dedicated project workers
Outcomes Self-reported smoking cessation at 9 months gestation (late pregnancy*) and approxi-
mately 4.7 weeks after birth (0-5 months postpartum*)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 15% attrition (33/219) at follow-up. All
those lost to follow-up were treated as con-
tinuing smokers in this review
Selective reporting (reporting bias) Low risk Not apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemically validated with salivary thio-
cyanate in approximately a third of partici-
pants (n = 66), but no adjustment for mis-
classification
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Caregivers not blinded to this educational
intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation Unclear risk No process evaluation.
Equal baseline characteristics in study arms Unclear risk Differences between study participants and
refusals on variables available from the
WIC record were relatively minor for im-
portant variables as were study group dif-
ferences
Contamination of control group Low risk Health educator, not usual care provider,
offering intervention
McBride 1999
Methods 3-armed randomised control trial of an intervention to support women to stop smoking
and prevent relapse in pregnancy and postpartum
The study was conducted at the Group Health Cooperative of Puget Sound (Seattle,
USA) (HMO), and Park-Nicollet of Minnesota (USA), a multispecialty group practice.
Years of data collection not stated
Participants Inclusion criteria: Women who had completed the baseline survey, were < 20 weeks of
pregnancy, were currently smoking or had smoked in the 30 days before pregnancy but
had quit at the time of the baseline survey
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Exclusion criteria: Unable to speak English.
Recruitment: Women booked for a first prenatal visit were offered, by letter, study
participation and unless they opted out were given a baseline telephone interview to
assess smoking status. 9152 approached, 714 ineligible because of miscarriage, pregnancy
termination, inability to speak English; 697 (8%) refused; 262 could not be reached
by telephone after repeated attempts. 7479 (82%) completed survey. 1007/7479 (13%)
were current smokers or recent quitters and were randomised: 897 participated (457
from Seattle, 440 from Minnesota), C = 297, I1 = 294, I2 = 306. Current smoker at
baseline = 56% (C = 165, I1 = 176, I2 = 160).
Baseline characteristics: Mean cigarettes/day before pregnancy = 14.9; Current mean
cigarettes/day = 4.8. Mean age 27.7 years; Household income >= 30000 $US 67%;
College graduates 17%; 88% white
Progress+ coding: None.
Interventions There were 3 stages of change based interventions, all delivered by mail or telephone
without involving prenatal care providers.
Control: Self-help booklet “Stop now for your baby”; 5th grade reading level; health
effects of smoking during pregnancy; specific suggestions for quitting (setting date, en-
listing support). For recent quitters: stress reduction techniques; suggestions for handling
high-risk situations; pregnancy-appropriate behavioural alternatives to smoking.
Intervention 1: High intensity interventions in pre and postpartum groups also re-
ceived: (i) a personalised letter acknowledging baseline readiness for change, personal
health concerns, motivation to quit, comparison with other pregnant women who had
successfully quit. (ii) relapse prevention kit within 2 weeks of completing the 28 week
follow-up survey. (iii) a booklet which discussed transition from pregnancy and factors
that influence cessation and relapse; practical tips for high-risk situations, strategies for
avoiding self-defeating reactions to slips, personal anecdotes from women who quit. (iv)
3 antenatal counselling phone calls: 2 weeks after the booklet and 1 and 2 months later.
Calls were open-ended but with standardised protocol based on motivational interview-
ing and with stage-based objectives average 8.5 min.
Intervention 2: The pre-post group received as for group 2 + an additional 3 counselling
calls in the first 4 months after birth reinforcing themes from the Relapse Prevention
booklet; 3 newsletters at 2, 6 and 12 months postpartum about health effects of envi-
ronmental tobacco smoke and the importance of being a non-smoking parent
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention. Intervention 1 and 2 were only reported as combined outcomes
in late pregnancy, and included in this review. Postpartum outcomes are reported by
intervention group and combines smokers at baseline and spontaneous quitters
Intensity: Frequency (C = 2, I = 6); Duration (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Self-reported 7-day point prevalence abstinence at 28 weeks’ gestation (late pregnancy*)
, with sample biochemically validated. (combined I1&I2); Relapse prevention in late
pregnancy (spontaneous quitters*); Abstinence at 8 weeks (0-5 months*); 6 months* (6-
11 months); and 12 months (12-17 months) postpartum (combined baseline smokers
and spontaneous quitters). Response rates were 92% at 28 weeks; 91% at 8 weeks’
postpartum; 89% at 6 months postpartum; 87% at 12 months postpartum
A subsequent paper reports partner abstinence.
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Notes Process evaluation describes participation in specific intervention components, including
relapse prevention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described.Theywere stratified by base-
line smoking status
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 110/1007 (11%) attrition. 88 miscarried
and 22 were sent wrong intervention ma-
terial and were excluded from analysis. 897
women included in final analysis. For self-
reported smoking status non-respondents
were treated as continuing smokers
Selective reporting (reporting bias) Unclear risk Smoking outcomes only reported and only
combined outcomes for abstinence at 28
weeks’ gestation
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Salivary cotinine analysis. Salivary cotinine
requested from all who reported abstaining
for 7 days (< 20 ng/mL as cut-off ). 64%-
78% returned saliva samples and as there
were no differences, outcomes reported are
based on self-reported status
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind providers and women
to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All samples were analysed for cotinine at
the American Health Foundation labora-
tory. The computer-assisted telephone sur-
veys were implemented by trained inter-
viewers who had no role in intervention ac-
tivities
Incomplete implementation Low risk Over 90% in the intervention group re-
called receiving the self-help booklet, re-
lapse prevention kit, counselling calls and
newsletters
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Equal baseline characteristics in study arms Unclear risk There were some baseline differences re-
ported in text.
Contamination of control group Low risk The intervention was delivered via mail
and telephone without involving prenatal
health care providers
McBride 2004
Methods 3-armed randomised controlled trial of counselling and social support interventions to
support women to stop smoking during pregnancy and prevent relapse post-partum
The study was conducted inWomack ArmyMedical Centre at Fort Bragg in Feyettville,
North Carolina (USA) from 1996 to 2001
Participants Inclusion criteria: <= 20 weeks pregnant, >= 18 years of age, current smokers or recent
quitters (i.e., were smokers in the 30 days prior to pregnancy but not smoking at intake),
livingwith an intimate partner, andwilling tohave the partner contacted for participation
in the study
Exclusion criteria: Not further specified.
Recruitment: 6156 woman screened at first prenatal clinic appointments were sent
introductory letters with a toll-free number to call to decline contact. 997 pregnant
smokers or recent quitters underwent further screening and 625 eligible women were
randomised
Baseline characteristics: Active smokers (C = 91, I1 = 87, I2 = 89). Recent quitters
(C = 107, I1 = 105, I2 = 104). Current mean cigarettes per day 6 (SD 5). 52% had a
partner who smoked
Mean age 24 years; Household income >= 20000 $US 44%; >high school 52%; 96%
married; 77% white
Progress+ coding: none.
Interventions Control: ’Usual care’ where women received provider advice to quit smoking at the first
prenatal visit and were mailed the American Cancer Society’s self-help guide, “Make
Yours a Fresh Start Family,” written at the fifth-grade reading level and designed for
pregnant women
Intervention 1 (woman only): Control plus late pregnancy relapse-prevention kit (a
booklet and gift items) and 6 counselling calls (3 in pregnancy and 3 in postpartum)
initiated by a health advisor, who used a standardised protocol based on motivational
interviewing techniques. All intervention contacts were completed by 4 months post-
partum. Prenatal calls were timed to occur in each trimester and emphasised using self-
help materials to take stage-appropriate steps towards cessation or to develop skills for
remaining abstinent. Postpartum calls were timed to occur at monthly intervals and
emphasised skills for remaining abstinent in the transition from pregnancy to parenting
Intervention 2 (partner-assisted group): Woman only intervention plus a PA adjunct,
inwhich the smoker describedhowher partner could be a coach to build andmaintain the
confidence she needed to quit smoking. An “It Takes Two” booklet and companion video
were developed to guide couples in discussing support behaviours related to the woman’s
smoking. Partners received 6 separate calls (3 in pregnancy and 3 postpartum) from the
woman’s health advisor. These calls were made separately to the 2 individuals (pregnant
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woman and partner) and guided by a motivational interviewing protocol similar to that
used for counselling the women. The second and fourth calls to the couple focused on
developing a written agreement regarding helpful partner support behaviours. Partners
who smoked were given self-help cessation guides, free nicotine patches if needed, and
stage-appropriate counselling
Main intervention strategy: Social support (multiple intervention) compared to a less
intensive intervention. Intervention 2 compared to control in this review
Intensity: Frequency (C = 2, I = 6); Duration (C = 1, I = 5). Estimate as duration of
calls not reported
Intervention provided by dedicated project staff: efficacy study
Outcomes Self-reported point prevalence abstinence at 28 weeks pregnancy (late pregnancy*), re-
lapse prevention at 28 weeks pregnancy (late pregnancy*), continued abstinence of com-
bined spontaneous quitters and smokers at 2 (0-5*), 6 (6-11*) and 12 (12-17) months
postpartum
Partner cessation and perceived support were reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Reported as ’stratified by smoking status,
partners smoking status and partners will-
ingness to be involved and randomised to
one of 3 conditions’
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 42 (7%) women who miscarried were ex-
cluded resulting in a sample of 583 (C =
198, I1 = 192, I2 = 193). An ITT approach
was used, in which all randomised women
(other than those who hadmiscarried) were
included in the final analysis as continuing
smokers. Drop out rates did not differ sig-
nificantly across groups
Selective reporting (reporting bias) Low risk All primary outcomes appear to be re-
ported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status only.
174Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
McBride 2004 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants to so-
cial support intervention, requiring partner
consent
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Partner participation decreased steadily
throughout the trial
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk Care providers not providing intervention.
McLeod 2004
Methods 4-armed cluster-randomised trial (2x2) to support women to stop smoking in pregnancy
and breastfeed postpartum
Study conducted in the lower North Island, New Zealand, with recruitment from June
1999 to September 2000
Participants Inclusion criteria: The midwifery team was the unit of randomisation, which were
stratified by locality and randomised into 1 of 4 groups. All midwives in selected localities
in the lower north island were invited to take part. Midwives asked all pregnant women
who had smoked at the time they conceived to take part in the study
Exclusion criteria: Not further specified.
Recruitment: 93/121 (77%) midwives invited (from 62 midwifery teams), agreed to
participate, and were randomised into 1 of 4 study arms (C = 23,I1 = 22,I2 = 22, I3 = 26)
. 61 midwives recruited women to the study (76%). 46/349 (13%) women approached
declined to take part in the study, 6 were ineligible, and 297 were recruited (C=60, I1=
60, I2=69, I3=108)
Baseline characteristics: Partner smoking (C = 50%, I1 = 47%, I2 = 62%, I3 = 49%).
Mean age: C = 24.9, I1 = 26.1, I2 = 27.3, I3 = 25.1. Maori: C = 42%. I1 = 36%. I2 =
20%, I3 = 27%. Over 50% in receipt of community services card.
Progress+ coding: Low SES.
Interventions Intervention developed with provider input and detailed discussion of provider views
included
Control: ’Usual’ maternity care from a midwife, which ranged from asking about smok-
ing, giving advice to quit and to providing more detailed smoking-cessation advice
Intervention 1 (smoking education): Midwife training to implement education and
support for smoking cessation and reduction
Intervention 2 (breastfeeding): Midwife training and support to implement education
and support for breastfeeding for women who smoked
Intervention 3 (combined): Midwife training to implement smoking education and
breastfeeding programmes
Smoking education included motivational interviewing provided by a midwife (who was
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allocated an extra funded visit and given 4 hours training with a counsellor), flip-chart,
video-tape
Main intervention strategy: Counselling (single intervention) compared to usual care.
Groups 1 and 3 compared to groups 2 and 4 in this review
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 2). Usual care intensity: F = 1,
D = 1
Intervention provided by existing staff (midwives): Effectiveness study
Outcomes Biochemically validated smoking cessation at 28 and 36 weeks’ gestation* (late preg-
nancy), and 6 weeks and 4 months postpartum* (0-5 months postpartum). Smoking
reduction outcomes of self-reported ’cut down a little’ or ’cut down significantly’ are not
included in this review as outcomes unclear
Breastfeeding outcomes also reported.
Notes Design effect for clustering reported, so outcome figures used
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random sequence generation using excel
for each stratum.
Allocation concealment (selection bias) Low risk Group allocation by external statistician.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Missingdata formost outcomes, 28%attri-
tion for 4month postnatal follow-up. Only
women who moved from the area were ex-
cluded from analysis in this review
Selective reporting (reporting bias) Unclear risk Smoking status only reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Serum cotinine samples provided by 108
women. 17/19 self-reported non-smokers
had cotinine levels consistent with non-
smoking, but outcomes not adjusted for
misclassification. 15 ng/mL cut-off level
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind midwives to alloca-
tion group.Women were not aware of mid-
wife group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Incomplete implementation Unclear risk There were problems with some midwives
not recruiting any women to the study, but
the degree of implementation among those
women recruited is not reported
Equal baseline characteristics in study arms High risk When compared with control group,
women in the smoking group were older
and less likely to beMaori. Also the number
of women recruited to the combined group
was much larger than the other groups,
which suggests potential issueswith recruit-
ment
Contamination of control group Unclear risk Cluster-study design to avoid contamina-
tion.
Messimer 1989
Methods Cluster-randomised controlled trial to test the effectiveness of the ALA smoking in
pregnancy intervention to support women to stop smoking in pregnancy
Study conducted in 11 private obstetric practices in Michigan and Upper Wisconsin
(USA), with recruitment from August 1985 to June 1986
Participants Inclusion criteria: 24 physicians in 11 private practices participated in the study (12
family physicians and 12 obstetricians). Study practices randomised into ’roughly equal
groups’. Women smoking at first antenatal appointment, less than 28 weeks’ gestation
were recruited to study
Exclusion criteria: Not further specified.
Recruitment: All women attending those clinics invited to participate. After giving
informed consent, each woman was assigned a code number and had a questionnaire
pack placed in her chart. 639 women screened (5 refusals), 206 smokers (32%), 69/209
had quit since becoming pregnant and 137 continuing smokers were included in the
study (C = 70, I = 67)
Baseline characteristics: Pre-pregnancy mean cigs per day = 20; current mean cigarettes
per day = 11
98% white, 70% married, majority (80%) completed high school
Progress+ coding: None.
Interventions Control: 3 counselling sessions with physician on risks, ashtrays removed from waiting
rooms and staff asked not to smoke in front of patients
Intervention: Control plus (i) use of ALA materials (because you love your baby flip
chart; because you love your baby packets, because you love your baby poster) (ii) en-
couragement to send off for materials (freedom from smoking manual), (iii) slide tape
presentation at each women’s first obstetrics visit
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention
Intensity: Frequency (C = 3, I = 5), Duration (C = 1, I = 2).
Intervention provided by existing staff (physicians): Effectiveness study
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Outcomes Self-reported smoking abstinence at 32-36 weeks’ gestation (late pregnancy*) and first
postpartum visit (timing not specified but assumed is standard 6 weeks pp visit), 0-5
months pp*
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified by size - and then assigned by coin
toss.
Allocation concealment (selection bias) High risk Allocation not concealed with coin toss
randomisation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 7 miscarriages (C = 4, I = 3), 2
therapeutic abortions (C = 0, I = 2), 11
moved (C = 6, I = 5) and 8 had an incom-
plete dataset (C = 4, I = 4). Those with in-
complete dataset were re-included as con-
tinuing smokers in this review (C = 60, I =
57)
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of smoking sta-
tus (self-report only)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind providers and women
to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Exact rates not reported - but ’only minor
deviations’ suggests very high implementa-
tion
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Cluster-randomised by clinic - so unlikely
to have ALA materials
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Methods Randomised controlled trial of nurse telephone support, which aimed to reduce infants
born low birthweight and preterm, and included advice on smoking
Study conducted in a community public clinic in the USA. Location and dates of data
collection unclear
Participants Inclusion criteria: Women with a preterm labour risk score of at least 7 on the Wake
Forest University School of Medicine risk assessment tool; English-speaking; access to
telephone; 22-32 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: 1850/3127 (59.2%) eligible women contacted. 1554 (84%) agreed to
participate and were randomised (C = 779, I = 775)
Baseline characteristics: 21.2% (n = 253) identified themselves as smokers.
Black = 1113, White or other = 320.
Progress+ coding: Not coded for this review as outcomes unable to be included
Interventions Control: Booklet about preventing preterm labour, available in regular clinic. $10 gift
certificate for completing questionnaire at 34 weeks’ gestation
Intervention: As control + instruction about signs of preterm labour, nurse telephone
call schedule. 3 telephone calls per week which addressed: assessment of health status
(including cigarette use); recommendations; and discussion of additional issues impor-
tant to mother. $25 gift certificate at 37 weeks or after the birth of their baby if they
returned their assessment and remained in contact with the nurse by telephone
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Not coded as outcomes not able to be included.
Outcomes Low birthweight and preterm births. Outcomes not included in study as unclear what
proportion of outcomes were related to smokers. Furthermore, other aspects of the
intervention (other than smoking cessation) may have impacted on perinatal outcomes
so not included in this review
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random assignment by biostatistician us-
ing computer randomisation table
Allocation concealment (selection bias) Low risk Opaque sealed envelopes.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 7.8% attrition due to moving or multiple
pregnancies, leaving 1433 included in birth
outcome analysis. I = 718, C = 715
Selective reporting (reporting bias) Unclear risk Smoking rates not reported, though not the
primary aim of study
Other bias Low risk No other bias detected.
179Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Moore 1998 (Continued)
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking, but not reported as
an outcome in this study
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and providers not able to be
blinded to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessor blinded.
Incomplete implementation Low risk Process evaluation not reported.
Equal baseline characteristics in study arms Low risk No significant differences between groups.
Contamination of control group Unclear risk Telephone intervention so unlikely calls
were made to wrong women
Moore 2002
Methods Cluster-randomised trial of self-help booklets to support women to stop smoking and
prevent relapse in pregnancy
Study conducted in 3 NHS hospital trusts in England (UK), with recruitment fromMay
1998 to July 2000
Participants Inclusion criteria: Midwives were the unit of randomisation. Women attending first
visit; >= 16 years; < 17 weeks’ gestation; literate in English were eligible. Smokers counted
as those who reported “I smoke now”, “I smoke now but have cut down since I thought
I might be pregnant”, or “I have stopped smoking since I thought I might be pregnant”
Exclusion criteria: Not further specified.
Recruitment: All 128 community midwives in 3 trusts agreed to participate and were
randomly allocated to 6 strata (C = 64, I = 64). Three midwives went on maternity leave
and did not recruit any women (C = 64, I = 61). 8,586 women screened and 1527/1803
(85%) eligible women consented to participate (C = 803, I = 724)
Baseline characteristics: Current smokers: C = 97, I = 97; Current but reduced since
pregnancy: C = 464, I = 445 (All current smokers C = 561, I = 542); Recent quitters:
C = 242, I = 182. Mean cigarettes per day before pregnancy: C = 15.1, I = 16. Mean
cigarettes per day at baseline C = 5.5, I = 6.4
Maternal age: C = 26.7, I = 27.2. Left full time education by 16 years: C = 63.6%, I =
61%.
Progress+ coding: Low SES.
Interventions Control:Midwives continued to give routine advice according to usual practice.
Intervention: Midwives spent at least 5 minutes introducing a series of 5 self-help
booklets “Stop for Good”, based on stages of change theory, and gave them a copy of
the first booklet. Subsequent booklets were mailed directly to the woman
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 1). Usual care intensity: F =
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1, D = 1
Intervention provided by existing staff: Effectiveness study
Outcomes 7-day point prevalence abstinence at 26 weeks’ gestation (late pregnancy*), with 94%
validated by urine cotinine (80 ng/mL). Self-reported mean cigarettes per day in late
pregnancy*. Relapse prevention for recent quitters not reported separately so outcomes
for smokers and recent quitters are combined in this analysis.
Stillbirths or neonatal deaths (not included as unable to separate), and preterm births (<
27 weeks) not included as rates < 36-37 weeks not reported. Reported as ’attrition’
Notes Reported intracluster correlation of 0.031 used to adjust outcome data for inclusion in
outcome tables. Sample size justification
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified random allocation by computer-
generated random numbers. 118 midwives
stratified according to workload and ran-
domly allocated to provide intervention or
control care
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 92/1527 (6%) excluded from analysis due
to miscarriage or termination (C = 36, I
= 40), stillbirth or neonatal death (C = 9,
I = 6)-not included as unable to separate,
preterm birth (C = 1). Those lost to further
follow-up (C = 50, I = 68) were included as
continuing smokers in this review, leaving
1435 (C = 757, I = 678)
Selective reporting (reporting bias) High risk Outcomes not reported separately for base-
line smokers and spontaneous quitters
Other bias Unclear risk Some unequal recruitment in each arm
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine levels analysed (cut-off 60
ng/mL and 100 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Midwives randomised. Educational inter-
vention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessment blinding not re-
ported.However, follow-up rates were high
in both groups, and all data coding and
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cleaningwas undertakenblind to treatment
allocation
Incomplete implementation High risk Detailed qualitative and quantitative pro-
cess analysis of participants’ and midwives’
views of the intervention, which suggested
poor implementation in some areas
Equal baseline characteristics in study arms High risk There were some differences between the 2
treatment groups at baseline, most notably
in the numbers of women who had stopped
smoking before the booking appointment
and in the quantity of cigarettes consumed
before the pregnancy and at the time of
booking
Contamination of control group High risk Some concerns about contamination of
control group reported.
Naughton 2012
Methods Pilot randomised controlled trial to evaluate the feasibility, acceptability and potential
effectiveness of tailored leaflets and SMS text messaging self-help intervention (MiQuit)
to support women to stop smoking in pregnancy
Study conducted in 7 National Health Service Trusts in the south east, east and north
east of England (UK), with recruitment between December 2008 and October 2009
Participants Inclusion criteria: Pregnant women less than 21 weeks’ gestation, 16 years of age and
over, smoked >= 7 cigarettes per week, owned or had regular use of a mobile phone, and
could understand written English
Exclusion criteria: Not further specified.
Recruitment: 625 women were referred by midwives to the study and 207/512 (40%)
eligible women agreed to participate and were randomised to the study (C = 105, I =
102)
Baseline characteristics: Cigarettes per day before pregnancy and at enrolment reported
by 6 categories and equal in both arms. Majority (over 60%) 11-20 cigs/day before
pregnancy and approx 50% 4-10 cigarettes/day at enrolment
Median age 26-27 years; 16% did not complete high school; 100% white
Progress+ coding: None.
Interventions Control: Participants received a non-tailored self-help leaflet, whichmatched the tailored
leaflet in format and style, and the same assessment texts as MiQuit participants but no
intervention texts
Intervention:Participants receive MiQuit tailored self-help leaflet by post. Thereafter
automated tailored text message component of intervention is initiated. 80 texts sent
out over 11 weeks. MiQuit participants could also request instant response supportive
texts at any time of the day
Main intervention strategy: Health education (multiple intervention) compared to less
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intensive intervention
Intensity: Frequency: (C = 2, I = 5), Duration: (C = 1, I = 1).
Technological intervention: Unclear whether efficacy or effectiveness study
Outcomes Biochemically validated 7-day point prevalence at 3-month follow-up (late pregnancy)
*, self-reported 4-week point prevalence, initiation and frequency of quit attempts and
7-day point prevalence at 3 and 7 weeks after enrolment; Self-efficacy (5-point scale),
acceptability measures
Notes Process evaluation showed 98% intervention and 89% control participants received the
leaflet and 87% intervention participants reported reading text messages at least once
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Generation of the randomisation tables
and allocation of participants were imple-
mented in a computer programme and
managed by SS who had no contact with
participants or involvement in data collec-
tion or entry
Allocation concealment (selection bias) Low risk ’The allocation sequence was concealed
from other members of the research team,
midwives, and participants’ (p570)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-outs due to miscarriage or stillbirth
were excluded from the analysis (I = 6, C =
3). Reported as combined figure. 11% fur-
ther attrition for other reasons (I = 10, C =
13), were included in analysis as continu-
ing smokers (C = 96, I = 102)
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking cessation with salivary cotinine (<
13 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women unlikely to be blinded to educa-
tional intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk ’FN undertook data collection and was
blinded to group allocation until all data
had been collected.’ (p570)
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Incomplete implementation Low risk 90%MiQuit participants reported reading
all the leaflet at least once
Equal baseline characteristics in study arms Low risk There were not differences between trial
arms on baseline variables except that more
participants in the control arm had smoked
in a previous pregnancy (difference ad-
justed for in analyses)
Contamination of control group Low risk Technological intervention so low risk of
contamination between study arms
Olds 1986
Methods 4-armed randomised controlled trial which aimed to improve the uptake of prenatal
care and pregnancy outcomes (especially low birthweight), and included advice about
smoking
Study conducted in a semi-rural county of New York State (USA), with recruitment
between April 1978 and September 1980
Participants Inclusion criteria: Pregnant women with no prior live births + any of the following:
< 19 years; single; low socio-economic status, and any other women with no prior live
births who wished to participate in the program
Exclusion criteria: > 25 weeks’ gestation (though some were enrolled at 25-29 weeks)
Recruitment: Through private obstetricians’ offices, planned parenthood, public schools
health department antenatal clinics and other health and human service agencies. 10%
of target population entered prenatal care too late, 10% were not referred from private
care. 500 women were interviewed and 400 enrolled (80%). Families were stratified by
marital status, race, and 7 geographic regions (C = 90, I1 = 94, I2 = 100, I3 = 116). 141
smokers (C = 64, I = 77).
Baseline characteristics: Mean cigarettes per day at intake: C = 6.94, I = 7.65.
47% < 19 years old, 62% single, 61% low SES (15% had none of these factors). Non-
Whites (46) excluded because too few; serious maternal or fetal conditions (20) excluded
Progress+ coding: Low SES.
Interventions Control: Health and developmental screening of the baby at 12 and 24 months;
Intervention 1: Control + free transport to pregnancy and well-child visits (control);
Intervention 2: 1+ nurse home visits during pregnancy (intervention);
Intervention 3: 2+ nurse home visits in child’s first 2 years.
The focus of the home visiting was individualised from a detailed curriculum dealing
with information on fetal and infant development; improvement of maternal diet; mon-
itoring weight gain; elimination of cigarettes, alcohol and drugs; identifying pregnancy
complications; encouraging rest, exercise and hygiene; preparing for labour birth and
early newborn care. The intervention was also described as enhancement of informal
support systems (partners, family and friends) and linkage of parents to community
services, including nutritional care, prenatal providers and other services
Main intervention strategy: Social support (tailored intervention) compared to usual
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care. Intervention 2&3 (nurse-visiting arms) compared to control and intervention 1
arms (no nurse visiting) in this review.
Intensity: Freqency (C = 0, I = 6), Duration (C = 0, I = 4). Usual care intensity: F = 0,
D = 0
Intervention provided by dedicated study team: Efficacy study
Outcomes Cotinine levels taken in a subsample (n =116), but nowomen reported smoking cessation
at 32 weeks’ gestation (late pregnancy)*. Mean cigarettes per day at 32 weeks (late
pregnancy*). No mean cotinine levels reported for inclusion. Self-reported reduction
in cigarettes, but not reported as a mean for inclusion in this review. Birth outcomes
were not included as aspects of the intervention, other than smoking cessation, may
potentially improve birth outcomes
Notes SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 6.5% attrition (C = 12, I = 14) due tomov-
ing or miscarriage. However outcomes for
307/400 women only reported. Outcomes
for all smokers at intake reported
Selective reporting (reporting bias) Low risk Detailed range of outcomes reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Serum cotinine analysis on subsample of
116. No self-reported cessation to validate
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Home visitation programme. Blinding of
participants and personnel not viable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The interviewers and medical record re-
viewers hired by the research project did
not know to which treatment the women
had been assigned
Incomplete implementation Unclear risk Not reported.
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Equal baseline characteristics in study arms High risk Women assigned anurse had less social sup-
port.
Contamination of control group Low risk Home visits.
Olds 2002
Methods 3-armed randomised controlled trial of home visiting during pregnancy by paraprofes-
sionals and nurses to improve maternal and child health, and included advice about
smoking
The study was conducted in 21 prenatal clinics in Denver (USA) from March 1994 to
June 1995
Participants Inclusion criteria: Pregnant women with no previous live births and either qualified for
Medicaid or had no private medical insurance
Exclusion criteria: Not further specified.
Recruitment: By written invite, and were not required to respond. 735/1135 eligible
women participated in the study, 70 of whom were smokers (C = 25, I1 = 21,I2 = 24).
Baseline characteristics: Not reported among smoking subgroup.
Interventions Control: Developmental screening and referral services for children at 6, 12, 15, 21 and
24 months old
Intervention 1 (Paraprofessional): Screening and referral plus paraprofessional home
visiting for first 2 years of infants life. Aimed to improve maternal and fetal health,
improve health and development of child, and enhance parents personal development
Intervention 2 (Nurse): Screening and referral plus nurse home visiting for first 2
years of infants life. Aimed to improve maternal and fetal health, improve health and
development of child, and enhance parents personal development
Main intervention strategy: Social support. Not coded or compared in this review as
outcomes unable to be included
Outcomes Outcomes not able to be included in meta-analysis, as only mean reduction in cotinine
reported. See Table 1 for outcome summary.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random sequence.
Allocation concealment (selection bias) Unclear risk Allocation conducted in separate data cen-
tre.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear whether all randomised smokers
were included in cotinine analysis
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Selective reporting (reporting bias) High risk Smoking cessation rates not reported, but
are not a primary outcome of this study
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Unclear whether all randomisedwomen in-
cluded in cotinine analysis
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers and women not able to be
blinded as social support intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded to allocation.
Study team unaware of allocation, unless
the participant told them
Incomplete implementation Low risk Paraprofessionals completed an average of
6.3 visits and nurses an average of 6.5 visits
Equal baseline characteristics in study arms Unclear risk Baseline characteristics of smokers not re-
ported. But treatment groups similar with
’few exceptions’
Contamination of control group Low risk Home visits.
Ondersma 2012
Methods 4-armed (2x 2 factorial design) randomised controlled trial of a computer-delivered brief
intervention (CD-5As) and incentives to support women to stop smoking in pregnancy
The studywas conducted in 4 prenatal care clinics inDetroit,MI (USA)with recruitment
from July 2008 to November 2009, and final evaluation completed by January 2010
Participants Inclusion criteria: Pregnant women aged 18 years or older, being no further than 27
weeks’ gestation, and reporting smoking in the past week
Exclusion criteria: Unable to understand spoken English.
Recruitment: 1317 women were screened while in the clinic waiting area. 110/114
(96%) eligible women provided consent and were randomised (C = 26, I1: CD-5As only
= 26, I2: CM-Lite only = 28, I3 = CM-Lite+CD 5As = 30).
Baseline characteristics: Average cigarettes per day in week prior to recruitment: mean
= 8 (SD 8.2). 70% lived with a smoker. 52.8% had a fagerstrom score >= 4 (nicotine
dependence)
Mean age 27.9 (6.4); 90% Black. K6 emotional distress 14.9.
Progress+ coding: Low SES and ethnic minority.
Interventions Control: Usual Care from prenatal care from care-providers without influence from the
research team
Intervention 1 CD-5As only: Computer delivered brief intervention designed to be
consistent with ’5As national guidelines (USA)’ (Ask, Advise, Assess, Assist, Arrange)
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and-for those who are unwilling to set a quit goal-the 5Rs (with steps involving the
highlighting of Relevance, Risks, Rewards, Roadblocks, and Repetition). The ’Advice’
included a 5 minute video featuring a male Black Obstetrician and 3 testimonials from
women of varying race, which was direct but designed to be positive and frame the
benefits of quitting rather than the risks of smoking
Intervention 2 CM-Lite (incentives) only: This modified version of ’contingency man-
agement’ was designed for use with non-treatment-seeking persons in a health care set-
ting with the presumption of (a) at least occasional repeat office visits and (b) limited
ability of medical staff to monitor participants or participate in training. Thus, no proac-
tive tracking was provided in CM-Lite: It was designed to be patient initiated, with staff
checking eligibility if and when a patient asks to have their smoking status verified rather
than relying on staff to check the eligibility of every incoming patient. CM-Lite calls for
testing at prenatal care visits only and unlimited incentivisation attempts, but only up to
a maximum of 5 episodes of reinforcement (in the form of retail gift cards worth $50),
only at prenatal clinic visits, each at least a week apart. CM-Lite was delivered with the
help of a website which facilitated the process of verifying eligibility of participants, pro-
vided step-by-step guidance in how to conduct a valid test for urinary cotinine, recorded
the results of testing, and provided a record of all incentive attempts and their outcome
Intervention 3 CD-5As + CM-Lite combined.
Main intervention strategy: Incentives (tailored intervention) compared to usual care.
Intervention 2 compared with control in this review
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 1). Usual care intensity unclear:
F = 0, D = 0
Technological intervention: unclear whether delivered by existing staff (Effectiveness
study) or dedicated project staff (efficacy study)
Outcomes Biochemically validated 7-day point prevalence at 10-week follow-up (late pregnancy*)
with CO and urinary cotinine. Secondary help-seeking (Quitline), self-reported sus-
tained abstinence in the past 30 days, Fagerstrom Test for nicotine dependence; K6mea-
sure of overall emotional distress; Acceptability (satisfaction-related measures)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer randomisation of all partici-
pants into either CD-5As or time con-
trol conditions and after participants com-
pleted all computer-delivered content-re-
search assistants used a predetermined list
of computer-generated random numbers
to further randomise half of all participants
into the CM condition
Allocation concealment (selection bias) Unclear risk Not reported.
188Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ondersma 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 16/110 (14.5%) lost to follow-
up. All analyses were on an intent-to-treat
basis that analysed participants as allocated
to condition without respect to completion
of treatment elements. Only 2 women who
withdrew due to miscarriage (one in com-
bined arm and 1 in usual care arm) were
excluded from the analysis in this review
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported 7-day abstinence biochemi-
cally validated with expired CO (< 4 ppm)
and urinary cotinine (< 100 ng/mL)*
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Each intervention involved the same level
of interaction with the computer and
took the same approximate amount of
time, thus keeping research assistants blind
to computer-delivered intervention condi-
tion. Not feasible to blind participants
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is not stated whether outcome assessors
were blinded.
Incomplete implementation Unclear risk Process evaluation showed all participants
assigned to CD-5As condition completed
the items and evaluations and gave high
satisfaction ratings. Of the participants as-
signed to CM-Lite only 37.9% initiated
testing of at least 1 urine sample (mean 3.
7, SD 1.9)
Equal baseline characteristics in study arms Low risk There were no significant differences be-
tween conditions on any of the baseline
characteristics examined, although 1 vari-
able (minority vs. non-minority race) was
below P = .10 and so was controlled for in
subsequent analyses
Contamination of control group Low risk The risk of contamination between study
arms is low as interventions are all provided
via technology
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Methods Randomised controlled trial of counselling interventions to support women to stop
smoking in pregnancy
Study conducted in a public antenatal clinic in Melbourne, Victoria, Australia. Data
collected from April 1994 to June 1996
Participants Inclusion criteria: Women who identified as “current smokers” at their first antenatal
visit at approximately 12 weeks’ gestation (“even a puff in the last 7 days”)
Exclusion criteria: >20 weeks’ gestation; twin pregnancy; not literate in English; drug
dependency
Recruitment: 9193 women screened, 1942 (21%) current smokers and 625 (7%) spon-
taneous quitters (not included in study but described in Panjari 1997). 1013/1942 smok-
ers (52%) agreed to participate (929 refused or not eligible) and were randomised (C =
537, I = 476).
Baseline characteristics: Mean cigarettes per day = 21 before pregnancy and 11 at time
of first antenatal visit. 74% had a smoking partner
Mean age 26 years.
Progress+ coding: Low SES as authors note mostly low income women.
Interventions Control: Usual care, which included advice at the discretion of the caregiver, and 0
pamphlet “Smoking & Pregnancy” distributed during a group pregnancy information
session
Intervention: As for the control group plus 4 counselling sessions by a midwife specif-
ically trained and employed to provide smoking cessation counselling, using CBT. Ses-
sions included video presentation, interactive discussion and strong verbal messages.
These were followed up with a 5 to 10 minute personalised counselling session
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 3). Usual care intensity: F = 1,
D = 1
Intervention provided by dedicated project staff: efficacy study
Outcomes Self-reported smoking cessation biochemically validated with urine cotinine at 36 weeks’
gestation (late pregnancy*), 6 weeks postpartum (0-5 months)*, and 6 months (6-11
months*) postpartum*. Preterm births*, mean birthweight*, proportion LBW* (< 2500
g)
Reduction in mean cigarettes/day* and mean urinary cotinine levels*
Breastfeeding at 6 weeks and 6 months postpartum. General health assessment at first
visit and 36 weeks
General health questionnaire (including stress and depression measurement) at baseline
and end of pregnancy
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information.
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Allocation concealment (selection bias) Unclear risk Described as “randomly allocated”.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 28% attrition (381/1013). 72/1013 (C =
35, I = 37) were excluded as they were over
20 weeks’ gestation, had a twin pregnancy
or were transferred to the chemical depen-
dency clinic. 209/1013 (C=109, I=100) ex-
cluded due to transfer to another hospi-
tal, miscarriage, termination of pregnancy
and withdrawal from the study. The num-
bers of those who withdrew from the study
were not reported separately in this group,
therefore all were re-included as continu-
ing smokers in this review (but were not
included in mean outcome data)
Selective reporting (reporting bias) Low risk A detailed list of birth outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine levels measured at base-
line and in late pregnancy (< 115/ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention delivered by
clinic midwife.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed 71% women in
the intervention group received the full in-
tervention
Equal baseline characteristics in study arms Low risk There were no statistically significant dif-
ferences between women allocated to the
intervention and the control groups in
terms of socio-demographic variables and
smoking patterns
Contamination of control group Low risk Intervention provided by a research mid-
wife, not usual care provider
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Parker 2007
Methods 3-armed randomised controlled trial aimed to evaluate the feasibility, cost and effec-
tiveness of a telephone counselling intervention to support women to stop smoking in
pregnancy
Study conducted at 22 urban prenatal care clinics in Rhode Island (Connecticut) and
Massachusetts (USA). Study period not reported
Participants Inclusion criteria: Pregnant women who had smoked at least 1 puff of a cigarette within
the past 30 days, no more than 26 weeks pregnant, had access to a telephone where she
could be reached, and speak English or Spanish
Exclusion criteria: Not further specified.
Recruitment: 8526 pregnant women were assessed at their first or second visit. 1065/
1582 eligible women (67%) agreed to participate and were randomly assigned to 3 con-
ditions (C (self-helpmaterials)=378; I1 (Self-helpmaterials+quit and win contest) = 329;
I2 (self-help materials + quit and win contest + motivational interviewing counselling
calls = 358)
Baseline characteristics: Strateifed by participation in calls: Mean cigarettes per day at
baseline: 7.9 (6.3) to 8.7 (5.8). Baseline cotinine: 869 to 1239 mg/mL
Majority white, 40% <= 11 years education.
Progress+ coding: Low SES as 80% Medicaid recipients.
Interventions Control: Participants received self-help materials, which included a quit kit (A Smoker’s
Guide to Quit Smoking) and a video (Commit to Quit), which had been shown to be
effective in significantly reducing exposure or assisting pregnant women to quit smoking
(SCRIPT trials)
Intervention 1: Received the quit kit and were enrolled in a “Quit and Win” (Q&W)
monetary incentive lottery program. Eligibility for the prize (US$100) was restricted to
smokers who reported abstinence for at least 30 days and had their report confirmed by
urinary cotinine.
Intervention 2: Received the quit kit, the Q&W program, and up to 3 Motivational
Interviewing telephone calls
This review compares the control group and Intervention 2.
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 1, I = 4), Duration (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Self-reported smoking cessation biochemically validated with urinary cotinine (< 80
ng/mL) at 32 weeks’ gestation (late pregnancy)*, 6 weeks and 6 months postpartum
(outcomes not reported). Cost-effectiveness analysis
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
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Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: C = 101/378 (27%), I = 118/358
(33%) by 6 months postpartum (reasons
not reported). All randomised women in-
cluded in analysis
Selective reporting (reporting bias) High risk Smoking cessation at 6weeks and 6months
postpartum not reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemical validation of self-reported
smoking status using urinary cotinine
(<80ng/mL). Conference report states only
219 women with biochemically confirmed
smoking status were included in report.
But pg 1045 states “Samples were obtained
from 114 women during the first prenatal
visit, from 113 during the third trimester,
and 23 during the 6 month postpartum
visit.Wewere unable to contact the remain-
der of the women, and therefore did not
have samples to confirm their self-reported
smoking status”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not feasible for participants and personnel
to be blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed researchers were
unable to reach 14%, 86% received 1 call,
60% 2 calls and 46% 3 calls
Equal baseline characteristics in study arms Low risk The absence of significant differences
for multiple salient predictors and other
weaker predictors of smoking behaviour
change strongly suggested that the call
groups were comparable at baseline
Contamination of control group Low risk Specific counsellors providing intervention
so low risk of contamination
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Patten 2009
Methods Randomised controlled pilot study of a targeted intervention to support pregnantAlaskan
Native women to stop smoking in pregnancy
Study conducted in the Y-K Delta region in Western Alaska (USA), with recruitment
from 2007 to 2008
Participants Inclusion criteria: Pregnant Alaskan women ≥ 18 years, ≤ 24 weeks’ gestation, self-
reported smoking or Iqmik/ST use in the last 7 days, planning to quit in the next 30
days, access to a telephone and VCR/DVD player, and willing to participate in all study
procedures
Exclusion criteria: Planning an abortion, current (past 3 months) participation in phar-
macological or behavioural tobacco treatment, and another woman from her household
had enrolled
Recruitment: 293 women expressed an interest in the study and were referred to study
coordinator. 81 did not attend screening appointment, 114 reported not smoking and 4
were ineligible. 35/94 (37%) of the remaining eligible women agreed to participate and
were randomised (C = 18, I = 17)
Baseline smoking characteristics: Current tobacco use (in past 7 days): Iqmik C = 44%
(8), I = 47% (8); Commercial chew C = 22% (4), I = 18% (3); Cigarette smoking C =
33% (6), I = 35% (6). Spouse/partner uses tobacco: C = 78% (14), I = 54% (7). Smoking
ban in the home C =89% (16), I= 88% (14). Chewing ban in the home C = 12% (2) ,
I = 19% (3)
Baseline characteristics not reported.
Progress+ coding: Low SES, ethnic minority population.
Interventions Control: Participants in the control arm received an intervention consistent with the 5-
component treatment (5A’s) recommended for pregnant smokers by the Clinical Practice
Guideline: Ask, Advise, Assess, Assist, and Arrange. At the first visit, participants in this
condition received a brief (5-min) face-to-face intervention based on the 5A’s and 4
pregnancy and culturally specific brochures. The counsellor encouraged and assisted the
participant to set a quit date. Participants requesting NRT or another medication from
the counsellor were referred to the YKDRH clinical cessation program and enrolment
in this program was tracked as part of this study
Intervention: At the first visit women in the intervention group received:
(i) a self-help guide adapted from the SCRIPT trials (Windsor 1999) and from culturally
appropriate brochures developed and used by the YKDRH clinical cessation program
(ii) 15-25 minutes of face-to-face counselling based on the 5A’s
(iii) a video which was produced that included stories of Alaska Native women who
stopped using tobacco during pregnancy. Focus groups suggested that story-telling was a
potentially acceptable intervention component. The counsellor then discussed the video
with the woman
(iv) A further 4 x 10-15 minute proactive interactive sessions were provided by telephone,
based on a counsellor manual which was developed based on completed evaluation
research, atWeeks 1, 2, 4, and 6. These sessions provided opportunities for the counsellor
to teach additional cessation skills and reinforce self-efficacy. Thewomanwas encouraged
to set a quit date at each contact, if she had not quit
Main intervention strategies: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 2, I = 6), Duration (C = 2, I = 3).
Intervention provided by dedicated study staff: Efficacy study
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Outcomes Biochemically validated tobacco use in (salivary cotinine< 20n g/mL) 60 days post ran-
domisation (late pregnancy*). Acceptability to women
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk 35 participants were stratified by primary
type of tobacco used (Iqmik, commercial
ST, or cigarettes) and randomly assigned
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: C = 1/18 (6%), I = 5/17 (29%)
. 1 miscarriage in each study arm excluded
from this analysis. All other drop outs
counted as continuing smokers
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported tobacco use status biochemi-
cally validated using salivary cotinine (< 20
ng/mL). Some women were using NRT
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported.
Incomplete implementation Low risk Process evaluation showed good treatment
compliance and acceptability of interven-
tion
Equal baseline characteristics in study arms High risk Level of education and spouse/partner
smoking unequal.
Contamination of control group High risk Assessments and interventions provided by
the same individual in each community
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Pbert 2004
Methods Cluster-randomised controlled trial of implementation of the “Quit Together” program
which aims to support women to stop smoking and prevent relapse in pregnancy
Study conducted WIC clinics in Massachusetts (USA) of implementation, with data
collection from May 1997 to November 2000
Participants Unit of randomisation was 6 community health centres with on-site WIC programs,
prenatal services and paediatric services, and patients of diverse race and ethnicity. 1
control site was dropped due to low recruitment
Inclusion criteria: Pregnant women, English or Spanish speaking, less than 32 weeks’
gestation, current smoker or spontaneous quitter, planning to remain in area for 6months
after delivery
Exclusion criteria: Not further specified.
Recruitment: 7853 women screened. 609/693 (88%) eligible smokers and ex-smokers
consented, completed baseline interviews and were randomised (C = 300, I = 309)
Baseline characteristics: Current smokers (C =72.3%, I = 70.2%), spontaneous quitters
(C = 27.7%, I = 29.8%). Mean cigarettes per day before pregnancy: C = 18.43, I = 14.
89
Mean age 26 years.White (C = 78.6%, I = 22.8%), Black (C = 1.8%, I = 39%), Hispanic
(C = 4.7%, I = 27.6%). Unmarried: C = 60.8%, I = 68.8%. Medicaid C = 63.1%, I =
65.5%. < High school C = 62.2%, I = 46.7%
Progress+ coding: Low SES as high proportion of WIC recipients.
Interventions Control: Usual care condition, in which no training or intervention occurred
Intervention: The dissemination intervention consisted of:
(i) provider training based on national clinical practice guidelines
(ii) an office practice management system for routine screening and follow-up reminders,
and (iii) establishment of program boards. The intervention to women was based on
motivational interviewing and the “4A’s” from the ’SCRIPT trial’ conducted byWindsor
2000b.
Main intervention strategy: Counselling (single intervention and intensive dissemina-
tion) compared to usual care
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1). Usual care intensity: F = 0,
D = 0
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated smoking cessation and relapse prevention at 1 month postpar-
tum combined (late pregnancy*), and 3 (0-5*) and 6 (6-11*) months postpartum. 6-
month figures not reported in text but estimated from Figure 3 to be I = 11%, C = 4%
Mean cigarettes/day* estimated from figure 4.
Associated references describe detailed organisational change and implementation pro-
cesses for the clinic setting, subanalysis of a range of outcomes by socio-economic status;
and clinical knowledge of nicotine dependence (Bonollo 2002).
Notes No estimates of clustering effect reported, so sensitivity analysis conducted and intra-
cluster correlation of 0.10 used to adjust data for inclusion in outcome tables (see table
2 for adjustment details)
SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk 34/609 (6%) had a miscarriage and 12/
609 (2%) transferred to another health ser-
vice. 13 women excluded for other reasons
(unexplained), but they are not reported
by intervention group to be re-included
and the figures reported in the flow chart
are combined with drop-outs for other rea-
sons. Also high loss to follow-up. 550/609
women included in this analysis
Selective reporting (reporting bias) Unclear risk Trial part of a nutritional program, but only
smoking outcomes in this report
Other bias Unclear risk One control site dropped due to low re-
cruitment. Otherwise recruitment to study
arms appears balanced
Biochemical validation of smoking absti-
nence (detection bias)
Low risk A woman was considered to be a smoker
if she reported smoking in 30 days prior
to 1 month postpartum interview. Salivary
cotinine was analysed for women reporting
abstinence in 7 days prior to the interview
(<= 20 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Sites aware of allocation status.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Process evaluation not reported.
Equal baseline characteristics in study arms Unclear risk While no differences between SI and UC
were statistically significant, some were
large (e.g., race/ethnicity, education). This
reflects the variability in size and race/eth-
nicity distributions among CHCs, the unit
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of randomisation
Contamination of control group Low risk Cluster design to avoid contamination.
Petersen 1992
Methods 3-armed randomised controlled trial of self-help materials and counselling to support
women to stop smoking and prevent relapse during pregnancy and postpartum
Study conducted at a large Boston HMO (USA), with recruitment from March 1986
to September 1988
Participants Inclusion criteria: English-speaking literate women enrolling in prenatal care; who
reported themselves as currently occasional or regular smokers or who had quit smoking
in the previous 3 months
Exclusion criteria: < 18 years of age; > 24 weeks’ gestation.
Recruitment: 1442 women screened during early pregnancy class. 317 current smokers
and recent quitters were identified. Participants from 3 centres were randomised to
control and first intervention (I1) arms, and participants from a fourth arm were not
randomly allocated and are not included in analysis ion this review. 93/317 attrition,
leaving 224 included (C = 78, I1 = 71, I2 (not randomised) = 75).
Baseline characteristics: Baseline smokers : 142 (C = 47, I1 = 43, I2 = 52) and baseline
spontaneous quitters: 104 (C = 36, I1 = 34, I2 = 34) analysed at 6 months gestation.
Majority 17-28 years, No participants less than high school, less than $US 20000/yr (C
= 18.7%, I1 = 20%, I2 = 32.3%). Over 80% married and majority white.
Progress+ coding: None.
Interventions Control: Routine obstetric care, including a mailed list of community-based smoking
cessation resources other pregnancy-related health education materials. Brief repeated
counselling by obstetricians and midwives for both groups as part of routine care.
Intervention 1: Pregnancy-specific self-helpmanual (AmLungAssoc andHarvardCom-
munity Health Plan (HMO)) and audiotape on safe aerobic exercise and pregnancy-
related relaxation, mailed with other health-related education. Smoking component em-
phasised behavioural strategies for quitting, issues and concerns specific to pregnant
women, non-smoking as part of a continuum of care in pregnancy; included a mainte-
nance section for the postpartum period
Intervention 2: As for I1 plus training for obstetrician and nurse practitioner to provide
training, and support letters from physician
Main intervention strategy: Health education (single intervention) compared to usual
care. Intervention 1 and control compared in this review as the I2 group was not ran-
domised.
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1). Usual care intensity: F = 3,
D = 2
Intervention provided by dedicated project staff: Efficacy study
Outcomes Smoking cessation for smokers and spontaneous quitters at 6 months gestation (late
pregnancy* and 8 weeks postpartum (0-5 months*)
Description of costs.
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Notes Substantial misclassification of non-smoking self-report at 6 months gestation 24%
controls 21% intervention (and 30% in clinic where the interventionwasmore intensive)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers. Allocation to
intervention arm2was not randomised but
offered to all eligible enrollees at 1 clinic:
therefore data from this intervention arm
are not included in the review
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk 93/ 317 (29%)were excluded fromanalyses
due to miscarriage, therapeutic abortion,
moving, or left the Harvard Health Plan,
leaving 217 included. However, 246 (C =
83, I1 = 77, I2 = 86) ’baseline smokers and
spontaneous quitters’ included in analysis
at 6 months gestation and 219 included in
8 weeks postpartum. It is not clear which
randomisedwomen are included in analysis
Selective reporting (reporting bias) Unclear risk None apparent but results were not simple
to interpret.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation in 50% women.
Those refusing urine test were coded as
smoking
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk State that caregivers were blind as materials
to the intervention group were mailed. Not
feasible to blind women
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All women received materials for interven-
tion 1 used in this review. Some implemen-
tation problems noted with the counselling
arm (I2), but that was not included in this
review.
Equal baseline characteristics in study arms High risk Differences in educational attainment.
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Contamination of control group Low risk Unlikely with mail out of materials.
Polanska 2004
Methods Cluster-randomised trial of intervention to support women to stop smoking and prevent
relapse in pregnancy and postpartum
Study conducted in the Lodz district, Poland, with data collection fromDecember 2000
to December 2001
Participants Unit of randomisation was maternity units, selected from 33 in district and stratified by
size. Control = 1 small, 2 medium, 2 big; Intervention = 2 small, 4 medium, 4 big (as
higher refusal expected in intervention arms
Inclusion criteria: Current smokers or women who quit 1 month before the visit
Exclusion criteria: Not further specified.
Recruitment: 15/33 maternity units were allocated to intervention (10) or control (5)
groups
All pregnant women screened. 194/194 (100%) eligible women in control group and
216/275 (78.5%) eligible women in the intervention group agreed to participate
Baseline characteristics: Current smokers: C = 156, I = 158. Spontaneous quitters: C
= 38, I = 58. Cigarettes per day: < 5 (C = 8.8%, I = 10.3%), 5-50 (C = 54.7%, I = 46%)
, > 10 (C = 36.5%, I = 43.7%). Fagerstrom score 0-6 (C = 98.9%, I = 92.3%)
Mean age: C = 25.9, I = 25.5; < 12 years education: C = 76.2%, I = 74.3%; Unmarried:
C = 39.2%, I = 52.5%
Progress+ coding: Low SES population as described by author.
Interventions Control: Received standard written information about health risks of smoking
Intervention: Received 4-9 midwife home visits, based on a booklet translated from
English (Ottawa) toPolish and adapted toPolish conditions: “How to talk about smoking
with high risk pregnant smokers”
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 4). Usual care intensity: F = 1,
D = 1
Intervention provided by midwives, which appear to be existing staff, though this is not
explicitly reported: coded as effectiveness study
Outcomes Self-reported smoking cessation ’shortly after delivery at home’ (0-5 months postpar-
tum*)
Relapse prevention rates* in text (p274). Mean birthweight* calculated by combined
smokers and quitters in Table 6
An associated reference (Polanska 2005) reports relapse after 12 months* (12-17 months
postpartum). All randomised from women from original study included as denominator
and those not included in the follow-up analysis assumed to have relapsed in this review.
Spontaneous quitters and smokers combined from Table 2 to calculate self-reported
abstinence at 12 months
Notes No estimates of clustering effect reported, so sensitivity analysis conducted and intra-
cluster correlation of 0.10 used to adjust data for inclusion in outcome tables as shown
in Table 2.
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Notes random allocation, but no descrip-
tion of how this occurred. Only 15/33 eli-
gible clinics allocated
Allocation concealment (selection bias) Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: Miscarriages:
Smokers: I = 9/158 and C = 12/156.
Spontaneous quitters: I = 2/58 and C= 1/
38. Not included in analysis
Those lost to follow-up: Smokers: (C = 6,
I = 6) and Spontaneous quitters (C = 0,
I = 2) are included in analysis of smoking
outcomes
Selective reporting (reporting bias) Unclear risk Birthweight and relapse prevention out-
comes difficult to interpret and unable to
be included
Other bias Unclear risk Twice as many sites were allocated to the
intervention arms as the control arms as it
was assumed more women would refuse to
participate in intervention activities. How-
ever recruitment to study arms was equal
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status only.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel not blinded to
this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk No. of visits received not reported.
Equal baseline characteristics in study arms High risk Intervention group more likely to be mar-
ried, have fewer children, and have a higher
smoking addiction
Contamination of control group Unclear risk Cluster-design tominimise risk of contam-
ination.
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Methods 3-armed randomised controlled trial of 2 brief interventions to support women to stop
smoking in pregnancy
Study conducted in an inner urban setting, Toledo, Ohio (USA), with recruitment from
December 1987 to March 1989
Participants Inclusion criteria: Not specified.
Exclusion criteria: > 28 weeks’ gestation.
Recruitment: All 1,164 patients screened, 486 current smokers (42%). 293 refused or
were ineligible (40% participation). 193 smokers randomised to study (C = 71, I1 = 52,
I2 = 70).
Baseline characteristics: Baseline smoking not reported.
Mean age=22.6 (5.6), ranging from 15-43 years. 58% single, 70% white, 87% had not
graduated from high school. Author describes population as “Typically low income,
single and poor”
Progress+ coding: Low SES.
Interventions Control: Usual care not specified or assessed but “usual for physicians to address this
issue with participants at least 1 prenatal visit”.
Intervention 1: American Lung Association self-help booklet (with brief overview and
explanation) emphasising behaviour modification skills, relation techniques and the sup-
port of significant others, and were given an opportunity to ask questions of the health
educator. Progress reviewed with health educator at the second visit
Intervention 2: Tailored educational videotape 6.5minutes, potential fetal risks, benefits
if mother quit + pamphlet on how to quit and opportunity to ask questions of the health
educator. 1 month later they viewed a second 4 min video and the health educator was
available to answer questions
Main intervention strategy: Counselling (single intervention) compared to usual care.
The control and intervention 2 (video-tape) are compared in this review
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). Usual care intensity: F = 1,
D = 1
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated smoking cessation ’two or three weeks prior to delivery’ (late
pregnancy*). Smoking reduction* and mean cigarettes/day*
Notes Program was developed with input from a questionnaire (based on Health Belief Model)
and open-ended questions about the advantages and disadvantages of smoking when
pregnant from local population.
Commentary on the contextual factors in the lives of indigent women which lead them
to have different perceptions about the relative importance of smoking
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
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Allocation concealment (selection bias) High risk Tossed die (allocation could therefore be
changed). Method resulted in 3 unequal
groups, so randomisation to only 2 groups
for some of the study period, which was
the control and intervention 2 (videotape)
group, compared in this review
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition 44% (C = 46, I1 = 13,I2 = 25)
. Reasons for attrition not reported. How-
ever all drop-outs treated as continuing
smokers in this review
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking cessation was biochemically val-
idated using exhaled CO (<= 7 ppm cut-
off )
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 44% did not receive intervention.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Specific educators providing intervention
(pregnancy care providers not involved)
Reading 1982
Methods Randomised controlled trial of ultrasound feedback on health beliefs and behaviours to
improve maternal health, including smoking
Study conducted in London, England (UK). Recruitment dates not specified
Participants Inclusion criteria: Caucasian origin, aged between 18 and 32 years, married or within
a stable relationship, attending King’s College Hospital antenatal booking clinics
Exclusion criteria: Women with a previous history of miscarriage, extended infertility
investigations, or meet criteria for risk of congenital malformations
Recruitment: Women ’briefly informed that the study involved a continuing evaluation
of aspects of obstetric care and that they would be seen on occasions throughout the
pregnancy’. 6 women refused. 194 women recruited (see associated reference (Reading
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1982), and were randomised to 3 arms: control (delayed ultrasound) = 55;I1 (low feed-
back) = 62; and I2 (high feedback = 67). The control arm was added during the course of
recruitment and is not included in this review. 129 women included, 65 (50%) smokers
at baseline (I1 = 26/62, I 2= 39/67).
Baseline characteristics: Smoking characteristics not reported. Selective inclusion cri-
teria: Pregnant women at 10-14 weeks’ gestation; 18 to 32 years; 85% had planned
pregnancy, at low risk of complications; 86% nulliparous
Progress+ coding: None.
Interventions Control:Women were assessed in the clinic following a delay interval
Intervention 1 (low feedback): Routine ultrasound at 16 weeks’ gestation in which
women were unable to view the monitor screen, did not receive specific visual or verbal
feedback, and they received a global evaluation of the form “all is well”.
Intervention 2 (high feedback): Women were shown the monitor screen and provided
with standardized visual and verbal feedback as to fetal size, shape, and movement. No
clear smoking cessation component
Main intervention strategy: Feedback (single intervention) compared to usual care.
Intervention 1 (low feedback) compared to Intervention 2 (high feedback) in this review.
Control group details only reported in associated reference, so no smoking outcomes
available
Intensity: Frequency (C = 0, I=1), Duration (C = 0, I = 1). Usual care intensity: F = 0,
D = 0
Unclear whether dedicated project staff delivered the intervention or not
Outcomes Self-reported smoking cessation at 16 weeks’ gestation (late pregnancy*), without bio-
chemical validation. Self-reported reduction in smoking*
Notes Cites evidence for the reliability of self-report.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “assigned at random”.
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition: 3/129 (2%) from low feedback
group in smoking outcomes. But consider-
able amounts of missing data for some vari-
ables. Those lost to follow-up not included
in ITT analysis, and unclear whether they
were smokers at baseline so not re-included
Selective reporting (reporting bias) Unclear risk Data collected not specified.
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of quitting.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Intervention with verbal feedback, so not
feasible to blind women. State that those
providing care were not involved in the
study
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk 3/62 low feedback group did not attend
next visit at 16 weeks
Equal baseline characteristics in study arms Low risk Data in Tables 1 and 2 seem similar.
Contamination of control group High risk Assuming same ultrasonographer provid-
ing intervention for control and interven-
tion groups
Rigotti 2006
Methods Randomised controlled trial of a telephone counselling intervention to support women
to stop smoking and prevent relapse during pregnancy and postpartum
Study conducted in a network-managed care organisation and a group of 65 community
based prenatal care practicesMassachusetts, NewEngland (USA), with recruitment from
September 2001 to July 2004
Participants Inclusion criteria: Pregnant smokers (at least 1 cigarette in the past 7 days), at least
18 years of age, 26 weeks or less gestation, willing to consider altering smoking during
pregnancy, reachable by telephone, English speaking and expected to live inNewEngland
for the next year
Exclusion criteria: Not further specified.
Recruitment: Smokers initially identified on ’Obstetric Risk Assessment’ form, yielded
low recruitment so 65/140 obstetric or family practices agreed to refer patients and 35
sent in 1 or more referral forms. 1444 pregnant smokers were referred to the study and
665 assessed as eligible. 442/446 (66%) agreed to participate and were randomised (C
= 222, I = 220)
Baseline characteristics: Mean cigarettes per day before pregnancy: C = 20.8, I = 20.9;
Current mean cigarettes per day: C = 10, I = 10.4; Partner smoking: C = 62%, I = 71%
Mean age: C = 28.1, I = 28.9; Mean years education: C = 13, I = 13.1; White: C = 87%,
I = 88%; Private health insurance: C = 70%, I = 75%. Depression in last month: C = 1.
3%, I = 1.3%
Progress+ coding: None.
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Interventions Control: In addition to usual care, the control group were mailed a validated preg-
nancy-tailored smoking cessation booklet, and their prenatal care providers were sent
the ACOG smoking cessation practice guideline, with a reminder to address smoking
at the participant’s visits. The enrolment call concluded with a trained counsellor pro-
viding brief smoking counselling (less than 5 minutes). Smokers who requested further
assistance were referred to the Massachusetts telephone quitline
Intervention: The intervention group received as for the control group, plus a series of
telephone calls accompanied by additional mailed written materials. Each participant
had a dedicated counsellor who offered up to 90minutes of counselling during pregnancy
and up to 15 minutes over the 2 months postpartum. The trained counsellor tailored the
call to the participant’s needs, consistent with the 5-step smoking cessation guideline,
and drew on social learning theory and the transtheoretical model of change, the health
belief model, and the principles of motivational interviewing
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 2, I = 4), Duration (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated 7-day point prevalence abstinence at 28 weeks to term (late
pregnancy*), and 3 (0-5) months postpartum*. Also measured reduction in smoking
(proportion >50% reduction in cigarettes per day*), sustained abstinence at both time-
points, and number of quit attempts
Self-efficacy and social support at baseline and follow-up. Concerns about weight gain
reported in an associated reference (Berg 2008). Women’s satisfaction with the interven-
tion.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Low risk Stated that recruiters were not aware of
group allocation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 21/442 (5%)were excluded from
the analysis due to miscarriage (C = 10/
220, I = 11/222). 113 women did not have
final assessment due to refusal (22%), baby
born before assessment or lost to follow-
up, but were included in the final analysis
(ITT analysis) and in this review (C = 209,
I = 212). Missing data (up to 30%) for out-
comes measured in the postnatal period
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Selective reporting (reporting bias) High risk Not clear if all outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Salivary cotinine (<= 20ng/mL cut-off )
confirmation in 66%, and those refusing to
provide a sample were included as contin-
uing smokers
Blinding of participants and personnel
(performance bias)
All outcomes
High risk All providers and women sent smoking ces-
sation practice guideline
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Mean number of calls received was 5.
Equal baseline characteristics in study arms High risk Both groups were similar, though the in-
tervention group had a significantly higher
proportion of women who hadmade a quit
attempt this pregnancy and had social sup-
port to quit from partner and significant
differences in parity, gestation, and partner
smoking
Contamination of control group Low risk Trained counsellors delivering intervention
not usual care givers
Secker-Walker 1994
Methods Randomised controlled trial of counselling to support women to stop smoking in preg-
nancy and postpartum
Study conducted at the University of Vermont, Burlington (USA), with recruitment
from May 1984 to June 1987
Participants Inclusion criteria: Pregnant women less than 25 weeks’ gestation, smoking at least 1
cigarette a day
Exclusion criteria: Not further specified.
Recruitment: Women receiving prenatal care from obstetricians and nurse-midwives,
or residents through Maternal, Infant & Child clinic for under-insured or non-insured
women, were randomly assigned (23% Medicaid in study). 775/808 (96%) smokers
invited agreed to participate. 175/775 women spontaneously quit before their first visit
and were randomised into a separate study of relapse prevention (C = 86, I = 89) (Secker-
Walker 1995). 600 smokers randomised (C = 300, I = 300).
Baseline characteristics: Mean cigarettes per day pre-pregnancy C = 25.1, I = 24.4.
Mean cigarettes per day at first prenatal visit: C = 12.4, I = 14.1
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Mean age: 24 years; Less than high school: C = 30.7%, I = 28.2%; Medicaid recipient
C = 23.2%, I = 25.3% (50% private insurance)
Progress+ coding: Low SES due to high rates of women who hadn’t completed high
school
Interventions Control: ’Usual advice about smoking provided by obstetrician or midwife’.
Intervention: Counselling from a trained health educator who: addressed concerns re
smoking and pregnancy, health benefits of stopping, perception of the advantages and
disadvantages of stopping, problem solving around those issues and coming to a decision.
If agreeing to quit and formulating a plan, women were provided with skills rehearsal
and a pregnancy-specific booklet. Follow-up at second antenatal clinic, 36 weeks and
6-week check (where infant health and parental role modelling was discussed) and re-
encouraged to quit.
Health educators given selected readings, discussion, rehearsal with psychologist + health
educator (both former smokers) about smoking and smoking cessation counselling tech-
niques + American Lung Association training group for class leaders + 4-week pilot
The relapse prevention component was individualised but carried out within a defined
protocol. Counselling about preventing relapse and a booklet. Follow-up at second ante-
natal clinic, 36 weeks and 6-week check (where infant health and parental role modelling
was discussed)
Main intervention strategy: Counselling (multiple intervention) compared to usual
care
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 3). Usual care intensity: F = 1,
D = 1
Intervention provided by dedicated project staff: Efficacy study
Outcomes Smoking cessation at 36 weeks’ gestation (75% biochemically validated with cotinine)
(late pregnancy*), Long-term quitting measured at 8-15 months’ pp (6-11 months pp*)
, 16-24 pp (18 months postpartum), and 25-54 pp (self-reported)
Relapse prevention* reported in associated reference (Secker-Walker 1995).
Mean birthweight*, low birthweight*, other smoking-related complications (PPROM,
placental abruption and placenta praevia)
Reduction in mean cotinine/creatinine ratio at 36 weeks’ gestation
Notes Sample size calculated for 10% increase (from 10% to 20%) in quitting.
No adjustment for misclassification.
Recall of advice about smoking.
Separate paper (Secker-Walker 1992) evaluates training program for residents.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk Not stated. Unclear when randomisation
took place.
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Smokers: Attrition 39/600 (6.5%) due to
miscarriage (27), fetal deaths (7), infant
deaths (5), 48 transferred care (C = 24, I =
24), and were excluded from analysis, leav-
ing C = 258, I = 255
Further losses were: 41 dropped out of
study (C = 4, I = 37), and 59 were lost to
follow-up (C = 28, I = 31), but were re-in-
cluded in this review as continuing smok-
ers, but are not included in mean birth-
weight and other birth outcomes analyses.
Significant difference in pregnancy drop-
out rates for I (13% drop-out rate ) and C
(1.4% drop-out rate). Those lost to follow-
up smoked more
Voluntary drop-outs treated as continuing
smokers for some analyses
Spontaneous quitters: attrition 8/175 (5%)
due to miscarriage (5), abortion (1), fetal
demise (1), and infant death (1) and lost
records (2) were excluded from analysis,
leaving C = 80, I = 85. Further attrition:
transferred care (15)-not reported by study
arm, dropped out of study (9), lost to fol-
low-up (8), re-included in baseline as con-
tinuing smokers in this review
Differential withdrawal in I and C groups
a concern; good information collected on
drop-outs being different
Selective reporting (reporting bias) Unclear risk Data collected not specified. Only smoking
outcomes reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine/creatinine ratio levels
measured at 36 weeks (< 80 ng/mg)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention in antenatal clin-
ics.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All but 9 intervention women not lost to
follow-up received all 3 counselling ses-
sions before 36 weeks, and 89% received
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the postpartum 1
Equal baseline characteristics in study arms High risk Mostly similar but women in intervention
group tended to smoke more cigarettes at
time of their first visit
Contamination of control group Low risk A separate health educator provided inter-
vention.
Secker-Walker 1997
Methods Randomised controlled trial of a videotape to support women to stop smoking in preg-
nancy
Study conducted in the offices of ’University Associates in Obstyetrics and Gynecology’,
in Burlington, Vermont (USA), with recruitment from November 1992 to April 1993
Participants Inclusion criteria: Pregnant women smoking ’an average of one or more cigarettes per
day’
Exclusion criteria: Not further specified.
Recruitment: Women recruited through University prenatal clinics where obstetricians
and nurse-midwives provide private prenatal care, and residents provide prenatal care
for under-insured women. 60/67 (89%) smokers who were invited agreed to participate
and were randomly assigned (C = 30, I = 30)
Baseline characteristics: Mean cigarettes per day before pregnancy = 22.6.
Mean age: 23 years; 30% married; 33% had less than high school education; 98% white
Progress+ coding: Low SES in this review as participants recruited from a state-sup-
ported clinic for underinsured women
Interventions Control: Advice from an obstetrician or nurse-midwife (as per prompt sheet) and a
booklet on quitting. The protocol for this advice has been described in Secker-Walker
1992.
Intervention: As for control plus a 29-minute videotape of 4 women going through the
process of quitting during pregnancy; talking about feelings; coping with weight gain;
getting support, which could be borrowed and taken home. Based on social learning
theory
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention
Intensity: Frequency (C = 1, I = 2), Duration (C = 1, I = 2).
Unclear if technological intervention provided by existing staff or dedicated project staff
Outcomes Smoking cessation in late pregnancy* (36/40), biochemically validated with exhaled CO
measurements
Process evaluation included perceptions of the videotape contents
Notes
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 4/60 (7%) women, all in the intervention
had a miscarriage and 7 (C = 2, I = 5)
moved to another care-provider, and were
excluded from the analysis
3 (C = 1, I = 2) lost to follow-up butwere re-
included in this review, leaving C = 28, I =
21. Loss to follow-up not balanced, greater
loss from the intervention group
Selective reporting (reporting bias) Unclear risk Not apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk ExhaledCO (<8 ppm) used to validate self-
reported smoking cessation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 53% viewed the videotape. 17% had no
VCR, and 10% reported having no time
Equal baseline characteristics in study arms High risk Mean exhaled CO level was significantly
lower in intervention group
Contamination of control group Low risk Video tape unlikely to be provided to
women in control group
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Methods Randomised controlled trial of a counselling intervention to support women to stop
smoking in pregnancy and prevent relapse postpartum
The study was conducted in offices of the ’University Associates in Obstetrics and Gy-
necology’ in Vermont (USA), with recruitment from October 1988 to October 1992
Participants Inclusion criteria: Woman who reported smoking 1 or more cigarettes per day at onset
of pregnancy
Exclusion criteria: Not further specified.
Recruitment: Women recruited through the state-supported (Maternal and Infant Care)
prenatal clinic for underserved women or attending the Adolescent clinic for women 12
to 18 years. 524/544 (96%) women who were invited agreed to participate and were
randomised. 399 current smokers (C = 202, I = 197); 125 spontaneous quitters (C = 63,
I = 62) (separate paper).
Baseline characteristics: Smokers: Mean cigarettes per day before pregnancy C = 25.1, I
= 26.1; mean cigarettes per day at first prenatal visit: C = 11.8, I = 13.4. Another smoker
in the household (C = 82.6%, I = 78.5%)
Mean age: 23 years, < high school (C = 41%, I = 48%), 27%married; medicaid recipients
(C = 73.1%, I = 71.9%); Adolescent clinic (C = 13.5%, I = 11.9%)
Spontaneous quitters: Mean cigarettes per day before pregnancy (C = 14.1, I = 13.5).
Other smokers in household (C = 64%, I = 70%)
Mean age: C = 21.9, I = 20.9; < high school (C = 27%, I = 36%); 29%married; Medicaid
recipients (C = 68.1%, I = 65.1%); adolescent clinic (C = 14.9%, I = 11.4%)
Progress+ coding: Low SES.
Interventions Control: Physician acknowledged women’s smoking, gave a rationale for quitting, strong
recommendation to quit and provided smoking cessation booklet designed for pregnant
women. All participants received: baseline questionnaire, measurement of exhaled CO,
and brief standardised health risk message from a research nurse about the effects of
smoking on the fetus and pregnancy.
Intervention: A structured smoking cessation protocol provided by physicians trained
in its use (Secker-Walker 1992) at 1st, 2nd, 3rd and 5th visits: acknowledging the
woman’s smoking, her exhaled CO level, any progress towards quitting, rationale for
and unambiguous recommendation to quit, asking how she felt about quitting and
acknowledging her response, asking how she could be helped and telling her about the
counsellor, eliciting a commitment to change smoking behaviour before the next prenatal
visit and referring her to the counsellor. The aim was to gain her agreement to set a
quit date, a date when she would quit for 24 hours or a date when she would cut her
consumption by half. Counsellor advised women on ways to accomplish the behaviour
change.
2nd, 3rd, 5th and 7th visit included praise for those who had quit with referral to
counsellor for help in staying quit. 36 week visits included a briefer protocol followed
with referral for those who wanted to change, praise for success and referral to a nurse
counsellor if smoking
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention
Intensity: Frequency (C = 1, I = 5), Duration (C = 1, I = 3).
Intervention provided by existing staff, with referral to a counsellor: Effectiveness study
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Outcomes Biochemically validated 7-day point prevalence abstinence at 36 weeks’ gestation (late
pregnancy *) and 1 year postpartum*. Mean cigarettes per day at 36 weeks’ gestation*
and 12 months postpartum. Mean birthweight*. Low birthweight*
Relapse prevention at 36 weeks’ gestation (late pregnancy*) and 12 months postpartum
reported in associated reference (Secker-Walker 1998b)
Preterm births* are reported in attrition and are re-included in both numerator and
denominator for this outcome
Notes Methods included a detailed process evaluation of participants’ views and recall of
provider advice. Sample size justification
Separate paper reports relationship between exhaledCO and birthweight (Secker-Walker
1997b)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk High attrition. More than 25% lost to fol-
low-up in pregnancy and more than 30%
lost to longer-term follow-up
Smokers: 109/399 (27% attrition) 24 (6%)
women with miscarriage (14), fetal demise
(5) and infant deaths (5) were excluded
from analysis and are not reported by group
allocation. Report states 376 women re-
main included (instead of 375) (C = 191,
I = 185)
68 women transferred care (C = 34, I = 34)
, 17 delivered before 36 weeks (C = 8, I = 9)
and were not included in 36-week analysis
12 women withdrew from study (C = 5, I
= 7) and 3 lost to follow-up (C = 3), and
were re-included as continuing smokers in
this review, but are not included in mean
cigarettes per day or perinatal outcomes.
114 (I) and 110 (UC) were contacted 1
year after birth, including 16 (I) and 18
(UC) lost to follow-up during pregnancy.
Women with adverse outcomes were not
included in the analysis
Spontaneous quitters: 33/125 (26%) attri-
tion. Women with miscarriage (5), abor-
tion (1), infant death (1), pregnancy loss (1)
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, moving to another clinic or moving (22;
C = 13, I = 9), delivering before 36 weeks
(I = 2). All excluded from analysis leaving
C = 48, I = 44
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported cessation with biochemical
validation by exhaled CO (<6 ppm) or uri-
nary cotinine (<500 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Intervention by clinic staff. Notes flagged.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Methods included a detailed process eval-
uation of participants’ views and recall of
provider advice and suggests ‘to a large ex-
tent the intervention was implemented as
planned’
Equal baseline characteristics in study arms Unclear risk No significant differences except for larger
proportion of women in intervention
group had not made a quit attempt in the
past
Contamination of control group Unclear risk No women in cessation group received ces-
sation counselling beyond the physician ad-
vice. Though the same physician provided
advice so unclear if this was influenced by
the intervention
Sexton 1984
Methods Randomised controlled trial of a multifaceted intervention to support women to stop
smoking in pregnancy
Study conducted in a large university hospital obstetric clinic in Baltimore (USA) with
enrolment over a 2.5 year period (dates not specified)
Participants Inclusion criteria: Pregnant women who were smoking >= 10 cigarettes/day immedi-
ately prior to pregnancy, <18 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: Eligible women sought by a variety of methods but majority were attend-
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ing 1 of 52 private obstetricians or a hospital antenatal clinic. Obstetric staff sought
permission for study staff to contact women. 935 women recruited (participation rate
unclear) (C = 472, I = 463). 157/935 had spontaneously quit (C = 17% or 80, I = 16% or
74, which only add up to 154). Smoking rates among spontaneous quitters not reported
separately so all randomised women included in analyses
Baseline characteristics: Mean cigarettes per day pre-pregnancy: C = 20.7, I = 20.9;
mean cigarettes per day at randomisation: C = 11.7, I = 10.7
Mean age 24.9 years, Mean education 12.3 years, Black C = 41.3%, I = 40.3%
Progress+ coding: None.
Interventions Control: Usual care, not further specified.
Intervention: At least 1 personal visit, supplemented by frequent mail and telephone
contacts (at least 1 visit and 1 call/month) from 1 of 2 health educators (MEd level,
trained in pregnancy counselling and smoking intervention), providing information,
support, practical guidance and behavioural strategies for quitting.
Information on quitting and health risks of smoking was mailed every 2 weeks with
“homework” linked to telephone calls; group sessions were also available. There was a
monthly lottery and in the last year of the study a monthly newsletter. Hypnosis was
offered by discontinued as poorly accepted
Main intervention strategy: Counselling (tailored) compared to usual care.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 6). Usual care intensity: F = 0,
I = 0
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported smoking at eight months gestation (late pregnancy*)
Mean cigarettes per day* at 8 months gestation and mean thiocyanate*
Mean birthweight*; low birthweight*; very low birthweight*, perinatal deaths*, neonatal
deaths*, stillbirths*
% Apgar scores <7 at 1 minute and 5 minutes; length and head circumference
Notes Change of criteria for enrolment after the first 185 as 35% of these had smoked < 10/
day and 71% of that group had quit spontaneously with little relapse.
Detailed account of the intervention is in Nowicki 1984.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 56/935 (6%), 35 miscarriages (C
= 17/572, I = 18/463), 1 fetal death (C =
1), 20 stillbirths (C = 11, I = 9) excluded
from analysis, leaving C = 443, I = 436.
Women lost to follow-up included as con-
tinuing smokers in this review.Missingdata
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for mean outcomes not included
Selective reporting (reporting bias) High risk Extensive range of outcomes reported.
Outcomes not reported separately for
spontaneous quitters
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking outcomes were not
validated by salivary thiocyanate, despite it
being collected. Mean thiocyanate for each
group reported only
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Group sessions in the interventionwere not
readily accepted
Equal baseline characteristics in study arms Low risk Groups ’similar’ at time of randomisation.
Contamination of control group Low risk Specific personnel employed to deliver in-
tervention - not usual carers
Solomon 2000
Methods Randomised controlled trial of telephone peer support to help women stop smoking in
pregnancy
Study conducted in a large obstetric practice in Burlington, Vermont (USA), with re-
cruitment from 1996 to 1997
Participants Inclusion criteria: Women reporting smoking at least 1 cigarette in the past week at
their first antenatal visit
Exclusion criteria: Not further specified.
Recruitment: 151/186 (81%) women approached agreed to participate and were ran-
domised (C = 74, I = 77)
Baseline characteristics: Mean cigarettes/day before pregnancy: C = 20.2, I = 22.6;
Mean cigarettes per day at first visit: C = 9.8, I = 10.5. Mean exhaled CO: C = 11.3, I =
11.3. Mean other smokers in household: C = 1.5, I = 1.3
Mean age C = 23.7, I = 23.1; Mean years education: C = 11.5, I = 11.7; White: C =
96%, I = 94.8%. Medicaid recipient: C = 74.6%, C = 77.5%
Progress+ coding: Low SES.
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Interventions Control: Received brief smoking cessation advice (including encouraging a quit date)
from a midwife or obstetrician at each of the 3 prenatal visits and stage appropriate
printed materials. Midwives and obstetricians were provided with a 45 minute training
session and protocol prompt sheets were placed in charts at first prenatal visits
Intervention: Received the same as the control group, plus any women in the experi-
mental visit who reported they possibly, probably or definitely intended to quit smoking
were offered telephone peer support by the obstetrician/midwife. The telephone peer
support was provided by a female ex-smoker, who received 8 hours of training. The
support person called the participant within several days of referral to provide support,
encouragement and reinforcement of positive changes in smoking behaviour. Ongoing
calls typically occurred on a weekly basis, but more frequently around a quit date. On
average calls lasted 10 minutes
Main intervention strategy: Social support (tailored intervention) compared to a less
intensive intervention
Intensity: Frequency: (C = 3, I = 6), Duration (C = 1, I = 4).
Unclear whether intervention provided by dedicated or existing staff
Outcomes Biochemically validated 7-day point prevalence abstinence at 28-34/40 gestation (late
pregnancy*)
Proportion of smoking reduction bymore than 50%* was reported for a proportion (135
women) but unclear how many had dropped out of intervention and control groups.
As report states ’no significant difference’ in dropouts by intervention group (total n =
16) we have imputed 8 for each arm and calculated the number of reductions from a
proportion of the remaining sample
Movement in stages of change also reported for this group.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States participantswere randomised into ei-
ther experimental or control condition
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 16/151 (11%) attrition at follow-up. Un-
clear how many from each arm, so out-
comes (> 50% reduction and SOC move-
ment) reported as a proportion of those
remaining were not able to be included.
All randomised women were included in
the primary outcome of smoking cessation,
with those lost to follow-up treated as con-
tinuing smokers
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine assessment at 28-34weeks
used to confirm smoking status (cut-off
<80 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to allocation.Medical charts flagged
and referral for social support required by
care providers
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed 53% received
the peer intervention. 9 (12%) had low in-
tentions of quitting smoking during preg-
nancy and were never offered the peer sup-
port, 9 (12%) had no home telephone and
were not referred, and 15 (19%) refused
the offering, leaving 44 (57%) who were
referred for peer support. Data from log
sheets completed by the telephone support
person revealed that 3 women referredwere
never reached; therefore, only 53% of the
women in the experimental condition re-
ceived the peer support intervention
Equal baseline characteristics in study arms Low risk Baseline comparisons of women in the ex-
perimental and control conditions revealed
no significant differences in demographics,
pregnancy history, or smoking information
Contamination of control group Low risk Unlikely telephone counselling would have
been provided to control group in error
Stotts 2002
Methods Randomised controlled trial of intensive late pregnancy intervention to support ’resistant’
smokers to stop smoking in pregnancy
Study conducted in 3 large multispecialty clinics in Houstan and Dallas metropolitan
areas, Texas (USA). Enrolment over a 17-month period, dates not specified
Participants Inclusion criteria: Women were screened for eligibility into 2 concurrent studies: Preg-
nant women who smoked more than 5 cigarettes per week prior to pregnancy, fluent
in English, over 18 years, less than 20 weeks’ gestation at first prenatal visit. Women
who continue to smoke at 28 weeks’ gestation, after having counselling and 8 self-help
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booklets earlier in pregnancy care, and had telephone access, were eligible for this study
Exclusion criteria: Women who had quit smoking at 28 weeks (continuous abstinence
for 28 days), were enrolled in a large trial to prevent postpartum relapse (Project PANDA)
Recruitment: 6956 (99%) women completed intake screening. 1255 current and recent
smokers received brief intervention in early pregnancy as described by Ershoff 1989.
522/1255 (42%) had transferred care, had fetal demise or abortion, were over 34 weeks’
gestation, or could not be reached. All 269/733 (37%)who reported continuing to smoke
at 28 weeks and were randomised to this study, as data collection and implementation
were adopted as routine procedures, and required no formal written consent (C = 135,
I = 134)
Baseline characteristics: > 61 cigarettes/week before pregnancy: I = 57.9%, C = 43%;
Partner smoking: C = 62.5%, I = 69.6%
Mean age: C = 28.1, I = 28.6; Married: C = 71.1%, I = 65.7%, White: C = 76.3%, I =
81.3%. < high school: C = 11%, I = 9%
Progress+ coding: None.
Interventions Control: All women smoking at intake (< 20 weeks), were provided with MI counselling
(3-5 mins) and a series of 8 motivational self-help books (first given in person and 7
mailed weekly thereafter), based on “stage of change” program as described by Ershoff
1989.
Intervention: The high intensity intervention group (and their partners) then received:
(i) a 20-30 min MI telephone counselling call (conducted by trained counsellors and
nurse health educators),
(ii) a personalised, stages of change based feedback letter,
(iii) a final MI-based telephone call conducted 4-5 days after the feedback letter was sent
The MI counselling calls were adapted from the Motivational Enhancement Therapy
developed for Project MATCH (Miller 1992).
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention
Intensity: Frequency: (C = 6, I = 6), Duration: (C = 1, I = 3).
Intervention provided by dedicated project staff: efficacy study
Outcomes Biochemically validated smoking cessation at 34 weeks’ gestation (late pregnancy*)
Self-reported smoking cessation at 6 weeks, 3 months* and 6 months* postpartum
Movement in “stages of change”. Breastfeeding rates and general health behaviours ob-
tained but not reported
Discussion of provider views.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random number list.
Allocation concealment (selection bias) Unclear risk No details provided.
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Stotts 2002 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 35% attrition for cotinine testing: 175/269
provided cotinine subsample (C = 82, I =
84). 39% attrition for 6 weeks postpartum
follow-up
All women lost to follow-up for coti-
nine validated smoking status at 36/40
were included in this review as continuing
smokers. Analysis includes all randomised
women
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine analysis (cut-off 80 ng/
mL) for a subset of the sample at 34 weeks’
gestation, but womenwithout cotinine val-
idation were included as continuing smok-
ers. Postpartum outcomes self-reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel likely to have
been aware of group allocation, though no
formal consent requested
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Described as “single blind” (cotinine anal-
ysis performed blind)
Incomplete implementation High risk Only 55% of the experimental group re-
ceived the full intervention (32% were
never able to be reached). Implementation
analysis suggested an effect in women who
received full implementation: 43% vs 34%
control group
Equal baseline characteristics in study arms High risk Group differences were found on number
of cigarettes smoked per week at baseline,
but nodifferences in demographic variables
Contamination of control group Low risk Specific counsellors delivered the interven-
tion.
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Stotts 2004
Methods Randomised controlled trial (pilot study) of motivational interviewing intervention to
support women to stop smoking in pregnancy
Study conducted in a university-based, public obstetric/gynaecology clinic (USA). Exact
location and recruitment dates not reported
Participants Inclusion criteria: Pregnant women who reported smoking in the past 7 days who were
at least 16 years of age, fluent in English, less than 28 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: Women attending a university-based, public obstetric/gynaecology clinic.
Unclear how many women were approached or eligible, though author communication
reports challenges with recruitment. 54 women randomised (C = 28, I = 21, from author
communication)
Baseline characteristics: Not reported but discussion describes women as ’socio-eco-
nomically disadvantaged pregnant smokers’
Progress+coding: Low SES.
Interventions Control: Usual care, which in this university-based prenatal clinic included physicians
or nurses acknowledging a pregnant woman’s reported smoking and recommending that
she quit
Intervention: MI intervention over the course of 8 weeks: (i) 1 face-to-face MI ses-
sion; (ii) 3 MI-based telephone counselling calls; and (iii) 1 personalised feedback letter
providing assessment results. MI incorporated specific counselling strategies, including
personalized and objective feedback, to create a supportive, non-confrontational envi-
ronment through which clients can resolve ambivalence and initiate change
Main intervention strategy: Counselling (multiple intervention) compared to usual
care
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 2). Usual care intensity F = 1,
I = 1
2 masters-level counsellors delivered the intervention: Efficacy study
Outcomes Biochemically validated smoking cessation at post-treatment assessment (late preg-
nancy*)
Stages of change, processes of change, self-efficacy, decisional balance, and depression
scores also reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States women ’were randomized’ into an
intervention or usual care condition
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Outcomes reported as percentages. 5
women excluded from the analysis (as per
author communication) for which there
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Stotts 2004 (Continued)
was no data (C = 2, I = 3), so abstinent per-
centages are based on C = 5/28 and I = 3/
21. These women were included as contin-
uing smokers in this review
Selective reporting (reporting bias) Unclear risk Primary outcomes reported, author com-
munication states low recruitment so fo-
cused on other outcomes in this pilot study
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemically validated smoking cessation
with salivary cotinine (cut-off > 20 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Low risk Not reported but author states “ Ini-
tial comparisons of socio-demographic and
smoking history variables revealed no dif-
ferences between the MI and UC groups”
Contamination of control group Low risk Unlikely as intervention delivered by spe-
cific counsellors.
Stotts 2009
Methods 3-armed randomised controlled trial of personalised feedback during ultrasound and
counselling to support women to stop smoking in pregnancy
The study was conducted in Women, Infant and Child (WIC) clinics in Houston and
Harris County Area, University of Texas Houston Medical School obstetric clinics and
the local community (USA). Recruitment years not reported
Participants Inclusion criteria: Pregnant women reporting having smoked a cigarette in the past 7
days; age 16 years and older; English speaking, and gestational age between 16 and 26
weeks (to recruit later-pregnancy continuing smokers who have had the most difficulty
stopping smoking for the pregnancy)
Exclusion criteria: Not further specified.
Recruitment: Via routine prenatal screening and widely distributed advertisements. 4,
258 women were screened. 360/725 (49.6%) of eligible women agreed to participate
and were randomly assigned to 3 conditions: C (BP) = 120, I1 (BP + US) = 120, I2 (MI
+ US) = 120.
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Stotts 2009 (Continued)
Baseline characteristics: Mean number of cigarettes per day: C = 11.72 (8.73), I1 =
11.78 (9.47), I2 = 11.03 (8.14). Partner smoking: C = 68 (68), I1 = 82 (79.6), I2 = 76
(72.4). Baseline cotinine: C = 117, I1 = 116, I2 = 131.
Mean gestational age: C = 23.63, I2 = 22.48, I2 = 21.12; Mean age: 24.65,I1 = 25.45,
I2 = 25.21; Mean years education: C = 11.40, I1 = 11.37, I 2= 11.63; White: C = 65.
22%, I1= 57.02%, I2 = 49.57% (remainder African-American and Hispanic); Income
<$US15,000/yr: C = 49.58%, I1 = 55.85%, I2 = 56.67%.
Progress+ coding: Low SES.
Interventions Control (BP): Best Practice or “BP” counselling based on the Agency for Healthcare
Research Quality practice guidelines for identifying patients who smoke and intervening
for smoking cessation (5A’s and 5R’s). Nurses trained and instructed to keep counselling
to 10-15 minutes. Participants were also given American Cancer Society literature on
prenatal smoking cessation and the toll-free number for the quit smoking hotline
Intervention 1: BP+ Ultrasound feedback sessions lasting approximately 30 minutes .
In addition to providing routine ultrasound results, the ultrasound session was designed
to provide information regarding the effect of cigarette smoke on the fetus using a
motivational style. The sonographers received 2hours of training and a laminated prompt
card. Smoking risk messages were incorporated into discussion
Intervention 2: BP+US+ Motivational Interviewing consisting of 1 45- to 50-min,
face-to-face, individual counselling session conducted immediately after the ultrasound;
1 personalised feedback letter mailed 1 week later; and 1 follow-up counselling session
conducted via telephone 2 weeks subsequent to the initial session, provided by master’s
level counsellors. Elements of the transtheoretical model were included and smoking in
the household and social networks were also addressed
Main intervention strategy: Feedback (multiple intervention) compared to a less in-
tensive intervention
Intensity: Frequency: (C = 2, I = 4), Duration: (C = 1, I = 3).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated smoking cessation at 8 months gestation (late pregnancy*)
’Predictors of abstinence’ including: Stages of change, depression (Beck’s Depression
Inventory), baseline smoking, ethnicity, and social networks reported
Notes Concerns about potential distress with the ultrasounds intervention were considered in
a pilot study of 30 women (Groff 2005) indicated no significant increase in anxiety post-
ultrasound
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A block randomisation method, using
blocks of 6 (2 per condition), was used to
generate 360 slots, 120 per intervention
group
Allocation concealment (selection bias) Unclear risk Not reported.
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Stotts 2009 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition:16/360 (4.4%), C = 6, I1 = 5, I2
= 5 (reasons not reported). Analyses were
conducted using an ITT approach with
all randomised participants included in the
baseline and those lost to follow-up treated
as continued smoking
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported smoking status biochemically
validated using salivary cotinine (< 20 ng/
mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor blinding not reported.
Incomplete implementation Unclear risk Procecss evaluation not reported.
Equal baseline characteristics in study arms Low risk Treatment group differences only for ges-
tational age at baseline
Contamination of control group Low risk Low risk of contamination as counselling
provided by specialist counsellors, not ac-
cessible to the control group
Strecher 2000
Methods Randomised controlled trial of computer generated messages to support women to stop
smoking in pregnancy
Study conducted in 2 university hospitals in North Carolina and Michigan (USA), with
recruitment from December 1996 to December 1997
Participants Inclusion criteria: Women who have “smoked 100 cigarettes in their lifetime and still
smoking” or “had quit since becoming pregnant”
Exclusion criteria: Not further specified.
Recruitment: Unclear how many women screened during first prenatal visit. using a
self-administered computer screening program. 173 women randomised (C = 85, I =
88)
Baseline characteristics: Mean cigarettes per day before pregnancy: C = 18.7, I = 20.3;
current mean cigarettes per day: C = 11.8, I = 12.9; Mean cotinine: C = 2597, I = 2701;
Mean smokers in household: C = 1.1, I = 1.0
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Strecher 2000 (Continued)
Mean age: C = 26.6, I = 25.5; Mean education: C = 12.5, I = 12.5; White: C = 81.2%,
I = 87.4%
Progress+ coding: None.
Interventions Control: Received “a pregnant woman’s guide to quit smoking” at the first visit
Intervention: Entered personal data into a hand-held computer at antenatal visits, which
subsequently generated personalised tailored messages, which were posted to the woman
Main intervention strategy: Health education (single intervention) compared to less
intensive intervention
Intensity: Frequency (C = I, I = 6), Duration (C = 1, I = 2).
Unclear if intervention provided by dedicated project or existing staff as technological
intervention
Outcomes Biochemically validated smoking cessation at 6 weeks postpartum* (0-5 months pp)
Biochemically validated cessation at 24/40 gestation (’mid-term’) and self-reported ces-
sation 3 months postpartum but outcomes not reported
Mean cigarettes per day and cotinine concentrations collected and reported as ’not
significant’ but actual figures not reported
Participant evaluation of using hand-held computers and reactions to computerised
materials
Notes Numbers in paper inconsistent: I = 88, C = 85 in methods section, I = 104, C = 87 in
results section. No justification for change of denominators
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk By computer algorithm.
Allocation concealment (selection bias) Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcome data (C = 87, I = 104) are incon-
sistent with figures reported as randomised
inmethods and baseline data table (C = 85,
I = 88). If comparing outcome data using
ITT and excluding those ’lost to follow-up’
it appears that more than 30% of the con-
trol group (30/87) were lost to follow-up.
In this review we have used the ITT data
(C = 87, I = 104) as the denominator
Selective reporting (reporting bias) High risk Results are conflicting and actual figures for
pregnancy (24/40) are not reported, nor are
figures for mean cigarettes per day or coti-
nine concentrations
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine analysis at 24 weeks’ ges-
tation and at 6 weeks postpartum (cut-off
< 80ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel not blinded to
intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Process evaluation not reported.
Equal baseline characteristics in study arms Low risk Baseline comparisons revealed no signif-
icant differences in age, race, education,
number of cigarettes smoked before preg-
nancy, and baseline stage of change
Contamination of control group Low risk Technological intervention so contamina-
tion unlikely.
Tappin 2000
Methods Randomised controlled trial (pilot study) of home based motivational interviewing to
support women to stop smoking in pregnancy
Study conducted in a Glasgow Hospital, Scotland (UK), with recruitment from March
to May 1997
Participants Inclusion criteria: Women who identified as smokers on a questionnaire at antenatal
clinic booking
Exclusion criteria: Not further specified.
133/393 (34%) women screened identified as smokers and 100/133 (75%) agreed to
participate and were randomised (C =5 0, I = 50)
Baseline characteristics: Mean cigarettes per day pre-pregnancy C = 18.1, I = 19.6;
current mean cigarettes per day C = 13.2, I = 14.8; partner smoking: C = 82%, I = 90%;
Mean cotinine C = 126 ng/mL, I = 136 ng/mL
Mean age: C = 25.9, I = 26.6; 76% ’severely deprived’ participants
Progress+ coding: Low SES.
Interventions Control: Received usual advice from their prenatal providers, which should include
information about smoking
Intervention: Received 2-5 motivational interviewing sessions (mean 2.6 hours), based
on stages of change, in the clients’ home conducted by a midwife with 3 weeks training
in smoking cessation counselling
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 4). Usual care intensity: F =
1, D = 1
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Tappin 2000 (Continued)
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated smoking cessation at >=27/40 (late pregnancy*)
Mean birthweight*, preterm births*, stillbirths*.
Ranking interviews measured movement around the ’cycle of change’
Detailed evaluation of participant and midwifery views of interventions
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomnumbers stratified by deprivation.
Allocation concealment (selection bias) Low risk Group allocation by telephone.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Low attrition (2%). Some missing data for
cotinine validation. Smoking outcome re-
sults reported for all of those randomised,
and those with missing data counted as
continuing smokers in this review
Selective reporting (reporting bias) Low risk Detailed outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Serum cotinine levels measured.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Good process evaluation of implemen-
tation quality according to rating tool,
showed 79% of women in the intervention
group received at least 2 counselling ses-
sions
Equal baseline characteristics in study arms Low risk No apparent difference.
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Contamination of control group Low risk Specific counsellors provided intervention
at home so contamination unlikely. Less
than 20% of the control group recalled be-
ing given smoking information at the time
of booking
Tappin 2005
Methods Randomised controlled trial of home-based counselling to support women to stop smok-
ing in pregnancy
Study conducted in 2 hospitals inGlasgow, Scotland (UK), with recruitment fromMarch
2001 to May 2003
Participants Inclusion criteria: Women reporting smoking at prenatal booking visit and less than or
equal to 24 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: 762/1684 (45%) eligible women agreed to participate (C = 411, I = 351)
Baseline characteristics: Current mean cigarettes per day: C = 11.3, I = 11.7; At least
1 other smoker in house: C = 66%, I = 65%
Mean age: C = 26.9, I = 26.5; Most deprived social category (6-7): C = 73%, I = 69%
Progress+ coding: Low SES.
Interventions Control:Midwives provided standardhealth promotion including informationon smok-
ing in pregnancy from a book given to all women in pregnancy in Scotland
Intervention: Women also were offered 2-5 additional home visits of about 30 minutes
duration from the same study midwife
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 4). Usual care intensity: F =
1, D = 1
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated and self-reported quitting soon after the routine 36 week ante-
natal visit (late pregnancy*), reduction (mean cotinine*, self-reported*, and biochemi-
cally validated, which was at least half baseline measurement*), and increased smoking,
mean birthweight*, preterm delivery*, very low birthweight*, low birthweight*, neonatal
death*, stillbirths*, and admission to NICU*
Data collected on other adverse events including antenatal admissions, miscarriage, ter-
mination of pregnancy, and assisted delivery
Discussion of participant and provider views of intervention and thorough process eval-
uation showed good implementation
Notes Sample size calculated by recruitment to achieve sufficient power not able to be achieved
Risk of bias
Bias Authors’ judgement Support for judgement
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Tappin 2005 (Continued)
Random sequence generation (selection
bias)
Low risk Stratified central randomisation.
Allocation concealment (selection bias) Low risk Group allocation provided by central ad-
ministrator.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 29/762 (4%)women lost to follow-up: fetal
loss = 6 (C = 2, I = 4) were excluded from
this analysis; no late interview or cotinine
= 10 (C = 5, I = 5), Not traceable 12 (C
= 7, I = 5). Some missing data for cotinine
validation
All randomised participants (except fetal
losses) included in smoking outcomes, and
those with missing data counted as contin-
uing smokers
Selective reporting (reporting bias) Low risk Detailed outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Serum cotinine (cut-off <13.7 ng/mL) or
salivary cotinine (cut-off < 14.2 ng/mL)
used to validate self-reported abstinence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Midwife intervention, with caregivers not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk ’A second administrator, blind to the ran-
dom allocation, established a primary out-
come’
Incomplete implementation High risk 26% of women did not have any home vis-
its.
Equal baseline characteristics in study arms Low risk No apparent major difference noted.
Contamination of control group Low risk Research midwives provided the interven-
tion.
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Methods Randomised controlled trial of counselling intervention to support women to stop smok-
ing and prevent relapse in pregnancy
Study conducted in a large public antenatal clinic, in Rotunda Ireland, with recruitment
during 3 months in 1995
Participants Inclusion criteria: Women who ’currently smoke’ or had spontaneously quit since be-
coming pregnant
Exclusion criteria: Non-viable pregnancy identified at first visit or intending to deliver
at another hospital
Recruitment: 967/524 (54%) women attending the public clinic were smokers. 418/
518 (81%) eligible women agreed to participate and were randomised (C = 209, I = 209)
Baseline characteristics:Current smoker: C = 192, I = 203; Spontaneous quitter: C =
17, I = 6; 34% smoked more than 20 cigarettes per day currently; Partner smoking: C
= 74%, I = 69.9%
< 21 years age C = 17%, I = 24%; Mean gestation at first visit I = 15.5, C = 15.3; Not
living with partner C = 39.2%, I = 42.6%; age finished education C = 16.1, I = 16.0;
Lower social class C = 71.5%, I = 70.9%
Progress+ coding: Low SES.
Interventions Control: Routine prenatal advice on a range of health issues, from midwives and obste-
tricians
Intervention: As for the control group + (i) structured 1 to 1 counselling by a trained
facilitator (based on stages of change theory); (ii) partners invited to be involved in the
program; (iii) an information pack (developed in collaboration with a focus group of
women), which included a self-help booklet; (iv) and invited to join a stop smoking
support group. A CO monitor was available for the intervention group, to quantify
smoking habit and act as a motivational tool
Main intervention strategy: Counselling (tailored) compared to usual care.
Intensity: Frequency: (C = 0, I = 5); Duration (C = 0, I = 2). Usual care intensity: F =
1, D = 1
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated smoking cessation* and relapse prevention* at delivery (late
pregnancy) and 3months postpartum among baseline smokers* and spontaneous quitter.
Mean cigarettes per day at delivery*, reduction in daily cigarettes since first visit, quit
attempts, comparisons of quitters and non quitters at various stages.
Infant outcomes at birth (singleton births): mean birthweight*, proportion LBW (2500
g)*, preterm births*, stillbirths*, neonatal deaths*, NICU admissions*, delivery type,
mean gestation
Infant outcomes at 3months postpartum: neonatal deaths, attendance at GP; attendance
or admission to hospital
Notes Detailed process analysis and participant feedback of program implementation
Risk of bias
Bias Authors’ judgement Support for judgement
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Thornton 1997 (Continued)
Random sequence generation (selection
bias)
Unclear risk Random number tables with restricted ran-
domisation in groups of 10
Allocation concealment (selection bias) Low risk Sealed opaque envelopes.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 31/418 (7%) attrition at delivery (I = 13/
209 or 6.2%, C 18/209 or = 8.6%). Mis-
carriage (7), delivered elsewhere (3), moved
overseas (2), changed care provider (7) or
never returned to Rotunda hospital after
first visit (12), and were excluded from this
analysis
All other women lost to follow-up counted
as continuing smokers in this review
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Exhaled CO measurement on 145/209
womenonpostnatal ward (cut-off < 4ppm)
. Presume smoking outcomes reported are
those biochemically validated although this
is not explicitly stated
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and study
personnel to counselling intervention. In-
tervention provided by trained facilitator,
with staff unaware of allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Detailed process evaluation describes how
women rarely initiated contact at subse-
quent visits and the groups sessions were
poorly attended
Equal baseline characteristics in study arms High risk Intervention group were less likely to have
spontaneously quit, or be employed
Contamination of control group Low risk Research facilitator provided intervention.
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Tsoh 2010
Methods Randomised controlled trial of a computer-delivered brief intervention ’Video Doctor’
to support women to stop smoking in pregnancy
Study conducted as part of ’Health in Pregnancy’ study in 5 community prenatal clinics
in San Francisco Bay Area (USA), with recruitment from 2006 to December 2007
Participants Inclusion criteria: Pregnant women ’smoking in the past 30 days’ who were English-
speaking, 18 years or older, and less than 26 weeks pregnant
Exclusion criteria: Not further specified.
Recruitment: 1208 women were screened for eligibility in the prenatal clinic waiting
rooms and 114 refused (91% participation in screening). 42/410 (10%) eligible women
identified as smokers on a risk assessment using a laptop computer via a low-literacy
computerised interview with audio voiceover, and were randomised (C = 19, I = 23)
Baseline characteristics: Current mean cigarettes per day I = 6.8, C = 6.7.
Mean age C = 26.8, I = 27.5; White C = 31.6%, I = 17.4% (remaining Hispanic, Back
or ’other’); Less than high school C = 21.1%, I = 26.1%; Married C = 26.3%, I = 47.
8%
Progress+ coding: None.
Interventions Control: Received the clinic’s usual care and did not interact with the ’Video Doctor’
program. All participants received a gift card ($30-$50) for completing assessments
Intervention: Participants received tailored advice from ’Video Doctor’, a multimedia
interactive intervention delivered on a laptop computer via a secure Internet connection.
An actor-portrayed Video Doctor delivered interactive
risk-reduction messages designed to simulate an ideal discussion with a prenatal health
care provider who provided non-judgmental counselling following several key principles
ofmotivational interviewing. At the conclusion of each intervention session, the program
automatically printed 2 documents: (a) a cueing sheet for providers, which offered a
summary of the patient’s risk profile and suggested risk-reduction counselling statements;
and (b) an educational worksheet for participants with questions for self-reflection, harm
reduction tips, and local resources. The cueing sheet was placed in the patient’s medical
record for the provider’s use during the prenatal appointment
Main intervention strategy: Counselling (multiple intervention) compared to usual
care
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). Usual care intensity: F = 0,
D = 0
Technological intervention which prompted usual care providers: Effectiveness study
Outcomes Self-reported 30-day abstinence after 1 month and 2 months (late pregnancy*). Mean
reduction in cigarettes smoked per day and days smoked
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Women reporting risks were stratified by
risk combination and randomly assigned
by the computer to intervention or usual
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care groups
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: I = 5/23 (22%), C = 5/19 (26%)
at 1-month follow-up and I = 9/23 (39%)
, C = 13/19 (32%) at 2-month follow-up
(reasons not reported)
All randomised participants included in
analysis and women lost to follow-up
treated as continuing smokers in this review
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking cessation outcomes
only - no biochemical validation of smok-
ing status
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel as intervention includes counselling
component
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessor not reported.
Incomplete implementation Low risk Only 3 women in the usual care group did
not recall receiving provider advice
Equal baseline characteristics in study arms Low risk Similar baseline characteristics.
Contamination of control group Unclear risk Some risk of contamination between study
arms as same provider delivering coun-
selling to intervention and control groups.
Process evaluation showed77.8% interven-
tion group received 2 provider advice ses-
sions, compared to 21.4% control group
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Tuten 2012
Methods 3-armed randomised controlled trial of contingent incentives to support women to stop
smoking in pregnancy
Study conducted in the Center for Addiction and Pregnancy Treatment, at the Johns
Hopkins Bayview Medical Center, Baltimore (USA), with recruitment from May 2005
to January 2009
Participants Inclusion criteria: Requiring methadone during pregnancy, nicotine dependent or
smoking 10 or more cigarettes daily, aged 18 years or older, <= 30 weeks’ gestation, and
capable of providing informed consent
Exclusion criteria: Nicotine replacement therapy.
Recruitment: 1072/1181 women screened smoked (90.7%). 125/1072 were eligible,
and 102/125 (82%) agreed to participate, and were randomised to 3 conditions (C =
32, I1 (non-contingent incentives) = 28, I2 (contingent incentives) = 42).
Baseline characteristics: Current mean cigarettes per day = 18.0.
Mean age 30.8 years; 65% Caucasian; 11.1 mean years education; 85.3% currently
single. 94.7% unemployed
Progress+ coding: Low SES.
Interventions Control: As part of usual care, inpatients at the centre are provided with specific infor-
mation about the adverse effects associated with cigarette smoking for the mother and
the infant. In addition, patients are provided with educational materials about risks of
smoking during pregnancy. During follow-up obstetric appointments, patients are asked
routinely about their cigarette smoking and commended on efforts to abstain. TAU par-
ticipants were informed that they would be compensated for providing urine and breath
samples, but that they would not earn incentives as part of their study participation
Intervention 1 (non-contingent incentives): Participants were informed that they had
the chance to earn vouchers, but whether they earned a voucher and the amount they
earned was determined by an already generated schedule and thus was not linked to their
own cigarette smoking. NCBI participants were required to leave CO and urine samples
to receive any voucher earnings generated by the ’yoked’ schedule, for 12 weeks or until
delivery
Intervention 2 (contingent incentives): Incentives contingent upon cigarette smoking
reduction or abstinence for a period of 12 weeks or until delivery. Smoking targets
were minimal during the initial weeks of intervention, and increased gradually to ensure
adequate learning and reinforcement. Incentives could be earned for each sample left
on Monday, Wednesday and Friday (3 samples per week) if the following reduction and
abstinence targets were met: week 1: any reduction; weeks 2-4: 10% reduction; weeks
5-7: 25% reduction; weeks 8-9: 50% reduction; week 10-11: 75% reduction; and week
12 until delivery: abstinence (CO < 4 ppm.). Participants had the opportunity to earn
a $7.50 voucher for the first smoking reduction target, and the value of the voucher
increased by $1/day for each consecutive target met throughout the 12-week incentive
period to amaximumof $41.50. If a contingent participant failed tomeet the tobacco use
reduction target during the 12-week incentive period, she earned $0 for that sample and
the incentive schedule was reset to the original voucher value of $7.50. If the participant
again met the target reduction on 5 consecutive occasions, she earned vouchers at the
previously attained level
Main intervention strategy: Incentives (single intervention) compared to usual care.
Contingent incentives compared to usual care in this review
Intensity: Frequency: (C = 0, I = 6), Duration (C = 0, I = 5). Usual care intensity: F =
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3, D = 2
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated point prevalence abstinence after 12 weeks of intervention
(late pregnancy*); 75% cotinine reduction (> 50% reduction*); mean cotinine*; mean
cigarettes per day 1 and three months post intervention* and 6 weeks postpartum
Mean birthweight*, preterm births*, low birthweight*, NICU admissions*
Spontaneous abortion, length of hospital stay, mean gestational age at delivery, mean 1-
and 5-minute Apgars, urine toxicology and treatment for NAS
Comparisons with non-contingent incentives (arm 2) are also reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States patients were ’randomly assigned’ to
1 of 3 conditions
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk 33% attrition (34/102) for pregnancy and
birth outcomes and no explanation as to
reasons for missing data. Unclear whether
all women randomisedwere included in the
outcome assessment, as percentage results
only are reported. Assume all persons not
meeting ’nonsmoking targets’ (p1872) are
counted as continuing smokers
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported,
except smoking outcomes postpartum
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk CO sampling to evaluate changes during
in-patient treatment phase and urine coti-
nine (cut-off 200 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to incentives intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessment was
blinded.
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Incomplete implementation Low risk This was a well accepted intervention with
high rates of participation among all 3 con-
ditions
Equal baseline characteristics in study arms Low risk The conditions did not differ significantly
on demographic, pre-treatment or baseline
cigarette smoking measures
Contamination of control group Low risk Unlikely given the design of the study.
Valbo 1994
Methods Randomised controlled trial of ultrasound feedback and cognitive-behavioural modifi-
cation, to support women to stop smoking in pregnancy
Study conducted in the National University Hospital, Oslo, Norway (Europe), with
recruitment from June 1990 to October 1991
Participants Inclusion criteria: Pregnant women attending antenatal clinic for 18 weeks for ultra-
sound, and still smoking 10 cigarettes per day or more (heavy smokers)
Exclusion criteria: Not further specified.
Recruitment: Not stated how many women approached or eligible (1800 births/year,
study over 15 months). 112 women randomised (C = 56, I = 56)
Baseline characteristics: Mean cigarettes per day at 18 weeks’ gestation: C = 14.8, I =
12.5. Smoking partner: C = 80%, I = 74%
Mean age: C = 28.4, I = 20.2.
Progress+ coding: None.
Interventions Control: Routine 18-week ultrasound and information on the negative effects of smok-
ing and encouragement to quit, reinforced by a pamphlet, provided at the time of the
ultrasound examination.
Intervention: At the time of the 18 week ultrasound scan, offered the Windsor self-
help manual (translated into Norwegian) describing a 10-day program which includes
relapse prevention. During ultrasound (by midwife and obstetrician) women were given
information about the negative effects of smoking. 2 weeks later women were sent
an encouraging reminder and an appointment for an additional 32-week scan by an
obstetrician, in which women were further encouraged to quit. A second reminder was
sent 2 weeks later
Main intervention strategy: Feedback (multiple intervention) compared to usual care.
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). Usual care intensity: F = 1,
D = 1
Intervention provided by existing staff: Effectiveness study
Outcomes Self-reported abstinence at delivery (late pregnancy*); self-reported reduction in smoking
at birth* mean cigarettes per day at birth*. Stillbirths* reported in attrition and re-
included in both numerator and denominator for this outcome
Notes Process evaluation suggested that the acceptance of the manual was low (mean score 2.
6 on 7 point scale) and that it was staff involvement which had the most impact
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “consecutively randomised”.
Allocation concealment (selection bias) High risk Women consecutively randomised into 2
groups.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: one stillbirth in intervention arm
excluded from analysis. 7 women who did
not returnquestionnaires (C=6, I = 1)were
not included in the study report but have
been re-included as continuing smokers in
this review (C = 56, I = 55)
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and
providers to educational intervention and
ultrasound. Although it is unclear if con-
sent was sought so participants may have
been blind
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk No process evaluation reported but assume
most women received manual and ultra-
sounds
Equal baseline characteristics in study arms Unclear risk Intervention group had significantly higher
daily smoking on entry
Contamination of control group High risk Usual care providers offering intervention
and control components
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Methods Randomised controlled trial of hypnosis to support women to stop smoking during
pregnancy
Study conducted in Buskerud Central Hospital in Oslo, Norway (Europe), with recruit-
ment from January 1992 to June 1993
Participants Inclusion criteria: Women still smoking at 18 week ultrasound visit.
Exclusion criteria: Not further specified.
Recruitment: Expected numbers of pregnant smokers were 630. 158 (25%) agreed to
participate and were randomised (78, I = 80)
Baseline characteristics: Mean cigarettes/day prior to pregnancy I = 15.6, C = 15.0;
Mean cigarettes per day at 18 weeks’ gestation C = 9.7, I = 11.3; Partner smoking C =
73%, I = 71%
Mean age C = 26.5, I = 27.9.
Progress+ coding: None.
Interventions Control: “Routine pregnancy health care”.
Intervention: Anaesthesiologist provided 2 x 45 minute sessions at 2 week interval of
a protocol-based script (Handbook of the American Society of Clinical Hypnosis); the
tape played after hypnosis was established emphasised the unpleasant effects of smoking,
affirmed her wish to quit, encouraged her will and capacity to quit, and instructed her
in meeting cravings with relaxation techniques and self-hypnosis, explained during the
session. Second visit tape was different with more weight on her capacity and taking
control. Both tapes avoided “moralizing about her responsibility for pregnancy outcome”
Main intervention strategy: Counselling (single intervention) compared to usual care.
Intensity: Frequency (C = 0, I = 4); Duration (C = 0, I = 3). Usual care intensity: F = 0,
D = 0
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported abstinence at birth (late pregnancy*), mean cigarettes per day at birth*,
Self-reported reduction in smoking*
(The SD used in the analysis in this review was calculated from a P value = 0.2 given in
the paper) and increase at end of pregnancy,
Perinatal deaths*.
Notes Process evaluation did not rate the intervention highly: mean score of 2.05/7
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The numbers from 1 to 100 were set up
in random order, and by drawing lot, the
women willing to participate were ran-
domised into the intervention or control
group
Allocation concealment (selection bias) Unclear risk Women allocated to groups by drawing lots
(it was not clear when this took place)
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Of 80 allocated to intervention 13 did not
receive an appointment in time, and 15
did not attend, and were excluded from the
analysis
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Unclear risk Not other bias’ detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Psychological intervention, authors state
that usual caregivers were not aware of
group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 28/80 women randomised did not receive
the intervention
Equal baseline characteristics in study arms High risk Significantly more smokers in intervention
group at entry.
Contamination of control group Low risk Dedicated hypnotist provided interven-
tion.
Vilches 2009
Methods 4-armed cluster-randomised controlled trial of counselling interventions to support
women to stop smoking in pregnancy
Study conducted in primary health care clinics in Malaga, southern Spain, with data
collection from 2001-2003
Participants Inclusion criteria: 12/23 community clinics selected to balance neighbourhood SES
(low, medium, and high). Women included if less than 15 weeks’ gestation and smoked
at least 1 cigarette since knowing they were pregnant
Exclusion criteria: not further specified.
Recruitment: 12 clinics ’randomly selected’, stratified by SES status of neighbourhood.
3 randomly allocated to each study arm, based on SES status (3 levels, low, medium,
high: so 1 level each study arm). Clinics balanced across study arms
Women identified in 1999 in a preconceptual program (2,932 women screened in 23
clinics-38% were smokers). 719 eligible smokers from the 12 clinics were invited, of
whom 455 agreed to participate (63% participation). 132 women spontaneously quit
smoking after baseline and 27 had a spontaneous abortion; both were excluded from the
study. 296 women were randomised (C = 54, I1 = 71, I2 = 47, I3 = 124).
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Baseline characteristics: Mean cigarettes per day before becoming pregnant 20.6 (9.
58); Fagerstrom score: 4.78 (SD 5.38)
97.7% married. Education: 4% did not complete junior high school, 45% completed
junior level only (9 years), 33% 12 years school, 17% university level. SES: 4.8% high,
24.6% medium/high, 53.4% medium/low, 17.1% low SES
Progress+ coding: None.
Interventions Control: Usual care.
All 3 interventions were based on CBT, adapted to pregnant women taking into account
factors important to women for smoking and quitting, but differ in intensity (frequency
and duration).
Intervention 1 (low intensity): 1 session 30 minutes by midwives who were trained
in smoking cessation psychosocial education, provided with audiovisual materials and
gave women a pamphlet. Delivered in 2nd trimester, usually before week 24. Included
smokers and those who had spontaneously quit. Able to invite companions or people
involved in pregnancy to session. Session covered basic smoking risks and benefits of
quitting, motivational therapy and CBT for self-control to quit smoking, self-monitor-
ing, developing alternative behaviours, stimulus control, setting a quit date and how to
obtain social support.
Intervention 2 (medium intensity): I1+ additional 3 group sessions x 90 mins over 4
weeks in 3rd trimester (weekly and then after 15 days) in clinic. Provided by midwife
with additional training. Reviewed homework, introduced topic of day, set objectives
and activity to complete before the following week. Recommended that by second week
they abstain from tobacco. Only pregnant women invited to groups (6-10 women in
each group), no partners. Audiovisual materials and self help guide to support sessions.
Intervention 3 (high intensity): I1+5 x 90 mins weekly group sessions in 3rd trimester
provided by clinical psychologist. Midwife present in sessions. Reviewed homework,
set objectives and goals etc (similar to I2), counselled to quit smoking on 4th week of
program. Used audiovisual equipment. CO monitoring and feedback provided in 2nd
session with motivational interviewing. Included relapse prevention. Companions not
included in group sessions
Main intervention strategy: Counselling (multiple intervention) compared to usual
care. Intervention 3 (high intensity) and control (usual care) compared in this review
Intensity: Frequency (C = 0, I = 6); Duration (C = 0, I = 5). Usual care intensity: F = 0,
D = 0
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported mean cigarettes per day in late pregnancy*; Mean exhaled CO; Mean
birthweight*
Biochemically validated point prevalence abstinence rates not reported. Breastfeeding
rates at 8 weeks postpartum reported
Notes Report in Spanish.
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk Clinics described as ’randomly assigned’.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 455 consented and 132 excluded as they
spontaneously quit smoking, and further
27 excluded due to spontaneous abortion.
Substantial attrition in this study (92% in
I3): 296 randomised, 204 started interven-
tion and 142 completed intervention and
used in the analysis. Not able to be re-in-
cluded as mean outcomes only reported (e.
g. mean cigs/day, mean CO).
Randomised : C = 54, I1 = 71,I2 = 47, I3
= 124.
Started intervention: C = 54,I1 = 71, I2 =
12, I3 = 67
Completed intervention and analysed: C =
54, I1 = 71, I2 = 8, I3 = 9.
Selective reporting (reporting bias) High risk Biochemically validated smoking cessation
rates, proportion of preterm births, and
stages of change outcomes stated as primary
and secondary outcomes and not reported
Other bias High risk Tried to balance women across study arms
and clinics (40 per arm per clinic) but were
unable to achieve this
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Exhaled CO validation measured but bio-
chemically confirmed smoking cessation
rates not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk States clinics were not aware of allocation.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessors blinded.
Incomplete implementation Unclear risk Only 8% completed the high and medium
intensity interventions (group sessions)
Equal baseline characteristics in study arms Unclear risk Baseline characteristics not reported by in-
dividual study arm
241Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Vilches 2009 (Continued)
Contamination of control group Unclear risk Cluster-randomised trial design minimises
risk of contamination
Walsh 1997
Methods Randomised controlled trial of a counselling intervention to support women to stop
smoking in pregnancy
Study conducted in a public hospital antenatal clinic inNewcastle, Australia, with screen-
ing from January 1990 to May 1991
Participants Inclusion criteria: Pregnant women attending their first antenatal clinic appointment
who answered yes to ’Are you a smoker?”, were less than 26 weeks’ gestation, ill or
psychologically unwell
Exclusion criteria: Not further specified.
Recruitment: 1,909 pregnant women were screened by midwives, 725 smokers (38%).
293/538 (54%) eligible women agreed to participate and were randomised (C = 145, I
= 148)
Baseline characteristics: Not reported.
Progress+ coding: None
Interventions Control: Doctor and midwife both informed women that smoking was an important
cause of pregnancy problems and they should stop; Midwife provided a package (sticker,
pamphlet on risks of smoking and2-page cessation guide), none ofwhichwere specifically
tailored to pregnant women.
Intervention (CBT): (i) 2-3 minute standardised risk information from Doctor.
(ii) 14 minute video on risk information rebuttal of barriers to quitting, cessation tips
and 10-minute standardised information
(iii) Counselling from midwife after the video, using a flip chart, with negotiation of a
quit date whenever possible
(iv) Self-helpmanual on risks, barriers and cessation plus 4 packets of confectionary gum
(v) Lottery chance (4 prizes) for biochemically validated abstainers at the next visit
(vi) Social support from accompanying adult (partner/friend/other) via support tip sheet,
contract and form letter, chart, reminder sticker in the medical record, form-letter and
sticker from 1st visit Midwife mailed within 10 days + 2nd visit and 34 to 36 week visit
5 minute counselling from Midwife and 1-2 minute risk advice from Doctor. Women
still smoking at 34-36 weeks were advised to attend an external cessation course
Main intervention strategy: Counselling (tailored) compared to a less intensive inter-
vention
Intensity: Frequency (C = 2, I = 3); Duration (C = 1, I = 2).
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated point prevalence abstinence at 34 weeks’ gestation (late preg-
nancy*) and 6-12 weeks’ postpartum*. Preterm births* are reported in attrition and re-
included in both numerator and denominator for this outcome
Program costs and time commitments.
Discussion of provider views and implementation issues in associated reference (Walsh
2000).
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Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Low risk Described as “precoded questionnaires in
manila envelopes”.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 14% due to: Leaving clinic (C =
7, I = 7), miscarriage or termination (C =
10, I = 10), and preterm birth (C = 3, I = 4)
, leaving 252 included in analysis (C = 125,
I = 127)
25% lost to follow-up and further missing
data for some variables including cotinine
validation, however thosewithmissingdata
were treated as continuing smokers in the
analysis
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine was measured and
revealed discrepancy with self-reported
smoking status. biochemically validated
with salivary cotinine (I = 86%, C = 78%)
Cotinine data inconsistent with self-report
were 52% in controls and 12% in the in-
tervention group
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention by usual care
providers and notes flagged
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Midwives involved in recruitment to the
trial had variable ’success’ in consent rates
(9%-76%). Overall participation was quite
low (54%)
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Equal baseline characteristics in study arms Low risk Report states baseline characteristics were
equal on 12 variables tested
Contamination of control group Unclear risk Same care providers for both groups.
Windsor 1985
Methods 3-armed randomised trial controlled trial (SCRIPT trial I) of interventions to support
women to stop smoking in pregnancy
Study conducted in public health clinics in Birmingham, Alabama (USA), fromOctober
1983 to September 1984
Participants Inclusion criteria: Pregnant women presenting for their first prenatal visit who reported
smoking at least 1 cigarette in the last 7 days
Exclusion criteria: >= 32 weeks’ gestation.
Recruitment: 460/1838 (25%) pregnant women screened were current smokers. 368/
460 (80%) agreed to participate. Unclear exactly how many randomised to each group
as attrition not reported by study arm
Baseline characteristics: No baseline data on cigarettes/day.
Mean age: 23.6; Black: 57%; Mean years education 11.5.
Progress+ coding: Low SES as attending public clinics.
Interventions Control: Smoking cessation advice routinely given at prenatal visits: 2-3 minutes within
a group prenatal education session at the 1st visit, whenmaternity clinic staff recommend
quitting.
Intervention 1:10 minute standardised counselling session from a health educator (B
Comm H Ed) + ALA “Freedom from smoking” (ALA) manual (17 day self-directed
plan for quitting) + “Because you love your baby” pamphlet on the dangers and risk of
smoking and the benefits of quitting.
Intervention 2: as for I1 except that the manual was “A pregnant woman’s self-help
guide to quit smoking” (instead of the ALA manual)
Main intervention strategy: Counselling (multiple intervention) compared to usual
care. Control and Intervention 2 compared in this review
Intensity: Frequency: (C = 0, I = 1); Duration: (C = 0, I = 1). Usual care intensity: F =
1, D = 1
Intervention provided by dedicated study staff (health educators): Efficacy study
Outcomes Biochemically validated point prevalence abstinence at mid-pregnancy, and during last
month of pregnancy or within 48 hours of birth (late pregnancy*); and number of women
who self-reported reduction in smoking in late pregnancy*
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 29/338 (9%) due to: leaving sys-
tem or moved (9), miscarriage or termina-
tion (10), and 10 who went to poorly at-
tended group discussions (this intervention
abandoned), leaving 309 included in anal-
ysis (C = 104, I1 = 103, I2 = 102). All
other women lost to follow-up were treated
as continuing smokers
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking cessation using salivary thiocynate
<100 ug/mL
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Educational intervention by health educa-
tors in antenatal clinics. Participants un-
likely to be blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk “Multiple attempts were made to bring
pregnant smokers together for a peer-led,
focused group discussion: not feasible in
this setting”.
Pre-trial assessment showed no nurses (n =
80) had smoking cessation training and less
than 20% felt confident to advise women
on how to stop
Equal baseline characteristics in study arms Low risk Characteristics in study arms appear equal.
Contamination of control group Low risk Administered by trained health educators,
not involved in pregnancy care
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Methods Randomised controlled trial (SCRIPT trial II) of a cognitive behaviour therapy inter-
vention to support women to stop smoking in pregnancy
Study conducted in 4 public maternity clinics of the Jefferson County Health De-
partment in Birmingham, Alabama (USA), with recruitment from September 1987 to
November 1989
Participants Inclusion criteria: Pregnant women who self-reported smoking during the first prenatal
visit ’at least one puff of one cigarette in the last 7 days’
Exclusion criteria: >= 32 weeks’ gestation, did not stay for visit or did not return,
prisoners, or had difficulty reading the baseline questionnaire
Recruitment: 1171/4352 (27%) of women screened at first prenatal visit were current
smokers and 210 (3%) spontaneous quitters (who were included in a separate trial: Lowe
1997). 994/1061 (94%) eligible women agreed to participate and were randomised (C
= 501, I = 493)
Baseline characteristics: Mean cotinine 114 ng/mL. 45% had low cotinine levels (< 99
ng/mL)
Mean age = 24.6 years; Mean education = 12.4 years; Black = 52%
Progress+ coding: Low SES in this review as attending public maternity clinic
Interventions Control: 2-minute talk on smoking in 30 minute group session at first antenatal visit
in which women were urged to quit and given 2 pamphlets: “Smoking and the two of
you”’+ “Where to find help if you want to stop” including the name, contact phone
number and cost of their local program.
Intervention: Based on cognitive behaviour therapy:
(i) 15-minute standardised cessation skills and risk counselling session from trained
female health education counsellor + 7-day self-directed cessation guide on how to quit
written at 6th Grade level
(ii) Clinic reinforcement (chart sticker) + letter from Doctor within 7 days
(iii) Social support in form of a ’buddy’ letter, contract and buddy tip sheet + monthly
newsletter with testimonials, cessation tips and additional information on risks
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 1, I = 4), Duration: (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated point prevalence abstinence at 4-8 weeks after first visit (mid-
point), 32 weeks’ gestation (late pregnancy*). “Significant” reduction* if cotinine at least
50% value of baseline cotinine*
Cost estimates.
Separate trial reports data on spontaneous quitters (Lowe 1997).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
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Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 180/994 (18%) due withdrawal
from the service,miscarriage or abortion (C
= 87, I = 93) were not included in analysis,
leaving C = 414, I = 400
Further 15% lost to follow-up survey or
cotinine analysis included as continuing
smokers in this review
Selective reporting (reporting bias) Unclear risk Data on gestation and birthweight were
collected but the published analysis is by
stopping smoking and the timing of cessa-
tion rather than by allocation, so not in-
cluded in outcome tables
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of smoking status
using salivary cotinine (cut-off >= 30 ng/
mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Notes flagged. Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showed 100% imple-
mentation of counselling and social sup-
port, and 88% for re-inforecement at sub-
sequent visits
Equal baseline characteristics in study arms Low risk NS difference in baseline cotinine.
Contamination of control group Low risk Trained counsellor, not pregnancy care
provider, delivered the intervention
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Windsor 2011
Methods Randomised controlled trial (SCRIPT Trial III) of counselling intervention provided by
routine care staff (effectiveness study) to support women to stop smoking in pregnancy
Study conducted in 16 /67 counties providing Medicaid care in Birmingham, Alabama
(USA). Counties matched by number of smokers and percentage Black and White
women, and 1 county per dyad (n=8) randomly selected to participate in study. There
were 10 prenatal care clinics and 28 regular staff members in the 8 counties selected.
Recruitment dates not reported, but study conducted over 5 years
Participants Inclusion criteria: Pregnant women who reported ≥1 cigarette (’even one puff ’) in the
last 7 days, or had a cotinine level ≥20 ng/mL
Exclusion criteria: Not further specified.
Recruitment: 6,514 women were screened at first antenatal visit and 1340/1736 (77%)
eligible smokers agreed to participate. 1 trial site dropped out leaving 1,093 who were
randomised (C=546, I=547)
Baseline characteristics: Cigarettes per day: C= 9.8 (&10.3 among drop-outs), I=10.
4 (&12.0 among dropouts); Lives with smoker: C=69.8 (&75.3% among dropouts), I=
73.7 (&66% among dropouts). Mean cotinine: C=163, I=181
Mean age: 22 years; Black C=15.7%, I=15.4%.
Progress+ coding: Low SES as Medicaid clinics.
Interventions Staff orientation and assessment, and 3 hours SCRIPT training for staff in intervention
sites
Control: All participants received 4 elements of the “5A’s” best practice guidelines (Ask-
Advise-Remind)
Intervention: Participants received (Assist) Procedures 4 through 8:
(i) A 14 minute ’Commit to Quit Smoking During and After Pregnancy’ video
(ii) A ’Pregnant Woman’s Guide to Quit Smoking’ written at 6th grade reading level and
includes a 10 day self-help guide for cessation (Windsor 1985), and
(iii) A ≤10-minute counselling session (MI)
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C=2, I=2), Duration (C=1, I=2).
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated point prevalence abstinence in late pregnancy* (>60 days after
first visit, and <90 days postpartum)
Number with a “significant reduction” in cotinine* (>50ng/mL at baseline and <50% at
follow up, quitters not included as significant reducers)
An additional ’historical’ control group also provides comparison pre and post interven-
tion
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as ’randomly selected’ counties.
Then “Smokers were randomly assigned at
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Windsor 2011 (Continued)
each clinic to an experimental group or
control group after screening, consent, and
baseline assessment”
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: C=97/546 (17%) and I=95/547
(17%). Reasons for drop-out not reported.
An intent-to-treat policy was used in the
computation of impact rates and all drop-
outs included as continuing smokers in this
review
Selective reporting (reporting bias) Unclear risk Unclear if there was 1 or 2 assessments (i.
e. 1 assessment between >60 days after first
visit and <90 days post partum; or 2 ’assess-
ments performed >60 days after first visit,
and <90 days postpartum’). Only 1 assess-
ment reported.
Other bias High risk Figures inTable 1 (baseline, C=546, I=547)
conflict with the outcome denominator in
Table 2, which is reported to include those
lost to followup (C=549, I=544). Figures
reported in Table 1 used for denominator
and Table 2 for numerator in this report
Biochemical validation of smoking absti-
nence (detection bias)
High risk 72% self-reported quitters validated with
biochemical verification (salivary cotinine
<20ng/mL). 10% non-disclosure of smok-
ing detected
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel not blinded to
counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showed reasonable im-
plementation (over 80%)
Equal baseline characteristics in study arms Unclear risk Equal on all variables apart from mean co-
tinine (ng/mL)
Contamination of control group High risk Process evaluation suggests there was sig-
nificant contamination of the randomised
control group with regular clinic staff pro-
249Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Windsor 2011 (Continued)
viding the intervention to both study arms
AFP: alpha fetoprotein
ALA: American lung association
AN: antenatal
BP: blood pressure
C: control group
CBT: cognitive behavioural therapy
CI: Confidence interval
CO: carbon monoxide
GP: general practitioner
HMO: Health Maintenance Organisation
I: intervention group
ICC: Intracluster correlation co-efficient
ITT:intention to treat
LBW: low birthweight
MI: motivational interviewing
min: minutes
MRFIT: randomised trial of health promotion carried out in the US
NICU: neonatal intensive care unit
NNTB: number needed to benefit
NRT: nicotine replacement therapy
OPD: out-patient department
Pls: principal investigators
ppm: parts per million
PPROM: preterm, prelabour rupture of the membranes
SD: Standard deviation
SES: socioeconomic status
SHO: senior house officer
TFS: teen fresh start
TFSB: teen fresh start + peer support
UC: usual care
UK: United Kingdom
US: ultrasound
USA: United States
vs: versus
WIC: Food program for Women, Infants and Children in the US
Characteristics of excluded studies [ordered by study ID]
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Study Reason for exclusion
Albrecht 2011 Program description only, not a randomised controlled study.
Andrews 2007 Women included were not-pregnant, plus quasi-randomised study design
Berlin 2008 Double-blind study of nicotine replacement therapy.
Boshier 2003 Cohort study, not a randomised study design.
Bowden 2010 Cohort study only, no control or comparison group.
Brandon 2012 Part of the intervention is provided during pregnancy but primary aim of the study is to prevent relapse after
pregnancy and post-partum outcomes only reported
Britton 2006 Quasi-experimental design. Control and experimental convenience samples collected consecutively
Chan 2005 Controlled observational study of Bupropion for smoking cessation in pregnancy
Coleman 2007 Randomised controlled trial of pharmacological intervention with equal psychosocial support in both arms
Culp 2007 Controlled trial/evaluation of “The Community-Based Family Resource and Support” (CBFRS) Program.
Control group not randomised
DeVries 2006 Quasi-cluster-randomised study with inadequate sequence generation (40 practices selected with matched
controls)
Disantis 2010 Non-randomised postpartum intervention to promote smoking cessation and breastfeeding
Dixon 2009 Longitudinal cohort study only.
Edwards 2009 Evaluation of ’SMART moms’ project, which has no control group
El-Mohandes 2013 Randomised-controlled trial of pharmacological interventions (nicotine replacement therapy) with equal
psychosocial support in both study arms
Emmons 2000 Controlled trial/evaluation of the “Healthy Baby Second Hand Smoke Study” uses historical controls. Good
documentation of implementation problems
Ershoff 1983 The intervention took place in 1 HMO clinic with historical controls from the same clinic and concurrent
controls from a second clinic. There was no randomisation of clinics and no adjustment of the data for
clustering
Everett-Murphy 2010 Evaluation of smoking cessation counselling using a historical control group only (pre-post study design,
not randomised and no contemporary control group)
Ferguson 2012 Pregnant women excluded from this study (non-pregnant study population)
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Ferreira-Borges 2005 Pre-test post-test control group design (not randomised).
Fish 2011 Intervention aimed at partners of pregnant women only. Pregnant women not included in the intervention
French 2007 Controlled clinical trial of postpartum relapse prevention. Excluded as not a trial during pregnancy, and not
randomised
Gadomski 2011 Evaluation of ’The BABY and ME-Tobacco Free’ program for relapse prevention postpartum. Quasi-exper-
imental design with non-randomised control group (matched randomly selected controls)
Gebauer 1998 Study of effect of one 15-minute counselling session and a follow-up telephone call, performed 1994-95,
using historical controls from 1993-1994
Gillies 1987 In this controlled clinical trial the intervention was carried out in 1 hospital with another hospital in the
same city acting as a control, after a prior descriptive study which showed the similarity between the 2 in
terms of social and demographic factors including smoking. There was no randomisation and recruitment
differed substantially across the 2 sites. Data for smoking reduction and smoking cessation are combined in
the paper with no separate data on cessation and no adjustment for clustering
Grange 2005 Cohort study design.
Hahn 2005 Controlled trial with a volunteer sample of non-pregnant contest registrants, compared with a randomly
selected group of smokers not exposed to the campaign/contest. Context registrants not randomised and
there is evidence of differences between groups
Hannover 2008 Counselling intervention aimed at relapse prevention postpartum only. Screened for participation during
birth admission
Herbert 2011 Intervention to reduce ’Environmental Tobacco Smoke’ exposure aimed at postpartum relapse prevention
only
Higgins 2004 Pilot study with 37/53 participants consecutively assigned (not randomised)
Hotham 2006 Randomised controlled trial of pharmacotherapy (nicotine replacement therapy) with equal psychosocial
support in both study arms
Hymowitz 2006 Postpartum trial only which measures paediatrician implementation of smoking cessation and relapse pre-
vention interventions
Jaakola 2001 Controlled study, not randomised, of effects of a population-based smoking cessation program and its impact
on smoking in pregnancy. Controls were matched on inclusion criteria from another district
Johnston 2011 Cohort smoking data from a randomised controlled trial of maternal vaccines
Kaper 2006 Non-pregnant population.
Kapur 2001 Randomised controlled trial of pharmacotherapy with equal psychosocial support in both study arms
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Karatay 2010 Evaluation of a motivational interviewing intervention with no control group
Kazemi 2012 Intervention aimed at partners of pregnant women only to reduce passive tobacco smoke exposure for
pregnant women in Iran
Kientz 2005 Unable to determine number allocated to each trial arm and unclear what happened if unequal flip of coin
Koren 2009 Randomised controlled trial of pharmacotherapy with equal psychosocial support in both study arms
Langford 1983 Prenatal classes, rather than individual women, were randomly allocated to provide the intervention or not.
The intervention was provided in late pregnancy with no outcome data collected during pregnancy but only
data 4 months after birth. There was no adjustment for cluster-randomisation in the analysis of the study
findings
Lee 2008 Intervention aimed at partners of pregnant women only to reduce passive tobacco smoke exposure for
pregnant women in China
Loke 2005 Intervention aimed at smoking cessation in men (partners of pregnant women)
Lowe 1998a Quasi-randomised study with inadequate sequence generation (allocation by alternate clinic weeks)
Lowe 1998b Quasi-randomised study with inadequate sequence generation (allocation by alternate clinic weeks)
MacArthur 1987 Quasi-randomised study with inadequate sequence generation (allocation by date of clinic visit)
Mauriello 2011 Formative research only for a non-randomised intervention with no control group
Miller 2003 A pilot study of a pharmacological intervention (Bupropion).
Mullen 1997 Study designed to promote postpartum smoking cessation (not antepartum or part of a trial conducted in
pregnancy)
Murray 2008 Intervention to promote smoking cessation among a general (not specifically pregnant) primary care popu-
lation
O’Connor 1992 Quasi-randomised study with inadequate sequence generation (alternate allocation according to day of week)
Oncken 2008 Randomised controlled trial of pharmacotherapy (nicotine replacement therapy) with equal psychosocial
support in both arms
Peden 2008 Quasi-randomised study with sequential allocation to study arms
Phillips 2012 Intervention aimed at post-partum relapse prevention only.Mother’s were recruited during infant’s admission
to NICU
Polanska 2011 Observational cohort study only with no comparison group.
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Pollak 2007 Randomised controlled trial of pharmacotherapy (nicotine replacement therapy) and equal psychosocial
support in both arms
Power 1989 The intervention in this trial was unusual in that the focus was on anticipated benefits of smoking cessation
to women themselves (not on harm to the fetus and infant), and on alternative coping strategies, with
a designated midwife-facilitator to answer queries and provide friendly advice and encouragement. The
intervention was carried out in 1 hospital with another being a comparison setting, after a prior study which
showed the similarity between the 2 in social and demographic factors including smoking rates. There was
no randomisation. Recruitment differed significantly across the 2 hospitals. Data for smoking cessation and
smoking reduction are combined with no separate data on cessation and no adjustment for clustering
Ratner 1999 Postpartum intervention only. No interventions in pregnancy.
Reitzel 2010 Intervention aimed at postpartum relapse prevention only.
Rush 1992 Quasi-experimental study with inadequate sequence generation (group allocation by alternate weeks)
Scott 2000 This controlled clinical trial of the impact of using interactive software to promote smoking cessation, was
excluded as it used historical controls
Shakespeare 1990 Not a smoking in pregnancy intervention.
Stanton 2004 Intervention aimed at partner’s of pregnant women only. Aim was to maximise potential of life-changing
period for men too. Did not include pregnant women
Suplee 2004 Randomised trial of relapse prevention counselling in the postpartum period only (not pregnancy)
Sutton 2007 Intervention of tailored smoking cessation letters, self-help materials and counselling for the general popu-
lation (not specifically pregnant women)
Valanis 2001 This prospective controlled clinical trial design to test the effect of a low intensity intervention, used historical
controls
Valbo 1991 Quasi-experimental study with inadequate sequence generation (3 months consecutive recruitment for each
arm)
Wadland 2007 General study population (not pregnant). Implementation trial to change provider behaviour and increase
referrals to quitline. Estimated smoking cessation outcome data only
Wiggins 2004 Cluster-randomised controlled trial comparing 2 postnatal interventions to improve maternal health
Wilkinson 2010 Quasi-experimental design with a non-randomised controlled pre-post test study design
Windsor 2000a Quasi-experimental study with inadequate sequence generation (80% control group not randomly assigned)
Winickoff 2010 Intervention aimed at postpartum relapse prevention only with women recruited during birth admission
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Wisborg 1998 This randomised study of the effect of midwifery training on smoking cessation intervention implementation
and pregnancy outcomes, was excluded due to concerns about allocation concealment (clinic day allocation)
Wisborg 2000 Randomised controlled trial of a pharmacological intervention (nicotine replacement therapy) and equal
psychosocial support in both study arms
Yilmaz 2006 Postnatal intervention in pediatric setting.
HMO: Health Maintenance Organisation
NICU: neonatal intensive care unit
Characteristics of ongoing studies [ordered by study ID]
Althabe 2012
Trial name or title Not stated.
Methods Cluster-randomised controlled trial.
Participants Pregnant women attending antenatal care in Argentina and Uruguay
Interventions A multifaceted intervention to implement the “5A’s” strategy
Outcomes Provision of smoking advice and smoking abstinence.
Starting date Not stated.
Contact information F. Althabe: Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health
Policy (IECS), Buenos Aires, Argentina
Notes
Blasco Oliete 2004
Trial name or title Not stated.
Methods Randomised clinical trial.
Participants Pregnant women smoking at least 1 cigarette each day attending 4 clinics in Madrid, Spain
Interventions Brief counselling (3 to 5 minutes) on smoking cessation compared with a group intervention over 3 half-hour
sessions
Outcomes Not clear.
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Blasco Oliete 2004 (Continued)
Starting date Not clear.
Contact information meliton65@eresmas.com No response from authors to written request for further trial information on 18/7/
2012
Notes Original article in Spanish.
Study report (2004) describes the study design. No papers including results have yet been identified
Everett 2008
Trial name or title Not stated.
Methods Ongoing study of intervention to promote smoking cessation among men and women during pregnancy
Participants Pregnant women and their partners.
Interventions Not clear.
Outcomes Not clear.
Starting date Not clear.
Contact information everettk@health.missouri.edu Minimal study information provided in response to email request sent 18/7/
2012
Notes
Lasater 2007
Trial name or title Reducing ETS exposure of pregnant women and newborns.
Methods Randomised 2-arm study in 6 prenatal clinics designed to develop and evaluate the efficacy of 5 tailored
DVDs in reducing exposure to ETS among low-income pregnant/postpartum women
Participants Pregnant women who attend first prenatal visit by 16 weeks’ gestation who are exposed to tobacco smoke
daily. Exclusion criteria: women expecting complications or multiple births
Interventions Provision of tailored DVDs to take home.
Outcomes Salivary cotinine concentration of mother and baby.
Starting date Feb 2006
Contact information Thomas M Lasater, Brown University, Rhode Island.
email: thomas lasater@brown.edu
Notes
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Loukopoulou 2011
Trial name or title M-SCOPE
Methods Randomised controlled trial which aims to test whether offering Greek pregnant smokers a high intensity
intervention increases smoking cessation during pregnancy, when compared to a low intensity intervention
Participants Pregnant women smoking more than 5 cigarettes per week recruited in the second trimester of pregnancy
Interventions The control group will receive 5 mins of brief advice and a leaflet, while the intervention group will receive
30 minutes of counselling by a trained health professional (based on 5A’s) and a self-help manual
Outcomes Biochemically validated smoking cessation at end of pregnancy and 6months postpartum, infant birthweight,
gestational age and other health-related complications in pregnancy
Starting date November 2009 to June 2012.
Contact information vardavas@hsph.harvard.edu
Notes Preliminary results reported in an abstract published in ’Chest’ were provided in response to written request
for further trial information sent on 18/7/2012. However these outcomes were not reported in sufficient
detail to be included in this review
Lynagh 2012
Trial name or title An RCT protocol of varying financial incentive amounts for smoking cessation among
pregnant women
Methods RCT (pilot).
Participants 90 consenting pregnant women.
Interventions 2 intervention arms will be assessed: (1) a $AUD20 incremental personal financial incentive; and (2) a
$AUD40 incremental personal financial incentive.
Women from both intervention groups will have an opportunity to receive a PFI at 8 study intervention
sessions contingent upon smoking abstinence
Outcomes (i) consent rates; (ii) loss to follow-up rates of study participants and (iii) participant compliance with saliva and
hair cotinine analyses for biochemical validation of smoking status. Womens perceptions of the intervention
will also be ascertained by 6 interview questions
Starting date Not clear.
Contact information marita.lynagh@newcastle.edu.au
Notes Australian New Zealand Clinical Trials Registry (ANZCTR) number: ACTRN12612000399897
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Mejdoubi 2011
Trial name or title Nurse Family Partnership in Dutch preventive health care.
Methods Randomised controlled trial.
Participants High risk pregnant women. The VoorZorg program target’s women that definitely need support: most have
4 or more risk factors such as poverty, (sexual) violence in the past or present relationship, no support of a
network and alcohol- or drug abuse
Interventions VoorZorg: The primary aim is to reduce child abuse and other goals are to improve health outcomes in
pregnancy. It is based on Bandura’s Self-Efficacy Theory; Brofenbrenner’s ecological model, and Bowlby’s
Attachment theory. Similar to intervention by Olds 1984 in the USA. Voorzorg consists of approximately 10
nurse home visits during pregnancy, 20 during the first year of the child’s life and 20 during the second year
of the child’s life. The duration for each visit in 1.5 hours and nurses use manuals. Incentives provided for
participation in study
Outcomes Smoking cessation.
Starting date Not stated.
Contact information crijnen@xs4all.nl No response to written request for further information sent to trial authors on 18/7/2012
Notes
Robling 2012
Trial name or title Building Blocks - a trial of home visits for first time mothers
Methods Individually randomised controlled trial.
Participants First time pregnancy:
1. Women aged 19 years or under (at recruitment/consent)
2. Lives within the catchment area covered by the local family nurse partnership (FNP) team
3. First pregnancy confirmed by health services (including those expecting multiple birth) unless previous
pregnancy ended in miscarriage, stillbirth or termination
4. Recruited no later than 24 weeks.
5. Gillick competent to provide adequate informed consent to research participation including competence
in English at conversational level or higher
Interventions This trial will assess the effectiveness of the FNP in England compared with existing universal services
Outcomes Primary:
1. Changes in prenatal tobacco use (maternal measure), measured at baseline and 34 - 36 weeks’ gestation
interviews
2. Birthweight (child measure), measured at birth (collected afterwards)
3. Emergency attendances/admissions within 2 years of birth, measured at all timepoints
4. Proportion of women with a second pregnancy within 2 years of first birth, measured at all timepoints
Secondary:
1. Intention to breastfeed
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Robling 2012 (Continued)
2. Prenatal attachment
3. Injuries and ingestions
4. Breast feeding (initiation and duration)
5. Language development
6. Education
7. Employment
8. Income/benefits
9. Home (tenure)
10. Health status
11. Self-efficacy
12. Social support
13. Paternal involvement
Starting date Not clear.
Contact information Dr Mike Robling: Associate Director South East Wales Trials Unit
Department of Primary Care and Public Health
7th Floor Neuadd Meirionnydd
Cardiff University
Heath Park
http://www.cardiff.ac.uk/medic/subsites/buildingblocks/index.html
Notes ISRCTN23019866
Ruger 2008
Trial name or title Not stated.
Methods Randomised controlled trial.
Participants 302 low-income pregnant women less than 28 weeks pregnant, English or Spanish-speaking, and who were
not receiving inpatient drug treatment were recruited frommultiple obstetric sites in the Boston metropolitan
area (USA). Current smokers or women smoking in the past 3 months (recent quitters) were included
Interventions Motivational interviewing interventions to promote smoking cessation and reduce environmental tobacco
smoke exposure provided during 3 home visits, with feedback provided about the household nicotine levels
Outcomes Smoking cessation at end of pregnancy and relapse prevention; infant health outcomes; life-years and quality
of life; primary cost data and economic analysis
Starting date 1997-2000
Contact information jennifer.ruger@yale.edu
Notes Written request for further trial information sent 18/7/2012, but advised that results were not yet available
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Tappin 2012
Trial name or title Cessation in Pregnancy Incentives Trial (CPIT).
Methods Individually randomised controlled trial.
Participants 600 pregnant smokers identified at maternity booking who, when contacted by specialist cessation services,
agree to having their details passed to the NHS Smokefree Pregnancy Study Helpline to discuss the trial
Interventions Standard care plus the additional offer of financial voucher incentives to engage with specialist cessation
services and/or to quit smoking during pregnancy
£50 for attending a face-to-face appointment with their NSPS adviser and setting a quit date;
£50 if quit 4 weeks after their quit date corroborated by a carbon monoxide breath test result less than 10
ppm collected by a research nurse;
£100 if quit after 12 weeks corroborated by a carbon monoxide breath test collected by a research nurse;
£200 if they self-report quit for at least 2 months when contacted for primary outcome assessment by the
Helpline at 34 to 38 weeks’ gestation
Outcomes Self-reported smoking in late pregnancy verified by cotinine measurement
Starting date Recruitment started in December 2011. On 9 June 2012, 199 of 600 were enrolled in the 12 month trial
Contact information David Tappin: david.tappin@glasgow.ac.uk
Paediatric Epidemiology and Community Health Unit, Section of Child
Health, Division of Developmental Medicine, Glasgow University, Yorkhill
Campus, Glasgow G3 8SJ, Scotland, U.K
Notes Current Controlled Trials ISRCTN87508788
Ussher 2012
Trial name or title Physical activity as an aid to smoking cessation during pregnancy (LEAP) trial
Methods Individually randomised controlled trial.
Participants Pregnant women who smoke at least 1 cigarette a day (and at least 5 cigarettes a day before pregnancy), and
are between 10 and 24 weeks pregnant
Interventions Supervised exercise on a treadmill plus physical activity consultations
Outcomes Self-reported and biochemically validated continuous abstinence from smoking between a specified quit date
and the end of pregnancy
Starting date The LEAP trial began recruiting patients in April 2009, and recruitment will close in November 2012
Data collection for the primary outcome is due to be completed in July 2013. As of October 2nd 2012, 768
women were recruited
Contact information Michael Ussher: mussher@sgul.ac.uk
Division of Population Health Sciences and Education, St George’s University of London, Cranmer Terrace,
London SW17 ORE, UK
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Notes ISRCTN48600346
Zhu 2004
Trial name or title Telephone intervention (California Smokers’ Helpline) or pregnant smokers
Methods Randomised trial.
Participants Pregnant smokers who called the helpline for services.
Interventions Control group received a self-help quit kit of writtenmaterials, including the AmericanCancer Society booklet
for pregnant smokers. Intervention group received the quit kit plus up to 7 counselling calls
Outcomes Self-reported smoking cessation in third trimester.
Starting date
Contact information Shu-Hong Zhu 2004, University of California. szhu@ucsd.edu
Notes Author emailed 2008, advised that results would not be available until publication. No response to written
request for further trial information on 18/7/2012
ETS: environmental tobacco smoke
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D A T A A N D A N A L Y S E S
Comparison 1. Smoking cessation interventions: counselling vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 27 11979 Risk Ratio (M-H, Random, 95% CI) 1.44 [1.19, 1.75]
1.1 Single interventions 10 3753 Risk Ratio (M-H, Random, 95% CI) 1.12 [0.89, 1.42]
1.2 Multiple interventions 11 4407 Risk Ratio (M-H, Random, 95% CI) 1.59 [1.15, 2.21]
1.3 Tailored interventions 6 3819 Risk Ratio (M-H, Random, 95% CI) 1.49 [1.01, 2.20]
2 Abstinence in late pregnancy:
biochemically validated only
18 9250 Risk Ratio (M-H, Random, 95% CI) 1.25 [1.03, 1.50]
2.1 Single interventions 7 3413 Risk Ratio (M-H, Random, 95% CI) 1.03 [0.85, 1.25]
2.2 Multiple interventions 7 3860 Risk Ratio (M-H, Random, 95% CI) 1.39 [0.94, 2.04]
2.3 Tailored interventions 4 1977 Risk Ratio (M-H, Random, 95% CI) 1.42 [0.84, 2.41]
3 Continued abstinence (relapse
prevention) in late pregnancy
for spontaneous quitters
8 688 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.93, 1.21]
3.1 Single interventions 2 100 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.93, 1.07]
3.2 Multiple interventions 3 297 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.93, 1.26]
3.3 Tailored interventions 3 291 Risk Ratio (M-H, Random, 95% CI) 1.19 [0.97, 1.46]
4 Abstinence at 0 to 5 months
postpartum
10 Risk Ratio (M-H, Random, 95% CI) Subtotals only
4.1 Single interventions 5 1164 Risk Ratio (M-H, Random, 95% CI) 1.52 [1.13, 2.05]
4.2 Multiple interventions 4 1097 Risk Ratio (M-H, Random, 95% CI) 2.32 [1.44, 3.72]
4.3 Tailored interventions 1 367 Risk Ratio (M-H, Random, 95% CI) 0.88 [0.80, 0.97]
5 Abstinence at 6 to 11 months
postpartum
6 2458 Risk Ratio (M-H, Random, 95% CI) 1.33 [1.00, 1.77]
5.1 Single interventions 2 776 Risk Ratio (M-H, Random, 95% CI) 1.34 [0.93, 1.92]
5.2 Multiple interventions 3 1055 Risk Ratio (M-H, Random, 95% CI) 1.47 [0.86, 2.52]
5.3 Tailored interventions 1 627 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.40, 2.46]
6 Abstinence at 12 to 17 months
postpartum
2 431 Risk Ratio (M-H, Random, 95% CI) 2.20 [1.23, 3.96]
6.1 Single interventions 1 109 Risk Ratio (M-H, Random, 95% CI) 2.55 [1.05, 6.21]
6.2 Multiple interventions 1 322 Risk Ratio (M-H, Random, 95% CI) 1.97 [0.91, 4.29]
7 Abstinence at 18+ months
postpartum
2 934 Risk Ratio (M-H, Random, 95% CI) 1.25 [0.57, 2.73]
7.1 Multiple interventions 2 934 Risk Ratio (M-H, Random, 95% CI) 1.25 [0.57, 2.73]
8 Reduction in late pregnancy:
biochemically validated
3 1311 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.54, 2.26]
8.1 Single interventions 1 756 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.34, 1.20]
8.2 Multiple interventions 2 555 Risk Ratio (M-H, Random, 95% CI) 1.50 [0.71, 3.20]
9 Reduction in late pregnancy: self
reported (various definitions)
2 323 Risk Ratio (M-H, Random, 95% CI) 1.61 [1.06, 2.43]
9.1 Single interventions 2 323 Risk Ratio (M-H, Random, 95% CI) 1.61 [1.06, 2.43]
10 Biochemical measures in late
pregnancy: mean cotinine
3 1742 Std. Mean Difference (IV, Random, 95% CI) -0.05 [-0.14, 0.05]
10.1 Single interventions 2 1328 Std. Mean Difference (IV, Random, 95% CI) -0.06 [-0.17, 0.05]
10.2 Multiple interventions 1 414 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.21, 0.18]
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11 Mean cigarettes per day in late
pregnancy
9 3368 Std. Mean Difference (IV, Random, 95% CI) -0.25 [-0.46, -0.03]
11.1 Single interventions 5 1928 Std. Mean Difference (IV, Random, 95% CI) -0.06 [-0.30, 0.18]
11.2 Multiple interventions 2 270 Std. Mean Difference (IV, Random, 95% CI) -0.60 [-1.02, -0.18]
11.3 Tailored interventions 2 1170 Std. Mean Difference (IV, Random, 95% CI) -0.43 [-0.83, -0.03]
12 Low birthweight infants (<
2500 g)
6 3836 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.70, 1.08]
12.1 Single interventions 2 1460 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.56, 1.11]
12.2 Multiple interventions 1 414 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.45, 2.61]
12.3 Tailored interventions 3 1962 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.66, 1.32]
13 Very low birthweight infants (<
1500 g)
2 1666 Risk Ratio (M-H, Random, 95% CI) 1.27 [0.60, 2.71]
13.1 Single interventions 1 731 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.32, 2.59]
13.2 Tailored interventions 1 935 Risk Ratio (M-H, Random, 95% CI) 1.83 [0.62, 5.43]
14 Preterm births 5 2653 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.64, 1.27]
14.1 Single interventions 3 1571 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.60, 1.17]
14.2 Tailored interventions 2 1082 Risk Ratio (M-H, Random, 95% CI) 1.13 [0.46, 2.80]
15 Mean birthweight 9 4846 Mean Difference (IV, Random, 95% CI) 36.72 [0.70, 72.74]
15.1 Single interventions 4 1880 Mean Difference (IV, Random, 95% CI) 45.65 [-10.17, 101.
48]
15.2 Multiple interventions 2 624 Mean Difference (IV, Random, 95% CI) 84.65 [-95.37, 264.
67]
15.3 Tailored interventions 3 2342 Mean Difference (IV, Random, 95% CI) 23.25 [-52.12, 98.
62]
16 Perinatal deaths 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
16.1 Single interventions 1 130 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
16.2 Tailored interventions 1 935 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.52, 2.31]
17 Stillbirths 4 2212 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.51, 2.30]
17.1 Single interventions 2 859 Risk Ratio (M-H, Random, 95% CI) 2.58 [0.38, 17.48]
17.2 Tailored interventions 2 1353 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.41, 2.10]
18 Neonatal deaths 3 2095 Risk Ratio (M-H, Random, 95% CI) 2.06 [0.61, 6.92]
18.1 Single interventions 1 762 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.07, 18.65]
18.2 Tailored interventions 2 1333 Risk Ratio (M-H, Random, 95% CI) 2.35 [0.61, 9.07]
19 NICU admissions 2 1140 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.52, 1.29]
19.1 Single interventions 1 762 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.47, 1.07]
19.2 Tailored interventions 1 378 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.55, 2.46]
Comparison 2. Smoking cessation interventions: counselling vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 16 5247 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.00, 1.82]
1.1 Single interventions 5 735 Risk Ratio (M-H, Random, 95% CI) 1.51 [0.90, 2.54]
1.2 Multiple interventions 10 4260 Risk Ratio (M-H, Random, 95% CI) 1.23 [0.84, 1.78]
1.3 Tailored interventions 1 252 Risk Ratio (M-H, Random, 95% CI) 2.39 [1.03, 5.56]
2 Abstinence in late pregnancy:
biochemically validated only
12 2858 Risk Ratio (M-H, Random, 95% CI) 1.46 [1.15, 1.85]
2.1 Single interventions 5 735 Risk Ratio (M-H, Random, 95% CI) 1.51 [0.90, 2.54]
2.2 Multiple interventions 6 1871 Risk Ratio (M-H, Random, 95% CI) 1.38 [1.05, 1.80]
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2.3 Tailored interventions 1 252 Risk Ratio (M-H, Random, 95% CI) 2.39 [1.03, 5.56]
3 Continued abstinence (relapse
prevention) in late pregnancy
(spontaneous quitters)
4 692 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.98, 1.13]
3.1 Single interventions 2 204 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.88, 1.18]
3.2 Multiple interventions 2 488 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.96, 1.17]
3.3 Tailored interventions 0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4 Abstinence at 0 to 5 months
postpartum
6 1980 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.82, 1.66]
4.1 Single interventions 1 82 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.11, 3.60]
4.2 Multiple interventions 4 1646 Risk Ratio (M-H, Random, 95% CI) 1.19 [0.99, 1.43]
4.3 Tailored interventions 1 252 Risk Ratio (M-H, Random, 95% CI) 12.80 [1.70, 96.35]
5 Abstinence at 6 to 11 months
postpartum
3 1271 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.83, 1.40]
5.1 Single interventions 1 105 Risk Ratio (M-H, Random, 95% CI) 2.45 [0.50, 12.08]
5.2 Multiple interventions 2 1166 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.80, 1.38]
6 Abstinence at 12 to 17 months
postpartum
2 1188 Risk Ratio (M-H, Random, 95% CI) 1.25 [0.71, 2.20]
6.1 Multiple interventions 2 1188 Risk Ratio (M-H, Random, 95% CI) 1.25 [0.71, 2.20]
7 Reduction in late pregnancy:
self-reported > 50%
2 1235 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.07, 1.71]
7.1 Multiple interventions 2 1235 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.07, 1.71]
8 Reduction in late pregnancy:
biochemically validated
2 857 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.98, 1.87]
8.1 Multiple interventions 2 857 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.98, 1.87]
9 Mean cigarettes per day in late
pregnancy
2 397 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.30, 0.09]
9.1 Single interventions 1 121 Std. Mean Difference (IV, Random, 95% CI) 0.01 [-0.34, 0.37]
9.2 Multiple interventions 1 276 Std. Mean Difference (IV, Random, 95% CI) -0.16 [-0.40, 0.08]
10 Low birthweight infants (<
2500 g)
2 503 Risk Ratio (M-H, Random, 95% CI) 0.58 [0.32, 1.04]
10.1 Single interventions 1 227 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.25, 1.21]
10.2 Multiple interventions 1 276 Risk Ratio (M-H, Random, 95% CI) 0.61 [0.25, 1.50]
11 Preterm births 3 794 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.47, 1.42]
11.1 Single interventions 1 227 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.25, 1.21]
11.2 Multiple interventions 1 308 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.46, 2.95]
11.3 Tailored interventions 1 259 Risk Ratio (M-H, Random, 95% CI) 1.30 [0.30, 5.71]
12 Mean birthweight 3 546 Mean Difference (IV, Random, 95% CI) 56.02 [-31.46, 143.
50]
12.1 Single interventions 1 227 Mean Difference (IV, Random, 95% CI) 57.00 [-93.50, 207.
50]
12.2 Multiple interventions 2 319 Mean Difference (IV, Random, 95% CI) 76.01 [-88.59, 240.
61]
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Comparison 3. Smoking cessation interventions: health education vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 3 374 Risk Ratio (M-H, Random, 95% CI) 1.51 [0.64, 3.59]
1.1 Single interventions 2 229 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.49, 3.42]
1.2 Multiple interventions 1 145 Risk Ratio (M-H, Random, 95% CI) 4.06 [0.46, 35.41]
2 Abstinence in late pregnancy:
biochemically validated only
2 229 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.49, 3.42]
2.1 Single interventions 2 229 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.49, 3.42]
3 Mean cigarettes per day in late
pregnancy
2 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
3.1 Single interventions 1 552 Std. Mean Difference (IV, Random, 95% CI) -0.72 [-0.89, -0.55]
3.2 Multiple interventions 1 135 Std. Mean Difference (IV, Random, 95% CI) -0.32 [-0.66, 0.02]
Comparison 4. Smoking cessation interventions: health education vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy:
biochemically validated
2 851 Risk Ratio (M-H, Random, 95% CI) 1.50 [0.97, 2.31]
1.1 Single interventions 1 653 Risk Ratio (M-H, Random, 95% CI) 1.46 [0.88, 2.43]
1.2 Multiple interventions 1 198 Risk Ratio (M-H, Random, 95% CI) 1.59 [0.68, 3.73]
2 Abstinence at 0 to 5 months
postpartum
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Single interventions 2 844 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.52, 3.22]
Comparison 5. Smoking cessation interventions: feedback vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 2 355 Risk Ratio (M-H, Random, 95% CI) 4.39 [1.89, 10.21]
1.1 Multiple interventions 2 355 Risk Ratio (M-H, Random, 95% CI) 4.39 [1.89, 10.21]
2 Reduction in late pregnancy:
various definitions
2 355 Risk Ratio (M-H, Random, 95% CI) 1.69 [1.24, 2.31]
2.1 Multiple interventions 2 355 Risk Ratio (M-H, Random, 95% CI) 1.69 [1.24, 2.31]
3 Preterm births 2 3111 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
3.1 Multiple interventions 2 3111 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
4 Mean birthweight 2 3006 Mean Difference (IV, Random, 95% CI) 79.43 [-53.05, 211.
91]
4.1 Multiple interventions 2 3006 Mean Difference (IV, Random, 95% CI) 79.43 [-53.05, 211.
91]
5 Stillbirths 2 2960 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.69, 2.39]
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5.1 Multiple interventions 2 2960 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.69, 2.39]
Comparison 6. Smoking cessation interventions: feedback vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy:
biochemically validated
2 319 Risk Ratio (M-H, Random, 95% CI) 1.19 [0.45, 3.12]
1.1 Single interventions 1 79 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.16, 2.22]
1.2 Multiple interventions 1 240 Risk Ratio (M-H, Random, 95% CI) 1.69 [0.89, 3.20]
Comparison 7. Smoking cessation interventions: incentives vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late
pregnancy:biochemically
validated
2 129 Risk Ratio (M-H, Random, 95% CI) 3.59 [0.10, 130.49]
1.1 Single interventions 1 74 Risk Ratio (M-H, Random, 95% CI) 20.72 [1.28, 336.01]
1.2 Tailored interventions 1 55 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.25, 3.23]
Comparison 8. Smoking cessation interventions: social support vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy
(peer and partner support)
6 734 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.94, 1.78]
1.1 Single interventions 2 224 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.57, 3.18]
1.2 Multiple interventions 3 359 Risk Ratio (M-H, Random, 95% CI) 1.48 [0.74, 2.95]
1.3 Tailored interventions 1 151 Risk Ratio (M-H, Random, 95% CI) 1.22 [0.59, 2.52]
2 Abstinence in late pregnancy:
biochemically validated (peer
support only)
5 554 Risk Ratio (M-H, Random, 95% CI) 1.49 [1.01, 2.19]
2.1 Single interventions 2 224 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.57, 3.18]
2.2 Multiple interventions 2 179 Risk Ratio (M-H, Random, 95% CI) 2.26 [1.15, 4.46]
2.3 Tailored interventions 1 151 Risk Ratio (M-H, Random, 95% CI) 1.22 [0.59, 2.52]
3 Abstinence at 0 to 5 months
postpartum
2 473 Risk Ratio (M-H, Random, 95% CI) 1.36 [0.46, 4.07]
3.1 Single interventions 1 82 Risk Ratio (M-H, Random, 95% CI) 5.8 [0.33, 101.27]
3.2 Multiple interventions 1 391 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.87, 1.41]
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4 Abstinence at 6 to 11 months
postpartum
2 486 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.83, 1.42]
4.1 Multiple interventions 2 486 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.83, 1.42]
Comparison 9. Maternal health intervention with smoking cessation component: social support (tailored) vs
usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Self-reported 1 492 Risk Ratio (M-H, Random, 95% CI) 1.83 [1.22, 2.73]
1.2 Biochemically validated 1 141 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Self-reported mean cigarettes per
day in late pregnancy
2 542 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-0.45, -0.11]
2.1 Self-reported 1 401 Std. Mean Difference (IV, Random, 95% CI) -0.24 [-0.43, -0.04]
2.2 Biochemically validated 1 141 Std. Mean Difference (IV, Random, 95% CI) -0.40 [-0.73, -0.06]
Comparison 10. Maternal health intervention with smoking cessation component: social support vs less intensive
intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 2 316 Risk Ratio (M-H, Random, 95% CI) 0.80 [0.46, 1.39]
1.1 Single interventions 1 66 Risk Ratio (M-H, Random, 95% CI) 0.45 [0.09, 2.16]
1.2 Tailored interventions 1 250 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.48, 1.57]
2 Abstinence in late pregnancy:
biochemically validated
1 250 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.48, 1.57]
2.1 Tailored interventions 1 250 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.48, 1.57]
Comparison 11. Interventions for smoking cessation in pregnancy versus control: subgrouped by main interven-
tion strategy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy:
self-reported and biochemically
validated (non-winsorised)
70 21948 Risk Ratio (M-H, Random, 95% CI) 1.45 [1.27, 1.64]
1.1 Counselling 45 17681 Risk Ratio (M-H, Random, 95% CI) 1.37 [1.17, 1.59]
1.2 Health education 5 1225 Risk Ratio (M-H, Random, 95% CI) 1.47 [1.02, 2.13]
1.3 Feedback 5 739 Risk Ratio (M-H, Random, 95% CI) 2.09 [1.17, 3.72]
1.4 Incentives 4 426 Risk Ratio (M-H, Random, 95% CI) 3.09 [1.34, 7.15]
1.5 Social support 10 1683 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.97, 1.73]
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1.6 Other 1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
2 Abstinence in late pregnancy:
biochemically validated only
(non-winsorised)
49 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Counselling 30 11924 Risk Ratio (M-H, Random, 95% CI) 1.27 [1.11, 1.47]
2.2 Health education 4 1080 Risk Ratio (M-H, Random, 95% CI) 1.43 [0.98, 2.08]
2.3 Feedback 3 563 Risk Ratio (M-H, Random, 95% CI) 1.70 [0.71, 4.08]
2.4 Incentives 4 426 Risk Ratio (M-H, Random, 95% CI) 3.09 [1.34, 7.15]
2.5 Social support 7 945 Risk Ratio (M-H, Random, 95% CI) 1.31 [0.90, 1.91]
2.6 Other 1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
3 Continued abstinence (Relapse
prevention) in late pregnancy
for spontaneous quitters
14 Risk Ratio (M-H, Random, 95% CI) Totals not selected
3.1 Counselling 12 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3.2 Health education 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3.3 Social support 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4 Abstinence at 0 to 5 months
postpartum
26 Risk Ratio (M-H, Random, 95% CI) Totals not selected
4.1 Counselling 18 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 Health education 3 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4.3 Incentives 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
4.4 Social support 3 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
5 Abstinence at 6 to 11 months
postpartum
13 Risk Ratio (M-H, Random, 95% CI) Totals not selected
5.1 Counselling 10 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
5.2 Incentives 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
5.3 Social support 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
6 Abstinence at 12 to 17 months
postpartum
5 Risk Ratio (M-H, Random, 95% CI) Totals not selected
6.1 Counselling 4 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
6.2 Social support 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
7 Abstinence at 18+ months
postpartum
2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
7.1 Counselling 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
8 Smoking reduction: numbers of
women reducing smoking in
late pregnancy
15 Risk Ratio (M-H, Random, 95% CI) Totals not selected
8.1 Self-reported some
reduction in smoking (various
definitions)
5 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
8.2 Self-reported > 50%
reduction in smoking
4 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
8.3 Biochemically validated
reduction
6 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
9 Smoking reduction: biochemical
measures in late pregnancy
6 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
9.1 Mean cotinine levels 5 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
9.2 Mean thiocynate level 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
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10 Smoking reduction:
self-reported mean cigarettes
per day measured in late
pregnancy or at delivery
20 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
10.1 Counselling 11 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
10.2 Health education 3 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
10.3 Feedback 2 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
10.4 Incentives 1 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
10.5 Social support 3 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
11 Low birthweight (under 2500
g)
14 8562 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.71, 0.94]
11.1 Counselling 8 4339 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.68, 1.01]
11.2 Health education 2 1172 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.49, 1.55]
11.3 Feedback 1 2848 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.63, 1.06]
11.4 Incentives 2 124 Risk Ratio (M-H, Random, 95% CI) 0.45 [0.22, 0.93]
11.5 Social support 1 79 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.33, 2.99]
12 Very low birthweight (under
1500 g)
3 4366 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.62, 2.01]
12.1 Counselling 2 1666 Risk Ratio (M-H, Random, 95% CI) 1.27 [0.60, 2.71]
12.2 Feedback 1 2700 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.35, 2.32]
13 Preterm birth (under 37 weeks) 14 7852 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.70, 0.96]
13.1 Counselling 8 3447 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.71, 1.20]
13.2 Health education 2 1170 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.55, 1.56]
13.3 Feedback 2 3111 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
13.4 Incentives 2 124 Risk Ratio (M-H, Random, 95% CI) 0.49 [0.22, 1.08]
14 Mean birthweight 19 9859 Mean Difference (IV, Random, 95% CI) 40.78 [18.45, 63.10]
14.1 Counselling 12 5392 Mean Difference (IV, Random, 95% CI) 39.93 [9.12, 70.74]
14.2 Health education 2 1172 Mean Difference (IV, Random, 95% CI) 27.35 [-53.88, 108.
58]
14.3 Feedback 2 3006 Mean Difference (IV, Random, 95% CI) 79.43 [-53.05, 211.
91]
14.4 Incentives 2 147 Mean Difference (IV, Random, 95% CI) 213.78 [20.16, 407.
40]
14.5 Social support 1 142 Mean Difference (IV, Random, 95% CI) 28.0 [-152.48, 208.
48]
15 Perinatal deaths 4 4465 Risk Ratio (M-H, Random, 95% CI) 1.13 [0.72, 1.77]
15.1 Counselling 2 1065 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.52, 2.31]
15.2 Health education 1 552 Risk Ratio (M-H, Random, 95% CI) 4.40 [0.49, 39.08]
15.3 Feedback 1 2848 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.59, 1.87]
16 Stillbirths 7 5414 Risk Ratio (M-H, Random, 95% CI) 1.22 [0.76, 1.95]
16.1 Counselling 5 2454 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.55, 2.33]
16.2 Feedback 2 2960 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.69, 2.39]
17 Neonatal deaths 4 4905 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.44, 3.06]
17.1 Counselling 3 2095 Risk Ratio (M-H, Random, 95% CI) 2.06 [0.61, 6.92]
17.2 Feedback 1 2810 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.08, 2.07]
18 NICU admissions 4 1264 Risk Ratio (M-H, Random, 95% CI) 0.78 [0.59, 1.04]
18.1 Counselling 2 1140 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.52, 1.29]
18.2 Incentives 2 124 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.47, 1.21]
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Analysis 1.1. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Baric 1976 9/63 2/47 1.4 % 3.36 [ 0.76, 14.82 ]
Dunkley 1997 4/50 0/50 0.4 % 9.00 [ 0.50, 162.89 ]
McLeod 2004 30/163 13/109 4.9 % 1.54 [ 0.84, 2.82 ]
Moore 2002 88/523 108/567 8.1 % 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 6.0 % 1.20 [ 0.75, 1.93 ]
Pbert 2004 5/26 2/18 1.4 % 1.73 [ 0.38, 7.96 ]
Price 1991 4/71 1/70 0.7 % 3.94 [ 0.45, 34.41 ]
Tappin 2000 2/48 2/49 0.9 % 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 4.7 % 1.05 [ 0.56, 2.00 ]
Valbo 1996 5/52 8/78 2.5 % 0.94 [ 0.32, 2.71 ]
Subtotal (95% CI) 1819 1934 31.1 % 1.12 [ 0.89, 1.42 ]
Total events: 197 (Experimental), 186 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 10.11, df = 9 (P = 0.34); I2 =11%
Test for overall effect: Z = 0.95 (P = 0.34)
2 Multiple interventions
Gielen 1997 12/193 11/198 3.7 % 1.12 [ 0.51, 2.48 ]
Hartmann 1996 27/113 16/106 5.3 % 1.58 [ 0.91, 2.77 ]
Haug 1994 42/229 8/93 4.1 % 2.13 [ 1.04, 4.37 ]
Kendrick 1995 48/822 65/1063 7.1 % 0.95 [ 0.67, 1.37 ]
Lawrence 2003 17/309 5/283 2.7 % 3.11 [ 1.16, 8.33 ]
Lillington 1995 7/16 4/18 2.6 % 1.97 [ 0.70, 5.50 ]
Mayer 1990 8/72 2/77 1.4 % 4.28 [ 0.94, 19.48 ]
Secker-Walker 1994 29/255 26/258 5.8 % 1.13 [ 0.68, 1.86 ]
Stotts 2004 3/24 5/30 1.7 % 0.75 [ 0.20, 2.83 ]
Tsoh 2010 6/23 2/19 1.4 % 2.48 [ 0.56, 10.89 ]
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Windsor 1985 14/102 2/104 1.5 % 7.14 [ 1.66, 30.62 ]
Subtotal (95% CI) 2158 2249 37.4 % 1.59 [ 1.15, 2.21 ]
Total events: 213 (Experimental), 146 (Control)
Heterogeneity: Tau2 = 0.12; Chi2 = 18.21, df = 10 (P = 0.05); I2 =45%
Test for overall effect: Z = 2.78 (P = 0.0055)
3 Tailored interventions
Eades 2012 1/124 2/107 0.6 % 0.43 [ 0.04, 4.69 ]
Hajek 2001 80/365 73/367 7.9 % 1.10 [ 0.83, 1.46 ]
Hegaard 2003 23/327 7/320 3.4 % 3.22 [ 1.40, 7.39 ]
Loeb 1983 42/477 39/486 6.6 % 1.10 [ 0.72, 1.67 ]
Sexton 1984 167/436 79/443 8.3 % 2.15 [ 1.70, 2.71 ]
Thornton 1997 20/190 14/177 4.6 % 1.33 [ 0.69, 2.55 ]
Subtotal (95% CI) 1919 1900 31.5 % 1.49 [ 1.01, 2.20 ]
Total events: 333 (Experimental), 214 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 20.07, df = 5 (P = 0.001); I2 =75%
Test for overall effect: Z = 2.02 (P = 0.043)
Total (95% CI) 5896 6083 100.0 % 1.44 [ 1.19, 1.75 ]
Total events: 743 (Experimental), 546 (Control)
Heterogeneity: Tau2 = 0.10; Chi2 = 57.75, df = 26 (P = 0.00033); I2 =55%
Test for overall effect: Z = 3.68 (P = 0.00023)
Test for subgroup differences: Chi2 = 3.45, df = 2 (P = 0.18), I2 =42%
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Analysis 1.2. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 2
Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
McLeod 2004 30/163 13/109 6.5 % 1.54 [ 0.84, 2.82 ]
Moore 2002 88/523 108/567 14.4 % 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 8.7 % 1.20 [ 0.75, 1.93 ]
Pbert 2004 5/26 2/18 1.4 % 1.73 [ 0.38, 7.96 ]
Price 1991 4/71 1/70 0.7 % 3.94 [ 0.45, 34.41 ]
Tappin 2000 2/48 2/49 0.9 % 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 6.0 % 1.05 [ 0.56, 2.00 ]
Subtotal (95% CI) 1654 1759 38.6 % 1.03 [ 0.85, 1.25 ]
Total events: 179 (Experimental), 176 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.47, df = 6 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
2 Multiple interventions
Gielen 1997 12/193 11/198 4.3 % 1.12 [ 0.51, 2.48 ]
Hartmann 1996 27/113 16/106 7.1 % 1.58 [ 0.91, 2.77 ]
Kendrick 1995 48/822 65/1063 11.3 % 0.95 [ 0.67, 1.37 ]
Lawrence 2003 17/309 5/283 3.1 % 3.11 [ 1.16, 8.33 ]
Secker-Walker 1994 29/255 26/258 8.2 % 1.13 [ 0.68, 1.86 ]
Stotts 2004 3/24 5/30 1.8 % 0.75 [ 0.20, 2.83 ]
Windsor 1985 14/102 2/104 1.5 % 7.14 [ 1.66, 30.62 ]
Subtotal (95% CI) 1818 2042 37.4 % 1.39 [ 0.94, 2.04 ]
Total events: 150 (Experimental), 130 (Control)
Heterogeneity: Tau2 = 0.12; Chi2 = 12.53, df = 6 (P = 0.05); I2 =52%
Test for overall effect: Z = 1.66 (P = 0.098)
3 Tailored interventions
Eades 2012 1/124 2/107 0.6 % 0.43 [ 0.04, 4.69 ]
Hajek 2001 80/365 73/367 13.6 % 1.10 [ 0.83, 1.46 ]
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hegaard 2003 23/327 7/320 4.0 % 3.22 [ 1.40, 7.39 ]
Thornton 1997 20/190 14/177 5.8 % 1.33 [ 0.69, 2.55 ]
Subtotal (95% CI) 1006 971 24.0 % 1.42 [ 0.84, 2.41 ]
Total events: 124 (Experimental), 96 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 6.59, df = 3 (P = 0.09); I2 =54%
Test for overall effect: Z = 1.30 (P = 0.19)
Total (95% CI) 4478 4772 100.0 % 1.25 [ 1.03, 1.50 ]
Total events: 453 (Experimental), 402 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 26.32, df = 17 (P = 0.07); I2 =35%
Test for overall effect: Z = 2.31 (P = 0.021)
Test for subgroup differences: Chi2 = 2.64, df = 2 (P = 0.27), I2 =24%
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Analysis 1.3. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 3
Continued abstinence (relapse prevention) in late pregnancy for spontaneous quitters.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 3 Continued abstinence (relapse prevention) in late pregnancy for spontaneous quitters
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Pbert 2004 16/23 12/16 8.3 % 0.93 [ 0.63, 1.37 ]
Polanska 2004 38/38 23/23 32.1 % 1.00 [ 0.93, 1.07 ]
Subtotal (95% CI) 61 39 40.3 % 1.00 [ 0.93, 1.07 ]
Total events: 54 (Experimental), 35 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.06 (P = 0.95)
2 Multiple interventions
Lillington 1995 15/16 17/19 19.1 % 1.05 [ 0.86, 1.28 ]
Lowe 1997 37/52 25/45 11.4 % 1.28 [ 0.94, 1.75 ]
Secker-Walker 1994 31/85 31/80 8.2 % 0.94 [ 0.64, 1.39 ]
Subtotal (95% CI) 153 144 38.7 % 1.08 [ 0.93, 1.26 ]
Total events: 83 (Experimental), 73 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.70, df = 2 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.00 (P = 0.32)
3 Tailored interventions
Eades 2012 10/24 2/8 1.0 % 1.67 [ 0.46, 6.06 ]
Hajek 2001 72/111 68/128 17.9 % 1.22 [ 0.99, 1.51 ]
Thornton 1997 3/6 10/14 2.1 % 0.70 [ 0.29, 1.66 ]
Subtotal (95% CI) 141 150 21.0 % 1.19 [ 0.97, 1.46 ]
Total events: 85 (Experimental), 80 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.76, df = 2 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 1.70 (P = 0.090)
Total (95% CI) 355 333 100.0 % 1.06 [ 0.93, 1.21 ]
Total events: 222 (Experimental), 188 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 12.70, df = 7 (P = 0.08); I2 =45%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Chi2 = 3.22, df = 2 (P = 0.20), I2 =38%
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Analysis 1.4. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 4
Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Dunkley 1997 2/50 0/50 1.0 % 5.00 [ 0.25, 101.58 ]
McLeod 2004 17/106 9/82 15.6 % 1.46 [ 0.69, 3.11 ]
Panjari 1999 54/339 47/393 67.6 % 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 1/18 1.2 % 0.69 [ 0.05, 10.36 ]
Polanska 2004 28/62 6/38 14.5 % 2.86 [ 1.31, 6.26 ]
Subtotal (95% CI) 583 581 100.0 % 1.52 [ 1.13, 2.05 ]
Total events: 102 (Experimental), 63 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.96, df = 4 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 2.74 (P = 0.0062)
2 Multiple interventions
Haug 1994 42/229 8/93 43.9 % 2.13 [ 1.04, 4.37 ]
Lawrence 2003 25/309 10/283 44.1 % 2.29 [ 1.12, 4.68 ]
Lillington 1995 4/16 2/18 9.3 % 2.25 [ 0.47, 10.69 ]
Mayer 1990 5/72 0/77 2.7 % 11.75 [ 0.66, 208.84 ]
Subtotal (95% CI) 626 471 100.0 % 2.32 [ 1.44, 3.72 ]
Total events: 76 (Experimental), 20 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.30, df = 3 (P = 0.73); I2 =0.0%
Test for overall effect: Z = 3.47 (P = 0.00053)
3 Tailored interventions
Thornton 1997 145/190 153/177 100.0 % 0.88 [ 0.80, 0.97 ]
Subtotal (95% CI) 190 177 100.0 % 0.88 [ 0.80, 0.97 ]
Total events: 145 (Experimental), 153 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.48 (P = 0.013)
Test for subgroup differences: Chi2 = 25.03, df = 2 (P = 0.00), I2 =92%
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Analysis 1.5. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 5
Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 5 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Panjari 1999 54/339 47/393 61.5 % 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 0/18 0.8 % 2.11 [ 0.09, 49.08 ]
Subtotal (95% CI) 365 411 62.3 % 1.34 [ 0.93, 1.92 ]
Total events: 55 (Experimental), 47 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.08, df = 1 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 1.59 (P = 0.11)
2 Multiple interventions
Gielen 1997 7/193 2/198 3.3 % 3.59 [ 0.76, 17.07 ]
Haug 1994 35/229 10/93 18.6 % 1.42 [ 0.73, 2.75 ]
Secker-Walker 1994 5/157 6/185 5.9 % 0.98 [ 0.31, 3.16 ]
Subtotal (95% CI) 579 476 27.9 % 1.47 [ 0.86, 2.52 ]
Total events: 47 (Experimental), 18 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.74, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.39 (P = 0.16)
3 Tailored interventions
Hajek 2001 9/315 9/312 9.8 % 0.99 [ 0.40, 2.46 ]
Subtotal (95% CI) 315 312 9.8 % 0.99 [ 0.40, 2.46 ]
Total events: 9 (Experimental), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 1259 1199 100.0 % 1.33 [ 1.00, 1.77 ]
Total events: 111 (Experimental), 74 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.35, df = 5 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 1.99 (P = 0.047)
Test for subgroup differences: Chi2 = 0.53, df = 2 (P = 0.77), I2 =0.0%
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Analysis 1.6. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 6
Abstinence at 12 to 17 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 6 Abstinence at 12 to 17 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Polanska 2004 22/69 5/40 43.3 % 2.55 [ 1.05, 6.21 ]
Subtotal (95% CI) 69 40 43.3 % 2.55 [ 1.05, 6.21 ]
Total events: 22 (Experimental), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.06 (P = 0.039)
2 Multiple interventions
Haug 1994 34/229 7/93 56.7 % 1.97 [ 0.91, 4.29 ]
Subtotal (95% CI) 229 93 56.7 % 1.97 [ 0.91, 4.29 ]
Total events: 34 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.71 (P = 0.087)
Total (95% CI) 298 133 100.0 % 2.20 [ 1.23, 3.96 ]
Total events: 56 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.18, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 2.65 (P = 0.0081)
Test for subgroup differences: Chi2 = 0.18, df = 1 (P = 0.67), I2 =0.0%
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Analysis 1.7. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 7
Abstinence at 18+ months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 7 Abstinence at 18+ months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Lawrence 2003 14/309 7/283 51.8 % 1.83 [ 0.75, 4.47 ]
Secker-Walker 1994 7/157 10/185 48.2 % 0.82 [ 0.32, 2.12 ]
Total (95% CI) 466 468 100.0 % 1.25 [ 0.57, 2.73 ]
Total events: 21 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.10; Chi2 = 1.45, df = 1 (P = 0.23); I2 =31%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 8
Reduction in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 8 Reduction in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 14/347 26/409 35.7 % 0.63 [ 0.34, 1.20 ]
Subtotal (95% CI) 347 409 35.7 % 0.63 [ 0.34, 1.20 ]
Total events: 14 (Experimental), 26 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.41 (P = 0.16)
2 Multiple interventions
Windsor 1985 31/205 7/104 31.0 % 2.25 [ 1.02, 4.93 ]
Gielen 1997 14/125 13/121 33.3 % 1.04 [ 0.51, 2.13 ]
Subtotal (95% CI) 330 225 64.3 % 1.50 [ 0.71, 3.20 ]
Total events: 45 (Experimental), 20 (Control)
Heterogeneity: Tau2 = 0.15; Chi2 = 2.04, df = 1 (P = 0.15); I2 =51%
Test for overall effect: Z = 1.05 (P = 0.29)
Total (95% CI) 677 634 100.0 % 1.11 [ 0.54, 2.26 ]
Total events: 59 (Experimental), 46 (Control)
Heterogeneity: Tau2 = 0.26; Chi2 = 6.04, df = 2 (P = 0.05); I2 =67%
Test for overall effect: Z = 0.28 (P = 0.78)
Test for subgroup differences: Chi2 = 2.93, df = 1 (P = 0.09), I2 =66%
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Analysis 1.9. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 9
Reduction in late pregnancy: self reported (various definitions).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 9 Reduction in late pregnancy: self reported (various definitions)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Price 1991 37/123 10/70 37.0 % 2.11 [ 1.12, 3.97 ]
Valbo 1996 22/52 24/78 63.0 % 1.38 [ 0.87, 2.18 ]
Total (95% CI) 175 148 100.0 % 1.61 [ 1.06, 2.43 ]
Total events: 59 (Experimental), 34 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.19, df = 1 (P = 0.27); I2 =16%
Test for overall effect: Z = 2.26 (P = 0.024)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 10
Biochemical measures in late pregnancy: mean cotinine.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 10 Biochemical measures in late pregnancy: mean cotinine
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Panjari 1999 318 720 (688) 356 769 (735) 38.9 % -0.07 [ -0.22, 0.08 ]
Tappin 2005 290 113 (70) 364 117 (83) 37.4 % -0.05 [ -0.21, 0.10 ]
Subtotal (95% CI) 608 720 76.2 % -0.06 [ -0.17, 0.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.09 (P = 0.27)
2 Multiple interventions
Secker-Walker 1994 188 1208 (1384) 226 1228 (1612) 23.8 % -0.01 [ -0.21, 0.18 ]
Subtotal (95% CI) 188 226 23.8 % -0.01 [ -0.21, 0.18 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.13 (P = 0.89)
Total (95% CI) 796 946 100.0 % -0.05 [ -0.14, 0.05 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.20, df = 2 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Chi2 = 0.17, df = 1 (P = 0.68), I2 =0.0%
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Analysis 1.11. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 11 Mean
cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 11 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Moore 2002 353 10.3 (5.6) 403 10.1 (5.4) 13.0 % 0.04 [ -0.11, 0.18 ]
Panjari 1999 284 8.7 (7.6) 326 11.5 (9.7) 12.8 % -0.32 [ -0.48, -0.16 ]
Pbert 2004 119 8 (6.5) 172 10.5 (6.5) 11.8 % -0.38 [ -0.62, -0.15 ]
Price 1991 71 4.3 (8.1) 70 2.3 (5.6) 10.4 % 0.29 [ -0.05, 0.62 ]
Valbo 1996 52 9.9 (5.4) 78 9 (4.4) 10.0 % 0.19 [ -0.17, 0.54 ]
Subtotal (95% CI) 879 1049 58.1 % -0.06 [ -0.30, 0.18 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 23.87, df = 4 (P = 0.00008); I2 =83%
Test for overall effect: Z = 0.51 (P = 0.61)
2 Multiple interventions
Hartmann 1996 107 9.1 (6.5) 100 12.2 (6.5) 11.2 % -0.48 [ -0.75, -0.20 ]
Vilches 2009 9 0.11 (0.33) 54 5.36 (5.76) 5.3 % -0.97 [ -1.69, -0.24 ]
Subtotal (95% CI) 116 154 16.5 % -0.60 [ -1.02, -0.18 ]
Heterogeneity: Tau2 = 0.04; Chi2 = 1.53, df = 1 (P = 0.22); I2 =35%
Test for overall effect: Z = 2.81 (P = 0.0050)
3 Tailored interventions
Sexton 1984 388 6.4 (8.7) 395 12.8 (11.5) 13.0 % -0.63 [ -0.77, -0.48 ]
Thornton 1997 196 10.4 (8.3) 191 12.5 (10.7) 12.3 % -0.22 [ -0.42, -0.02 ]
Subtotal (95% CI) 584 586 25.4 % -0.43 [ -0.83, -0.03 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 10.51, df = 1 (P = 0.001); I2 =90%
Test for overall effect: Z = 2.11 (P = 0.035)
Total (95% CI) 1579 1789 100.0 % -0.25 [ -0.46, -0.03 ]
Heterogeneity: Tau2 = 0.09; Chi2 = 65.66, df = 8 (P<0.00001); I2 =88%
Test for overall effect: Z = 2.27 (P = 0.023)
Test for subgroup differences: Chi2 = 5.79, df = 2 (P = 0.06), I2 =65%
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Analysis 1.12. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 12 Low
birthweight infants (< 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 12 Low birthweight infants (< 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Panjari 1999 20/337 37/391 17.0 % 0.63 [ 0.37, 1.06 ]
Tappin 2005 44/332 59/400 35.5 % 0.90 [ 0.63, 1.29 ]
Subtotal (95% CI) 669 791 52.5 % 0.79 [ 0.56, 1.11 ]
Total events: 64 (Experimental), 96 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 1.36 (P = 0.17)
2 Multiple interventions
Secker-Walker 1994 9/188 10/226 6.0 % 1.08 [ 0.45, 2.61 ]
Subtotal (95% CI) 188 226 6.0 % 1.08 [ 0.45, 2.61 ]
Total events: 9 (Experimental), 10 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.86)
3 Tailored interventions
Hegaard 2003 12/327 10/320 6.9 % 1.17 [ 0.51, 2.68 ]
Sexton 1984 31/463 42/472 23.4 % 0.75 [ 0.48, 1.18 ]
Thornton 1997 19/190 15/190 11.2 % 1.27 [ 0.66, 2.42 ]
Subtotal (95% CI) 980 982 41.5 % 0.93 [ 0.66, 1.32 ]
Total events: 62 (Experimental), 67 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.05, df = 2 (P = 0.36); I2 =2%
Test for overall effect: Z = 0.39 (P = 0.70)
Total (95% CI) 1837 1999 100.0 % 0.87 [ 0.70, 1.08 ]
Total events: 135 (Experimental), 173 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.98, df = 5 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Chi2 = 0.71, df = 2 (P = 0.70), I2 =0.0%
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Analysis 1.13. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 13 Very
low birthweight infants (< 1500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 13 Very low birthweight infants (< 1500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 6/331 8/400 51.7 % 0.91 [ 0.32, 2.59 ]
Subtotal (95% CI) 331 400 51.7 % 0.91 [ 0.32, 2.59 ]
Total events: 6 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.85)
2 Tailored interventions
Sexton 1984 9/463 5/472 48.3 % 1.83 [ 0.62, 5.43 ]
Subtotal (95% CI) 463 472 48.3 % 1.83 [ 0.62, 5.43 ]
Total events: 9 (Experimental), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
Total (95% CI) 794 872 100.0 % 1.27 [ 0.60, 2.71 ]
Total events: 15 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.84, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Chi2 = 0.84, df = 1 (P = 0.36), I2 =0.0%
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Analysis 1.14. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 14
Preterm births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 14 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Panjari 1999 18/339 34/391 27.8 % 0.61 [ 0.35, 1.06 ]
Tappin 2000 5/48 4/49 6.9 % 1.28 [ 0.36, 4.47 ]
Tappin 2005 35/342 43/402 39.9 % 0.96 [ 0.63, 1.46 ]
Subtotal (95% CI) 729 842 74.6 % 0.83 [ 0.60, 1.17 ]
Total events: 58 (Experimental), 81 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.07, df = 2 (P = 0.35); I2 =4%
Test for overall effect: Z = 1.06 (P = 0.29)
2 Tailored interventions
Hegaard 2003 7/334 10/330 11.4 % 0.69 [ 0.27, 1.80 ]
Thornton 1997 14/209 8/209 14.0 % 1.75 [ 0.75, 4.08 ]
Subtotal (95% CI) 543 539 25.4 % 1.13 [ 0.46, 2.80 ]
Total events: 21 (Experimental), 18 (Control)
Heterogeneity: Tau2 = 0.22; Chi2 = 2.03, df = 1 (P = 0.15); I2 =51%
Test for overall effect: Z = 0.26 (P = 0.79)
Total (95% CI) 1272 1381 100.0 % 0.90 [ 0.64, 1.27 ]
Total events: 79 (Experimental), 99 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 4.93, df = 4 (P = 0.29); I2 =19%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Chi2 = 0.38, df = 1 (P = 0.54), I2 =0.0%
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Analysis 1.15. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 15 Mean
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 15 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Panjari 1999 337 3250 (526) 391 3166 (589) 16.3 % 84.00 [ 2.99, 165.01 ]
Polanska 2004 149 3104 (745) 144 3138 (1090) 2.7 % -34.00 [ -248.49, 180.49 ]
Tappin 2000 48 3205 (578) 49 3271 (578) 2.4 % -66.00 [ -296.06, 164.06 ]
Tappin 2005 351 3078 (602) 411 3048 (642) 14.1 % 30.00 [ -58.42, 118.42 ]
Subtotal (95% CI) 885 995 35.4 % 45.65 [ -10.17, 101.48 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.42, df = 3 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 1.60 (P = 0.11)
2 Multiple interventions
Secker-Walker 1994 279 3291 (468) 282 3255 (466) 17.6 % 36.00 [ -41.29, 113.29 ]
Vilches 2009 9 3398.89 (489.78) 54 3140.83 (375.12) 1.1 % 258.06 [ -77.20, 593.32 ]
Subtotal (95% CI) 288 336 18.7 % 84.65 [ -95.37, 264.67 ]
Heterogeneity: Tau2 = 9247.95; Chi2 = 1.60, df = 1 (P = 0.21); I2 =38%
Test for overall effect: Z = 0.92 (P = 0.36)
3 Tailored interventions
Hegaard 2003 327 3401 (578) 320 3433 (578) 13.9 % -32.00 [ -121.08, 57.08 ]
Sexton 1984 463 3278 (627) 472 3186 (566) 17.8 % 92.00 [ 15.39, 168.61 ]
Thornton 1997 380 3267 (624) 380 3266 (613) 14.2 % 1.00 [ -86.95, 88.95 ]
Subtotal (95% CI) 1170 1172 45.9 % 23.25 [ -52.12, 98.62 ]
Heterogeneity: Tau2 = 2581.28; Chi2 = 4.79, df = 2 (P = 0.09); I2 =58%
Test for overall effect: Z = 0.60 (P = 0.55)
Total (95% CI) 2343 2503 100.0 % 36.72 [ 0.70, 72.74 ]
Heterogeneity: Tau2 = 368.17; Chi2 = 9.11, df = 8 (P = 0.33); I2 =12%
Test for overall effect: Z = 2.00 (P = 0.046)
Test for subgroup differences: Chi2 = 0.47, df = 2 (P = 0.79), I2 =0.0%
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Analysis 1.16. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 16
Perinatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 16 Perinatal deaths
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Valbo 1996 0/52 0/78 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 52 78 0.0 [ 0.0, 0.0 ]
Total events: 0 (Experimental), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
2 Tailored interventions
Sexton 1984 14/463 13/472 1.10 [ 0.52, 2.31 ]
Subtotal (95% CI) 463 472 1.10 [ 0.52, 2.31 ]
Total events: 14 (Experimental), 13 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.81)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours experimental Favours control
287Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.17. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 17
Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 17 Stillbirths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2000 1/48 0/49 5.6 % 3.06 [ 0.13, 73.34 ]
Tappin 2005 2/351 1/411 9.9 % 2.34 [ 0.21, 25.72 ]
Subtotal (95% CI) 399 460 15.5 % 2.58 [ 0.38, 17.48 ]
Total events: 3 (Experimental), 1 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.97 (P = 0.33)
2 Tailored interventions
Sexton 1984 9/463 11/472 74.6 % 0.83 [ 0.35, 1.99 ]
Thornton 1997 2/209 1/209 9.9 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 672 681 84.5 % 0.92 [ 0.41, 2.10 ]
Total events: 11 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.45, df = 1 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
Total (95% CI) 1071 1141 100.0 % 1.08 [ 0.51, 2.30 ]
Total events: 14 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.41, df = 3 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Chi2 = 0.94, df = 1 (P = 0.33), I2 =0.0%
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Analysis 1.18. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 18
Neonatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 18 Neonatal deaths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 1/351 1/411 19.2 % 1.17 [ 0.07, 18.65 ]
Subtotal (95% CI) 351 411 19.2 % 1.17 [ 0.07, 18.65 ]
Total events: 1 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
2 Tailored interventions
Sexton 1984 5/454 2/461 55.1 % 2.54 [ 0.50, 13.02 ]
Thornton 1997 2/209 1/209 25.7 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 663 670 80.8 % 2.35 [ 0.61, 9.07 ]
Total events: 7 (Experimental), 3 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.21)
Total (95% CI) 1014 1081 100.0 % 2.06 [ 0.61, 6.92 ]
Total events: 8 (Experimental), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.22, df = 2 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.66), I2 =0.0%
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Analysis 1.19. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 19 NICU
admissions.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 19 NICU admissions
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 32/351 53/411 69.8 % 0.71 [ 0.47, 1.07 ]
Subtotal (95% CI) 351 411 69.8 % 0.71 [ 0.47, 1.07 ]
Total events: 32 (Experimental), 53 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
2 Tailored interventions
Thornton 1997 14/189 12/189 30.2 % 1.17 [ 0.55, 2.46 ]
Subtotal (95% CI) 189 189 30.2 % 1.17 [ 0.55, 2.46 ]
Total events: 14 (Experimental), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
Total (95% CI) 540 600 100.0 % 0.82 [ 0.52, 1.29 ]
Total events: 46 (Experimental), 65 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.33, df = 1 (P = 0.25); I2 =25%
Test for overall effect: Z = 0.85 (P = 0.40)
Test for subgroup differences: Chi2 = 1.33, df = 1 (P = 0.25), I2 =25%
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Analysis 2.1. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2000 3/42 5/40 3.3 % 0.57 [ 0.15, 2.24 ]
Dornelas 2006 15/53 5/52 5.2 % 2.94 [ 1.15, 7.51 ]
Ershoff 1989 33/126 20/116 8.3 % 1.52 [ 0.93, 2.49 ]
Ershoff 1999 25/131 21/126 8.0 % 1.15 [ 0.68, 1.94 ]
Secker-Walker 1997 5/21 0/28 1.0 % 14.50 [ 0.85, 248.56 ]
Subtotal (95% CI) 373 362 25.9 % 1.51 [ 0.90, 2.54 ]
Total events: 81 (Experimental), 51 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 7.41, df = 4 (P = 0.12); I2 =46%
Test for overall effect: Z = 1.55 (P = 0.12)
2 Multiple interventions
Cook 1995 8/23 2/20 3.1 % 3.48 [ 0.83, 14.52 ]
McBride 1999 72/341 30/160 9.1 % 1.13 [ 0.77, 1.65 ]
Messimer 1989 8/30 4/29 4.5 % 1.93 [ 0.65, 5.73 ]
Parker 2007 63/358 42/378 9.2 % 1.58 [ 1.10, 2.28 ]
Patten 2009 0/16 1/17 0.9 % 0.35 [ 0.02, 8.08 ]
Rigotti 2006 21/209 16/212 7.3 % 1.33 [ 0.71, 2.48 ]
Secker-Walker 1998 19/142 14/149 7.1 % 1.42 [ 0.74, 2.73 ]
Stotts 2002 27/134 28/135 8.4 % 0.97 [ 0.61, 1.56 ]
Windsor 1993 57/400 35/414 9.0 % 1.69 [ 1.13, 2.51 ]
Windsor 2011 65/547 127/546 9.8 % 0.51 [ 0.39, 0.67 ]
Subtotal (95% CI) 2200 2060 68.3 % 1.23 [ 0.84, 1.78 ]
Total events: 340 (Experimental), 299 (Control)
Heterogeneity: Tau2 = 0.24; Chi2 = 42.78, df = 9 (P<0.00001); I2 =79%
Test for overall effect: Z = 1.07 (P = 0.28)
3 Tailored interventions
Walsh 1997 17/127 7/125 5.8 % 2.39 [ 1.03, 5.56 ]
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Subtotal (95% CI) 127 125 5.8 % 2.39 [ 1.03, 5.56 ]
Total events: 17 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.043)
Total (95% CI) 2700 2547 100.0 % 1.35 [ 1.00, 1.82 ]
Total events: 438 (Experimental), 357 (Control)
Heterogeneity: Tau2 = 0.22; Chi2 = 56.79, df = 15 (P<0.00001); I2 =74%
Test for overall effect: Z = 1.94 (P = 0.052)
Test for subgroup differences: Chi2 = 2.10, df = 2 (P = 0.35), I2 =5%
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Analysis 2.2. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2000 3/42 5/40 2.8 % 0.57 [ 0.15, 2.24 ]
Dornelas 2006 15/53 5/52 5.5 % 2.94 [ 1.15, 7.51 ]
Ershoff 1989 33/126 20/116 14.3 % 1.52 [ 0.93, 2.49 ]
Ershoff 1999 25/131 21/126 13.2 % 1.15 [ 0.68, 1.94 ]
Secker-Walker 1997 5/21 0/28 0.7 % 14.50 [ 0.85, 248.56 ]
Subtotal (95% CI) 373 362 36.5 % 1.51 [ 0.90, 2.54 ]
Total events: 81 (Experimental), 51 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 7.41, df = 4 (P = 0.12); I2 =46%
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Test for overall effect: Z = 1.55 (P = 0.12)
2 Multiple interventions
Cook 1995 8/23 2/20 2.5 % 3.48 [ 0.83, 14.52 ]
Patten 2009 0/16 1/17 0.6 % 0.35 [ 0.02, 8.08 ]
Rigotti 2006 21/209 16/212 10.5 % 1.33 [ 0.71, 2.48 ]
Secker-Walker 1998 19/142 14/149 9.8 % 1.42 [ 0.74, 2.73 ]
Stotts 2002 27/134 28/135 15.2 % 0.97 [ 0.61, 1.56 ]
Windsor 1993 57/400 35/414 18.4 % 1.69 [ 1.13, 2.51 ]
Subtotal (95% CI) 924 947 57.0 % 1.38 [ 1.05, 1.80 ]
Total events: 132 (Experimental), 96 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 5.47, df = 5 (P = 0.36); I2 =9%
Test for overall effect: Z = 2.34 (P = 0.019)
3 Tailored interventions
Walsh 1997 17/127 7/125 6.5 % 2.39 [ 1.03, 5.56 ]
Subtotal (95% CI) 127 125 6.5 % 2.39 [ 1.03, 5.56 ]
Total events: 17 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.043)
Total (95% CI) 1424 1434 100.0 % 1.46 [ 1.15, 1.85 ]
Total events: 230 (Experimental), 154 (Control)
Heterogeneity: Tau2 = 0.04; Chi2 = 14.37, df = 11 (P = 0.21); I2 =23%
Test for overall effect: Z = 3.14 (P = 0.0017)
Test for subgroup differences: Chi2 = 1.51, df = 2 (P = 0.47), I2 =0.0%
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Analysis 2.3. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 3 Continued abstinence (relapse prevention) in late pregnancy (spontaneous quitters).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 3 Continued abstinence (relapse prevention) in late pregnancy (spontaneous quitters)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Dornelas 2006 10/14 16/19 3.8 % 0.85 [ 0.58, 1.25 ]
Ershoff 1989 73/87 67/84 28.0 % 1.05 [ 0.91, 1.21 ]
Subtotal (95% CI) 101 103 31.8 % 1.02 [ 0.88, 1.18 ]
Total events: 83 (Experimental), 83 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 1.07, df = 1 (P = 0.30); I2 =7%
Test for overall effect: Z = 0.25 (P = 0.80)
2 Multiple interventions
McBride 1999 225/259 110/137 61.6 % 1.08 [ 0.98, 1.19 ]
Secker-Walker 1998 28/44 33/48 6.5 % 0.93 [ 0.69, 1.24 ]
Subtotal (95% CI) 303 185 68.2 % 1.06 [ 0.96, 1.17 ]
Total events: 253 (Experimental), 143 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 1.04, df = 1 (P = 0.31); I2 =4%
Test for overall effect: Z = 1.21 (P = 0.23)
3 Tailored interventions
Subtotal (95% CI) 0 0 0.0 % 0.0 [ 0.0, 0.0 ]
Total events: 0 (Experimental), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 404 288 100.0 % 1.05 [ 0.98, 1.13 ]
Total events: 336 (Experimental), 226 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.33, df = 3 (P = 0.51); I2 =0.0%
Test for overall effect: Z = 1.34 (P = 0.18)
Test for subgroup differences: Chi2 = 0.21, df = 1 (P = 0.65), I2 =0.0%
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Analysis 2.4. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 4 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2000 2/42 3/40 3.8 % 0.63 [ 0.11, 3.60 ]
Subtotal (95% CI) 42 40 3.8 % 0.63 [ 0.11, 3.60 ]
Total events: 2 (Experimental), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.51 (P = 0.61)
2 Multiple interventions
McBride 1999 222/600 89/297 52.4 % 1.23 [ 1.01, 1.51 ]
Messimer 1989 3/30 3/29 4.9 % 0.97 [ 0.21, 4.41 ]
Rigotti 2006 14/209 15/212 17.9 % 0.95 [ 0.47, 1.91 ]
Stotts 2002 14/134 14/135 18.0 % 1.01 [ 0.50, 2.03 ]
Subtotal (95% CI) 973 673 93.3 % 1.19 [ 0.99, 1.43 ]
Total events: 253 (Experimental), 121 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.83, df = 3 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 1.83 (P = 0.067)
3 Tailored interventions
Walsh 1997 13/127 1/125 2.9 % 12.80 [ 1.70, 96.35 ]
Subtotal (95% CI) 127 125 2.9 % 12.80 [ 1.70, 96.35 ]
Total events: 13 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.47 (P = 0.013)
Total (95% CI) 1142 838 100.0 % 1.17 [ 0.82, 1.66 ]
Total events: 268 (Experimental), 125 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 6.74, df = 5 (P = 0.24); I2 =26%
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Chi2 = 5.80, df = 2 (P = 0.05), I2 =66%
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Analysis 2.5. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 5 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 5 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Dornelas 2006 5/53 2/52 2.7 % 2.45 [ 0.50, 12.08 ]
Subtotal (95% CI) 53 52 2.7 % 2.45 [ 0.50, 12.08 ]
Total events: 5 (Experimental), 2 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
2 Multiple interventions
McBride 1999 172/600 77/297 86.1 % 1.11 [ 0.88, 1.39 ]
Stotts 2002 10/134 14/135 11.2 % 0.72 [ 0.33, 1.56 ]
Subtotal (95% CI) 734 432 97.3 % 1.05 [ 0.80, 1.38 ]
Total events: 182 (Experimental), 91 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.09, df = 1 (P = 0.30); I2 =8%
Test for overall effect: Z = 0.37 (P = 0.71)
Total (95% CI) 787 484 100.0 % 1.08 [ 0.83, 1.40 ]
Total events: 187 (Experimental), 93 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 2.11, df = 2 (P = 0.35); I2 =5%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Chi2 = 1.05, df = 1 (P = 0.31), I2 =5%
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Analysis 2.6. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 6 Abstinence at 12 to 17 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 6 Abstinence at 12 to 17 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
McBride 1999 145/600 71/297 64.1 % 1.01 [ 0.79, 1.29 ]
Secker-Walker 1998 21/142 12/149 35.9 % 1.84 [ 0.94, 3.59 ]
Total (95% CI) 742 446 100.0 % 1.25 [ 0.71, 2.20 ]
Total events: 166 (Experimental), 83 (Control)
Heterogeneity: Tau2 = 0.11; Chi2 = 2.69, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 0.78 (P = 0.43)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 7 Reduction in late pregnancy: self-reported > 50%.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 7 Reduction in late pregnancy: self-reported > 50%
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Rigotti 2006 61/209 46/212 50.8 % 1.35 [ 0.97, 1.87 ]
Windsor 1993 67/400 51/414 49.2 % 1.36 [ 0.97, 1.91 ]
Total (95% CI) 609 626 100.0 % 1.35 [ 1.07, 1.71 ]
Total events: 128 (Experimental), 97 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 2.50 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 8 Reduction in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 8 Reduction in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cook 1995 6/23 4/20 8.4 % 1.30 [ 0.43, 3.97 ]
Windsor 1993 67/400 51/414 91.6 % 1.36 [ 0.97, 1.91 ]
Total (95% CI) 423 434 100.0 % 1.35 [ 0.98, 1.87 ]
Total events: 73 (Experimental), 55 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 1.84 (P = 0.065)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 9 Mean cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 9 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Ershoff 1999 60 8.1 (8) 61 8 (8) 30.6 % 0.01 [ -0.34, 0.37 ]
Subtotal (95% CI) 60 61 30.6 % 0.01 [ -0.34, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.95)
2 Multiple interventions
Secker-Walker 1998 135 10.2 (8.4) 141 11.5 (7.8) 69.4 % -0.16 [ -0.40, 0.08 ]
Subtotal (95% CI) 135 141 69.4 % -0.16 [ -0.40, 0.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
Total (95% CI) 195 202 100.0 % -0.11 [ -0.30, 0.09 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.62, df = 1 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.07 (P = 0.29)
Test for subgroup differences: Chi2 = 0.62, df = 1 (P = 0.43), I2 =0.0%
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Analysis 2.10. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 10 Low birthweight infants (< 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 10 Low birthweight infants (< 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ershoff 1989 9/118 15/109 56.9 % 0.55 [ 0.25, 1.21 ]
Subtotal (95% CI) 118 109 56.9 % 0.55 [ 0.25, 1.21 ]
Total events: 9 (Experimental), 15 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
2 Multiple interventions
Secker-Walker 1998 7/135 12/141 43.1 % 0.61 [ 0.25, 1.50 ]
Subtotal (95% CI) 135 141 43.1 % 0.61 [ 0.25, 1.50 ]
Total events: 7 (Experimental), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
Total (95% CI) 253 250 100.0 % 0.58 [ 0.32, 1.04 ]
Total events: 16 (Experimental), 27 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.82 (P = 0.069)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.88), I2 =0.0%
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Analysis 2.11. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 11 Preterm births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 11 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ershoff 1989 9/118 15/109 50.0 % 0.55 [ 0.25, 1.21 ]
Subtotal (95% CI) 118 109 50.0 % 0.55 [ 0.25, 1.21 ]
Total events: 9 (Experimental), 15 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
2 Multiple interventions
Secker-Walker 1998 9/151 8/157 35.9 % 1.17 [ 0.46, 2.95 ]
Subtotal (95% CI) 151 157 35.9 % 1.17 [ 0.46, 2.95 ]
Total events: 9 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.33 (P = 0.74)
3 Tailored interventions
Walsh 1997 4/131 3/128 14.1 % 1.30 [ 0.30, 5.71 ]
Subtotal (95% CI) 131 128 14.1 % 1.30 [ 0.30, 5.71 ]
Total events: 4 (Experimental), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.73)
Total (95% CI) 400 394 100.0 % 0.82 [ 0.47, 1.42 ]
Total events: 22 (Experimental), 26 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.90, df = 2 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Chi2 = 1.90, df = 2 (P = 0.39), I2 =0.0%
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Analysis 2.12. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 12 Mean birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 12 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Ershoff 1989 118 3366 (578) 109 3309 (578) 33.8 % 57.00 [ -93.50, 207.50 ]
Subtotal (95% CI) 118 109 33.8 % 57.00 [ -93.50, 207.50 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
2 Multiple interventions
Cook 1995 23 2961 (578) 20 2713 (578) 6.4 % 248.00 [ -98.36, 594.36 ]
Secker-Walker 1998 135 3256 (452) 141 3221 (506) 59.8 % 35.00 [ -78.09, 148.09 ]
Subtotal (95% CI) 158 161 66.2 % 76.01 [ -88.59, 240.61 ]
Heterogeneity: Tau2 = 5405.09; Chi2 = 1.31, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 0.91 (P = 0.37)
Total (95% CI) 276 270 100.0 % 56.02 [ -31.46, 143.50 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.31, df = 2 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
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Analysis 3.1. Comparison 3 Smoking cessation interventions: health education vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 3 Smoking cessation interventions: health education vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Burling 1991 9/70 4/69 39.0 % 2.22 [ 0.72, 6.86 ]
Petersen 1992 6/43 8/47 47.0 % 0.82 [ 0.31, 2.17 ]
Subtotal (95% CI) 113 116 86.0 % 1.29 [ 0.49, 3.42 ]
Total events: 15 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.21; Chi2 = 1.72, df = 1 (P = 0.19); I2 =42%
Test for overall effect: Z = 0.52 (P = 0.61)
2 Multiple interventions
Lilley 1986 4/72 1/73 14.0 % 4.06 [ 0.46, 35.41 ]
Subtotal (95% CI) 72 73 14.0 % 4.06 [ 0.46, 35.41 ]
Total events: 4 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.21)
Total (95% CI) 185 189 100.0 % 1.51 [ 0.64, 3.59 ]
Total events: 19 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.17; Chi2 = 2.76, df = 2 (P = 0.25); I2 =28%
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Chi2 = 0.89, df = 1 (P = 0.35), I2 =0.0%
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Analysis 3.2. Comparison 3 Smoking cessation interventions: health education vs usual care, Outcome 2
Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 3 Smoking cessation interventions: health education vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Burling 1991 9/70 4/69 45.7 % 2.22 [ 0.72, 6.86 ]
Petersen 1992 6/43 8/47 54.3 % 0.82 [ 0.31, 2.17 ]
Total (95% CI) 113 116 100.0 % 1.29 [ 0.49, 3.42 ]
Total events: 15 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.21; Chi2 = 1.72, df = 1 (P = 0.19); I2 =42%
Test for overall effect: Z = 0.52 (P = 0.61)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Smoking cessation interventions: health education vs usual care, Outcome 3
Mean cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 3 Smoking cessation interventions: health education vs usual care
Outcome: 3 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Donovan 1977 263 9.2 (9.7304) 289 16.4 (10.2) 100.0 % -0.72 [ -0.89, -0.55 ]
Subtotal (95% CI) 263 289 100.0 % -0.72 [ -0.89, -0.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.19 (P < 0.00001)
2 Multiple interventions
Lilley 1986 66 13.1 (9.1) 69 16 (9.1) 100.0 % -0.32 [ -0.66, 0.02 ]
Subtotal (95% CI) 66 69 100.0 % -0.32 [ -0.66, 0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.067)
Test for subgroup differences: Chi2 = 4.31, df = 1 (P = 0.04), I2 =77%
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Analysis 4.1. Comparison 4 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 1 Abstinence in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hjalmarson 1991 56/444 18/209 73.9 % 1.46 [ 0.88, 2.43 ]
Subtotal (95% CI) 444 209 73.9 % 1.46 [ 0.88, 2.43 ]
Total events: 56 (Experimental), 18 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
2 Multiple interventions
Naughton 2012 12/96 8/102 26.1 % 1.59 [ 0.68, 3.73 ]
Subtotal (95% CI) 96 102 26.1 % 1.59 [ 0.68, 3.73 ]
Total events: 12 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
Total (95% CI) 540 311 100.0 % 1.50 [ 0.97, 2.31 ]
Total events: 68 (Experimental), 26 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.82 (P = 0.068)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
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Analysis 4.2. Comparison 4 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 2 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 2 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hjalmarson 1991 70/444 19/209 46.7 % 1.73 [ 1.07, 2.80 ]
Strecher 2000 94/104 79/87 53.3 % 1.00 [ 0.91, 1.09 ]
Subtotal (95% CI) 548 296 100.0 % 1.29 [ 0.52, 3.22 ]
Total events: 164 (Experimental), 98 (Control)
Heterogeneity: Tau2 = 0.41; Chi2 = 14.08, df = 1 (P = 0.00018); I2 =93%
Test for overall effect: Z = 0.55 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Smoking cessation interventions: feedback vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: feedback vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cope 2003 22/143 4/101 66.6 % 3.88 [ 1.38, 10.93 ]
Valbo 1994 11/55 2/56 33.4 % 5.60 [ 1.30, 24.11 ]
Total (95% CI) 198 157 100.0 % 4.39 [ 1.89, 10.21 ]
Total events: 33 (Experimental), 6 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.16, df = 1 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 3.43 (P = 0.00059)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
309Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.2. Comparison 5 Smoking cessation interventions: feedback vs usual care, Outcome 2 Reduction
in late pregnancy: various definitions.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: feedback vs usual care
Outcome: 2 Reduction in late pregnancy: various definitions
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cope 2003 42/143 20/101 44.2 % 1.48 [ 0.93, 2.37 ]
Valbo 1994 35/55 19/56 55.8 % 1.88 [ 1.24, 2.84 ]
Total (95% CI) 198 157 100.0 % 1.69 [ 1.24, 2.31 ]
Total events: 77 (Experimental), 39 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.55, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 3.31 (P = 0.00094)
Test for subgroup differences: Not applicable
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Analysis 5.3. Comparison 5 Smoking cessation interventions: feedback vs usual care, Outcome 3 Preterm
births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: feedback vs usual care
Outcome: 3 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cope 2003 6/149 13/114 33.9 % 0.35 [ 0.14, 0.90 ]
Haddow 1991 109/1423 137/1425 66.1 % 0.80 [ 0.63, 1.01 ]
Total (95% CI) 1572 1539 100.0 % 0.60 [ 0.28, 1.29 ]
Total events: 115 (Experimental), 150 (Control)
Heterogeneity: Tau2 = 0.21; Chi2 = 2.72, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.31 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 5.4. Comparison 5 Smoking cessation interventions: feedback vs usual care, Outcome 4 Mean
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: feedback vs usual care
Outcome: 4 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multiple interventions
Cope 2003 78 3260 (578) 80 3080 (578) 31.1 % 180.00 [ -0.27, 360.27 ]
Haddow 1991 1423 3263 (542) 1425 3229 (537) 68.9 % 34.00 [ -5.63, 73.63 ]
Total (95% CI) 1501 1505 100.0 % 79.43 [ -53.05, 211.91 ]
Heterogeneity: Tau2 = 6224.01; Chi2 = 2.40, df = 1 (P = 0.12); I2 =58%
Test for overall effect: Z = 1.18 (P = 0.24)
Test for subgroup differences: Not applicable
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Analysis 5.5. Comparison 5 Smoking cessation interventions: feedback vs usual care, Outcome 5 Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: feedback vs usual care
Outcome: 5 Stillbirths
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Haddow 1991 21/1423 17/1425 96.2 % 1.24 [ 0.66, 2.33 ]
Valbo 1994 1/56 0/56 3.8 % 3.00 [ 0.12, 72.10 ]
Total (95% CI) 1479 1481 100.0 % 1.28 [ 0.69, 2.39 ]
Total events: 22 (Treatment), 17 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.78 (P = 0.44)
Test for subgroup differences: Not applicable
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Analysis 6.1. Comparison 6 Smoking cessation interventions: feedback vs less intensive intervention,
Outcome 1 Abstinence in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 6 Smoking cessation interventions: feedback vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bauman 1983 3/36 6/43 34.2 % 0.60 [ 0.16, 2.22 ]
Subtotal (95% CI) 36 43 34.2 % 0.60 [ 0.16, 2.22 ]
Total events: 3 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
2 Multiple interventions
Stotts 2009 22/120 13/120 65.8 % 1.69 [ 0.89, 3.20 ]
Subtotal (95% CI) 120 120 65.8 % 1.69 [ 0.89, 3.20 ]
Total events: 22 (Experimental), 13 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.62 (P = 0.11)
Total (95% CI) 156 163 100.0 % 1.19 [ 0.45, 3.12 ]
Total events: 25 (Experimental), 19 (Control)
Heterogeneity: Tau2 = 0.27; Chi2 = 1.96, df = 1 (P = 0.16); I2 =49%
Test for overall effect: Z = 0.34 (P = 0.73)
Test for subgroup differences: Chi2 = 1.96, df = 1 (P = 0.16), I2 =49%
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Analysis 7.1. Comparison 7 Smoking cessation interventions: incentives vs usual care, Outcome 1
Abstinence in late pregnancy:biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: incentives vs usual care
Outcome: 1 Abstinence in late pregnancy:biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tuten 2012 13/42 0/32 44.2 % 20.72 [ 1.28, 336.01 ]
Subtotal (95% CI) 42 32 44.2 % 20.72 [ 1.28, 336.01 ]
Total events: 13 (Experimental), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.13 (P = 0.033)
2 Tailored interventions
Ondersma 2012 4/29 4/26 55.8 % 0.90 [ 0.25, 3.23 ]
Subtotal (95% CI) 29 26 55.8 % 0.90 [ 0.25, 3.23 ]
Total events: 4 (Experimental), 4 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
Total (95% CI) 71 58 100.0 % 3.59 [ 0.10, 130.49 ]
Total events: 17 (Experimental), 4 (Control)
Heterogeneity: Tau2 = 5.59; Chi2 = 5.57, df = 1 (P = 0.02); I2 =82%
Test for overall effect: Z = 0.70 (P = 0.49)
Test for subgroup differences: Chi2 = 4.03, df = 1 (P = 0.04), I2 =75%
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Analysis 8.1. Comparison 8 Smoking cessation interventions: social support vs less intensive intervention,
Outcome 1 Abstinence in late pregnancy (peer and partner support).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 8 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy (peer and partner support)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hennrikus 2010 7/54 1/28 2.4 % 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 21.5 % 1.12 [ 0.61, 2.06 ]
Subtotal (95% CI) 121 103 23.9 % 1.35 [ 0.57, 3.18 ]
Total events: 23 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 1.22, df = 1 (P = 0.27); I2 =18%
Test for overall effect: Z = 0.68 (P = 0.50)
2 Multiple interventions
Albrecht 1998 3/26 5/58 5.3 % 1.34 [ 0.35, 5.19 ]
Albrecht 2006 17/45 7/50 14.3 % 2.70 [ 1.23, 5.90 ]
McBride 2004 33/89 33/91 40.0 % 1.02 [ 0.70, 1.50 ]
Subtotal (95% CI) 160 199 59.7 % 1.48 [ 0.74, 2.95 ]
Total events: 53 (Experimental), 45 (Control)
Heterogeneity: Tau2 = 0.21; Chi2 = 4.87, df = 2 (P = 0.09); I2 =59%
Test for overall effect: Z = 1.11 (P = 0.27)
3 Tailored interventions
Solomon 2000 14/77 11/74 16.4 % 1.22 [ 0.59, 2.52 ]
Subtotal (95% CI) 77 74 16.4 % 1.22 [ 0.59, 2.52 ]
Total events: 14 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 358 376 100.0 % 1.29 [ 0.94, 1.78 ]
Total events: 90 (Experimental), 73 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 6.07, df = 5 (P = 0.30); I2 =18%
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Chi2 = 0.14, df = 2 (P = 0.93), I2 =0.0%
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Analysis 8.2. Comparison 8 Smoking cessation interventions: social support vs less intensive intervention,
Outcome 2 Abstinence in late pregnancy: biochemically validated (peer support only).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 8 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated (peer support only)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hennrikus 2010 7/54 1/28 3.6 % 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 37.7 % 1.12 [ 0.61, 2.06 ]
Subtotal (95% CI) 121 103 41.2 % 1.35 [ 0.57, 3.18 ]
Total events: 23 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 1.22, df = 1 (P = 0.27); I2 =18%
Test for overall effect: Z = 0.68 (P = 0.50)
2 Multiple interventions
Albrecht 1998 3/26 5/58 8.0 % 1.34 [ 0.35, 5.19 ]
Albrecht 2006 17/45 7/50 23.4 % 2.70 [ 1.23, 5.90 ]
Subtotal (95% CI) 71 108 31.5 % 2.26 [ 1.15, 4.46 ]
Total events: 20 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.77, df = 1 (P = 0.38); I2 =0.0%
Test for overall effect: Z = 2.36 (P = 0.018)
3 Tailored interventions
Solomon 2000 14/77 11/74 27.3 % 1.22 [ 0.59, 2.52 ]
Subtotal (95% CI) 77 74 27.3 % 1.22 [ 0.59, 2.52 ]
Total events: 14 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 269 285 100.0 % 1.49 [ 1.01, 2.19 ]
Total events: 57 (Experimental), 40 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 4.13, df = 4 (P = 0.39); I2 =3%
Test for overall effect: Z = 2.02 (P = 0.043)
Test for subgroup differences: Chi2 = 1.69, df = 2 (P = 0.43), I2 =0.0%
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Analysis 8.3. Comparison 8 Smoking cessation interventions: social support vs less intensive intervention,
Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 8 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hennrikus 2010 5/54 0/28 12.6 % 5.80 [ 0.33, 101.27 ]
Subtotal (95% CI) 54 28 12.6 % 5.80 [ 0.33, 101.27 ]
Total events: 5 (Experimental), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.20 (P = 0.23)
2 Multiple interventions
McBride 2004 81/193 75/198 87.4 % 1.11 [ 0.87, 1.41 ]
Subtotal (95% CI) 193 198 87.4 % 1.11 [ 0.87, 1.41 ]
Total events: 81 (Experimental), 75 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.41)
Total (95% CI) 247 226 100.0 % 1.36 [ 0.46, 4.07 ]
Total events: 86 (Experimental), 75 (Control)
Heterogeneity: Tau2 = 0.34; Chi2 = 1.32, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 0.56 (P = 0.58)
Test for subgroup differences: Chi2 = 1.28, df = 1 (P = 0.26), I2 =22%
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Analysis 8.4. Comparison 8 Smoking cessation interventions: social support vs less intensive intervention,
Outcome 4 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 8 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 4 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Albrecht 2006 4/45 7/50 5.2 % 0.63 [ 0.20, 2.03 ]
McBride 2004 71/193 65/198 94.8 % 1.12 [ 0.85, 1.47 ]
Total (95% CI) 238 248 100.0 % 1.09 [ 0.83, 1.42 ]
Total events: 75 (Experimental), 72 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.88, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 9.1. Comparison 9 Maternal health intervention with smoking cessation component: social
support (tailored) vs usual care, Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Maternal health intervention with smoking cessation component: social support (tailored) vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Self-reported
Belizan 1995 59/255 30/237 1.83 [ 1.22, 2.73 ]
Subtotal (95% CI) 255 237 1.83 [ 1.22, 2.73 ]
Total events: 59 (Experimental), 30 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.94 (P = 0.0033)
2 Biochemically validated
Olds 1986 0/77 0/64 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 77 64 0.0 [ 0.0, 0.0 ]
Total events: 0 (Experimental), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 9.2. Comparison 9 Maternal health intervention with smoking cessation component: social
support (tailored) vs usual care, Outcome 2 Self-reported mean cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Maternal health intervention with smoking cessation component: social support (tailored) vs usual care
Outcome: 2 Self-reported mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Self-reported
Belizan 1995 195 8.4 (8.1) 206 10.9 (12.5) 74.4 % -0.24 [ -0.43, -0.04 ]
Subtotal (95% CI) 195 206 74.4 % -0.24 [ -0.43, -0.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.35 (P = 0.019)
2 Biochemically validated
Olds 1986 77 13.39 (6.5) 64 16 (6.5) 25.6 % -0.40 [ -0.73, -0.06 ]
Subtotal (95% CI) 77 64 25.6 % -0.40 [ -0.73, -0.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.34 (P = 0.019)
Total (95% CI) 272 270 100.0 % -0.28 [ -0.45, -0.11 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.68, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 3.21 (P = 0.0013)
Test for subgroup differences: Chi2 = 0.68, df = 1 (P = 0.41), I2 =0.0%
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Analysis 10.1. Comparison 10 Maternal health intervention with smoking cessation component: social
support vs less intensive intervention, Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 10 Maternal health intervention with smoking cessation component: social support vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bullock 1995 2/31 5/35 12.7 % 0.45 [ 0.09, 2.16 ]
Subtotal (95% CI) 31 35 12.7 % 0.45 [ 0.09, 2.16 ]
Total events: 2 (Experimental), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
2 Tailored interventions
Bullock 2009 17/124 20/126 87.3 % 0.86 [ 0.48, 1.57 ]
Subtotal (95% CI) 124 126 87.3 % 0.86 [ 0.48, 1.57 ]
Total events: 17 (Experimental), 20 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Total (95% CI) 155 161 100.0 % 0.80 [ 0.46, 1.39 ]
Total events: 19 (Experimental), 25 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.58, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.80 (P = 0.42)
Test for subgroup differences: Chi2 = 0.57, df = 1 (P = 0.45), I2 =0.0%
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Analysis 10.2. Comparison 10 Maternal health intervention with smoking cessation component: social
support vs less intensive intervention, Outcome 2 Abstinence in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 10 Maternal health intervention with smoking cessation component: social support vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Tailored interventions
Bullock 2009 17/124 20/126 100.0 % 0.86 [ 0.48, 1.57 ]
Total (95% CI) 124 126 100.0 % 0.86 [ 0.48, 1.57 ]
Total events: 17 (Experimental), 20 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 11.1. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 1 Abstinence in late pregnancy: self-reported and biochemically
validated (non-winsorised).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 1 Abstinence in late pregnancy: self-reported and biochemically validated (non-winsorised)
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Baric 1976 9/63 2/47 3.36 [ 0.76, 14.82 ]
Cinciripini 2000 3/42 5/40 0.57 [ 0.15, 2.24 ]
Cinciripini 2010 58/128 51/129 1.15 [ 0.86, 1.53 ]
Cook 1995 8/23 2/20 3.48 [ 0.83, 14.52 ]
Dornelas 2006 15/53 5/52 2.94 [ 1.15, 7.51 ]
Dunkley 1997 4/50 0/50 9.00 [ 0.50, 162.89 ]
Eades 2012 1/124 2/107 0.43 [ 0.04, 4.69 ]
El-Mohandes 2011 44/106 38/92 1.00 [ 0.72, 1.40 ]
Ershoff 1989 33/126 20/116 1.52 [ 0.93, 2.49 ]
Ershoff 1999 25/131 21/126 1.15 [ 0.68, 1.94 ]
Gielen 1997 12/193 11/198 1.12 [ 0.51, 2.48 ]
Hajek 2001 80/365 73/367 1.10 [ 0.83, 1.46 ]
Hartmann 1996 27/113 16/106 1.58 [ 0.91, 2.77 ]
Haug 1994 42/229 8/93 2.13 [ 1.04, 4.37 ]
Hegaard 2003 23/327 7/320 3.22 [ 1.40, 7.39 ]
Kendrick 1995 48/822 65/1063 0.95 [ 0.67, 1.37 ]
Lawrence 2003 17/309 5/283 3.11 [ 1.16, 8.33 ]
Lillington 1995 7/16 4/18 1.97 [ 0.70, 5.50 ]
Loeb 1983 42/477 39/486 1.10 [ 0.72, 1.67 ]
Mayer 1990 8/72 2/77 4.28 [ 0.94, 19.48 ]
McBride 1999 72/341 30/160 1.13 [ 0.77, 1.65 ]
McLeod 2004 30/163 13/109 1.54 [ 0.84, 2.82 ]
Messimer 1989 8/30 4/29 1.93 [ 0.65, 5.73 ]
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Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Moore 2002 88/523 108/567 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 1.20 [ 0.75, 1.93 ]
Parker 2007 63/358 42/378 1.58 [ 1.10, 2.28 ]
Patten 2009 0/16 1/17 0.35 [ 0.02, 8.08 ]
Pbert 2004 5/26 2/18 1.73 [ 0.38, 7.96 ]
Price 1991 4/71 1/70 3.94 [ 0.45, 34.41 ]
Rigotti 2006 21/209 16/212 1.33 [ 0.71, 2.48 ]
Secker-Walker 1994 29/255 26/258 1.13 [ 0.68, 1.86 ]
Secker-Walker 1997 5/21 0/28 14.50 [ 0.85, 248.56 ]
Secker-Walker 1998 19/142 14/149 1.42 [ 0.74, 2.73 ]
Sexton 1984 167/436 79/443 2.15 [ 1.70, 2.71 ]
Stotts 2002 27/134 28/135 0.97 [ 0.61, 1.56 ]
Stotts 2004 3/24 5/30 0.75 [ 0.20, 2.83 ]
Tappin 2000 2/48 2/49 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 1.05 [ 0.56, 2.00 ]
Thornton 1997 20/190 14/177 1.33 [ 0.69, 2.55 ]
Tsoh 2010 6/23 2/19 2.48 [ 0.56, 10.89 ]
Valbo 1996 5/52 8/78 0.94 [ 0.32, 2.71 ]
Walsh 1997 17/127 7/125 2.39 [ 1.03, 5.56 ]
Windsor 1985 14/102 2/104 7.14 [ 1.66, 30.62 ]
Windsor 1993 57/400 35/414 1.69 [ 1.13, 2.51 ]
Windsor 2011 65/547 127/546 0.51 [ 0.39, 0.67 ]
Subtotal (95% CI) 8830 8851 1.37 [ 1.17, 1.59 ]
Total events: 1283 (Experimental), 992 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 121.09, df = 44 (P<0.00001); I2 =64%
Test for overall effect: Z = 4.01 (P = 0.000060)
2 Health education
Burling 1991 9/70 4/69 2.22 [ 0.72, 6.86 ]
Hjalmarson 1991 56/444 18/209 1.46 [ 0.88, 2.43 ]
Lilley 1986 4/72 1/73 4.06 [ 0.46, 35.41 ]
Naughton 2012 12/96 8/102 1.59 [ 0.68, 3.73 ]
Petersen 1992 6/43 8/47 0.82 [ 0.31, 2.17 ]
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Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Subtotal (95% CI) 725 500 1.47 [ 1.02, 2.13 ]
Total events: 87 (Experimental), 39 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.78, df = 4 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 2.06 (P = 0.039)
3 Feedback
Bauman 1983 3/36 6/43 0.60 [ 0.16, 2.22 ]
Cope 2003 22/143 4/101 3.88 [ 1.38, 10.93 ]
Reading 1982 19/39 6/26 2.11 [ 0.98, 4.57 ]
Stotts 2009 22/120 13/120 1.69 [ 0.89, 3.20 ]
Valbo 1994 11/55 2/56 5.60 [ 1.30, 24.11 ]
Subtotal (95% CI) 393 346 2.09 [ 1.17, 3.72 ]
Total events: 77 (Experimental), 31 (Control)
Heterogeneity: Tau2 = 0.18; Chi2 = 7.12, df = 4 (P = 0.13); I2 =44%
Test for overall effect: Z = 2.50 (P = 0.012)
4 Incentives
Donatelle 2000 34/112 9/108 3.64 [ 1.84, 7.23 ]
Heil 2008 15/37 4/40 4.05 [ 1.48, 11.11 ]
Ondersma 2012 4/29 4/26 0.90 [ 0.25, 3.23 ]
Tuten 2012 13/42 0/32 20.72 [ 1.28, 336.01 ]
Subtotal (95% CI) 220 206 3.09 [ 1.34, 7.15 ]
Total events: 66 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.35; Chi2 = 6.12, df = 3 (P = 0.11); I2 =51%
Test for overall effect: Z = 2.63 (P = 0.0084)
5 Social support
Albrecht 1998 3/26 5/58 1.34 [ 0.35, 5.19 ]
Albrecht 2006 17/45 7/50 2.70 [ 1.23, 5.90 ]
Belizan 1995 59/255 30/237 1.83 [ 1.22, 2.73 ]
Bullock 1995 2/31 5/35 0.45 [ 0.09, 2.16 ]
Bullock 2009 17/124 20/126 0.86 [ 0.48, 1.57 ]
Hennrikus 2010 7/54 1/28 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 1.12 [ 0.61, 2.06 ]
McBride 2004 33/89 33/91 1.02 [ 0.70, 1.50 ]
Olds 1986 0/77 0/64 0.0 [ 0.0, 0.0 ]
Solomon 2000 14/77 11/74 1.22 [ 0.59, 2.52 ]
Subtotal (95% CI) 845 838 1.29 [ 0.97, 1.73 ]
Total events: 168 (Experimental), 128 (Control)
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Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heterogeneity: Tau2 = 0.06; Chi2 = 12.45, df = 8 (P = 0.13); I2 =36%
Test for overall effect: Z = 1.74 (P = 0.082)
6 Other
Campbell 2006 10/98 6/96 1.63 [ 0.62, 4.32 ]
Subtotal (95% CI) 98 96 1.63 [ 0.62, 4.32 ]
Total events: 10 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Total (95% CI) 11111 10837 1.45 [ 1.27, 1.64 ]
Total events: 1691 (Experimental), 1213 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 169.07, df = 68 (P<0.00001); I2 =60%
Test for overall effect: Z = 5.61 (P < 0.00001)
Test for subgroup differences: Chi2 = 5.80, df = 5 (P = 0.33), I2 =14%
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Analysis 11.2. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 2 Abstinence in late pregnancy: biochemically validated only (non-
winsorised).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 2 Abstinence in late pregnancy: biochemically validated only (non-winsorised)
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Cinciripini 2000 3/42 5/40 0.57 [ 0.15, 2.24 ]
Cinciripini 2010 58/128 51/129 1.15 [ 0.86, 1.53 ]
Cook 1995 8/23 2/20 3.48 [ 0.83, 14.52 ]
Dornelas 2006 15/53 5/52 2.94 [ 1.15, 7.51 ]
Eades 2012 1/124 2/107 0.43 [ 0.04, 4.69 ]
El-Mohandes 2011 44/106 38/92 1.00 [ 0.72, 1.40 ]
Ershoff 1989 33/126 20/116 1.52 [ 0.93, 2.49 ]
Ershoff 1999 25/131 21/126 1.15 [ 0.68, 1.94 ]
Gielen 1997 12/193 11/198 1.12 [ 0.51, 2.48 ]
Hajek 2001 80/365 73/367 1.10 [ 0.83, 1.46 ]
Hartmann 1996 27/113 16/106 1.58 [ 0.91, 2.77 ]
Hegaard 2003 23/327 7/320 3.22 [ 1.40, 7.39 ]
Kendrick 1995 48/822 65/1063 0.95 [ 0.67, 1.37 ]
Lawrence 2003 17/309 5/283 3.11 [ 1.16, 8.33 ]
Moore 2002 88/523 108/567 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 1.20 [ 0.75, 1.93 ]
Patten 2009 0/16 1/17 0.35 [ 0.02, 8.08 ]
Pbert 2004 5/26 2/18 1.73 [ 0.38, 7.96 ]
Price 1991 4/71 1/70 3.94 [ 0.45, 34.41 ]
Rigotti 2006 21/209 16/212 1.33 [ 0.71, 2.48 ]
Secker-Walker 1994 29/255 26/258 1.13 [ 0.68, 1.86 ]
Secker-Walker 1997 5/21 0/28 14.50 [ 0.85, 248.56 ]
Secker-Walker 1998 19/142 14/149 1.42 [ 0.74, 2.73 ]
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Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Stotts 2002 27/134 28/135 0.97 [ 0.61, 1.56 ]
Stotts 2004 3/24 5/30 0.75 [ 0.20, 2.83 ]
Tappin 2000 2/48 2/49 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 1.05 [ 0.56, 2.00 ]
Walsh 1997 17/127 7/125 2.39 [ 1.03, 5.56 ]
Windsor 1985 14/102 2/104 7.14 [ 1.66, 30.62 ]
Windsor 1993 57/400 35/414 1.69 [ 1.13, 2.51 ]
Subtotal (95% CI) 5783 6141 1.27 [ 1.11, 1.47 ]
Total events: 735 (Experimental), 618 (Control)
Heterogeneity: Tau2 = 0.04; Chi2 = 45.34, df = 29 (P = 0.03); I2 =36%
Test for overall effect: Z = 3.35 (P = 0.00081)
2 Health education
Burling 1991 9/70 4/69 2.22 [ 0.72, 6.86 ]
Hjalmarson 1991 56/444 18/209 1.46 [ 0.88, 2.43 ]
Naughton 2012 12/96 8/102 1.59 [ 0.68, 3.73 ]
Petersen 1992 6/43 8/47 0.82 [ 0.31, 2.17 ]
Subtotal (95% CI) 653 427 1.43 [ 0.98, 2.08 ]
Total events: 83 (Experimental), 38 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.91, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.87 (P = 0.061)
3 Feedback
Bauman 1983 3/36 6/43 0.60 [ 0.16, 2.22 ]
Cope 2003 22/143 4/101 3.88 [ 1.38, 10.93 ]
Stotts 2009 22/120 13/120 1.69 [ 0.89, 3.20 ]
Subtotal (95% CI) 299 264 1.70 [ 0.71, 4.08 ]
Total events: 47 (Experimental), 23 (Control)
Heterogeneity: Tau2 = 0.35; Chi2 = 4.92, df = 2 (P = 0.09); I2 =59%
Test for overall effect: Z = 1.18 (P = 0.24)
4 Incentives
Donatelle 2000 34/112 9/108 3.64 [ 1.84, 7.23 ]
Heil 2008 15/37 4/40 4.05 [ 1.48, 11.11 ]
Ondersma 2012 4/29 4/26 0.90 [ 0.25, 3.23 ]
Tuten 2012 13/42 0/32 20.72 [ 1.28, 336.01 ]
Subtotal (95% CI) 220 206 3.09 [ 1.34, 7.15 ]
Total events: 66 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.35; Chi2 = 6.12, df = 3 (P = 0.11); I2 =51%
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Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Test for overall effect: Z = 2.63 (P = 0.0084)
5 Social support
Albrecht 1998 3/26 5/58 1.34 [ 0.35, 5.19 ]
Albrecht 2006 17/45 7/50 2.70 [ 1.23, 5.90 ]
Bullock 2009 17/124 20/126 0.86 [ 0.48, 1.57 ]
Hennrikus 2010 7/54 1/28 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 1.12 [ 0.61, 2.06 ]
Olds 1986 0/77 0/64 0.0 [ 0.0, 0.0 ]
Solomon 2000 14/77 11/74 1.22 [ 0.59, 2.52 ]
Subtotal (95% CI) 470 475 1.31 [ 0.90, 1.91 ]
Total events: 74 (Experimental), 60 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 6.38, df = 5 (P = 0.27); I2 =22%
Test for overall effect: Z = 1.41 (P = 0.16)
6 Other
Campbell 2006 10/98 6/96 1.63 [ 0.62, 4.32 ]
Subtotal (95% CI) 98 96 1.63 [ 0.62, 4.32 ]
Total events: 10 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Chi2 = 4.87, df = 5 (P = 0.43), I2 =0.0%
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Analysis 11.3. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 3 Continued abstinence (Relapse prevention) in late pregnancy for
spontaneous quitters.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 3 Continued abstinence (Relapse prevention) in late pregnancy for spontaneous quitters
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Dornelas 2006 10/14 16/19 0.85 [ 0.58, 1.25 ]
Eades 2012 10/24 2/8 1.67 [ 0.46, 6.06 ]
Ershoff 1989 46/87 67/84 0.66 [ 0.53, 0.83 ]
Hajek 2001 72/111 68/128 1.22 [ 0.99, 1.51 ]
Lillington 1995 15/16 17/19 1.05 [ 0.86, 1.28 ]
Lowe 1997 37/52 25/45 1.28 [ 0.94, 1.75 ]
McBride 1999 225/259 110/137 1.08 [ 0.98, 1.19 ]
Pbert 2004 16/23 12/16 0.93 [ 0.63, 1.37 ]
Polanska 2004 38/38 23/23 1.00 [ 0.93, 1.07 ]
Secker-Walker 1994 31/85 31/80 0.94 [ 0.64, 1.39 ]
Secker-Walker 1998 28/44 33/48 0.93 [ 0.69, 1.24 ]
Thornton 1997 3/6 10/14 0.70 [ 0.29, 1.66 ]
2 Health education
Petersen 1992 37/71 42/78 0.97 [ 0.71, 1.31 ]
3 Social support
McBride 2004 84/104 85/107 1.02 [ 0.89, 1.16 ]
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Analysis 11.4. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 4 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Cinciripini 2000 2/42 3/40 0.63 [ 0.11, 3.60 ]
Cinciripini 2010 24/128 23/129 1.05 [ 0.63, 1.76 ]
Dunkley 1997 2/50 0/50 5.00 [ 0.25, 101.58 ]
El-Mohandes 2011 42/106 25/92 1.46 [ 0.97, 2.19 ]
Haug 1994 42/229 8/93 2.13 [ 1.04, 4.37 ]
Lawrence 2003 25/309 10/283 2.29 [ 1.12, 4.68 ]
Lillington 1995 4/16 2/18 2.25 [ 0.47, 10.69 ]
Mayer 1990 5/72 0/77 11.75 [ 0.66, 208.84 ]
McBride 1999 222/600 89/297 1.23 [ 1.01, 1.51 ]
McLeod 2004 17/106 9/82 1.46 [ 0.69, 3.11 ]
Messimer 1989 3/30 3/29 0.97 [ 0.21, 4.41 ]
Panjari 1999 54/339 47/393 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 1/18 0.69 [ 0.05, 10.36 ]
Polanska 2004 28/62 6/38 2.86 [ 1.31, 6.26 ]
Rigotti 2006 14/209 15/212 0.95 [ 0.47, 1.91 ]
Stotts 2002 14/134 14/135 1.01 [ 0.50, 2.03 ]
Thornton 1997 145/190 153/177 0.88 [ 0.80, 0.97 ]
Walsh 1997 13/127 1/125 12.80 [ 1.70, 96.35 ]
2 Health education
Hjalmarson 1991 70/444 19/209 1.73 [ 1.07, 2.80 ]
Petersen 1992 38/71 41/78 1.02 [ 0.75, 1.38 ]
Strecher 2000 94/104 79/87 1.00 [ 0.91, 1.09 ]
3 Incentives
Donatelle 2000 22/103 6/102 3.63 [ 1.54, 8.58 ]
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(. . . Continued)
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heil 2008 9/37 1/40 9.73 [ 1.29, 73.13 ]
4 Social support
Bullock 2009 16/124 17/126 0.96 [ 0.51, 1.81 ]
Hennrikus 2010 5/54 0/28 5.80 [ 0.33, 101.27 ]
McBride 2004 81/193 75/198 1.11 [ 0.87, 1.41 ]
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Analysis 11.5. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 5 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 5 Abstinence at 6 to 11 months postpartum
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Cinciripini 2010 9/128 12/129 0.76 [ 0.33, 1.73 ]
Dornelas 2006 5/53 2/52 2.45 [ 0.50, 12.08 ]
Gielen 1997 7/193 2/198 3.59 [ 0.76, 17.07 ]
Hajek 2001 9/315 9/312 0.99 [ 0.40, 2.46 ]
Haug 1994 35/229 10/93 1.42 [ 0.73, 2.75 ]
McBride 1999 172/600 77/297 1.11 [ 0.88, 1.39 ]
Panjari 1999 54/339 47/393 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 0/18 2.11 [ 0.09, 49.08 ]
Secker-Walker 1994 5/157 6/185 0.98 [ 0.31, 3.16 ]
0.01 0.1 1 10 100
Favours control Favours experimental
(Continued . . . )
333Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Stotts 2002 10/134 14/135 0.72 [ 0.33, 1.56 ]
2 Incentives
Heil 2008 3/37 1/40 3.24 [ 0.35, 29.82 ]
3 Social support
Albrecht 2006 4/45 7/50 0.63 [ 0.20, 2.03 ]
McBride 2004 71/193 65/198 1.12 [ 0.85, 1.47 ]
0.01 0.1 1 10 100
Favours control Favours experimental
Analysis 11.6. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 6 Abstinence at 12 to 17 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 6 Abstinence at 12 to 17 months postpartum
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Haug 1994 34/229 7/93 1.97 [ 0.91, 4.29 ]
McBride 1999 145/600 71/297 1.01 [ 0.79, 1.29 ]
Polanska 2004 22/69 5/40 2.55 [ 1.05, 6.21 ]
Secker-Walker 1998 21/142 12/149 1.84 [ 0.94, 3.59 ]
2 Social support
McBride 2004 68/193 57/198 1.22 [ 0.92, 1.64 ]
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Analysis 11.7. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 7 Abstinence at 18+ months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 7 Abstinence at 18+ months postpartum
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Lawrence 2003 14/309 7/283 1.83 [ 0.75, 4.47 ]
Secker-Walker 1994 7/157 10/185 0.82 [ 0.32, 2.12 ]
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Analysis 11.8. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 8 Smoking reduction: numbers of women reducing smoking in late
pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 8 Smoking reduction: numbers of women reducing smoking in late pregnancy
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Self-reported some reduction in smoking (various definitions)
Cope 2003 42/143 20/101 1.48 [ 0.93, 2.37 ]
Price 1991 37/123 10/70 2.11 [ 1.12, 3.97 ]
Reading 1982 10/39 7/26 0.95 [ 0.42, 2.18 ]
Valbo 1994 35/55 19/56 1.88 [ 1.24, 2.84 ]
Valbo 1996 22/52 24/78 1.38 [ 0.87, 2.18 ]
2 Self-reported > 50% reduction in smoking
Hartmann 1996 34/107 20/100 1.59 [ 0.98, 2.57 ]
Rigotti 2006 61/209 46/212 1.35 [ 0.97, 1.87 ]
Solomon 2000 29/77 29/74 0.96 [ 0.64, 1.44 ]
Windsor 2011 87/544 65/549 1.35 [ 1.00, 1.82 ]
3 Biochemically validated reduction
Cook 1995 6/23 4/20 1.30 [ 0.43, 3.97 ]
Gielen 1997 14/125 13/121 1.04 [ 0.51, 2.13 ]
Tappin 2005 14/347 26/409 0.63 [ 0.34, 1.20 ]
Tuten 2012 20/42 2/32 7.62 [ 1.92, 30.25 ]
Windsor 1985 31/205 7/104 2.25 [ 1.02, 4.93 ]
Windsor 1993 67/400 51/414 1.36 [ 0.97, 1.91 ]
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Analysis 11.9. Comparison 11 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 9 Smoking reduction: biochemical measures in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 9 Smoking reduction: biochemical measures in late pregnancy
Study or subgroup Treatment Control
Std.
Mean
Difference
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Mean cotinine levels
El-Mohandes 2011 106 146 (139.4) 92 131.9 (117.6) 0.11 [ -0.17, 0.39 ]
Panjari 1999 318 720 (688) 356 769 (735) -0.07 [ -0.22, 0.08 ]
Secker-Walker 1994 188 1208 (1384) 226 1228 (1612) -0.01 [ -0.21, 0.18 ]
Tappin 2005 290 113 (70) 364 117 (83) -0.05 [ -0.21, 0.10 ]
Tuten 2012 42 4 (5.5) 32 8.4 (4.2) -0.87 [ -1.36, -0.39 ]
2 Mean thiocynate level
Sexton 1984 380 2094 (1209) 389 2452 (1228) -0.29 [ -0.44, -0.15 ]
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Analysis 11.10. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 10 Smoking reduction: self-reported mean cigarettes per
day measured in late pregnancy or at delivery.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 10 Smoking reduction: self-reported mean cigarettes per day measured in late pregnancy or at delivery
Study or subgroup Treatment Control
Std.
Mean
Difference
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Counselling
Ershoff 1999 60 8.1 (8) 61 8 (8) 0.01 [ -0.34, 0.37 ]
Hartmann 1996 107 9.1 (6.5) 100 12.2 (6.5) -0.48 [ -0.75, -0.20 ]
Moore 2002 353 10.3 (5.6) 403 10.1 (5.4) 0.04 [ -0.11, 0.18 ]
Panjari 1999 284 8.7 (7.6) 326 11.5 (9.7) -0.32 [ -0.48, -0.16 ]
Pbert 2004 119 8 (6.5) 172 10.5 (6.5) -0.38 [ -0.62, -0.15 ]
Price 1991 71 4.3 (8.1) 70 2.3 (5.6) 0.29 [ -0.05, 0.62 ]
Secker-Walker 1998 135 10.2 (8.4) 141 11.5 (7.8) -0.16 [ -0.40, 0.08 ]
Sexton 1984 388 6.4 (8.7) 395 12.8 (11.5) -0.63 [ -0.77, -0.48 ]
Thornton 1997 196 10.4 (8.3) 191 12.5 (10.7) -0.22 [ -0.42, -0.02 ]
Valbo 1996 52 9.9 (5.4) 78 9 (4.4) 0.19 [ -0.17, 0.54 ]
Vilches 2009 9 0.11 (0.33) 54 5.36 (5.76) -0.97 [ -1.69, -0.24 ]
2 Health education
Donovan 1977 263 9.2 (9.7304) 289 16.4 (10.2) -0.72 [ -0.89, -0.55 ]
Hjalmarson 1991 444 10.7 (6.4) 209 10.6 (2.1999) 0.02 [ -0.15, 0.18 ]
Lilley 1986 66 13.1 (9.1) 69 16 (9.1) -0.32 [ -0.66, 0.02 ]
3 Feedback
LeFevre 1995 1768 14.5 (6.5) 1803 13 (6.5) 0.23 [ 0.16, 0.30 ]
Valbo 1994 54 8 (4.8) 50 11 (4.6) -0.63 [ -1.03, -0.24 ]
4 Incentives
Tuten 2012 42 8.7 (36.2921) 32 16.9 (32.8098) -0.23 [ -0.69, 0.23 ]
5 Social support
Belizan 1995 195 8.4 (8.1) 206 10.9 (12.5) -0.24 [ -0.43, -0.04 ]
Bullock 1995 29 6 (6.5) 35 5 (6.5) 0.15 [ -0.34, 0.64 ]
Olds 1986 77 13.39 (6.5) 64 16 (6.5) -0.40 [ -0.73, -0.06 ]
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Analysis 11.11. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 11 Low birthweight (under 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 11 Low birthweight (under 2500 g)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Ershoff 1989 9/118 15/109 3.4 % 0.55 [ 0.25, 1.21 ]
Hegaard 2003 12/327 10/320 3.1 % 1.17 [ 0.51, 2.68 ]
Panjari 1999 20/337 37/391 7.6 % 0.63 [ 0.37, 1.06 ]
Secker-Walker 1994 9/188 10/226 2.7 % 1.08 [ 0.45, 2.61 ]
Secker-Walker 1998 7/135 12/141 2.6 % 0.61 [ 0.25, 1.50 ]
Sexton 1984 31/463 42/472 10.5 % 0.75 [ 0.48, 1.18 ]
Tappin 2005 44/332 59/400 15.9 % 0.90 [ 0.63, 1.29 ]
Thornton 1997 19/190 15/190 5.0 % 1.27 [ 0.66, 2.42 ]
Subtotal (95% CI) 2090 2249 50.8 % 0.83 [ 0.68, 1.01 ]
Total events: 151 (Treatment), 200 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.61, df = 7 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.83 (P = 0.067)
2 Health education
Donovan 1977 26/263 26/289 7.8 % 1.10 [ 0.66, 1.84 ]
Hjalmarson 1991 14/422 11/198 3.5 % 0.60 [ 0.28, 1.29 ]
Subtotal (95% CI) 685 487 11.3 % 0.87 [ 0.49, 1.55 ]
Total events: 40 (Treatment), 37 (Control)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.66, df = 1 (P = 0.20); I2 =40%
Test for overall effect: Z = 0.47 (P = 0.64)
3 Feedback
Haddow 1991 99/1423 121/1425 32.1 % 0.82 [ 0.63, 1.06 ]
Subtotal (95% CI) 1423 1425 32.1 % 0.82 [ 0.63, 1.06 ]
Total events: 99 (Treatment), 121 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.53 (P = 0.13)
4 Incentives
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heil 2008 3/34 8/39 1.3 % 0.43 [ 0.12, 1.49 ]
Tuten 2012 6/30 9/21 2.8 % 0.47 [ 0.20, 1.11 ]
Subtotal (95% CI) 64 60 4.1 % 0.45 [ 0.22, 0.93 ]
Total events: 9 (Treatment), 17 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 2.17 (P = 0.030)
5 Social support
Malchodi 2003 5/36 6/43 1.7 % 1.00 [ 0.33, 2.99 ]
Subtotal (95% CI) 36 43 1.7 % 1.00 [ 0.33, 2.99 ]
Total events: 5 (Treatment), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
Total (95% CI) 4298 4264 100.0 % 0.82 [ 0.71, 0.94 ]
Total events: 304 (Treatment), 381 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 10.26, df = 13 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 2.76 (P = 0.0058)
Test for subgroup differences: Chi2 = 2.77, df = 4 (P = 0.60), I2 =0.0%
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Analysis 11.12. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 12 Very low birthweight (under 1500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 12 Very low birthweight (under 1500 g)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Sexton 1984 9/463 5/472 29.6 % 1.83 [ 0.62, 5.43 ]
Tappin 2005 6/331 8/400 31.7 % 0.91 [ 0.32, 2.59 ]
Subtotal (95% CI) 794 872 61.3 % 1.27 [ 0.60, 2.71 ]
Total events: 15 (Treatment), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.84, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 0.63 (P = 0.53)
2 Feedback
Haddow 1991 8/1343 9/1357 38.7 % 0.90 [ 0.35, 2.32 ]
Subtotal (95% CI) 1343 1357 38.7 % 0.90 [ 0.35, 2.32 ]
Total events: 8 (Treatment), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.82)
Total (95% CI) 2137 2229 100.0 % 1.11 [ 0.62, 2.01 ]
Total events: 23 (Treatment), 22 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.16, df = 2 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.72)
Test for subgroup differences: Chi2 = 0.32, df = 1 (P = 0.57), I2 =0.0%
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Analysis 11.13. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 13 Preterm birth (under 37 weeks).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 13 Preterm birth (under 37 weeks)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Ershoff 1989 7/118 7/109 2.5 % 0.92 [ 0.33, 2.55 ]
Hegaard 2003 7/334 10/330 2.9 % 0.69 [ 0.27, 1.80 ]
Panjari 1999 18/339 34/391 8.6 % 0.61 [ 0.35, 1.06 ]
Secker-Walker 1998 9/151 8/157 3.1 % 1.17 [ 0.46, 2.95 ]
Tappin 2000 5/48 4/49 1.7 % 1.28 [ 0.36, 4.47 ]
Tappin 2005 35/342 43/402 14.7 % 0.96 [ 0.63, 1.46 ]
Thornton 1997 14/209 8/209 3.6 % 1.75 [ 0.75, 4.08 ]
Walsh 1997 4/131 3/128 1.2 % 1.30 [ 0.30, 5.71 ]
Subtotal (95% CI) 1672 1775 38.2 % 0.93 [ 0.71, 1.20 ]
Total events: 99 (Treatment), 117 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.43, df = 7 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
2 Health education
Donovan 1977 16/263 17/289 6.0 % 1.03 [ 0.53, 2.00 ]
Hjalmarson 1991 13/421 8/197 3.5 % 0.76 [ 0.32, 1.80 ]
Subtotal (95% CI) 684 486 9.5 % 0.92 [ 0.55, 1.56 ]
Total events: 29 (Treatment), 25 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.77)
3 Feedback
Cope 2003 6/149 13/114 3.0 % 0.35 [ 0.14, 0.90 ]
Haddow 1991 109/1423 137/1425 45.2 % 0.80 [ 0.63, 1.01 ]
Subtotal (95% CI) 1572 1539 48.2 % 0.60 [ 0.28, 1.29 ]
Total events: 115 (Treatment), 150 (Control)
Heterogeneity: Tau2 = 0.21; Chi2 = 2.72, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.31 (P = 0.19)
4 Incentives
Heil 2008 3/34 9/39 1.7 % 0.38 [ 0.11, 1.30 ]
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Tuten 2012 5/30 6/21 2.4 % 0.58 [ 0.20, 1.66 ]
Subtotal (95% CI) 64 60 4.1 % 0.49 [ 0.22, 1.08 ]
Total events: 8 (Treatment), 15 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.27, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.77 (P = 0.077)
Total (95% CI) 3992 3860 100.0 % 0.82 [ 0.70, 0.96 ]
Total events: 251 (Treatment), 307 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 11.85, df = 13 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 2.42 (P = 0.015)
Test for subgroup differences: Chi2 = 3.17, df = 3 (P = 0.37), I2 =5%
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Analysis 11.14. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 14 Mean birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 14 Mean birthweight
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Counselling
Cook 1995 23 2961 (578) 20 2713 (578) 0.4 % 248.00 [ -98.36, 594.36 ]
Ershoff 1989 118 3366 (578) 109 3309 (578) 2.2 % 57.00 [ -93.50, 207.50 ]
Hegaard 2003 327 3401 (578) 320 3433 (578) 6.3 % -32.00 [ -121.08, 57.08 ]
Panjari 1999 337 3250 (526) 391 3166 (589) 7.6 % 84.00 [ 2.99, 165.01 ]
Polanska 2004 149 3104 (745) 144 3138 (1090) 1.1 % -34.00 [ -248.49, 180.49 ]
Secker-Walker 1994 279 3291 (468) 282 3255 (466) 8.3 % 36.00 [ -41.29, 113.29 ]
Secker-Walker 1998 135 3256 (452) 141 3221 (506) 3.9 % 35.00 [ -78.09, 148.09 ]
Sexton 1984 463 3278 (627) 472 3186 (566) 8.5 % 92.00 [ 15.39, 168.61 ]
Tappin 2000 48 3205 (578) 49 3271 (578) 0.9 % -66.00 [ -296.06, 164.06 ]
Tappin 2005 351 3078 (602) 411 3048 (642) 6.4 % 30.00 [ -58.42, 118.42 ]
Thornton 1997 380 3267 (624) 380 3266 (613) 6.4 % 1.00 [ -86.95, 88.95 ]
Vilches 2009 9 3398.89 (489.78) 54 3140.83 (375.12) 0.4 % 258.06 [ -77.20, 593.32 ]
Subtotal (95% CI) 2619 2773 52.5 % 39.93 [ 9.12, 70.74 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 10.57, df = 11 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 2.54 (P = 0.011)
2 Health education
Donovan 1977 263 3172 (567) 289 3184 (510) 6.1 % -12.00 [ -102.29, 78.29 ]
Hjalmarson 1991 422 3430 (578) 198 3359 (578) 5.2 % 71.00 [ -26.58, 168.58 ]
Subtotal (95% CI) 685 487 11.3 % 27.35 [ -53.88, 108.58 ]
Heterogeneity: Tau2 = 1143.82; Chi2 = 1.50, df = 1 (P = 0.22); I2 =33%
Test for overall effect: Z = 0.66 (P = 0.51)
3 Feedback
Cope 2003 78 3260 (578) 80 3080 (578) 1.5 % 180.00 [ -0.27, 360.27 ]
Haddow 1991 1423 3263 (542) 1425 3229 (537) 31.7 % 34.00 [ -5.63, 73.63 ]
Subtotal (95% CI) 1501 1505 33.3 % 79.43 [ -53.05, 211.91 ]
Heterogeneity: Tau2 = 6224.01; Chi2 = 2.40, df = 1 (P = 0.12); I2 =58%
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(. . . Continued)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 1.18 (P = 0.24)
4 Incentives
Heil 2008 34 3355 (560) 39 3102 (556) 0.8 % 253.00 [ -3.67, 509.67 ]
Tuten 2012 42 2863 (694) 32 2701 (598) 0.6 % 162.00 [ -132.93, 456.93 ]
Subtotal (95% CI) 76 71 1.3 % 213.78 [ 20.16, 407.40 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.21, df = 1 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 2.16 (P = 0.030)
5 Social support
Malchodi 2003 67 3100 (481) 75 3072 (614) 1.5 % 28.00 [ -152.48, 208.48 ]
Subtotal (95% CI) 67 75 1.5 % 28.00 [ -152.48, 208.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Total (95% CI) 4948 4911 100.0 % 40.78 [ 18.45, 63.10 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 17.95, df = 18 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 3.58 (P = 0.00034)
Test for subgroup differences: Chi2 = 3.49, df = 4 (P = 0.48), I2 =0.0%
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Analysis 11.15. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 15 Perinatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 15 Perinatal deaths
Study or subgroup Treatment Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Sexton 1984 14/463 13/472 1.10 [ 0.52, 2.31 ]
Valbo 1996 0/52 0/78 0.0 [ 0.0, 0.0 ]
Subtotal (95% CI) 515 550 1.10 [ 0.52, 2.31 ]
Total events: 14 (Treatment), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.0, df = 0 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.81)
2 Health education
Donovan 1977 4/263 1/289 4.40 [ 0.49, 39.08 ]
Subtotal (95% CI) 263 289 4.40 [ 0.49, 39.08 ]
Total events: 4 (Treatment), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
3 Feedback
Haddow 1991 23/1423 22/1425 1.05 [ 0.59, 1.87 ]
Subtotal (95% CI) 1423 1425 1.05 [ 0.59, 1.87 ]
Total events: 23 (Treatment), 22 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
Total (95% CI) 2201 2264 1.13 [ 0.72, 1.77 ]
Total events: 41 (Treatment), 36 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.56, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Chi2 = 1.56, df = 2 (P = 0.46), I2 =0.0%
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
346Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 11.16. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 16 Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 16 Stillbirths
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Ershoff 1989 2/126 1/116 3.9 % 1.84 [ 0.17, 20.04 ]
Sexton 1984 9/463 11/472 29.1 % 0.83 [ 0.35, 1.99 ]
Tappin 2000 1/48 0/49 2.2 % 3.06 [ 0.13, 73.34 ]
Tappin 2005 2/351 1/411 3.9 % 2.34 [ 0.21, 25.72 ]
Thornton 1997 2/209 1/209 3.9 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 1197 1257 42.9 % 1.14 [ 0.55, 2.33 ]
Total events: 16 (Treatment), 14 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.58, df = 4 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.73)
2 Feedback
Haddow 1991 21/1423 17/1425 54.9 % 1.24 [ 0.66, 2.33 ]
Valbo 1994 1/56 0/56 2.2 % 3.00 [ 0.12, 72.10 ]
Subtotal (95% CI) 1479 1481 57.1 % 1.28 [ 0.69, 2.39 ]
Total events: 22 (Treatment), 17 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.78 (P = 0.44)
Total (95% CI) 2676 2738 100.0 % 1.22 [ 0.76, 1.95 ]
Total events: 38 (Treatment), 31 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.93, df = 6 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Chi2 = 0.06, df = 1 (P = 0.81), I2 =0.0%
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Analysis 11.17. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 17 Neonatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 17 Neonatal deaths
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Sexton 1984 5/454 2/461 35.6 % 2.54 [ 0.50, 13.02 ]
Tappin 2005 1/351 1/411 12.4 % 1.17 [ 0.07, 18.65 ]
Thornton 1997 2/209 1/209 16.6 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 1014 1081 64.6 % 2.06 [ 0.61, 6.92 ]
Total events: 8 (Treatment), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.22, df = 2 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.17 (P = 0.24)
2 Feedback
Haddow 1991 2/1402 5/1408 35.4 % 0.40 [ 0.08, 2.07 ]
Subtotal (95% CI) 1402 1408 35.4 % 0.40 [ 0.08, 2.07 ]
Total events: 2 (Treatment), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
Total (95% CI) 2416 2489 100.0 % 1.15 [ 0.44, 3.06 ]
Total events: 10 (Treatment), 9 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.69, df = 3 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Chi2 = 2.47, df = 1 (P = 0.12), I2 =59%
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Analysis 11.18. Comparison 11 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 18 NICU admissions.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 18 NICU admissions
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Tappin 2005 32/351 53/411 47.6 % 0.71 [ 0.47, 1.07 ]
Thornton 1997 14/189 12/189 14.8 % 1.17 [ 0.55, 2.46 ]
Subtotal (95% CI) 540 600 62.4 % 0.82 [ 0.52, 1.29 ]
Total events: 46 (Treatment), 65 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.33, df = 1 (P = 0.25); I2 =25%
Test for overall effect: Z = 0.85 (P = 0.40)
2 Incentives
Heil 2008 4/34 6/39 5.9 % 0.76 [ 0.24, 2.49 ]
Tuten 2012 14/30 13/21 31.7 % 0.75 [ 0.45, 1.25 ]
Subtotal (95% CI) 64 60 37.6 % 0.76 [ 0.47, 1.21 ]
Total events: 18 (Treatment), 19 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.18 (P = 0.24)
Total (95% CI) 604 660 100.0 % 0.78 [ 0.59, 1.04 ]
Total events: 64 (Treatment), 84 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.36, df = 3 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.69 (P = 0.090)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.80), I2 =0.0%
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A D D I T I O N A L T A B L E S
Table 1. Primary outcomes from studies which met inclusion criteria, however outcomes were not able to be included in meta-
analysis
Study ID Main findings Rationale for not including outcomes in meta-analy-
sis
Byrd 1993 There was no statistically significant difference in smok-
ing status among those who received either type of media
or nurse counselling
Results could not be included as smoking cessation rates
were not reported by intervention group
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Table 1. Primary outcomes from studies which met inclusion criteria, however outcomes were not able to be included in meta-
analysis (Continued)
Graham 1992 There was no decrease in the rate of low birthweight for
women who received the intervention
Smoking outcomes were not reported. Birthweight out-
comes were not included in this review, as aspects other
than the smoking component of the intervention may
have had an effect on birthweight, and it is unclear how
many smokers were in each group, or what proportion
quit
Haug 2004 There was no significant difference in smoking between
the intervention (motivational enhancement therapy)
and control groups on self-reported cigarettes per day,
mean carbon monoxide or mean cotinine
Study reports actual outcome data for movement in
stages of change only. Outcome data for smoking cessa-
tion, cigarettes per day, carbon monoxide and cotinine
levels are not reported
Hiett 2000 Significantly more women were able to quit smoking
when enrolled in the intervention
Actual cessation rates not reported (poster abstract only
available)
Hughes 2000 There was no difference between intervention and con-
trol groups in mean delta stage of change or 12-month
rate of maintained cessation in pregnant women (-0.62
vs -0.65)
Data from intervention and control
Outcomes were combined for intervention and control
groups in pregnant women. Unable to extract numbers
Lowe 2002 At 1 month, 65% of behaviourally-based intervention
hospitals agreed to provide materials about smoking ces-
sation, compared to 3% control hospitals. After 1 year,
43% intervention hospitals still providedmaterials, com-
pared to 9% of control hospitals. McNemar’s Chi2 in-
dicates a statistically meaningful difference between the
proportion of intervention hospitals implementing the
program and the proportion of control hospitals imple-
menting the program (2 1 = 12, P = 0.0005)
Implementation data only included. No smoking cessa-
tion data provided
Manfredi 1999 Compared to controls, smokers attending family plan-
ning, prenatal and well-child clinics, exposed to the in-
tervention were more likely to have quit (14.5% vs 7.
7%)
It was not possible to separate out which data was related
to pregnantwomen, as opposed towomen recruited from
family planning and well child clinics. Further, it was not
clear at what stage in pregnancy women were recruited
and what the post-partum time points were
Moore 1998 There was no significant difference in LBW were 10.9%
in the intervention group and 14.0% in controls (RR =
0.75, 95% CI 0.55 to 1.03). Preterm births rates were
9.7 in the intervention group and 11.0 in the controls
(RR = 0.87, 95% CI 0.62 to 1.22)
Smoking outcomes were not reported. Birthweight and
preterm birth outcomes were not included in this review,
as aspects other than the smoking component of the in-
tervention may have had an effect on birthweight and
preterm births
Olds 2002 Significant reduction in mean cotinine among women
who smoked at baseline. Mean reduction of 12.32 ng/
mL in the control group, compared to as mean reduction
of 259.00 ng/mL in nurse-home visiting group
Study reports the mean cotinine reduction only, not mean
cotinine levels or smoking cessation rates. It is also un-
clear how many randomised women were included in
this analysis
CI: confidence interval
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LBW: low birthweight
RR: risk ratio
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Table 2. Cluster-randomised trial adjustment details (Continued)
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Table 2. Cluster-randomised trial adjustment details (Continued)
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